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ABSTRACT 
Patients’ And Practitioners’ Views And Experiences Of Chronic Widespread 
Pain (Fibromyalgia) And Its Management In The UK And Libya 
 
Background & Aims: Chronic widespread pain conditions such as fibromyalgia are 
prevalent and costly to the economy. Diagnosis is based upon symptoms, and although 
fibromyalgia’s existence as a distinct clinical entity is debated, it causes great suffering 
and distress for those affected. Due to the unclear pathophysiology, controversy 
regarding its existence as a clinical entity, and variability in diagnosis, clinical 
management is often difficult, and frequently employs heterogeneous interventions. In 
addition, there is a paucity of literature from Middle Eastern countries on the condition, 
where the diagnostic label is not used. The purpose of this research study is to capture 
service users’ and service providers’ views and experiences of fibromyalgia and its 
management, including their views on the journey to diagnosis, current practice 
availability, emotional and life experience, information seeking, and experiences of 
seeking and receiving health care. It also aims to compare current practice for 
fibromyalgia in the UK with Libyan management procedures for chronic widespread 
pain.  
Research Method: A mixed methods approach was used in a two-phase study. Phase 1 
consisted of twelve semi-structured interviews conducted with people diagnosed with 
FMS. The participants also completed the Fibromyalgia Impact Questionnaire (FIQ) 
and the Toronto Alexithymia Scale (TAS).  Phase 2 consisted of a national survey of 
health and medical professionals from the British Pain Society and medical 
professionals in Libya regarding their views of and management practices for 
fibromyalgia. Findings were synthesised with qualitative findings 
 
Results: Using framework analysis, the following themes were identified from the 
qualitative study: journey to diagnosis, coping with the varying and unpredictable nature 
of symptoms, emotional impact, and the availability and satisfaction with healthcare 
practices and services.   The primary qualitative study highlighted some difficulties that 
the participants faced regarding a perceived lack of understanding by health and medical 
professionals as well as the general public regarding the management of the condition 
and its emotional and physical impact on their lives. These findings suggested that the 
ii 
 
patients were not managing daily living activities due to the disabling fatigue and 
worsening pain. This was corroborated by high FIQ scores and high alexithymia scores. 
This part of the study has also illustrated that a variety of intervention approaches are 
used with varying and often limited success.  
A total of n=69 respondents completed the survey, n=53 UK respondents and n=15 
Libyan respondents The results indicated that increasing numbers of people are 
diagnosed with fibromyalgia, though a range of different diagnostic labels are used. 
Treatment approaches in both countries were primarily focused on exercise and 
education, with CBT being used in the UK. Respondents from both countries agreed 
that there was a strong psychological overlay, though there was a  variation  between 
opinions regarding whether active management should aggravate pain temporarily in 
order to increase functional gains. 
Conclusions: The results indicate the high physical and emotional impact of 
fibromyalgia.  The participants’ perspectives have emphasised the need for support for 
people living with FMS, and the need for education and standardisation of approaches 
in clinical practice in both the UK and Libya. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
CONTENTS 
ABSTRACT .................................................................................................... i 
CONTENTS .................................................................................................. iii 
List of Tables ............................................................................................... xi 
List of Figures ............................................................................................ xv 
List of Appendices .................................................................................. xviii 
ACKNOWLEDGEMENTS .......................................................................... xix 
DECLARATION .......................................................................................... xxi 
PREFACE .................................................................................................. xxii 
GLOSSARY OF TERMS .......................................................................... xxiv 
CHAPTER ONE ............................................................................................. 1 
1.1 Introduction ........................................................................................... 2 
1.2. Research Methodology ........................................................................ 4 
1.3. Operational Definitions ........................................................................ 5 
1.4 Review of Background Literature .......................................................... 5 
1.4.1 Fibromyalgia Syndrome: An overview ............................................... 5 
1.4.2. Epidemiology of FMS ........................................................................ 7 
1.4.3. Diagnosis of FMS ............................................................................. 8 
1.4.3.1. ACR Criteria ............................................................................... 9 
1.4.3.2. WPI/SS Test Scores ................................................................. 10 
1.4.3.3. Labelling of FMS....................................................................... 11 
1.4.4. Etiology and Pathophysiology of FMS ......................................... 12 
1.4. 5. Co-morbid Factors of FMS ............................................................ 13 
1.4.6. Central Nervous System (CNS) Sensitization in FMS ..................... 14 
1.4. 7. The Neuroendocrine System and FMS .......................................... 14 
iv 
 
1.4.8. Autonomic Nervous System (ANS) and FMS .................................. 16 
1.4.9. Sleep Disturbance in FMS ........................................................... 16 
1.4.10. Genetic Factors in FMS ............................................................. 17 
1.411. Environmental Trigger Factors in FMS ....................................... 17 
1.4.12. Management and Treatment Approaches of FMS ..................... 18 
1.4.13. Pharmacological Approaches to FMS ........................................ 19 
1.4.14. Pain-treating Drugs in FMS ....................................................... 20 
1.4.15.  Multidimensional Approach to Management ............................. 22 
1.4.16. Cognitive Behaviour Therapy (CBT) .......................................... 23 
1.4.17.  Physical Therapy Approaches and Exercise Rehabilitation ...... 24 
1.4.18. Massage Therapy (MT) ............................................................. 26 
1.4.19. Spa Treatment ........................................................................... 27 
1.4.20. Coping Strategies in FMS .......................................................... 27 
1.4.21. Reduction of Stress ................................................................... 28 
1.4.22. Communication.......................................................................... 28 
1.4.23. Assessing the Impact of Fibromyalgia in Patients’ Daily Living. 29 
1.4.24. Patients’ Experiences of FMS. .................................................. 29 
1.4.25. Experiences of Being Diagnosed of FMS .................................. 30 
1.4.26. Patient Education. ..................................................................... 31 
1.4.27. Emotional Factors in FMS: Alexithymia ..................................... 32 
1.4.28. Etiology of Alexithymia ............................................................... 33 
1.4.29. Treatment of Alexithymia ........................................................... 34 
1.4.30. Conclusion .................................................................................... 35 
1.4.31 Aims and Objectives ....................................................................... 35 
1.4.32. Aims of the First Phase:  Interview Study .................................. 36 
1.4.33 Aims of the Second Phase: Survey Study .................................. 36 
v 
 
1.5. Thesis outline ................................................................................... 37 
CHAPTER TWO: RESEARCH METHODOLOGY ....................................... 40 
2. Introduction ............................................................................................ 41 
2.1. Aims of the Study ............................................................................... 41 
The overall aims of the study correspond to the study phases and are as 
follows: ...................................................................................................... 41 
2.2.Methodology ....................................................................................... 41 
2.3.Ethical Considerations ........................................................................ 42 
2.4. Research Perspective and Philosophy .............................................. 42 
2.5. Pragmatism ....................................................................................... 43 
2.6. Mixed Methods Theory and Practice ................................................. 43 
2.6.1. Qualitative Sampling .................................................................... 46 
2.6.2. The Qualitative Interviews with Stakeholders (Phase 1) .............. 46 
2.6.3 Analysis of Qualitative Data (Framework Analysis). ..................... 48 
2.7. Medical Research Council Framework .............................................. 49 
2.8. The Survey (Phase 2) ........................................................................ 50 
CHAPTER THREE ....................................................................................... 52 
3. INTRODUCTION ................................................................................... 53 
3.1 Background ....................................................................................... 53 
3.2.1 Experiences of living with Fibromyalgia .................................. 61 
3.2.2. Emotional Aspects of Fibromyalgia ......................................... 64 
3. 3 Aims: ................................................................................................. 67 
3.4 Methods ............................................................................................. 67 
3.4.1 Design and sampling ................................................................. 67 
3.4.2. Data collection ........................................................................... 69 
3.4.3. Schedule of semi-structured interview .................................... 69 
vi 
 
3.4.4. Data Analysis ............................................................................. 70 
3.4.5. Familiarisation ........................................................................... 71 
3.4.6. Thematic framework .................................................................. 72 
3.5. Findings ............................................................................................ 75 
3.5.1. Journey of Diagnosis ................................................................ 75 
3.5.2. Coping with variability and unpredictability of symptoms .... 82 
3.5.3. The availability and satisfaction with current healthcare 
practices and services ........................................................................ 90 
3.5.4 Emotional Influences ................................................................. 99 
3.6 Fibromyalgia Impact Questionnaire........................................... 106 
3.7 Toronto Alexithymia scale (TAS) ............................................... 107 
3.8 summary of key findings ................................................................. 108 
3.9 Discussion ....................................................................................... 108 
3.10 Conclusion ..................................................................................... 117 
CHAPTER FOUR ...................................................................................... 118 
4.1 Introduction ....................................................................................... 119 
4.1.1 Section A: United Kingdom Fibromyalgia Survey .......................... 119 
4.2 Aims .................................................................................................. 122 
4.3 Pilot study ......................................................................................... 122 
4.4 Methods ............................................................................................ 122 
4.4.1 Design of the questionnaire ........................................................ 122 
4.4.2 Ethical approval .......................................................................... 123 
4.4.3 Participants ................................................................................. 123 
4.4.4 Sample recruitment .................................................................... 124 
4.4.5 Design of the survey ................................................................... 125 
4.4.6 Data collection procedure ........................................................... 125 
vii 
 
4.4.7 Validity and reliability .................................................................. 126 
4.5 Data Analysis .................................................................................... 126 
4.6 Results .............................................................................................. 126 
4.6.1 Number of respondents ........................................................... 126 
4.6.2 Demographic data .................................................................... 127 
4.6.3 Diagnosis .................................................................................. 129 
4.6.4 Symptoms and functional activity .......................................... 138 
4.6.5 Clinical features ........................................................................ 141 
4.6.6 Primary symptoms: pain assessment and measurement ..... 143 
4.6.7 Pharmacological approaches: medication prescribed to patients 
with FMS ............................................................................................. 146 
4.6.8 Non-pharmacological interventional approaches ................. 148 
4.6.9. The use of a specific management programme by HCPs for FMS
 ............................................................................................................ 149 
4.6.10 Aims of fibromyalgia rehabilitation programmes ................ 152 
4.6.11 Clinicians’ attitudes and opinions ........................................ 153 
4.7 Section B: Fibromyalgia survey (Libyan) .......................................... 154 
4.7.1 Data collection ............................................................................ 154 
4.7.2 Data analysis .............................................................................. 154 
4.7.2.2. Diagnosis ................................................................................ 157 
4.7.2.3 Symptoms and functional activity ............................................ 165 
4.7.2.4. Clinical features ...................................................................... 168 
4.7.2.5 Primary symptoms: pain assessment and measurement ........ 169 
4.7.2.6 Pharmacological approaches: medication prescribed to patients 
with fibromyalgia .................................................................................. 170 
4.7.2.7 Non-pharmacological interventional approaches ..................... 172 
4.7 2.7 The use of a specific management programme for fibromyalgia173 
viii 
 
4.7.2.9 Clinicians’ attitudes and opinions ............................................ 175 
4.7.2.11 Descriptive comparison between the two groups (UK and 
Libyan HCPs) regarding the number of patients HCPs see each month.
 ............................................................................................................ 176 
4.7.2.12 Descriptive comparison between the two groups on referral 
sources............................................................................................... 177 
4.7.2.13 Comparison between the two groups on specific management 
programmes (SMP) for FM see table 4.7.29 ....................................... 177 
4.7.2.14 Comparison between UK and Libyan respondents’ answers on 
pharmacological management programmes. ...................................... 177 
4.7.2.15:  Descriptive comparison of the attitudes and opinions of UK and 
Libyan respondents. ............................................................................ 178 
4.8 Discussion ........................................................................................ 178 
4.8.1 Diagnosis and referral ................................................................ 179 
4.8.2 Symptoms and clinical features .................................................. 181 
4.8.3 Pain assessment and measurement .......................................... 182 
4.8.4. Pharmacological approaches: Medication prescribed to patients with 
fibromyalgia ......................................................................................... 183 
4.8.5 Non-pharmacological interventional approaches ........................ 184 
4.8.6 Clinicians’ attitudes and opinions .......................................... 185 
4.9. Summary of key findings of the survey .................................... 185 
4.10. Conclusions ............................................................................... 186 
Chapter Five: General Discussion, And Conclusions .......................... 188 
5.1 Introduction ........................................................................................ 189 
5.2 Aims of the Study.............................................................................. 189 
5.3 Original Contribution to Knowledge .................................................. 189 
5.4 Synthesis of Main Findings. .............................................................. 190 
5.4.1 Diagnosis and the Journey to Diagnosis. ....................................... 190 
ix 
 
5.4.2 Variability and Unpredictability of Symptoms ................................. 191 
5.4.3 Experience of Available Interventions and Management of Symptoms
 ............................................................................................................... 191 
5.4.4 Emotional Experience and Expression .......................................... 192 
5.4.5 Lack of Understanding ................................................................... 193 
5.4.6 Role of Self-Management .............................................................. 194 
5.4.7 Conclusion ..................................................................................... 194 
Chapter Six: Future Research and Recommendations ........................ 197 
1.1 Introduction ................................................................................... 198 
6.2 Future Research ............................................................................... 198 
6.2 Recommendations for Policy and Practice ....................................... 198 
6.3 Limitations ........................................................................................ 199 
6.9 Reflections of Undertaking the Study. ............................................... 200 
REFERENCES .......................................................................................... 203 
References................................................................................................ 204 
Appendices............................................................................................... 223 
APPENDIX 1.............................................................................................. 224 
APPENDIX 2.............................................................................................. 243 
APPENDIX 3.............................................................................................. 247 
APPENDIX 4.............................................................................................. 249 
APPENDIX 5.............................................................................................. 252 
APPENDIX 6.............................................................................................. 255 
APPENDIX 7.............................................................................................. 259 
APPENDIX 8.............................................................................................. 264 
APPENDIX 9.............................................................................................. 267 
APPENDIX 10 ............................................................................................ 270 
x 
 
APPENDIX 11 ............................................................................................ 278 
APPENDIX 12 ............................................................................................ 288 
APPENDIX 13 ............................................................................................ 291 
APPENDIX 14 ............................................................................................ 294 
APPENDIX 15 ............................................................................................ 298 
APPENDIX 16 ............................................................................................ 313 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xi 
 
List of Tables  
Tables  
Table 1.1: The Main And The Associated Symptoms Of The FMS Disease 6 
Table 1. 2: Main Associated Symptoms Of FMS Disease. 11 
Table 1. 3: Recommendations For Management Of FMS 22 
Table 3. 1: Show The Search Teams To Identify Existing Literature Review. 55 
Table 3.2. Inclusion and Exclusion Criteria 55 
Table 3.3: Characteristics of Qualitative Studies Located During The Literature 
Search 
57-59 
Table 3. 4: Interview Timetable. 68 
Table 3. 5: Characteristics Of Participants. 69 
Table3. 6:  Interview Guide. 70 
Table.3 7: Total FIQ score.    106 
Table 3.8:  The participants’ scores on the “difficulty describing feelings” category 107 
Table 3 9: The participants’ scores on the “difficulty identifying feeling” category 107 
Table 3. 10: The participants’ scores on the “externally oriented thinking” category 107 
Table 3. 11: The total scores and the average score of the sample 108 
Table 4 1: Response Rate 126 
Table 4. 2: Analysis Of Respondents By Region 127 
Table 4.3: Professional Specialties Of Respondents 128 
Table 4. 4: Clinical Settings In Which The Respondents Worked 129 
Table 4. 5: Proportion Of Patients Fitting The Description Of Fibromyalgia 130 
Table4.6: Number Of New Patients Fitting The Description Of Fibromyalgia In 
Last 12 Months               
 
131 
Table 4. 7: Proportion Of Patients Having A Diagnosis Of Fibromyalgia 132 
Table 4. 8: The Median Response For Patients Referred By Each Healthcare 
Source 
133 
 
xii 
 
Table 4. 9: How The Referral Of Patients With Fibromyalgia Is Best Described 133 
Table 4.10: Responses Regarding Whether Patients Were Considered To Have 
Fibromyalgia Only 
 
134 
Table 4.11: Patients Considered To Have Co-Morbid Conditions 135 
Table 4.12: Patients Considered To Have Fibromyalgia Under Other Diagnostic 
Labels 
 
136 
Table 4.13: Patients Seen Under Other Diagnostic Labels 137 
Table 4.14: Patients Showing An Increase In Pain As A Result Of An Increase In 
The Level Of Physical Activity 
 
139 
Table 4.15: Patients Using Assisted Equipment (E.G. Walking Aids) 140 
Table 4.16: Daily Living Aspects/Activities Most Affected By Fibromyalgia 141 
Table 4. 17:  Median Responses For Frequency Of Clinical Features Presented By 
Patients 
 
142 
Table 4. 18: Most Important Clinical Features To Patients 142 
Table 4.19:  Measurement Of Pain Intensity 143 
Table 4. 20: Measurement Of Pain Dimensions Other Than Its Intensity. 144 
Table 4.21: Use Of Standardised Assessment Scales Or Measures For 
Fibromyalgia Patients 
 
145 
Table 4. 22: Use Of Standardised Assessment Measures 145 
Table 4.23: Medications Prescribed To Patients With Fibromyalgia 146 
Table 4.24: Patients Presenting With Medications Specifically For Their 
Symptoms. 
147 
Table 4.25: Median Responses For Use Of Non-Pharmacological Interventional 
Approaches 
 
148 
Table 4.26:  Use Of A Specific Management Programme For Fibromyalgia 149 
Table 4.27: Frequency Of Prescribing Specific Management Programmes For 
Fibromyalgia  
 
150 
Table 4. 28: Responsivity Of Fibromyalgia Patients To Interventional Approaches 151 
xiii 
 
Table 4. 29: Breakdown of the reported aims of rehabilitation programmes 152 
Table 4.30: Median Responses To Attitudinal Questions 154 
Table 4.7. 1: Breakdown Of Respondents By City 154 
Table 4.7.2: Professional Specialties Of The Respondents 155 
Table 4.7.3: Clinical Settings Of The Respondents 156 
Table 4.7.4: Proportion Of Respondents Who Saw Patients Fitting Description Of 
Fibromyalgia 
 
157 
Table 4.7.5: Number Of New Fibromyalgia Patients Attending The Respondents’ 
Clinics In The Last 12 Months 
 
158 
Table 4.7.6: Proportion Of Patients Who Had A Diagnosis Of Fibromyalgia 159 
Table 4.7.7: The Median Response For Patients’ Referral Sources 160 
Table 4.7. 8:How Referral Of Patients With Fibromyalgia Is Best Described 161 
Table 4.7. 9: Proportion Of Patients Considered By Respondents To As Have 
Fibromyalgia Only 
 
162 
Table 4.7. 10: Patients Considered As Having Co-Morbid Conditions 162 
Table 4.7.11: Patients Considered By Respondents To Have Fibromyalgia Under 
Other Diagnostic Labels 
 
163 
Table 4.7. 12: Patients Seen Under Other Diagnostic Labels 164 
Table 4.7.13: Extent To Which Patients Showed An Increase In Pain As A Result 
Of An Increase In The Level Of Physical Activity 
165 
Table 4.7.14: Patients Using Assisted Equipment (E.G. Walking Aid) 166 
Table 4.7.15: Daily Living Aspects/Activities Most Affected By Fibromyalgia 167 
Table 4.7.16: Median Responses For Frequency Of Clinical Features Presented By 
Patients 
 
168 
Table 4.7.17: Most Important Clinical Features To Fibromyalgia Patients 169 
Table 4.7.18: Measurement Methods Of Pain Intensity 170 
Table 4.7. 19: Medications Prescribed To Patients With Fibromyalgia 171 
xiv 
 
Table 4.7.20: Patients Presenting With Medications Specifically For Their 
Symptoms 
 
172 
Table 4.7.21: Median Responses For The Use Of Non-Pharmacological 
Interventional Approaches 
173 
Table 4.7. 22: Use Of A Specific Management Programme For Fibromyalgia 173 
Table 4.7.23: Views Of The Respondents On The Responsivity Of Fibromyalgia 
Patients To Interventional Approaches 
 
174 
Table 4.7. 24: Aims Of A Fibromyalgia Rehabilitation Programme 175 
Table 4.7. 25: Median Responses To Attitudinal Questions 176 
Table 4.7.26 the number of participants/respondents 176 
Table 4.7.27:Number Of New Patients Seen Each Month (UK and Libyan 
Samples) 
176 
Table 4.7.28: Comparison Between UK And Libyan HCPs’ Responses On 
Patients’ Referral Sources 
 
177 
Table 4.7.29: Comparison Between UK And Libyan Respondents’ Answers On 
Specific Management Programmes 
 
177 
Table 4.7.30 Comparison between UK and Libyan respondents’ answers on 
pharmacological management programmes. 
177 
Table 4.7.31: Descriptive comparison of the attitudes and opinions of UK and 
Libyan respondents’. 
178 
 
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
xv 
 
List of Figures 
Figures: Introduction And Review Of Background Literature  
Figure 1. 1The tender points based on the 1990 ACR criteria for FMS 
diagnosis. The red dots indicate the 18 tender points. 
 
10 
Figures: Chapter Two: Research Methodology  
Figure 2.1 Convergent parallel design of the thesis, 45 
Figures:  
Figure 3. 1: Initial thoughts following familiarisation. 72 
Figure 3.2 Indexed thematic framework 74 
Figure 3.3: Development of the ‘Journey to diagnosis’ theme 77 
Figure 3. 4: Development of the ‘Coping with the variability and 
unpredictability of symptoms’ theme 
 
86 
Figure 3. 5: Development of: the ‘patients views, regarding availability and 
satisfaction with current healthcare practices and services’ theme 
 
94 
Figure 3. 6: Developing of the ‘Emotional aspects ‘theme 102 
Figures: section A survey  
Figure 4. 1: Analysis of respondents by region 127 
Figure 4. 2: Division of respondents according to their professional specialty 128 
Figure 4. 3: Clinical settings in which the respondents worked 129 
Figure 4. 4: Proportion of patients fitting the description of fibromyalgia 130 
Figure 4. 5: Number of new patients fitting the description of fibromyalgia in 
last 12 months 
 
131 
Figure 4. 6 Proportion of patients having a diagnosis of fibromyalgia 132 
Figure 4. 7: How the referral of patients with fibromyalgia is best described 133 
Figure 4.8: Responses regarding whether patients were considered to have 
fibromyalgia only 
135 
Figure 4.9: Patients considered to have co-morbid conditions 136 
 
xvi 
 
Figure 4.10: Patients considered having fibromyalgia under other diagnostic 
labels 
137 
Figure 4. 11: Patients seen under other diagnostic labels 138 
Figure 4.12: Patients showing an increase in pain resulting from an increase 
in the level of physical activity 
139 
Figure 4. 13: Patients using assisted equipment (e.g. walking aids) 140 
Figure 4.14: Daily living aspects/activities most affected by fibromyalgia 141 
Figure 4. 15: Most important clinical features to patients 143 
Figure 4. 16: Measurement of pain intensity 144 
Figure 4.17: Use of standardised assessment measures 146 
Figure 4. 18: Medication prescribed to patients with fibromyalgia 147 
Figure 4. 19: Patients presenting with medications specifically for their 
symptoms 
148 
Figure 4.20: Use of a specific management programme for fibromyalgia 150 
Figure 4. 21: Frequency of prescribing specific management programmes for 
fibromyalgia 
151 
Figure 5. 22: Responsivity of fibromyalgia patients to interventional 
approaches 
152 
Figure 4. 23: The reported aims of fibromyalgia rehabilitation programmes 153 
Figures: section B survey  
Figure 4.7.1: Breakdown of respondents by city 155 
Figure 4.7.2: Respondents per professional specialty 156 
Figure 4.7. 3: Clinical settings of the respondents 157 
Figure 4.7. 4: Proportion of respondents who saw patients fitting description 
of fibromyalgia  
 
158 
Figure 4.7.5: Number of new fibromyalgia patients attending the 
respondents’ clinics in the last 12 months 
159 
Figure 4.7.6: Proportion of patients who had a diagnosis of fibromyalgia 160 
Figure 4.7. 7: How referral of patients with fibromyalgia is best described 161 
xvii 
 
Figure 4.7. 8: Proportion of patients considered as having fibromyalgia only 162 
Figure 4.7. 9: Patients considered as having co-morbid conditions 163 
Figure 4.7.10: Patients considered by respondents to have fibromyalgia under 
other diagnostic labels 
164 
Figure 4.7.11: Patients seen under other diagnostic labels 165 
Figure 4.7 . 12: Extent to which patients showed an increase in pain as a 
result of an increase in the level of physical activity 
166 
Figure 4.7.13:Patients using assisted equipment (e.g. walking aid) 167 
Figure 4.7. 14: Daily living aspects/activities most affected by fibromyalgia 168 
Figure 4.7. 15: Most important clinical features to fibromyalgia patients 169 
Figure 4.7.16: Measurement methods of pain intensity 170 
Figure 4.7. 17: Medication prescribed to patients with fibromyalgia 171 
Figure 4.7.18: Patients presenting with medications specifically for their 
symptoms 
172 
Figure 4.7.19: Use of a specific management programme for fibromyalgia 174 
Figure 4.7.20: Views of the respondents on the responsivity of fibromyalgia 
patients to interventional approaches 
175 
 
 
 
 
 
 
 
 
 
 
 
 
 
xviii 
 
List of Appendices 
Appendix 1: Research Outputs 
Appendix 2 Conformation Letter Of Ethical Approval 
Appendix3 Fibromyalgia Support Group agreement letter 
Appendix 4  Invitation Letter for Interview Phase 1 of the Study   
Appendix 5 Patients consent form to participate in the phase 1 study  
Appendix 6 Interview Schedule for fibromyalgia patients interviews, phase 1 
Appendix 7 Participations information sheet interviews, phase 1 
Appendix 8 Fibromyalgia Impact Questionnaire 
Appendix 9 Self-report measurements Sheet Toronto  Alexithymia Scale 
(TAS) 
Appendix 10 Sample of transcript Fibromyalgia patient’s transcript from 
study 
Appendix 11 Agreement To Use Mailing Labels For Marketing Purposes 
(British Pain Society) 
Appendix 12 Recruitment Letter phase 2 Invitation Letter 
Appendix 13  Consent Form phase 2 
Appendix 14 Participations Information Sheet phase 2 
Appendix 15 Fibromyalgia Questionnaire, for phase 2   
Appendix 16 FIQ Results 
 
 
 
 
 
 
 
 
 
 
 
xix 
 
ACKNOWLEDGEMENTS 
First, all praise be to Allah the Almighty, for grating me the patience, courage and 
strength to complete my PhD study and for blessing me with loving and caring family, 
friends and colleagues, who have been such a great support in both my personal and 
educational life. Secondly, I would like to seize this opportunity to express my deepest 
gratitude to my supervisors. In particular, I would like to sincerely thank Professor 
Nicola Adams for giving me the opportunity to undertake this project, and for her 
valuable advice, support, attention and encouragement. Her incredible ideas have 
contributed significantly to the success of this research. I would also like to express my 
warm thanks to Dr Paul Davis who provided me with valuable support in the earlier 
stages of this research, and to Dr Jenni Monaghan for her patience, effort, suggestions, 
and the endless encouragement and support that she provided me with throughout my 
PhD research, and without whom I would not have been able to complete this research. 
Since joining my supervision team, both Dr Davis and Dr Monaghan consistently 
provided great help and support, particularly during the process of interpreting the 
results.   
I would also like to thank the members of British Pain Society and Libyan healthcare 
professionals who participated in my research study. In addition, I would like to thank 
all members of the fibromyalgia support group who give up their valuable time to be 
interviewed, and for giving me the opportunity to explore their experiences. Listening 
to them was very inspirational, and I thoroughly enjoyed meeting them. 
My acknowledgements would not be complete without thanking the biggest source of 
my strength, my family. I would like to sincerely thank my father, brothers, sisters, 
nephew, and nieces for their emotional support. I would like to dedicate this work to 
my beloved mother, who constantly prayed for my success.  Acknowledging them is 
the least I can do to show my appreciation to their invaluable support.  
With the whole of my heart, I would especially like to express my gratitude and 
gratefulness to my wife, for being around me throughout all the ups and downs I have 
been through. I would also like to extend my sincere appreciation to my wonderful 
daughters', Hana, Silma and my lovely, youngest daughter Saja, for their heartfelt 
xx 
 
support in my journey towards obtaining this degree. I wish them all the happiness and 
success in the world. 
Finally, I would like to thank the staff of the Sport, Exercise and Rehabilitation 
Department, who were so helpful and cooperative at all times, helped me achieve my 
goal. I would also like to thank my friends, Dr Mohamed Dabashi, Mr Ahmad 
Alhashmi and Mr Abdullatif Zouak, for putting up with me in my difficult moments, 
and for encouraging me to pursue my dream of obtaining this degree. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxi 
 
 
DECLARATION  
 
I declare that the work contained in this thesis has not been submitted for any other 
award, and that all of the work is my own. I also confirm that all work ideas, 
contributions and opinions are fully acknowledged within this thesis.  
Any ethical clearance for the research presented in this thesis has been approved. 
Ethical approval was sought and granted by the Department of Sport, Exercise and 
Rehabilitation Ethics Committee, Faculty of Health and Life Sciences, in May 2015 
and February 2016 (HLSSA300415). 
 
 
 
 
 
Name:              Sedik Abokdeer  
Signature:              Sedik 
Date:       10     /       06      /2019 
 
 
 
 
 
 
 
 
 
xxii 
 
 
PREFACE  
Personal background, influences and beliefs 
My interest in the area of chronic pain musculoskeletal disorders and such conditions 
as chronic low back pain CLBP and fibromyalgia began as I was nearing the end of my 
BSc in physiotherapy in the Faculty of Medical Technology at Nasser University. Libya 
1997. For my dissertation, I had chosen the title of an acupuncture approach for the 
management of chronic low back pain. I then continued my studies to MSc in the UK, 
at Northumbria University Faculty of Health and Life Sciences where I undertook a 
systematic review for my dissertation into the management of chronic low back pain. 
Following my graduation in 2005 from Northumbria University, I then proceeded to 
work in Libyan Health Authority public sector for 10 years in the area of 
musculoskeletal interventions. In 2007, I began work as physiotherapy lecturer in Libya 
and endeavoured to teach physiotherapy elements, practice and neuro- management and 
I have been mindful of responsiveness of model of health within physiotherapy and 
wider health care provision. Continuing to Ph.D. level, I became interested in chronic 
widespread pain CWP such as Fibromyalgia FMS as from my clinical work, I observed 
interactions between these conditions and CLBP and Neck pain. I became interested in 
research in this broader area of CWP assessing, screening and interventions approaches. 
In addition to my clinical and research interests, in my personal life, around 2007, my 
mother was living with chronic pain with unrefreshed sleeping and depression treated 
by anti-depression (Amitriptyline), unclear instruction been established to diagnose her 
illness. Fibromyalgia and CWP is not generally diagnosed in Libya and this furthered 
my interest in this condition as it is recognised and diagnosed in Western countries. I 
realised that when I had read about this illness and who is affected her daily live 
activates and communications, I wanted to develop this area of research further. In 
regard to my background as physiotherapist, my aim was to know more about this 
condition and how it affected people who suffer these symptoms. From reading the 
research data, I found that there is also some variability in the UK and Western countries 
regarding diagnosis, experiences of healthcare. Initially I wanted to carry out a clinical 
trial, however this proved too difficult for several reasons and it was difficult to establish 
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a suitable control and standard care is not clearly defined and I then decided to first of 
all establish what this was in the UK and then to explore stakeholders views. Thus my 
clinical, academic and personal background has influenced this research from its 
inception to the data collection. 
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1.1 Introduction 
Chronic widespread musculoskeletal pain conditions (CWP), such as fibromyalgia 
(FMS)  are prevalent and costly to the economy (Hauser et al., 2009), with a higher 
proportion of females affected (Sim and Adams., 2002). Although well recognised, 
fibromyalgia is also a rather controversial syndrome, for which there are broadly 
accepted. Diagnostic criteria recognised and defined by the American College of 
Rheumatology 1990 where the operational diagnostic criteria are a chronic widespread 
pain (CWP) defined as pain in all four quadrants of the body, and pain in the axial 
skeleton for at least 3 months  (Wolfe et al., 2010). Fibromyalgia is a multifactorial 
syndrome and is characterised by widespread pain and muscle tenderness, 
accompanied by debilitating fatigue and other comorbid symptoms, including 
psychological factors (Wolfe et al., 2010). Thus, diagnosis is based upon symptoms, 
and although fibromyalgia’s existence as a distinct clinical entity is debated, it is 
accepted that the syndrome causes great suffering and distress for those affected, 
impacting both the affected individuals and their families. Fibromyalgia  i s  costly 
to society, and places heavy demands and significant burden on the medical system. 
It has no specific diagnostic test and there is no ‘cure’ per se.  It is widely reported 
within the western world, though prevalence varies, due to differing diagnostic 
practices. The condition is also reported in Middle Eastern countries, however the 
specific diagnosis of ‘fibromyalgia’ is not widely used. There is a paucity of literature 
regarding the diagnosis and management of the condition in the Middle East, and this 
will also be investigated in the current study, due to the professional background and 
experience of the researcher. 
Affected individuals experience poor physical and social functioning and considerable 
distress. However, despite this, the condition is not well understood in terms of its 
pathophysiology. The aetiology is uncertain, but it is likely that the pathophysiology 
of FMS has both physical and psychosocial components. 
Some studies have suggested an aetiological and perpetuating role of stress 
mechanisms involving the HPA axis  (Abeles et al., 2007). Furthermore, it has been 
pointed out that the pathophysiology of FMS is complex and evolving, encompassing 
diverse issues such as disturbed patterns of sleep, altered cognitive impairment 
processing, decreased conditioned pain modulation at the spinal level, and increased 
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connectivity between various pain-processing areas of the brain. Depression and anxiety 
and the role of emotional processing have also been found to be important factors with 
the role of alexithymia and psychological distress implicated in the pain experience in 
FMS (Di Tella et al., 2017)The role of emotional factors will also be explored in this 
thesis. 
Most clinicians realise that fibromyalgia is difficult to treat. Thus, consequent clinical 
management is often difficult, with heterogeneous interventions being employed,  which 
can have variable outcomes. In the UK, it is difficult to ascertain what the standard care 
for FMS is and thus there are few UK based RCTs.  As such, one aim of this research 
was define current practice within the UK, which is reported in chapter 5, upon which a 
future RCT could be designed and developed. Extant management approaches in Libya 
will also be explored and comparisons will be drawn. 
Patients with FMS  often report considerable dissatisfaction with existing services, 
which are often patchy and unavailable to this group (Hardy-Pickering ), who found 
that many patients became frustrated with the lack of success of conventional 
treatments and accessed complementary or alternative medicine (CAM). One survey 
suggested that 91% of fibromyalgia sufferers had used some form of CAM (Ernst, 
2009). This research explores the interventions that patients have accessed in both 
the NHS and privately and their views regarding conventional approaches, and why 
they may seek alternative forms of therapy and interventions or different management 
approaches. It also explores their sources of information about treatment options, as 
well as other factors that influence their decision-making. 
In line with the current government initiatives, it is necessary to consult and consider 
the views of patients in developing evidence on which best practices are based. Thus, 
the central theoretical underpinning of this research study is evidence-based practice. 
The study examines current clinical practice, which has not yet been determined. 
Moreover, it also considers patients’ experiences and their views of their conditions 
and the interventions they have received. These considerations are presented in Chapter 
3. 
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1.2. Research Methodology 
Complex interventions are usually described as interventions that contain several 
interacting components.(Craig, 2008), and are presented in the MRC Framework for 
Complex Interventions. There are, however, several dimensions of complexity, which 
may concern a range of possible outcomes or their variability in the target population, 
rather than the number of elements in the intervention package itself. Implementation 
research seeks to identify which techniques are effective in encouraging the conversion 
of evidence into practice, and provide information about ‘real world’ variability in the 
effectiveness and cost efficiency of interventions, and about the practicalities of 
introducing and sustaining new treatments or services (Pinnock 2003). Before it is 
possible to design an interventional study, it is first necessary to establish the existing 
evidence, define what is considered to be standard care in the UK, and explore the 
views of stakeholders. These points and considerations constitute the focus of this 
research study. 
A mixed methods approach was adopted in this research using a qualitative and 
quantitative approach. This research seeks to describe important aspects associated 
with the FMS condition. Within this research, an exploration of existing literature in 
the field of health care professions, including a review of qualitative studies of 
patients’ experiences of living with CWP, was conducted. Semi-structured interviews 
were conducted to capture the experiences of individuals with chronic pain. The study 
was inspired by the philosophical perspectives of epistemology, pragmatism, 
theoretical appraisal and critical reflection, where qualitative research can provide a 
contextual, in depth understanding of people’s perspectives. The second phase of the 
study employed a descriptive survey to ascertain how FMS is managed within the 
UK by the various professions involved in the management of chronic widespread 
pain and the degree of variability of services within the UK and Libya. The purpose 
was to analyse the differences in approaches and explore attitudes and opinions 
regarding the outcome of fibromyalgia interventions that have been used in the clinical 
practice of rheumatologists, pain management specialists and physiotherapists. A 
survey was employed, and both quantitative and qualitative data was collected. The 
survey was developed based on an earlier study by Sim and Adams (2003b), who 
explored the management of fibromyalgia by physiotherapists and occupational 
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therapists. This study further investigates the management of fibromyalgia by a range 
of health professionals.  This will enable the development of an interventional design 
with appropriate control groups for a future study, in which standard care can be 
defined. 
1.3. Operational Definitions 
For the purposes of this research, the fibromyalgia syndrome is considered to be a 
debilitating chronic disorder, characterized by the presence of continual and 
widespread musculoskeletal pain lasting three months or longer. Symptoms can 
include fatigue, sleep disturbance, tender points, anxiety and depression, cognitive 
deficits in attention, concentration and memory, and other symptoms such as irritable 
bowel syndrome, morning stiffness, headaches, or cramps (ACR 2010). 
 
1.4 Review of Background Literature 
To contextualise and provide evidence for this research study, a review of the relevant 
literature was conducted.  The literature review was conducted in 2014, and 
subsequently updated in 2017. The following search terms and their combinations 
were used to search the CINAHL, COCHRANE, MEDLINE and PUBMED 
databases: ‘fibromyalgia’, ‘pathophysiology’, ‘randomised controlled trial’, 
‘experiences’, ‘physical functions’, ‘psychological variables’, ‘anxiety’, ‘depression’, 
‘quality of life’, ’coping’, ‘social support’, ‘musculoskeletal disorders’, ‘patient’s 
education’, ‘pain management’, ‘ cognitive behaviour therapy’, ‘non-pharmacological 
interventions’, ‘aerobics exercise’, ‘strengthening exercise’, ‘aquatics therapy’, 
‘randomized control trial’, and  ‘review article’. Grey literature was also searched to 
include key government reports on the subject. The reference lists in key studies 
provided a further source of literature.   
1.4.1 Fibromyalgia Syndrome: An overview 
Fibromyalgia, also known as fibromyalgia syndrome or FMS, is a disorder 
characterised by chronic widespread pain and fatigue. It is experienced in 
industrialized nations by up to 5% of the population (Clauw, 2007). In a review paper 
of the history of FMS and its diagnosis, the authors remarked that the condition causes 
widespread pain and muscle tenderness (sensitivity to touch) all over the body, leading 
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to non-refreshing sleep and generalized stiffness (Williams and Clauw., 2009). 
 These symptoms tend to be combined with a range of associated symptoms, such as 
irritable bowel syndrome, cognitive dysfunction, cold sensitivity, and depression, 
which can impact the lives of patients to varying degrees, as shown in  
Table 2.2.1. FMS is characterized by a variety of comorbidities, which makes it 
difficult to uniquely fit it into one illness classification. It is frequently co-morbid with 
other conditions, and a previous review of the history of the fibromyalgia syndrome 
found that it is often associated with abnormal stress reactivity and other psychological 
factors, with patients reporting that their symptoms worsened after physiological or 
mental stress and anxiety due to distressing occasions (Staud, 2007), thus resulting in 
compounding the condition. 
Table 1.1: The main and the associated symptoms of the FMS disease 
Main symptoms of FMS Associated symptoms of FMS 
Widespread muscular pain  
Generalised stiffness 
Persistent fatigue 
Non-refreshing sleep 
Irritable bowel syndrome  
Cognitive dysfunction 
Exercise intolerance 
Anxiety and reactive depression   
Numbness and tingling 
Cold sensitivity 
Headaches 
Temporomandibular joint (TMJ) dysfunction  
Myofascial pain syndrome 
Raynaud's phenomenon  
Irritable bladder  
Dysmenorrhoea 
Skin disorders  
Multiple sensitivities 
Autonomic dysfunction 
 
A survey study used a mailed questionnaire to a random sample of 533 adults with 
fibromyalgia over 50 years of age to measure the frequency and severity of distress 
caused by FMS symptoms(Shillam et al., 2011). The participants reported moderate 
functional limitations, however, it is worth noting that the impact of FMS extends 
beyond individual costs in the form of reduced quality of life, to causing a significant 
strain on society too. Depending on the seriousness of side effects, people with 
fibromyalgia have been found to miss somewhere between 5 to 39 days of work 
annually (Shillam et al., 2011). A USA study used administrative claims and data 
collected from n=4699 patients with FMS to compare FMS with other chronic 
conditions. Patients with FMS were found to be more incapacitated reportedly feeling 
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‘wiped out’, and had more than twice the yearly well-being expenses. The study 
findings suggested that, within the management of FMS, there may be large cost-offset 
opportunities for reductions in patient, physician, and employer burdens (Robinson et 
al., 2003). 
The diagnosis and viable treatment of fibromyalgia poses difficulties. Fibromyalgia is 
the second most common issue treated by rheumatologists, though a study Leventhal 
(1999) revealed that of those patients accepting treatment, under half experienced 
adequate help with the side effects of FMS. Pharmacological and non-
pharmacological approaches that have not appeared to help with a disorder that for a 
long time was thought to be "all in one's mind" leaves numerous people dissatisfied 
and unhappy with the current management approaches. 
1.4.2. Epidemiology of FMS  
Studying the epidemiology of FMS is important for understanding the impact of this 
disorder on people, families and society. The prevalence of fibromyalgia in the general 
population of the United States has been reported to be 3.4% in women and 0.5% in 
men (Wolfe et al., 2010), while the prevalence of FMS in the UK has been reported to 
be of the order of 2.5% of the population (Longley, 2006). Studies investigating the 
experience of being diagnosed with FMS reported that 50% to 80% of patients show 
decline in working memory, attention and executive function (Ablin and Buskila., 
2013), with women affected up to 10 times more commonly than men, and with this 
frequency increasing linearly with age (Sumpton and Moulin., 2008). Furthermore, 
the prevalence of FMS was found to increase progressively over 80 years of age, 
before starting to decline. FMS is typically considered to be a disorder that mostly 
affects women of 20 to 50 years of age; although, it is also found in men, children, and 
older people. 
FMS has been found to be more common in the relatives of patients with FMS, which 
could be due to the contribution of both environmental and genetic factors. 
Epidemiological studies have identified that FMS as one of the main causes of CWP. 
Furthermore, it is estimated that approximately 10% of the general population exhibit 
CWP complaints, clearly indicating that CWP is a main health problem in the Western 
world (Queiroz, 2013). Many studies have found higher rates of such complaints 
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among women compared to men, but the mechanisms responsible for skewed gender 
rates still remain unclear. FMS therefore represents a major social and economic 
burden for sufferers, families, and society, with important physical and psychological 
concerns for individuals. Moreover, it is characterised as a condition in which the 
central nervous sensitization is manifested by CWP, which is the fundamental 
symptom of FMS, and widespread tender points (hyperalgesia) (Queiroz, 2013, 
Azevedo et al., 2012). 
1.4.3. Diagnosis of FMS 
FMS is a common rheumatological disorder that is a characterized by chronic 
widespread pain (CWP), the presence of widespread tenderness, and multiple somatic 
symptoms. Since the publication of the American College of Rheumatology 
classification criteria for FMS, Wolfe et al. (2010) performed a multicentre study of 
829 patients diagnosed with fibromyalgia, where the control group went through 
physical examinations and interviews, including a widespread pain index (WPI) test, 
which measures the number of painful body regions. The study found that 25% of 
fibromyalgia patients did not satisfy the American College of Rheumatology ACR 
1990 classification  criteria for FMS diagnosis (Giordano et al., 1999). 
There are no direct diagnostic investigations, such as X-rays, blood tests, and magnetic 
resonance image (MRI) scans, for FMS. FMS is an extremely troublesome condition 
to manage, and there are also other health problems which can be confused with it  
(Wolfe et al., 1990). In a questionnaire-based trial study conducted with 558 patients, 
293 with FMS and 265 control patients, in Canada,  FMS patients did not differ 
statistically from controls in the variables studied (Barker, 2002). However, the study 
acknowledged that FMS should be diagnosed via a procedure of elimination, which 
may require several other medical conditions to be ruled out. In the elimination 
process, blood tests, a complete blood count (CBC), and erythrocyte sedimentation 
rate (ESR) tests can be performed to exclude other possible diseases such as lupus, 
anaemia, or polymyalgia rheumatica. In addition, a physical test can be useful for 
identifying tenderness and rejecting different reasons for muscle pain. Once other 
conditions have been eliminated, there are two other positive examinations that are 
generally utilized as part of FMS diagnosis according to the ACR criteria, namely the 
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widespread pain index (WPI) and the symptom severity score (SS score). The study 
concluded that a better understanding of the illness’ identity is needed.  
1.4.3.1. ACR Criteria 
The ACR criteria were first developed in the early 1990 , and started a period of 
increasing acknowledgment of this syndrome (Wolfe et al., 1990). The 1990 ACR 
criteria for FM diagnosis specified that the pain must be chronic and widespread, 
defined as axial pain, affecting both sides of the body, above and beneath the waist. 
Furthermore, the criteria also specified that the patient must have pain in at least 11 
out of 18 anatomic sites, known as “tender points”, as shown in Figure 1.1, on digital 
palpitation using a force of about 4 kilograms (kg), and that symptoms must last for 
no less than three months. These guidelines recommended that primary care 
physicians should, ideally, promptly recognise and optimally manage FMS (Meyer, 
2006). However, in a study conducted in 2010, the 1990 diagnosis criteria were 
updated to provide an alternative technique of analysis, where the diagnosis of FMS 
is no longer based on counting the number of tender points. Nevertheless, a full 
physical examination is still prescribed, alongside other analytic tests to distinguish 
the indications rather than the aetiology of FMS (Jahan et al., 2012).   
The study concluded that well-informed physicians should be able to improve function 
and reduce pain in patients with fibromyalgia. The reason for excluding the use of 
tender points for diagnosis is that it became clear that, tender point counts are rarely 
correctly performed in primary care (Marcus, 2009). (Wolfe et al., 2010, Buskila et 
al., 1997), As such, in the updated diagnostic criteria of 2010, all other characteristic 
features of FMS, such as symptoms of fatigue, sleep disturbance, and cognition 
problems were taken into consideration, and the tender points were replaced with the 
WPI and the SS test score (Wolfe et al., 2010). 
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Figure: 1. 1.The tender points based on the 1990 ACR criteria for FMS diagnosis. The red 
dots indicate the 18 tender points. 
1.4.3.2. WPI/SS Test Scores  
The modified 1990 criteria   for FMS diagnosis now utilise another method in place 
of tender points count, which incorporates the WPI and SS test scores (Jahan et al., 
2012). WPI comprises a total of 19 predefined body areas, and the score represents the 
number of painful areas in which the patient has experienced pain in the previous 14 
days (scoring 0-19)  (Wolfe et al., 2010). In the SS test (scoring 0-12), the severity 
level over the 14 days period is noted for the following three features: fatigue, waking 
unrefreshed and cognitive symptoms, as shown in Table 1.2. The severity level is rated 
on a Likert scale from 0 to 3, where 0 represents no problem, and 3 represents a  severe 
problem. The extent of somatic symptoms in general is also noted in the SS scale, and 
is scored from 0 to 3, where 0 means no symptoms, and 3 indicates a great number of 
symptoms (Wolfe et al., 2010). Given the scores from the WPI and SS tests, the criteria 
for FMS diagnosis were developed as follows: 
• WPI score of at least 7 and SS score of at least 5, or WPI 3–6 and SS ≥ 9. 
• Symptoms have been present at a similar level for at least three months. 
• No other diagnosable disorder otherwise explains the pain. 
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Table 1. 2: Main associated symptoms of FMS disease. 
Fatigue Waking unrefreshed Cognitive symptoms 
0 = No problem 0 = No problem 0 = No problem 
1 = Slight or mild problems; 
Generally mild or intermittent 
2 = Moderate; considerable 
1 = Slight or mild problems; 
Generally mild or intermittent 
2 = Moderate; considerable 
1 = Slight or mild problems; 
Generally mild or intermittent 
2 = Moderate; considerable 
 Problems; often present and/or 
at a moderate level 
3 = severe: pervasive, 
Problems; often present and/or 
at a moderate level 
3 = severe: pervasive, 
Problems; often present and/or 
at a moderate level 
3 = severe: pervasive, 
continuous, Life disturbing continuous, Life disturbing 
problems 
continuous, Life disturbing 
problems 
 
1.4.3.3. Labelling of FMS 
There have been a series of debates regarding the diagnosis of FMS, and thus the 
labelling of  FMS (White et al., 2002). In the London Fibromyalgia Epidemiology 
Study, a hundred individuals with FMS were identified. A Fibromyalgia Impact 
Questionnaire was used to measure their health status and function, and paired t-tests 
were used in analysing the data. A lack of a clear definition of the condition reported 
and the absence of clinical outcomes can be applied as FMS labels, as well as 
fluctuating influences on the long-term condition. Different assessments were utilised, 
which affected the labelling of the condition to variable degrees. In a review study by 
Hadler (2003), 22 surveys conducted in the USA were considered, and it was 
suggested that the diagnostic label of FMS medicalises symptoms, therefore 
promoting an increase in symptoms, as well as excessive somatic concerns. However, 
another study found that the FMS diagnostic label did not have a negative influence 
on clinical outcomes (White et al., 2002). 
The health care of FMS patients was compared before diagnosis and pre-labelling, and 
after diagnosis and post-labelling by Gelfand (2003). In a general population survey 
in London, Ontario, Canada, of a hundred non-institutionalized adults who met the 
1990 American College of Rheumatology criteria for fibromyalgia, it was found that 
recently diagnosed cases were satisfied with their health. No differences in health 
service post-labelling were found. There are guidelines that recommend that the 
diagnostic label of patients with FMS should be linked to their post primary diagnosis. 
It is also recommended that patients with FMS should be provided with clear 
information regarding the nature of the disease, strategy, planned treatment, and 
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expected outcomes., Fitzcharles et al., 2013d and  Häusera et al., 2010 ).A 
recommended that t the clinical diagnosis  of FMS  without any defining physical 
abnormality or biological marker are characterised by fluctuating, diffuse body pain 
and the frequent symptoms of sleep disturbance, fatigue and cognitive changees.in the 
absence of cause or cure ,treatment. In a systematic review of n=4 RCTs , guidelines 
including the American National Guidelines and those from Canada, Germany, and 
Israel, assessed by two independent reviewers in terms of guidelines inclusion criteria 
and recommendations,it was highlighted that both The American Pain Society (APS) 
and Association of the Scientiﬁc Medical Societiesin Germany (AWMF) assigned the 
highest level of recommendation to aerobic exercise, cognitive-behavioral therapy, 
amitriptyline, and multicomponent treatment. The APS and AWMF guidelines 
assigned higher ratings to CBT and multicomponent treatments. 
In the Israeli guidelines, it was reported that the consensus was that patients with FMS 
should have knowledge of a biopsychosocial model for fibromyalgia, whereby 
biological factors such as genetic predispositions, and psychosocial factors such as 
stress, contribute to the predisposition, triggering and perpetuation of FMS symptoms, 
including reduction of anxiety, often associated with chronic pain (Ablin and Buskila., 
2013). The Canadian guidelines established an extreme attention to prompting events 
such as physical or psychological traumatic events that may compromise patients’ care 
(Hauser et al., 2012a). On the other hand, the German guidelines implied that accurate 
information could be valuable in the education of patients, and could help them 
manage their condition. 
1.4.4. Etiology and Pathophysiology of FMS  
Aetiology and pathophysiology of the condition is uncertain (Sarzi-Puttini.  et al., 
2011 ). The pathophysiology of FMS involves a number of factors, such as 
abnormalities in the neuroendocrine and autonomic nervous systems, genetic factors, 
environmental stressors, and psychosocial variables (Bradley, 2009a). Furthermore, 
the pathophysiology of FMS provides a unique and complex set of challenges, starting 
with the nosology of the disorder. The development of FMS is possibly due to irregular 
central pain processing, rather than a dysfunction in the peripheral tissues where such 
pain is apparent.  Several mechanisms may be involved, such as central sensitization, 
the suppression of descending inhibitory pathways, excessive activity of glial cells, 
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and abnormalities in neurotransmitter release or regulatory proteins or both.  In 
addition, these mechanisms are probably not mutually exclusive.  
Significant progress has been made over the recent decades regarding the aetiology 
and pathogenesis of FMS, although, neither has yet to be fully understood. A review 
study highlighted that a number of factors are important for understanding the nature 
of FMS, such as the autonomic nervous system  and dysfunctions of the central 
nervous system, neurotransmitters, and the immune system, as well as external 
stressors and psychiatric and hormonal factors (Bellato et al., 2012). FMS is part of a 
family of associated disorders known as affective spectrum disorders (ASD), which 
ordinarily co-occur in individuals and co-aggregate in families. These disorders are 
partly caused by genetic factors, and physiological abnormalities can be central to their 
aetiology. Moreover, these factors are involved in other disorders that commonly co-
occur with FMS, and are also described in terms of persistent or recurrent pain and 
emotional distress, such as the temporomandibular disorder (TMD), and anxiety 
disorders. FMS can also occur at the same time as chronic inflammatory diseases, such 
as systemic lupus erythematosus, osteoarthritis, and rheumatoid arthritis (RA). The 
presence of one or more of these co-occurring factors can complicate the diagnosis 
and treatment of FMS.  
1.4. 5. Co-morbid Factors of FMS 
Co-morbid factors are involved in other disorders that commonly co-occur with FMS, 
and which are also characterized by persistent or recurrent pain and emotional distress, 
such as temporomandibular disorder (TMD), and anxiety disorders. A structured 
clinical interview of 108 individuals with fibromyalgia compared with 228 individuals 
without fibromyalgia concluded that there is a possibility that fibromyalgia might 
share underlying pathophysiological links with certain psychiatric disorders. (Arnold 
et al., 2006). A retrospective cohort study of a claims database examined the 
international classification of diseases. The study reported that FMS could also occur 
at the same time as chronic inflammatory diseases, such as systemic lupus 
erythematosus, osteoarthritis, and rheumatoid arthritis (RA) (Weir et al., 2006). 
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1.4.6. Central Nervous System (CNS) Sensitization in FMS 
Central sensitization plays a critical role in the mechanism of FMS, and can be 
described in terms of an enlarged response to stimulation mediated via CNS signalling. 
In a self-administrated questionnaire conducted with n=103 patients, data was 
gathered using a Minnesota Multiphasic Personality Inventory (MMPI), and analysed 
using SPSS. The participants were recruited from an outpatient rheumatology clinic, 
and the study concluded that pain severity may be influenced by physiological and 
psychological actors  (Yunus. et al., 1991). A review by (Staud, 2009) demonstrated 
that FMS patients showed psychophysical indications of mechanical, thermal, and 
electrical hyperalgesia. A number of earlier empirical studies of FMS demonstrated 
CNS pain processing abnormalities, such as the abnormal temporal summation of pain 
(Staud and Spaeth., 2008). 
Thus, a central sensitization abnormality of nociception has been defined in 
fibromyalgia. Vital nociceptor systems in the skin and muscles appear to undergo 
changes in FMS patients (Staud and Smitherman., 2002). This phenomenon, termed 
“wind-up”, appears as one main mechanism that reflects the increased excitability of 
spinal cord neurons after a painful stimulus, where subsequent stimuli of the same 
intensity are perceived as stronger (Kindler et al., 2011). This happens normally in 
everyone, but it is extreme in FMS patients. These findings indicate both an increased 
and a prolonged decay of nociceptive contribution in FMS patients, which provides 
strong evidence for the role of central sensitization in the pathogenesis of FMS (Gur 
and Oktayoglu., 2008). A better understanding of these mechanisms and their 
relationship to central sensitization and clinical pain may allow the  development of 
novel methods for the prevention and treatment of FMS symptoms (Gur and 
Oktayoglu., 2008).  
1.4. 7. The Neuroendocrine System and FMS 
FMS is commonly considered to be a stress-associated disorder that includes abnormal 
functioning in the hypothalamic pituitary adrenal (HPA) axis (Bradley, 2009a, Staud, 
2007). The HPA axis plays a main role in the control of responses to stress. Human 
stress associated with conditions such as FMS, chronic fatigue syndrome(CFS),and 
post-traumatic stress disorder are characterized via changes in HPA axis activity 
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(Becker and Schweinhardt., 2012). The HPA axis is altered in FMS (Williams and 
Clauw., 2009), although the consequences of the specific alterations are 
heterogeneous. In both  the central nervous system ( CNS) and  the autonomic nervous 
system (ANS) , hyper and hypo-activity in basal functioning and acute stress responses 
have been reported (Martinez-Lavin, 2007).  
It has been found that stress-related conditions increase the risk of developing FMS, 
depending  on different susceptibility factors, such as genetic make-up and gender 
(Staud, 2007). However, it is still uncertain which physiological developments 
mediate the relationship between stress and the development of FMS. Alterations in 
the HPA stress systems are often considered to be such mediators, with chronic stress 
exposure changing the function of this stress system, thereby producing FMS 
symptoms (Staud, 2007); (Schweinhardt et al., 2008, McVeigh et al., 2007). From this 
viewpoint, the basic symptom of the condition appears to be associated with changes 
in the HPA axis.  
In addition, it has been reported that the levels of clinical pain can be considered to be 
related to the concentrations of  corticotropin-releasing hormone (CRH) in the 
cerebrospinal fluid (CSF), and the salivary cortisol level (McLean et al., 2006). The 
endocrine system is a vital interface for responding to pathological developments such 
as inflammation, emotions, and to behavioural changes such as physical exercise 
(McLean et al., 2005). Studies of HPA axis functioning in FMS have, on average, 
shown normal basal levels, such as urinary free cortisol and normal salivary cortisol 
levels (Geenen et al., 2002). However, a study of the dynamic functioning of the HPA 
axis in response to psychological, physical, and pharmacological challenges identified 
variations from normal functioning (Griep et al., 1993). This study showed an 
exaggerated corticotrophin (ACTH) response to the exogenous corticotrophin-
releasing hormone (CRH) neurons, as a result of the upregulation of pituitary CRH 
receptors in FMS.   
Numerous studies have also shown that stress-related disorders are characterized by 
HPA dysfunction. It has also been found that hypocortisolemia is most commonly the 
main neuroendocrine abnormality. However, data is still inadequate to allow 
clarification of the pathophysiology of HPA dysfunction, the location of the defect, 
and the exact role of the hypocortisolemia in patients with stress. Whether this plays 
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a role in the progress of stress-related conditions, or happens through the natural 
history of FMS disorder (Tanriverdi et al., 2007) has yet to be elucidated. 
1.4.8. Autonomic Nervous System (ANS) and FMS 
FMS is observed in patients with autoimmune diseases, and can be a source of many 
of the symptoms of disability exhibited in these patients (Buskila, 2009) Abnormalities 
in autonomic nervous system (ANS) functions are often seen in FMS patients. Over 
the last decade, reports of ANS dysfunction in the aetiopathogenesis of FMS have 
increased, which may help explain the symptomatology and psychological and 
physical features found in patients with FMS (Buskila, 2009). The role of autonomic 
and immune factors, and their relationship to other conditions might provide 
information regarding the pathophysiology of FMS. Although FMS has been found 
not to be associated with systemic lupus erythematosus disease activity, the clinical 
characteristics of FMS can contribute to the misconstruction of lupus activity in FMS 
patients (Buskila and Sarzi-Puttini, 2008). A widespread pain can be enhanced and 
triggered by pain related to arthritis and autoimmune diseases, and generate a 
peripheral nerve pain in both neck and back regions (Buskila, 2009). Thus, there is a 
considerable overlap between symptoms, which may suggest similar mechanisms are 
behind the development of these symptoms.  
1.4.9. Sleep Disturbance in FMS 
FMS is often considered to be related to sleep disturbance, characterized by the 
experience of non-restorative sleep (Bradley, 2009a). The most common of complaints 
concerning sleep disruption are associated with polysomnographic features, with 
strong abnormalities seen in the continuity and architecture of sleep. Abnormal sleep 
recordings are characterised by the diminished efficiency of sleep, with increased 
numbers of awakenings. Furthermore, thy are also characterised by a decrease in the 
amount of slow wave sleep, and an abnormal alpha wave intrusion in the non-rapid 
eye movement, which is termed alpha-delta sleep (Dauvilliers and Touchon, 2001). In 
polysomnographic studies, alpha-delta sleep patterns, correlated to interrupted and 
non-restorative sleep, have often been observed in FMS patients (Dauvilliers and 
Touchon, 2001). Sleep disturbance can be linked to the decrease in energy and fatigue 
frequently found in FMS patients (Bradley, 2009a). Data on the distribution of sleep 
Chapter One Introduction and Review of Background Literature 
17 
 
types may provide new evidence on sleep fragmentation. Currently, the analysis of 
data has shown that  periods of nocturnal sleep and waking may be categorized via 
different statistical distributions in healthy individuals (Arnardóttir et al., 2010). 
1.4.10. Genetic Factors in FMS 
Based on incidences of FMS in families, several investigations have found that genetic 
factors can be associated with a predisposition to FMS, in combination with 
environmental triggers, such as infections and trauma. Hypothetically, the main gene 
polymorphisms which can be a risk factor for FMS are those associated with mood 
conditions, but such assumptions are frequently debatable (Cohen et al., 2002). Recent 
reports have stated that genetic factors can play a role in the pathogenesis of FMS, 
including serotoninergic receptors such as 5-HT2A, and polymorphisms in the T/T 
phenotype, such as the SLC6A4 serotonin transporter (Buskila, 2009) . 
Some studies have shown a role for gene polymorphisms in the serotoninergic, 
dopaminergic and catecholaminergic systems in the etiology of FMS (Buskila, 2009). 
Polymorphisms in the serotonin 5-HT2A receptor (T/T phenotype), serotonin 
transporter, and in the dopamine 4 receptor have hence been identified at the highest 
incidences in FMS patients (Buskila and Sarzi-Puttini, 2008). Moreover, 
environmental factors have been found to trigger the progress of FMS in genetically 
inclined individuals (Buskila, 2009). 
1.411. Environmental Trigger Factors in FMS 
In addition to the association of genetic factors with the pathophysiology of FMS, 
environmental trigger factors might also be involved, particularly in combination with 
other risk factors. These trigger factors include physical trauma, injury, and 
psychosocial stressors (Al-Allaf et al., 2002). Furthermore, these may arise from 
manual work, such as repetitive motions or squatting for extended periods of time, 
which have been fundamentally connected with the onset of several musculoskeletal 
pain disorders, including widespread pain (Harkness et al., 2004). In addition, other 
environmental factors like working in hot conditions have also been found to  increase 
the risk of developing widespread pain (Bradley, 2009a). A study by Davis et al. 
(2001) conducted a questionnaire-based survey of 50 participants with FMS, recruited 
from community seminars. The survey included a screening instrument, a pain-coping 
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inventory, and measures of personality dispositions. 
Cross-sectional analyses were employed, and it was reported that exposure to short-
term psychosocial stressor factors increased people’s symptoms, and may be linked 
with FMS. Thus, it can be seen that there are a variety of issues involving a range of 
pathophysiological mechanisms, with concomitant and consequent sequelae that may 
impact upon the physical and emotional experience of this condition. In addition, 
controversies and discrepant diagnoses by health professionals also affect the 
subsequent management and experience of health care, and health care seeking by 
patients. The next section discuses current management approaches to the condition. 
1.4.12. Management and Treatment Approaches of FMS 
Because of its unidentified aetiology and vague pathogenesis, there is as yet no 
standard treatment that can completely cure FMS. The treatment of FMS is mainly 
focused on the management of the disease to reduce the severity of symptoms 
(Marcus, 2009, Staud, 2007). A previous review by Ablin and Buskila. (2013) 
attempted to summarise the therapeutic advances and future directions in the 
management of FMS, and reported that improvements in the understanding of the 
pathophysiology of FMS have prompted changes in treatment, incorporating 
management using various pharmacological and non-pharmacological approaches, 
including complementary and alternative modes of management. There is evidence 
that non-pharmacological treatments, including cognitive behavioural therapy (CBT) 
and exercise, are effective in the management of FMS (Sim and Adams., 2002). This 
systematic review of 25 RCTs, reported upon the evidence for non-pharmacological 
interventions.  In a recent study, an RCT of 56 subjects in an outpatient rheumatology 
clinic were used to assess the effect of internet-based CBT on FIQ and tender point 
assessment. It was concluded that internet-based CBT could be beneficial in the 
treatment of FMS (Menga et al., 2014). 
 EULAR recommendations made by 19 FMS experts representing 11 European 
countries showed that there are other types of FMS non-pharmacological treatments 
used singly or in combinations, including physical therapy, massage therapy, 
acupuncture, homeopathy, dietary, and osteopathic manipulation (Carville et al., 
2008a). Furthermore, it was found that patients’ education, and spa therapy are also 
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used, and the study concluded that no guidelines exist for the management of FMS.  
There is some evidence of the effectiveness of multicomponent treatment, including 
pharmacology, and non –pharmacological approaches, such as aerobic activity and 
cognitive behavioural treatment, in reducing pain and other FMS-associated 
symptoms (Hauser et al., 2009, Sim and Adams., 2002). Based on meta-analyses, up 
to 90% of people suffering from FMS have utilized at least one type of 
pharmacological or alternative treatment to deal with the symptoms caused by FMS 
(Ernst, 2008). Another review study of the use of complementary or alternative 
medicine (CAM) interventions to treat and manage FMS symptoms, considered five 
systematic reviews in an evaluation of interventions. It was found that there were some 
beneficial effects of acupuncture, homoeopathy and hydrotherapy, whilst no 
therapeutic effects were discerned from chiropractic interventions for the treatment of 
FMS symptoms (Terry et al., 2012). However, for the majority of patients,  
pharmacological management remains the mainstay of therapy for FMS. 
In  recent years, a number of recommendations have been published by several 
organizations, including the European League Against Rheumatism (EULAR) 
(Carville et al., 2008a), the Association of the Scientific Medical Societies in Germany 
(AWMF) (Winkelmann et al., 2012). The Canadian Pain Society (CPS) (Fitzcharles 
et al., 2013d), and the American Pain Society (APS) (Burckhardt et al., 2005), in an 
effort to standardize the treatment of FMS. These organizations have provided 
evidence-based recommendations related to the evaluation and diagnosis of FMS, and 
the non-pharmacological and pharmacological therapies that can be used in its 
management. A comparison of these guidelines showing the strongest 
recommendations from each organization is presented in Table 1.3. 
1.4.13. Pharmacological Approaches to FMS  
 Analysis of the results of pharmacological management of FMS have shown 
equivocal findings, with some medications appearing to provide relief of some 
symptoms for some patients, but not for numerous others. Pharmacological agents 
influencing the central nervous system are thought to be the best pharmacological 
treatment of FMS. Decreasing pain in people with FMS is the essential objective of 
most drugs that aim to offer patients some assistance in coping better with their 
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condition.(Mease et al., 2011, Goldenberg et al., 2008).  
A RCT study of pregabalin conducted on 3808 patients with FMS found that a 
minority of patients achieve moderate or substantial pain relief. Beside pain centred 
therapies, drugs can be prescribed to target sleep issues and fatigue, as well as the 
possible side effects of co-existing conditions, such as irritable bowel syndrome, 
bladder distress, jaw pain, and headaches and migraines. Thus, drugs must be 
individualized according to patients’ symptoms (Straube et al., 2010).  
1.4.14. Pain-treating Drugs in FMS 
Around 20 to 40% of patients with FMS experience depression. The regular 
comorbidity of FMS with depression supports the utilization of antidepressant drugs 
for FMS (Goldenberg et al., 2004, Bennett, 2005), which can be used to treat mood, 
sleep and pain symptoms. They act on neurotransmitters to make them reduce or slow 
down pain-related messages (Marangell et al., 2011). Such drugs include amitriptyline 
and doxepin, as well as the selective serotonin reuptake inhibitors (SSRIs), duloxetine 
and milnacipran (Hauser et al., 2009). The objective of antidepressants is to reduce 
symptoms, and if utilised long term, their effects should be evaluated against 
symptoms. Some benefits have been reported with the use of duloxetine, milnacipran 
and amitriptyline; however, numerous individuals encounter more unfavourable 
impacts than benefits. A recent systematic review and meta-analysis designed in the 
form of a randomized controlled trial (RCT) of antidepressants in FMS patients with 
pharmacological placebo was conducted and included thirty-seven studies. It was 
concluded that physicians and patients should be realistic about the potential benefits 
of  using antidepressants in treating FMS symptoms (Hauser et al., 2012b). A UK 
study used RCTs with double-blind assessment of outcomes of five studies and 
included 4138 participants, where two authors examined issues of study quality 
independently. It was found that amitriptyline has been prescribed as a first-line 
treatment, but the evidence to support this utilisation is poor (Derry et al., 2012). 
Anti-epileptic drugs such as pregabalin and neurontin are also used for FMS treatment, 
as reported by a US review paper (Bennett, 2005), with varying degrees of success. 
USA-based RCTs showed that treatment for muscle tension and pain may incorporate 
a prescription for a muscle relaxant drug, such as Xanaflex (tizanidine) or Flexeril 
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(cyclobenzaprine) (Holman and Myers., 2005). 
Tramadol is another widely used analgesic that has a unique mechanism of action. 
Tramadol is the mildest of all opioids, and has been observed to be useful in patients 
with FMS (Bennett, 2005). It is an atypical pain reliever, in that has an alternate mode 
of activity compared to other opiates, as it boosts the action of serotonin and 
norepinephrine to higher levels than those of other opiates, to help further lessen 
anxiety. Alone or in combination  with acetaminophen, it is normally recommended 
at a dose of 200–300 mg/day to diminish FMS-related pain. However, RCTs results 
suggested that there is a hypothetical danger of seizures and serotoninergic disorders 
when tramadol is combined with specific SSRIs (Holman and Myers., 2005). On the 
other hand, tramadol combined with paracetamol is considered to be a compelling and 
all-around effective treatment for fibromyalgia (Moron Merchante et al., 2013). A 
previous review paper reported that opioids are also used for treating severe pain in 
patients with FMS, despite a lack of clinical trials in the USA (Nersesyan and Slavin., 
2007). Another review study highlighted that these drugs are not suggested by any 
present guidelines for the treatment of patients with FMS, as they might worsen 
symptoms such as fatigue and cognitive impairment (Bellato et al., 2012). 
Insomnia is a major issue in individuals with FMS. Studies have shown that 
continuous sleep disturbance inhibit the growth hormone, which is a critical restorative 
hormone, from being created by the body (Boomershine and Crofford., 2009). Without 
this hormone, muscles cannot completely recuperate, and neurotransmitters, such as 
serotonin, are not replenished. A cross-sectional study enrolled 172 patients with FMS 
and found that people with insomnia are often given medications such as Ambien 
(zolpidem),Lunesta (eszipoclone), or trazodone, to help them improve their non-
restorative sleep quality (Viola-Saltzman et al., 2010). 
Fatigue is considered as the second worst symptom after pain in patients with FMS. 
This issue is more serious than what individuals consider to be conventional tiredness, 
and strongly affects the quality of life. Fatigue can be due to a reduced thyroid 
hormone, and it has been shown that 30% of patients with FMS commonly experience 
extreme fatigue (Bazzichi et al., 2007).  
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1.4.15.  Multidimensional Approach to Management 
There have been a number of pharmacological advances in the management of FMS, 
many of which are used to control the symptoms. 
From the guidelines, it is apparent that pharmacological therapy plays a significant 
role in the management of symptoms, however, many of the side-effects are not 
tolerated well by patients. Thus, a multidimensional, multidisciplinary approach is 
necessary to treat the various aspects of this condition. There is promising evidence 
for the use of non-pharmacological approaches as part of a multidisciplinary approach. 
These approaches are reviewed below. 
Table 1.3 shows a comparison of guidelines from four organisations, indicating the 
strongest recommendations from each. The information in this table was taken 
from.(Fitzcharles et al., 2013a, Winkelmann et al., 2012, Burckhardt et al., 2005). 
Table 1. 3: Recommendations for Management of FMS 
American Pain 
Society (2005) 
European League  
Against 
Rheumatism 
(2008) 
German (2012)  Canadian Pain Society 
(2013) 
 
Tricyclic. 
Antidepressants: 
Amitriptyline. 
Cyclobenzaprine. 
Aerobic exercise. 
Cognitive 
behaviour 
therapy (CBT).  
Multicomponent 
therapy 
Tramadol.  
Antidepressants: 
amitriptyline, 
fluoxetine, 
duloxetine, 
milnacipran 
Pregabalin or 
pramipexole 
Aerobic exercise, 
CBT and 
multicomponent 
therapy 
Aerobic 
exercise. 
Cognitive 
behaviour 
therapy (CBT). 
Antidepressants. 
Multicomponent 
therapy 
Tricyclic.  
Antidepressants Serotonin 
norepinephrine reuptake 
inhibitors Selective 
serotonin.  
Reuptake inhibitors. 
Anticonvulsants.  
Cognitive behaviour therapy 
(CBT).  
Multimodal approach to 
treatment.  
Interventions that improve 
self-efficacy.  
Graduated exercise program. 
 
Many patients utilise non-pharmacological approaches, including complementary 
treatments. Surveys have demonstrated that 91% of patients with FMS utilised  
non-pharmacological treatments to manage the symptoms of FMS, with 66% utilising 
more than one complementary treatment. A survey study administered an interviewer-
based questionnaire to 221 consecutive rheumatology patients and 80 FMS patients, 
and reported that alternative medicine was being used by FMS patients  (Pioro-Boisset 
et al., 1996). (Adams and Sim, 2005). Such alternative therapies included holistic 
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movement therapy, energy therapy, balneotherapy, and osteopathic and chiropractic 
manipulation. As previously stated, treatment approaches are rarely standardised, and  
at breaking the cycle between symptoms and patterns of dysfunctional performance 
(White, 2001). Techniques  incorporated include relaxation, sleep hygiene, the pacing 
there is a heterogeneity of exercise programmes. In addition, there are few UK-based 
intervention studies, which may be due to the difficulty in defining a standard 
treatment, resulting in high variability between the usual treatments. Thus, despite the 
European guidelines on the recommendations of interventional approaches, there is no 
standard treatment approach for fibromyalgia in the UK, with considerable variation 
in the provision and availability of services. An earlier questionnaire-based study (Sim 
and Adams, 2003b) surveyed the physiotherapeutic management of FMS, although 
rheumatology and pain management clinics were not surveyed. Therefore, one aim of 
this research is to update this previous study, and describe the current clinical practice 
in the UK. This thus forms one phase of this research. 
1.4.16. Cognitive Behaviour Therapy (CBT) 
CBT has been extensively studied as a non-drug intervention for FMS. In a 
randomized study of n=58 patients with FMS (Ang et al., 2013), the participants 
underwent a combination therapy including milancipran, education, placebo and CBT. 
CBT which is frequently incorporated into multidisciplinary pain management 
programmes, had moderate effect on improving physical function and reducing pain 
compared to milnacipran, CBT is a composite of two methodologies; cognitive  
treatment, and behavioural treatment (White, 2001). It is a form of psychotherapy that 
mainly focuses on the understanding of how the patients’ thoughts and emotions may 
contribute to the dysfunctional negative thoughts and behaviours, and has been 
broadly used to treat depression and anxiety. An RCT-based study involved 56 
subjects undertaking an internet-based CBT, using the Fibromyalgia Impact 
Questionnaire (FIQ) as an outcome measure  found no significant difference in the 
FIQ scores  in both groups. (Menga et al., 2014). 
The fundamental aims of CBT are twofold: first, the recognition of and change to the 
dysfunctional thought patterns that are interfering with therapeutic progress; and 
secondly, the engagement of the individual in behavioural interventions aimed of 
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activity, scheduling social and leisure activities, coping with pain, education, and 
assertiveness training (Williams, 2003). In a RCTs-based study by Nielson et al 
(1992), a total of 131 patients with FMS were randomly selected. Data was analysed 
by a standard rating scale, and the results showed significant improvements in patients 
who accepted CBT with respect to pain severity and the number of pain-related 
behaviours (Nielson et al., 1992). 
In addition, a US review study demonstrated that CBT for FMS patients can improve 
pain, fatigue, and function (Williams, 2003). In contrast, a review of RCTs in 
Netherlands reported that limited change was seen in pain   and mood from six 
randomized controlled trials, and that the use of CBTs within a multi-component 
approach yielded the most benefits  (Koulil et al., 2007). In addition, a systematic 
review and meta-analysis of six trials (Lauche. et al., 2013) reported low quality 
evidence for short term improvement of quality of life. In a UK review paper providing 
an overview of published evidence for interventions in FMS (Adams and Sim, 2005), 
it was concluded that CBT interventions have proven useful in the treatment of FMS 
as part of multicomponent treatment. Different studies have used contrasting 
classifications and techniques of CBT within their programmes, normally as part of 
multimodal programmes that combine CBT with physical exercise rather than through 
CBT alone. In clinical practice, multimodal FMS treatment programmes with a 
combination approach are widely encouraged and have received some support from a 
systematic review (Sim and Adams., 2002). Despite evidence for the effectiveness of 
these interventions, and particularly exercise, patients still report dissatisfaction, and 
the use of these interventions   have high dropout rates. The reasons for this are 
explored in this research. 
1.4.17.  Physical Therapy Approaches and Exercise Rehabilitation 
A recent systematic review and meta-analysis of sixty randomised controlled trials 
(Sosa-Reina et al., 2017) concluded that aerobic and muscle strengthening exercises 
are the most effective ways of reducing pain, and improving the general well-being in 
people with fibromyalgia. In addition, combined exercise produced the most beneficial 
effect on symptoms of depression. Only one of these RCTs was conducted in the UK 
(Richards and Scott., 2002), and most trials  used the Fibromyalgia Impact 
Questionnaire (FIQ) as an outcome measure to assess pain, depression, physical and 
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functional impact of fibromyalgia, and the general well-being (FIQ total score). 
Although this meta-analysis considered previous systematic reviews and meta-
analyses (Hauser et al., 2010, Kelley et al., 2010), it was not able to draw conclusions 
about type, dose and duration of exercise, as few studies included such details. 
Adherence to exercise regimes was also an important issue that has been identified 
from reviews, and requires further investigation. Thus, one aim of this research is to 
identify whether physical and behavioural approaches are routinely used in UK 
practice, and the views of people with fibromyalgia regarding their participation in 
these approaches.  
A randomized controlled trial of 130 women with FM (Larsson et al., 2015) concluded 
that resistance exercise was found to be a feasible mode of exercise for women with 
FM, improving muscle strength, health status, and current pain intensity. Recently, an 
assessor-blinded randomized controlled multicentre trial of 130 women with FM 
(Ericsson et al., 2016) examined the effect of resistance exercise compared with active 
exercise. The study showed that person-centred progressive resistance exercise 
contributed to improvements in  physical fatigue in women with FM. In addition, a 
randomized controlled trial of eight women with FM, who completed the FIQ and a 
short-form health survey (SF-36), and were selected for controlled trials of 
straightening exercises, (Oliveira Gavi et al., 2014), concluded that strengthening 
exercises show greater and more rapid improvements in pain and strength than 
flexibility exercises. 
Aerobic exercises such as walking, cycling, dancing, pool exercises, and tai-chi are 
regularly prescribed, and it has been demonstrated that low or moderate intensity 
exercises are more successful in reducing the symptoms of FMS (Busch et al., 2011, 
Alentorn-Geli et al., 2008). It is understood that exercise adjusts inflammatory 
reactions through neuroendocrine components. Since FMS disorder is by all accounts 
related to a deregulation of the inflammatory reaction, it could be conceivable that 
exercise treatments could work at this level in FMS patients (Ortega et al., 2009). 
Exercise is therefore an important part of managing FMS, though what is less well 
known is the dose, duration and frequency of exercise required. In addition, many 
patients drop out of exercise programmes, the reasons for which are explored in this 
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research study. 
1.4.18. Massage Therapy (MT)  
Massage therapy (MT) can have immediate beneficial effects on improving pain, 
anxiety, and depression in patients with FM. A systematic review of nine randomized 
controlled trials involving 404 patients (Li et al., 2014) recommended that massage 
therapy should be one of the viable complementary and alternative treatments for FM. 
MT has been broadly utilised by up to 70% of patients suffering from FMS and seeking 
symptom relief (Wahner-Roedler et al., 2005). It is claimed that massage can reduce 
pain and muscle tension, improve the mood, and reduce sleep disturbance, via a 
complex interplay of both physical and psychological modes of action (Moyer et al., 
2004). 
Some studies have shown that massage therapy can be helpful in the management of 
FMS. Single-arm studies have shown significant short-term benefits in improving 
restorative sleep, and reducing fatigue and stiffness in patients with FMS (Field et al., 
2002).  
In addition, one study found sustained improvements in pain and sleep after patients 
were given MT sessions for about 6 months. After a one-year follow-up assessing the 
impact of a combined massage and ultrasound treatment, another study showed 
significant improvements in pain intensity, and function, and a reduction in complaints 
of non-restorative sleep (Citak-Karakaya et al., 2006). Nevertheless, these outcomes 
must be treated with caution, as in studies that exclude a control group placebo effects 
and spontaneous improvements in FMS symptoms cannot be eliminated. In contrast, 
no benefit of MT was found in a study performed by Alnigenis et al. (2001). However, 
this could be due to the low quality of the methodology used and the small sample 
size. In addition, in all of the studies cited above, the type of massage used was not 
specified. A review paper by Hardy-Pickerin et al. (2007) reported that massage 
therapy was often a popular choice with patients, despite limited research evidence for 
its effectiveness. The reasons for this are also explored in this research. 
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1.4.19. Spa Treatment 
Spa treatment covers a wide range of modalities, including hydrotherapy, 
balneotherapy, physiotherapy, mud-pack treatment, and exercise. A review conducted 
by Fioravanti et al. (2011) on mechanisms of thermal water and the application of 
mud, found that such techniques alleviate suffering in rheumatic diseases . The study 
concluded that the beneficial effects of spa therapy in some rheumatic diseases include 
changes in the environment, pleasant surroundings, and the absence of work duties. 
Spa treatment is a popular treatment for FMS in numerous European nations and 
Japan. A review study by (Guidelli et al., 2012)  concluded that spa therapy can 
represent a useful back-up to pharmacological treatment of FMS, or be a valid 
alternative for patients who do not tolerate pharmacological treatments. However, in 
spite of their long history, spa medications are still a subject of controversy, and their 
part in cutting edge prescription is still not clear due to the lack of controlled trials and 
the heterogeneity of the treatment (Guidelli et al., 2012). 
1.4.20. Coping Strategies in FMS 
Coping with FMS may be difficult due to the chronic  nature of the condition and the 
reported ‘invisibility’ of symptoms. Coping strategies are a key element of any pain 
management programme and of cognitive-behavioural therapy, and are designed to 
assist the patient to better manage their pain and other symptoms.  It has been 
suggested that FMS is a functional and psychological condition, and that symptoms 
are due to the somatization of stress (Gupta and Silman, 2004). In a descriptive study 
of 20 women with FMS (Homann et al., 2012), health assessment questionnaire, 
fibromyalgia impact questionnaire, and visual analogue scale were used. The study 
reported that psychological factors and dysfunction seem to be part of a complex 
mechanism, which might affect the quality of life of patients with FM and exacerbates 
the symptoms. Several theories imply that traumatic psychological factors discussed 
in earlier section of review and environmental factors are causes of FMS, and that it 
can, in part, be explained by neuroendocrine and CNS disturbances and responses to 
these factors.  
A number of studies have reported that coping with pain and other FMS symptoms is 
the main objective in managing FMS. Coping is defined as the way in which  a person  
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attempts to modify adverse aspects of their environment and stress (Jones et al., 2010). 
Although there is no single universally accepted definition of coping, there appears to 
be an emerging consensus among theoreticians, clinicians and researchers alike, that 
coping styles constitute an important component of the individual’s adaptation to the 
impact of different stressors, including extreme psychological trauma. It seems that it 
is not the stressor alone that leads to a serious outcome, but the way in which a person 
perceives and responds to it (Horesh et al., 1996 ).  
As there are no medications to eliminate FMS symptoms, the symptoms need to be 
coped with and managed by both patients and health professionals. Based on current 
evidence, a coping strategy is likely to include the reduction of stress, patient 
education, and physical strategies such as exercise. 
1.4.21. Reduction of Stress 
There are various theories which state that stress can play a critical role in triggering 
FMS symptoms (Schmidt et al., 2011), although whether this is aetiological or a result 
of the pain, fatigue and consequent reduced function, is unclear (Adams et al., 2006). 
However, there are a number of people with FMS who experience psychological 
symptoms such as anxiety and depression, and these are exacerbated around the time 
when FMS symptoms flare up (Glass et al., 2005). A systematic review and meta-
analysis of six randomized controlled trials (RCTs) with a total of 674 FMS patients 
(Lauche et al., 2013) used mindfulness-based stress reduction (MBSR) to treat 
fibromyalgia. Outcome measures were quality of life (QOL) and pain, including sleep 
quality, fatigue, depression and safety, and only minimal changes were found in pain, 
quality of life, depression and anxiety. 
1.4.22. Communication 
Communication is also important in a chronic disease such as FMS. A descriptive 
study used a questionnaire to survey n=254 FMS participants, and the descriptive 
parameters were calculated. (Ullrich et al., 2014), and concluded that service providers 
who communicate with FMS patients should employ an open and patient-centred 
communication style. Moreover, psychological variables were identified in all 
communication preferences, the ability of the health care professional to engage in 
effective communication can create a positive therapeutic alliance and encourage 
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behaviours to optimize the patient’s capacity to live as fully as possible with that 
specific illness. A survey study by Farin. et al. (2013) conducted on n=701 patients 
with chronic low back pain found that communication is very important for patients 
with chronic pain especially  for communication about emotional and FMS conditions.  
From previous studies, it is known that people with fibromyalgia feel that they are not 
understood, and that health professionals are not well informed about their condition 
(Sim and Adams, 2003b), in contrast to the views of health professionals themselves. 
The importance of good communication cannot therefore be underestimated. 
1.4.23. Assessing the Impact of Fibromyalgia in Patients’ Daily Living.
  
FIQ is a commonly used instrument in the diagnosis of FMS patients, and is commonly 
reported in evaluations of fibromyalgia’s impact on functions and daily living 
activities (Hauser et al., 2009, Sim and Adams., 2002). It is a self-report questionnaire 
developed to assess the health status of FMS patients (Burckhardt et al., 1991). A 
previous study conducted by (Rodero et al., 2010) used a 3-item instrument, and 
focused on patients’ capacity to perform functional activities, where two items were 
used to evaluate patients’ feeling, and the number of days of not feeling well or missed 
work in the past week. The last seven questions estimating the workability, pain, 
fatigue, morning tiredness, stiffness, and psychological features were assessed with 
the graphic analogue scale. Whilst a variety of outcome measures have been used in 
studies of fibromyalgia, these are generally used within RCT designs, and the 
psychometric instruments used include the Pain Visual Analogue Scale (PVAS) for 
pain intensity. The Hospital Anxiety and Depression Scale (HADS), the Medical 
Outcome Study Short Form 36 (SF-36), the Pain Catastrophising Scale (PCS), and the 
Fibromyalgia Impact Questionnaire (FIQ) are occasionally used. However, none of 
these captures the in-depth experiences of patients. This research seeks to both record 
the use of assessment instruments in fibromyalgia by clinicians, as well as capture the 
in depth and life experiences of patients. 
1.4.24. Patients’ Experiences of FMS. 
A number of studies have found that, despite the scale of the syndrome’s influence on 
their lives, females with FMS felt that their experiences were hidden from nearly 
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everyone except themselves (Soderberg and Lundman, 2001). Furthermore, 
individuals with FMS face the quandary of living with a condition that they find to be 
extremely limiting; while, at the same time, it is ‘invisible’ to other individuals 
(Raheim and Haland, 2006). A study by Paulson et al. (2002) conducted narrative 
interviews with 14 men with fibromyalgia, who were patients in the Swedish health 
care system, regarding the pain they experienced. Content analysis was used to analyse 
the data, and it was found that the subjects were struggling to achieve a tolerable 
existence, and specifically that individuals with FMS experienced basic changes to 
their social lives and interactions with society overall, which can bring about a 
decrease in social interaction, and thus, social support in the community. Baanders and 
Heijmans. (2007) also stated that living with a chronically sick individual affects the 
partner’s own life. A study by Rodham et al. (2010) conducted qualitative semi-
structured interviews with 4 women with FMS, aged between 38 and 65, and their 
spousal carers, who were interviewed separately. The participants all came from the 
south-west of England. The resulting transcripts were analysed using interpretative 
phenomenological analysis. More than half of the carers in the study described the 
strain on their own lives, whereas 20% cited changes in social relations and monetary 
issues. Although this small sample size limits the transferability of the findings, the 
participants reported feeling isolated from healthcare professionals, and this sense of 
isolation was evident for the carers as well as the people with FMS.   
A number of studies have centred on the life experience of individuals with FMS, 
while others have focused on their partners (Soderberg and Lundman, 2001). 
Considering that life partners form the central social support for patients with FMS, it 
is important to explore their experience of this burden of caring, and the effect of such 
burden on their relationships.  
1.4.25. Experiences of Being Diagnosed of FMS 
The diagnosis of FMS may be difficult, as not only are there no laboratory tests or 
imaging tests that can recognise the condition, but there are additionally various 
different conditions that share similar symptoms with FMS. When diagnosed with the 
condition, patients struggle to find a new identity to deal with the reality of living with 
a chronic condition, where they are socially identified and self-defined only by their 
disabled bodies.  
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Accepting a conclusion can be one of numerous defining moments in the lives of 
individuals with chronic disabilities (King et al., 2003). Nevertheless, clinical reality 
does not generally give a conclusion the ability to clarify disease.  
A study performed by Steihaug and colleagues (2002) interviewed 24 women who 
talked about their experiences with chronic pain. Participants were drawn from an 
action research project using focus group interviews, and data was analysed using 
Giorgi's principles of phenomenological analysis. The participants described their pain 
and symptoms as ‘limitless’, and stated that understanding the experience of living 
with such pain provided a clarification and acknowledgment of the pain experience. 
Furthermore, the participants established that recognition had an important effect on 
how much they benefited from an intervention programme. (Steihaug et al., 2002).   
1.4.26. Patient Education. 
In a recent randomised controlled clinical study of 66 patients diagnosed with FMS 
(Kocyigit et al., 2016), a 20-minute long education session on FMS was provided to 2 
groups (a balneotherapy group and a control group) at the beginning of the treatment, 
and patients were evaluated using the FIQ. It was concluded the combination of 
balneotherapy and patient education has both short- and long-term beneficial effects 
on   patients with fibromyalgia.  
In a study of seven women with FMS (Karper, 2016), the subjects attended a 
university-based programme three days per week, which involved ongoing group 
education. The patients were evaluated periodically with a fitness test and a rating 
scale in terms of pain and fatigue. The outcomes showed various positive results from 
participation in the programme. In another randomised controlled single blind study 
of 70 women with FMS (Bağdatlı et al., 2015), the subjects were divided into 
balneotherapy, hydro-pool and control groups. All patients took patient education 
about FMS and a home exercise programme. Outcome measures were based on FIQ 
and BDI, and it was concluded that patient education combined with two weeks of 
balneotherapy had effects that were more beneficial in patients with fibromyalgia 
compared to patient education alone. 
In a qualitative study by Robinson et al. (2016) that used an approach based on 
interpretive phenomenology analysis (IPA), ten patients with chronic musculoskeletal 
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pain were recruited from an NHS pain clinic in a hospital in the North East of England. 
The patients attended a group education session on pain neurophysiology education 
(PNE), and individual face to-face interviews with the researcher. The majority of the 
participants reported benefits from the PEN session, whereas a few reported no 
benefits. 
A recent systematic review consisting of a meta-analysis of randomised controlled 
trials of educational interventions for chronic pain included studies that were RCTs, 
and which measured pain for more than three months, as well as disability and the 
effect of education (Geneen et al., 2015), found that,  based on a small number of 
studies, limited evidence was found, and the difference in education levels was 
reported. It was concluded that education alone is not effective in reducing pain 
intensity or the associated disability in chronic pain conditions. 
Most specialists agree that an instructive or psychoeducational part of treatment is 
valuable, if not necessary, when treating FMS (Carville et al., 2007). Increasingly, 
educational programmes have become an important part of understanding the links 
between neurological procedures and behaviours, such as sleep, activity levels, and 
symptoms. These programmes have varied foci, but as a rule, attempt to allay the 
stigma often attached to FMS (Hassett and Gevirtz, 2009). A study by Goldenberg et 
al. (2008) set out recommendations regarding education that appear well-founded. In 
addition, it has been pointed that  patients education and  available information would  
be discussed the pathophysiological mechanisms of FMS in the bio-psychological 
context model thus the nature of the illness indicates that psychogenic implications 
were reported on patients with FMS. Education and behavioural programmes for FMS 
treatment protocols are necessary, particularly when combined with other modalities 
such as exercise, sleep hygiene, and activity pacing, using some form of behavioural 
intervention, and appear to improve the effectiveness of the treatment of FMS (Hassett 
and Gevirtz, 2009). Patients’ experiences of receiving information and education are 
further explored in this research study. 
1.4.27. Emotional Factors in FMS: Alexithymia 
Alexithymia has been identified as being widely present and pronounced in FMS 
patients (Baeza-Velasco et al., 2012). Furthermore, the understanding of the emotional 
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features and how they are linked to FMS may be challenging due to the personal 
elements of alexithymia in FMS. The emotional aspects could be linked to different 
extents of awareness that demonstrate the psychological and theoretical perspectives 
of people’s attitudes; including listening, understanding, acceptance, tolerance, 
confirmation and satisfaction. Individuals may attempt to express themselves and their 
experience using these terms to health professionals. Whilst the physical and cognitive 
aspects of the condition have received attention in the literature, there has been less 
attention devoted to the role of emotional factors, and to the education and behaviour 
programmes applied as intervention approaches for FMS. Therefore, this research 
study incorporates an assessment of this construct, in addition to patients’ own 
perspectives and experiences. 
The term alexithymia is derived from the Greek words “a” (lack), “lexis” (word), and 
“tymos” (emotion). It was first coined by (Sifneos, 1972 ), and recent studies have 
highlighted that it means difficulty in classifying and describing feelings. Alexithymia 
is a multifaceted identity characterised by in ability to control external feelings. 
Furthermore, a recent study has argued that alexithymia has multidimensional 
characteristics (Di Tella and Castelli, 2016). 
Alexithymia is a major disturbance of cognitive function. It is a deficiency in the 
cognitive development and control of emotion. Therefore, emotional features 
associated with FM could reflect the appearance of alexithymia. (Baeza-Velasco et al., 
2012). It has been demonstrated that FMS patients have a high rate of alexithymia, 
including anxiety and depression (De Gucht and Heiser, 2003). Furthermore, a number 
of studies have reported the existence of a relationship between alexithymia, anxiety 
and depression (Di Tella and Castelli, 2013). A recent study has shown that the 
prevalence of alexithymia-related behaviours in fibromyalgia sufferers was high, 
ranging between 15 to 20% of the population (Castelli et al., 2012 ). Furthermore, a 
number of studies have reported the existence of a relationship between alexithymia, 
anxiety and depression. (Di Tella and Castelli, 2013, Bagby et al., 1994). 
1.4.28. Etiology of Alexithymia 
Alexithymia is thought to be a personality trait. It appears to have an association with 
a few chronic conditions, including FMS, and its hypothesized that alexithymia is 
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correlated with brain abnormalities (Maes and Sabbe., 2014). It is unclear what causes 
alexithymia, although several theories have suggested that genetic, neurological, and 
environmental factors are  involved, although the role of genetic and environmental 
factors is still unclear. A study by Muftuoglu et al. (2004) reported that alexithymia 
features in migraine patients. In addition, it was pointed out that migraine patients 
were significantly more alexithymic, depressive, and anxious than healthy people 
(Muftuoglu et al., 2004). Furthermore, it was found that psychological distress was 
strongly liked to pain, and emotional aspects were correlated with autonomic 
reactivity, such as that of the autonomic nervous system and the HPA-axis system, 
which explain a considerable part of the alteration of pain process in FMS patients 
(Muftuoglu et al., 2004). Moreover, neuroimaging research has indicated that 
alexithymia can be correlated with a higher-level of cognitive deficiency in assessing 
emotional inputs, and the absence of neuronal structures representing the lower level 
of processing of emotional stimuli (Berthoz et al., 2002).  
FMS patients struggle to express themselves, which suggests that difficulties in the 
description of complaints could be due to alexithymia, characterized by the 
incapability to differentiate emotions from somatic states (Haviland et al., 2000). It 
has also been found that patients with alexithymia exhibit cognitive characteristics 
such as a dearth of fantasy, imagery, and daydreaming. Thus, because of the difficulty 
to experience and express emotions, alexithymia has been associated with 
somatosensory amplification, which is a tendency to focus on somatic sensations 
(Bradley, 2009a). 
1.4.29. Treatment of Alexithymia 
A recent Italian study investigated the link between alexithymia and depressive 
symptoms in fibromyalgia, in 181 subjects with FMS, and a healthy control group, 
using the Hospital Anxiety and Depression Scale and the Toronto Alexithymia Scale. 
It was concluded that a stronger link between alexithymia and depressive symptoms 
was found in FMS (Ghiggiaa et al., 2017). Furthermore, alexithymia can exacerbate 
depression and pain symptoms, but health professions treat alexithymia by 
concentrating on developing skills such as emotional self-awareness and vocabulary 
for emotions. (Bradley, 2009b, Bradley, 2009a)  
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The therapeutic strategy to deal with FM patients who have high alexithymia involves 
treatment modalities that offer the possibility to expand emotional consciousness, and 
the ability to direct and balance instinctual pressures and emotional arousal during 
cognitive procedure (Madenci et al., 2007). A higher comorbidity of psychiatric 
conditions underscores the importance of psychiatric interventions in FMS patients 
(Haviland et al., 2000), and as such, the study of alexithymia provides an interesting 
and important direction in fibromyalgia research. The extent and role of alexithymia 
in people with fibromyalgia are explored in this research study. 
1.4.30. Conclusion  
FMS is a complex syndrome that is often difficult to diagnose, and is extremely poorly 
understood. Furthermore, numerous aspects of this condition remain unidentified, and 
its pathogenesis is still not fully clear. However, modern functional neuroimaging 
techniques are providing important data about the involvement of the CNS. FMS 
should not be considered a diagnosis of exclusion, and the recently published ACR 
2010 criteria attempt to elucidate specifications for the differential diagnosis of FMS. 
The evidence suggests that a multidisciplinary approach to treatment is optimal. The 
clinician must take into consideration both drugs, in particular antidepressants and 
other neuromodulators, as well as non-pharmacological treatments, such as CBT. 
Treatment approaches are rarely standardised, and there is great variability in 
management. Furthermore, patients’ experiences of the condition need to be fully 
understood in order to manage the condition appropriately. Despite developments in 
research, FMS remains a challenging condition for many clinicians and patients, with 
many gaps in the existing literature. 
1.4.31 Aims and Objectives  
The overall purpose of the study is to capture service users’ and service providers’ 
views and experiences of fibromyalgia, and to explore health professionals’ current 
practice in this light.  
The thesis sought to answer the following research questions 
1. What are views and experiences of service users regarding their 
condition the impact upon their lives and how these influence their 
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health care seeking behaviours and experiences of interventions? 
2. What are the range of fibromyalgia interventions and the diagnostic/ 
assessment process they have experienced/sought? 
3. What is current practice regarding fibromyalgia in the UK and what is 
current practice in Libya. 
The aims of the study, corresponding to the two  phases of the research, are as follows: 
1. To explore FMS patients’ views and experiences regarding issues that impact 
upon their condition. 
2. To explore service users’ and service providers’ views regarding the 
experience and management of fibromyalgia. 
3. To explore the extent to which emotional issues impact upon the experience of 
fibromyalgia. 
4. To describe current FMS practice in the UK and Libya. This will provide 
information regarding the usual types of treatment and care for fibromyalgia, 
and the availability of services. 
5. To consider similarities and  differences in views and approaches  to the 
assessment and management of fibromyalgia  in the UK and Libya. 
6. To explore service users’ and service providers’ views and opinions regarding 
the nature of fibromyalgia, and the interventional approaches used.  
1.4.32. Aims of the First Phase:  Interview Study 
1. To explore the experiences of service users of the process of obtaining a 
diagnosis  
2. To explore the emotional experiences of sufferers 
3. To explore the experiences of the support received  
4. To explore the experiences of coping with and managing daily living activities  
5. To explore the interventions that have been accessed by sufferers, and their 
experiences of these interventions 
6. To explore the experiences of living with pain 
1.4.33 Aims of the Second Phase: Survey Study  
1. To describe the current FMS practices of service providers in the UK and 
Libya. 
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2. To consider similarities and  differences in views and approaches to the 
management of FMS in the UK and Libya. 
3. To explore attitudes and opinions regarding the nature of fibromyalgia and the 
outcomes to the interventions used. 
1.5. Thesis outline  
The study is divided into six chapters. An overview of each chapter is given below. 
Chapter One: Introduction and Review of Background Literature 
The first chapter starts the thesis by introducing the study and presenting the research 
questions and the aims and objectives of the research. A literature review and 
theoretical analysis of the assessment and management of chronic widespread pain are 
presented in this chapter, including a brief review of intervention approaches. 
Moreover, an appraisal of the relevant contexts that support the objectives of this 
research is conducted. A critical discussion of the pathophysiology of the condition 
and its assessment and management is also provided.  
 
Chapter 2: Overview of Research Methodology  
This chapter describes the philosophical approach that informed the choice of research 
methodology adopted in this study, and the paradigms used to explore the experiences 
of people living with chronic widespread pain. 
Chapter 3: Interviews with Patients   
This chapter presents the in-depth views and the life experiences of FMS patients. A 
framework analysis was chosen to conceptualise the perceptions of participants, by 
illustrating the experiences and journeys involved in the diagnosis, coping with pain 
and its unpredictability, the availability of services, the interventions approaches used 
to treat fibromyalgia and their effectiveness, and emotional aspects that impact the 
daily living activities. The framework analysis focuses on the situations, activities and 
anxieties of participants regarding their condition, and highlights the overall theme 
identified.  The chapter concludes with a discussion of the findings of the qualitative 
research on the experience of living with chronic pain.  
 
Chapter One Introduction and Review of Background Literature 
38 
 
Chapter 4: Survey of Health Practitioners 
This chapter explores service providers’ views and attitudes of assessments and 
intervention approaches used on FMS. Moreover, the chapter describes the current 
practice in the UK and the relevant consideration in Libya regarding FMS. The 
quantitative survey formed the method of data collection used, where the questionnaire 
was based on a previous study by Sim and Adams (2003b). The participants were 
recruited from the British Pain Society and the Libyan health and medical 
professionals (Physician, physiotherapists) and the results of the surveys were 
analysed to highlight the differences in the approaches used for the management of 
FMS between the UK and Libya.  
Chapter 5: General Discussion, Conclusions. 
The final chapter of this thesis describes the original contributions to knowledge made 
in this research. In addition, the chapter presents an analysis of the research findings 
regarding the diagnosis and the journey to diagnosis of fibromyalgia, the clinical 
features and the variability and unpredictability of symptoms; the experience of 
available interventions and the management of symptoms; and the emotional 
experience associated with the disorder. The lack of understanding of FMS and the 
role of self-management themes highlighted from the qualitative semi-structured 
interviews are also discussed in this chapter.  
Chapter 6: Future Research and Recommendations 
Finally, the thesis is concluded by highlighting the limitations of this research and 
providing recommendations for future research.   
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2. Introduction 
2.1. Aims of the Study 
  The overall aims of the study correspond to the study phases and 
are as follows: 
1. To explore FMS patients’ views and experiences regarding issues that impact 
upon their condition. 
2. To explore service users’ and service providers’ views regarding the 
experience and management of fibromyalgia. 
3. To explore the extent to which emotional issues impact upon the experience of 
fibromyalgia. 
4. To describe current FMS practice in the UK and Libya. This will provide 
information regarding the usual types of treatment and care for fibromyalgia, 
and the availability of services. 
5. To consider similarities and differences in views and approaches to the 
assessment and management of FMS in the UK and Libya. 
6. To explore service users’ and service providers’ views and opinions regarding 
the nature of fibromyalgia, and the interventional approaches used.  
The study detailed in this thesis aims to further develop the approaches already present 
in the growing body of research that questions diseases experience from the viewpoint 
of the person living with FMS. The significance of this study lies in the fact that very 
little research has been undertaken that specifically looks at illness experience in UK 
contexts. This chapter will describe the study’s underlying philosophical hypotheses 
and methodological approaches. The chapter will conclude with a brief summary of 
ethics in such research. The studies are detailed in subsequent chapters.  
2.2.Methodology  
The methodology for this study has been carefully chosen by considering the 
phenomenon under investigation and the relevance to the research question. Research 
questions often help to dictate the methodological approach that can be used to manage 
and conduct a study (Creswell, 2009 )  A rationale for the use of a mixed methods for 
the two phases of the study will be discussed. The two phases will occur concurrently 
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with data collected and analysed separately (Creswell & Plano-Clark, 2011), with the 
findings considered together during interpretation in the discussion. The qualitative 
study in Phase 1will use semi-structured interviews to collect data and analyse data 
using the Framework approach(Creswell, 2013).  Standardised questionnaires will be 
used to assess fibromyalgia impact and alexithymia. Quantitative survey data will be 
collected by means of an anonymous postal questionnaire in Phase 2. Most  
quantitative data will be gathered in the form of frequency counts and data will be 
analysed by means of appropriate descriptive statistics(Holloway and Wheeler., 2010) 
using SPSS software version 24. 
2.3.Ethical Considerations 
An ethics proposal was submitted to the Faculty of Health and Life Sciences, 
Northumbria University 3rd of March 2015, with ethical clearance for this study being 
granted the 12th of May 2015 (reference HLSSA300415, see the Appendix 3). 
Voluntary and informed consent was ensured. Each participant was provided with a 
participant information sheet, which advised on the purpose and nature of the study in 
this research. Participants had the opportunity to withdraw at any point. Moreover, 
care was taken to ensure that the wellbeing and safety of the participants. Participants 
well-being and dignity throughout exceeded the interest of the research process 
(Wassenaar & Mamotte, 2008). In addition, confidentiality was ensured to the all 
participants. No names were be used in this research in order to protect the identity of 
the participants. 
2.4. Research Perspective and Philosophy 
The inquiry paradigm is a set of the beliefs about the nature of reality and how it can 
be understood. These beliefs can be understood through the ontology and 
epistemology. The ontology is a concepts of knowledge about the type of fundamental 
entities that occur (Robson, 2011 ) .Epistemology is a philosophical assumption of 
how researchers gain knowledge and behind the theory is how things can be known 
and can be informed by qualitative literature (Carter and Little, 2007). The ontology 
looks at the assumptions about the nature of knowledge and reality, whereas the 
epistemology is concerned with understanding what kinds of knowledge can be 
studied (Healy and Perry., 2000  ). The researcher’s philosophical position clarifies 
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his/her understandings about the nature of knowledge and reality (ontology) and 
his/her relationship with knowledge and reality under research (epistemology) 
(Blaikie, 2007 ) This research project will explore, the processes involved and the 
factors are influencing interventions for fibromyalgia treatment approaches. 
2.5. Pragmatism 
Pragmatism is associated with mixed methods research on the use of multiple methods 
of data collection to inform the phenomena under study. It is an overarching 
philosophy, in terms of specific philosophy assumptions (Creswell, 2018). 
Pragmatism differs from postpositivism and focuses on the outcomes of the research 
situations, and consequences of inquiry rather than antecedent conditions,(Creswell, 
2013).  There are also many interpretations of pragmatism that have arose in the social 
science, but for many pragmatism as a worldview arises out of actions, situations and 
consequences rather than an antecedent conditions, there is a concern with 
applications, what works and solutions to problems.   
The problem is most important, and researchers decide the most appropriate 
approaches or methods to understand the problem (Creswell, 2011 ) . There are many 
mixed methods researchers and theorists that draw strong relations with mixed 
methodology and pragmatism , it is a practical approach to a problem and has strong 
relations with mixed methods research (Bazeley, 2003 ). 
Pragmatism avoids ontology by arguing that the reality is known through the human 
experience of it, it offers an epistemological basis for what researchers do normally 
seek to find a solution for issues identified through their experience (Neale, 2009 ). 
Pragmatism legitimises the mixing of qualitative and quantitative methods so that they 
solve research problems better than one approach employed in isolation (Neale, 2009 
), in order to fully capture service user and service provider views and experiences of 
Fibromyalgia a mixed methods approach was required. 
2.6. Mixed Methods Theory and Practice 
Mixed methods research incorporates the mixing of qualitative and quantitative data 
in a particular study or set of related studies, which may give a better comprehension 
of research issues and complex phenomena than either approach alone (O'Cathain, 
2009). Fibromyalgia is a complex phenomenon. Quantitative and qualitative health 
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research using mixed methods is increasing. However, health care research has been 
historically dominated by medical research with an agenda for treatment and cure 
using experimental clinical trials rather than the more subjective experiential agenda 
of qualitative inquiry (Creswell 2007). 
In the current study a mixed methods design has been adopted underpinned by a 
Pragmatism philosophy. This design also fits within the Medical Research Council 
guidance for complex interventions (Craig et al., 2008) As it establishes the state of 
the evidence and stakeholders views and will also elucidate what is usual treatment 
for FMS in the UK as this has not yet been explained. The information gained from 
the studies will provide requisite information upon which to develop and 
interventional randomised controlled trial in the future. 
The limitations of qualitative research alone include the complexity of analysing and 
doing justice to, the large quantities of data collected and issues related to rigour and 
quality, and transferability (Holloway and Wheeler., 2010). Many researchers are 
beginning to develop and employ mixed method designs in health and social sciences 
(Bergman, 2008 ). The mixed methods approach in this study involves two phases 
occurring in parallel. This will allow development of a comprehensive understanding 
the experience of Fibromyalgia and interventions from the patient perspective, and the 
wider context of treatments for Fibromyalgia from clinicians perspectives.(Creswell, 
2007 ). The researcher bases the inquiry on the assumption that collecting diverse 
types of data best provides an understanding of a research problem. The study includes 
a broad survey in order to generalize results to a population and then focuses, with a 
qualitative phase including, open-ended interviews to collect detailed views from 
participants(Creswell, 2013). 
It has been argued that there are many advantages of mixing both qualitative and 
quantitative research in single study and numerous mixed methods been reported in 
the scholarly journals for social scientists. Mixed methods allow the researcher to 
generalize the findings to both a population and develop a detailed view of the 
meaning of a phenomenon or perception for individuals. The advantages of collecting 
both closed ended quantitative data and open ended qualitative data prove 
advantageous to best understand a research problem (Creswell, 2013). There are four 
procedures or frameworks that include (convergent or parallel, explanatory, 
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exploratory, and embedded) to guide an examination of the use of mixed methods 
research for collecting both qualitative and quantitative data (Creswell, 2013). Within 
the current study a convergent or parallel approach was employed (Creswell, 2011 ), 
in order to capture the different types of data required separately, analyse these and 
then interpret the implications of the findings from each study within the discussion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Philosophical distinctions between quantitative and qualitative have become so 
blurred that researcher are left with an impression that differences among them are 
merely technical(Smith and Heshusius.,  1986  ). In fact mixed method is not explored 
the same phenomena and been reflected that quantitative methods cannot access some 
of the phenomena that health researchers are focus on for instance, lived experiences 
as patients, social interactions and patients' perspective of health care professional 
prospective (HCPs) patients interaction. The information will, describe the new 
interactions and debate between service providers and service users points view of 
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Figure 2.1 convergent parallel design of the thesis, informed by(Creswell, 2011 )  
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assessing and managing FMS and living experiences of been diagnosed with FMS. A 
framework is aimed of supporting the integration of different elements of the research 
process to ensure the effective and successful study of social and educational 
phenomena. In the framework there is no content structure of represents process and 
activities it can be realized as module that describes the process of plane and carrying 
out the research (Plowright, 2011 ). 
2.6.1. Qualitative Sampling 
Interviews will involve people living with FM; recruited from a fibromyalgia self- 
help group in the North East. The sample is purposive including both men and women 
aged 27-60 years. Participants will be approached via email to be confirmed to date 
and time of the interview.  Initial contact will be made via the Chair of the 
Fibromyalgia Group in the North East and the researchers invited to attend a general 
meeting to explain the study. Members will then be asked to provide their contact 
details if the wish to be contacted regarding participation in the study. Patients will not 
be recruited from the NHS. 
2.6.2. The Qualitative Interviews with Stakeholders (Phase 1) 
Interviews with individuals who have knowledge of the fibromyalgia condition can 
provide a valuable perspective. Interviews are the most commonly used data collection 
strategy in qualitative research (Nurkoosing, 2005 ). (Whittaker, 2012 , Lumley et al., 
2002)., (Bowling, 2009 ) cites the following as ‘advantages’ of utilising face-to-face 
interview methods, interviewers can probe fully greater depth of information can be 
obtained, and more complicated and detailed questions can be asked to clarify any 
uncertainties. These interviews will aim to capture additional information so as to 
further elucidate the experiences and perspectives of individuals.  Semi-structured 
interviews with the fibromyalgia self- help group will be conducted upon a purposive 
sample of approximately 12-15 participants, based upon previous qualitative studies 
such as  Tamara Marıa et al. (2017) set in Spain involved 13 women with FMS and a 
previous UK study by Lempp et al. (2009) involved 12 patients, each providing in 
depth experiences.  All the information collected will be kept confidential. With 
participants assigned a code and any other identifiable information in a secure filing 
cabinet at Northumbria University accessible to only the named researcher. This will 
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also be encrypted electronically. Only the research team will have access to this 
information. Any quotes that are used in the final report will be anonymised. Names 
and details of participants will not appear in any printed document. Case report forms 
(CRFs) – for example completed interview data will be stored securely in a locked 
cabinet at the Northumbria University and destroyed a year after the end of the 
research, data can be withdrawn of the request is made before a specified deadline. 
In order to help describe the sample recruited in this qualitative phase, The Toronto 
Alexithymia Scale (TAS-20) will be used for the participants to measure different 
facets of alexithymia including difficulty in identifying one's feelings and in 
distinguishing between emotions and bodily sensations and pain sensitivity. Toronto 
Alexithymia Scale (TAS-20) has become a widely used instrument for assessing this 
psychological construct in both research and clinical practice.(Bagby et al., 2006, 
Parker et al., 2003). Research has demonstrated that targeting alexithymia in other 
conditions can lead to clinical benefits; a possible research question could be whether 
interventions that aimed to enhance emotional expression or processing could lead to 
improved mental or physical health in those with FMS. A greater attention to the role 
of alexithymia in FMS may provide elucidation of emotional processing in 
fibromyalgia with its consequent effects on pain experience, affect and 
communication.  (Graugaard et al., 2004, Beresnevaite, 2000). The uses of self-report 
TAS in this research for assessing the impact of alexithymia on FMS patients by 
exploring how it is linked to FMS and the influences of alexithymia on patients’ daily 
living.     
In addition the Fibromyalgia Impact Questionnaire; (FIQ), and Toronto Alexithymia 
scale TAS-20) will be used in addition to the interview, this will extend the timescale 
of the interview by another 5 minutes. FIQ assesses impact of fibromyalgia subjective 
patient reports on scale, functional status instruments and clinical observations. The 
standardised scoring system provides an indication of the extent of impact of the 
condition upon the patient. Impact Measurement Scale (AIMS) was used to assess the 
content validity of 10 items, which consisted of work difficulty, feeling good, pain 
fatigue, rest and stiffness. (Bennett et al., 2009, Burckhardt et al., 1991). Therefore, to 
assess patients function and impact of fibromyalgia to augment the qualitative data, 
the validity of Fibromyalgia Impact Questionnaire measuring patient's' subjective 
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responses is a validated outcome measure frequently used in research studies of 
fibromyalgia. The TAS-20 used to indicate the agree or disagree with each statements 
on Likert scale, the results provided a TAS total score, and the three subscale score 
that measure different aspects of alexithymia include  difficult identifying 
feeling(DIF),difficult describe feeling(DDF) and externally-oriented thinking (EOT. 
DIF measures the ability to distinguish specific emotions or between emotions and the 
body sensations of emotional stimulation, DDF, which assesses the ability to verbalise 
one’s emotions to other people and EOT which evaluate the tendency of individuals 
to focus their attentions externally not on emotional experiences.(Lumley et al., 2007). 
2.6.3 Analysis of Qualitative Data (Framework Analysis). 
The qualitative phase of this mixed methods study will be analysed using the 
Framework Approach. The framework method sits within a broad family of analysis 
methods often termed thematic analysis (Gale et al., 2013). In the late 1980s 
Framework analysis was used in large scale policy research (Ritchie, 2003b) however 
has since been increasingly used in health research (Gale et al. 2013). These 
approaches identify commonalities and differences in qualitative data, before focusing 
on relationships between different parts of the data, thereby seeking to draw 
descriptive and/or explanatory conclusions clustered around themes (Ritchie,  2003 ). 
The Framework analysis provides clear steps to follow and produces outputs of 
summarised data to facilitate interpretation. These steps include familiarisation with 
the data, initial coding, followed by development of a thematic framework, application 
of this thematic framework to the remaining transcripts, and the thematic framework 
is developed as required based on emerging themes (Gale et al., 2013).  Charts are 
then developed to provide a summary overview of the data grouped into themes, and 
this facilitates overall interpretation.  During the charting stage elements and 
dimensions are explored within the data. Elements are small statements, which capture 
responses from individuals and are grouped into dimensions related to similar 
response. (Ritchie, 2003a). Following this dimensions are grouped into related 
categories, which following interpretation are refined and developed into overall final 
themes (Ritchie, 2003b). The Framework analysis is a flexible approach that can be 
adapted for use with many qualitative approaches that aim to generate themes, 
however, is not aligned with a particular epistemological, philosophical, or theoretical 
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approach(Gale et al., 2013), which fits with the approach of this thesis.  
2.7. Medical Research Council Framework 
A Framework for the Development and Evaluation of RCTs for complex interventions 
to improve Health has been published via the Medical Research Council MRC (De 
Silva. et al., 2014). Complex interventions are widely used in the health service, in 
public health practice, and in areas of social policy such as education, transport, and 
housing that have important health consequences (Pinnock et al., 2007). Complex 
interventions are usually described as interventions that contain several interacting 
components. There are, however, several dimensions of complexity: it may be to do 
with the range of possible outcomes, or their variability in the target population, rather 
than with the number of elements in the intervention package itself. Implementation 
research seeks to identify which techniques are effective for encouraging the version 
of evidence into practice and to provide information about ‘real world’ variability in 
effectiveness and cost effectiveness of interventions, and about the practicalities of 
introducing and sustaining new treatments or services (Pinnock et al., 2007, Pinnock 
et al.,  2003 ). Consequently, evaluations of complex interventions should be informed 
whether or not the intervention was ‘successful’and in a way that enables the 
intervention to be duplicated or modified for the purposes of further research or for 
larger scale implementation. It is important to provide a full explanation of the 
intervention application and implementation, and often  beneficial  to  interpret  the  
process  of  developing  and  implementing  the interventions, as well as the results of 
the evaluation (Wight and Abraham., 2000 , Wight et al., 1998  ). The proposed two 
phase research described above will seek to explore important aspects associated with 
the condition. Within this research, an exploration of existent literature will be 
conducted and appraised. Following this a qualitative study with people living with 
FMS will be conducted to develop an in depth understanding of management of the 
condition and guide future intervention development. A descriptive survey 
(questionnaire) in the health and social research is to convey the validity of level of 
health care with a particular intervention and the various services it provides in the 
UK. 
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2.8. The Survey (Phase 2) 
In order to elucidate current fibromyalgia practice, a survey method was  used. Surveys 
allow the development of theory directly based on data collected by the researcher 
(Holloway and Wheeler., 2010, Creswell, 2007 ). Survey research grew with a 
positivist approach to social science, it allows researcher to gather information and 
test multiple hypothesis in a single survey. For this purpose a survey is appropriate 
when the researcher wants to explore behaviour and beliefs. 
 A survey technique is often adopted where there is not much knowledge and research 
exists, concerning the phenomenon being studied. An initial literature review reveals 
very little research on the subject of the standard care for fibromyalgia both in the UK 
and in Libya. This study aimed to develop upon previous research ( Sim and Adams 
2003), by surveying a large national population of  arrange of health professionals in 
the UK. The survey’s capacity for generating computable data on large numbers of 
individuals who are known to be representative  of wider by practitioners as mean of 
capturing various of the elements of research phenomena (Bryman, 1988). 
Therefore, participants were recruited from the British Pain Society for survey phase 
2A and for survey phase 2B were recruited from Libyan healthcare professions, the 
questionnaire was adopted version from previous study by (Sim and Adams, 2003a), 
using a mailed questionnaire. The questionnaire modified a previous version used in 
the study above. The study was further extended to conduct an exploratory study in 
Libya with Libyan health and medical professionals regarding chronic widespread 
pain practice, management and assessment in Libya.  
 In this research, quantitative and qualitative research will be regarded as two 
emphatically different elements to explore the dimensions of the research study 
questions. This research project will explore, the processes involved and the factors 
are influencing interventions for fibromyalgia treatment approaches. 
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3. INTRODUCTION  
3.1 Background  
Fibromyalgia is a chronic musculoskeletal pain condition that is characterised by 
being challenging for healthcare professionals, due to the uncertainty of diagnosis, 
processes and treatment. The condition is often considered invisible, raising questions 
of credibility and understanding, and the impact of symptoms on physical and 
emotional aspects (Friedberg, 2010a). Diagnostic labels thus become an important 
factor in the experiences of individuals living with the condition finding the location 
and intensity of pain to be unpredictable and affecting the level of activities (Friedberg, 
2010b). The literature has either direct or indirect implications for primary care and 
professional practice, in relation to such issues as developing a more sensitive 
understanding of patients’ symptoms, and a more collaborative and fruitful therapeutic 
relationships. In contrast, the use of social, family and support group networks were 
found to be more psychological, and based on self-identity or self-image in a 
population of individuals living with chronic illness (Dwarswaard et al., 2015).  
Although a number of studies have been conducted to investigate the experiences of 
people living with fibromyalgia, many of these are not UK based, and there is 
considerable heterogeneity in the foci of studies, as identified in a previous qualitative 
synthesis study (Sim and Madden., 2008). Twenty-two separate studies were 
identified in Sim & Madden (2008) qualitative synthesis, and each study was 
evaluated using methodological criteria to provide a context for interpretation of 
substantive findings. The meta-synthesis review identified four central themes: 
experience of symptoms, search for a diagnosis, legitimacy, and coping. The 
intangible, ambiguous and invisible nature of pain in FMS is problematic for both 
patients and healthcare professionals, and raises important issues of legitimacy. As in 
other ‘invisible’ conditions, the individual’s social and moral credibility are under 
potential threat. The diagnostic journey undertaken by people with FMS, and the 
meaning attached to the diagnostic label, are important issues in the individual’s 
experience of the condition.  
Most of the studies of patients’ life experiences have tended to focus on the 
experiences of diagnosis and healthcare, and how the condition affects daily activities, 
including social interactions and personal relationships with GPs and HCRs regarding 
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the availability of intervention approaches, and how they currently treat patients. 
‘However this identifies an unmet need to focus on patient views of living with pain 
and the emotional factors that impact their condition’.  
A recent study in the UK by Sahar et al. (2016) included participants diagnosed with 
fibromyalgia (n=148), in a cross-sectional online questionnaire focused on self-
efficacy, acceptance, and coping. Participants with fibromyalgia were recruited from 
fibromyalgia support groups and organisations across the UK, and the United States 
of America (UAS) used online settings. Measurement outcomes were used, which 
included the Arthritis Self-Efficacy Scale, Chronic Pain Acceptance Questionnaire 
(CPAQ), Revised Fibromyalgia Impact Questionnaire (R-FIQ), Medical Coping 
Modes Questionnaire (MCMQ), The Present Pain Intensity (PPI), Tampa Scale for 
Kinesiophobia, and Pain Catastrophising Scale (PCS). Data was analysed using IBM 
SPSS 19. The study found no significant relationship between symptoms intensity and 
fibromyalgia impact.  
Coping and self-management is frequently observed as having multiple elements, in 
which self-efficacy is a central factor (Carnes et al., 2012, Miles et al., 2011). Thus, 
providing patients with knowledge may develop confidence with psychosocial 
aspects, and support people with chronic musculoskeletal pain such as FMS and   
fatigue syndrome to self-manage. Due to this study being a questionnaire, there is 
scope to develop qualitative literature exploring these areas to enhance depth of 
understanding.  
A literature review was conducted to identify qualitative literature exploring 
individuals living with chronic widespread pain and fibromyalgia.  Aveyard (2019) 
discusses a narrative or literature review can follow some systematic approaches such 
as transparent search terms and clear criteria. This approach has been adopted for this 
section.  
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.  The search terms and databases searched are shown in Table3.1  
Table 3. 1: Show the search teams to identify existing literature review.  
Database Search terms 
Science 
Direct 
Fibromyalgia and experience and qualitative 
Fibromyalgia and interventions and qualitative 
Fibromyalgia and Alexithymia and qualitative 
Interventions and chronic pain 
Pain experience and fibromyalgia 
Fibromyalgia and Patient perception 
Fibromyalgia and Patient satisfaction 
Fibromyalgia and health care 
Fibromyalgia and patient relationship 
Fibromyalgia and quality of life 
Fibromyalgia, Qualitative, interview, subjective and experience 
Fibromyalgia and Homeopathy 
PubMed PubMed and Medline searches were performed using the keywords 
Fibromyalgia and experience and qualitative 
Fibromyalgia and interventions and qualitative 
Fibromyalgia and Alexithymia and qualitative 
Existing qualitative literature that has explored experiences of daily living with 
fibromyalgia from patients’ perspective were identified from 17 qualitative studies. 
The studies were found from searches of the PubMed and Science Direct databases.  
Table 4.2 details the qualitative studies identified with this search, and their key 
characteristics and findings.  
Studies included in this study were qualitative and focused on individuals’ experiences of 
living with a chronic widespread pain (fibromyalgia). Publications were all written in the 
English language from the UK, USA, the Netherlands, South Africa, Turkey, Sweden, Spain, 
New Zealand, Finland and Norway. The narrative review included literature published after 
2009 to explore the literature published following Sim and Madden (2008). 
 
Table 3.2. Inclusion and Exclusion Criteria 
Inclusion Criteria                                                                                               Exclusion Criteria 
English language only 
Published literature only  
2009 towards  
Studies that explored patients perceptions of living 
experiences with pain 
Not English language  
unpublished literature  
pre2009  
Studies that explored patients perceptions 
quantitatively included systematic review     
Studies that explored the experiences effectiveness of 
interventions approaches 
 A descriptive quantitative studies 
studies are related to chronic widespread pain  Qualitative systematic reviews 
Chapter Three a Qualitative Study Of The Experiences Of People Living With Chronic Widespread  
(Fibromyalgia) Regarding Assessment, Management And Interventional Approaches 
57 
 
Table 3.3: Characteristics of qualitative studies located during the literature search  1 
Author Design Number of participants Findings 
  Tamara Marıa et al. 
(2017) 
An interpretive 
qualitative study  
13 women The physical symptomology, guilt, fear and a lack of understanding compromise 
the coping process. Women need the support of their partner, their socio-
family environment and health professionals. Nurses can aid the successful 
adjustment to complications related to fibromyalgia. 
Armentor (2017)   Qualitative descriptive 20 women Skepticism, disbelief and a lack of comprehension often led participants to avoid 
social interactions in attempt to hide from the stigma associated with 
disputed, hidden illness. 
Vincent et al. (2016)   A descriptive 
qualitative study 
44 participants Avoiding physical activities may indicate a lack of knowledge of or ability to use 
healthy coping strategies, and therefore, future research could evaluate the 
potential effects of teaching patients healthy coping strategies as one method 
to deal with symptom flares. 
 (Cooper and Gilbert, 
2016) 
 
A qualitative study 
utilising in -depth 
interviews 
15 people Support from family, partners, and peers plays an integral role in the process of 
accepting fibromyalgia diagnosis and seeking help from healthcare providers. 
Juuso et al. (2016) A qualitative approach 
utilising in -depth 
interviews 
15 women Women with FM experienced incapacity to work as they had previously and 
eventually accepted that their work life had changed or reached its end. Since 
their work had great significance in their lives, feelings of loss and sorrow 
were common. Women who were working, unemployed, or on sick leave 
described feelings of fear for their future work situations. 
Eilertsen et al. 
(2015) 
Qualitative thematic 
interviews 
95  patients The finding of this study similarities and differences experiences of fatigue were 
found across a long-term illnesses. Unpredictable fatigue, sleepiness were 
commonly expressed with pain and increased stress sensitivity. There were 
also a lack of energy as was the impact on social relationships and regarding 
how the patients managed their daily life .All patients felt a lack of 
understanding and disbelief from others. 
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Calsius, et al 2015 A phenomenological-
hermeneutic 
approach 
30  patients The study found that As alexithymia had no influence on the description of body 
awareness BA, it seems that FM patients primarily fail to express their BA 
without in fact being disembodied. 
Toussaint et al. 
(2014) 
Qualitative study 
utilising -focus 
Groups   
13 women Forgiveness education is acceptable and feasible in patients with fibromyalgia. 
This justifies further exploration of forgiveness as an emotion-focused self- 
management strategy to decrease psychological distress. 
Dennis et al. (2013)   Qualitative thematic 
interviews 
20 patients    Participants described enduring the course of a ‘giant mess’ of unpleasant 
symptoms, some of which were understood to be symptoms of fibromyalgia 
and some the interactive or parallel effects of comorbid illness. The 
respondents also demonstrated their considerable efforts at imposing order 
and sense on complexity and multiplicity, in terms of the instability of their 
symptoms. They expressed ambivalence towards diagnosis, doctors and 
medication, and we noted that each of the above areas appeared to come 
together to create a context of relational uncertainty, which undermined the 
security of connections to family, friends, colleagues and the workplace. 
Matthias et al. (2012) Qualitative interviews 26 patients patients identified the nurse care is playing an important role to help patients find 
what works for their pain; holding patients accountable for their pain 
management, also, motivating and providing emotional support to patients. 
De Vries et al. 
(2011) 
Qualitative study  
semi-structured 
interviews 
21 subjects The study found that behaviours promoting staying at work such as: raising 
adjustment latitude, changing pain-coping strategies, organizing 
modifications and conditions at work, finding access to healthcare services, 
and asking for support. Motivators and success factors for staying at work 
may be used for interventions in rehabilitation and occupational medicine, to 
prevent absenteeism, or to promote a sustainable return to work. 
Rodham et al. (2010)  Qualitative semi-
structured 
interviews 
Four women with FMS Loss of identity’ played a significant role in the way in which carers and people 
with FMS alike experienced and managed FM. This was compounded by the 
lack of belief, understanding and negative attitudes expressed by amateur 
people and professionals. 
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Escudero-Carretero 
et al. (2010) 
Qualitative study 
interviews focus 
groups. 
20 women and 1 man Patients describe a difficult experience, with symptoms that may involve 
incapacity for daily activities. Until knowing their diagnosis, they feel a lack 
of understanding and loneliness. They develop different coping strategies, as 
looking for information or association. From the health system they expect: 
attention and a fast diagnosis, accessibility to consultations, medical exams 
and therapies or an impulse for research. They want trained professionals, 
proactive attitudes, interest, empathy and information. 
Sallinen et al. (2011)   A qualitative study, 
narrative interview 
20 women Four types of experience concerning work ability were identified in the 
narratives: confusion, coping with fluctuating symptoms, being ‘in between’ 
and being over the edge of exhaustion. Severe pain and fatigue symptoms, 
combined with a demanding life situation and ageing, seemed to lead to 
substantial decrease in work ability and functioning over the long term. 
Lempp et al. (2009) A qualitative study -
interviews 
12 patients Patients expected more consultation time and effective treatment than they 
received. Subjective experiences and objective physical and emotional 
changes were non-overlapping. 
Arnold et al. (2008) qualitative study ,focus 
group    
48 women Fibromyalgia had a considerable negative impact on social and occupational 
function. Patients reported disrupted relationships with family and friends, 
social isolation, reduced activities of daily living and leisure activities, 
avoidance of physical activity, and loss of career or inability to advance in 
careers or education. 
2 
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   3.2.1 Experiences of living with Fibromyalgia 
Table 3.3 provides an overview of the current literature focusing on living with 
Fibromyalgia. This literature will be discussed in further detail to highlight what is 
known within this area, and the need for future research. In a qualitative study 
conducted in a rheumatology outpatient clinic, 12 patients were interviewed at medical 
school which included 11 female and 1 male age range of patients were 20-69 years 
(Lemp et al. 2009). The qualitative interviews were conducted in the UK, and aimed 
to understand the patients’ experience of living with this long-term condition (Lempp 
et al., 2009). Content and discourse analyses were used to analyse the data. The 
interview guide consisted of four areas, namely the experience of the onset of the 
illness, the development of FMS following diagnosis, the impact on patients' lives, 
work and family, and the patients’ expectations and experiences when seeking medical 
help in primary and secondary care.  The study found that patients expected more 
consultation time and effective treatment than they felt they received. Subjective 
experiences and objective physical and emotional changes were non-overlapping. This 
study however, did not explain the associations between these issues, and the 
explanatory models of patients and staff need to be considered.    
The four areas were explored by Lempp et al., (2009), where the themes presented 
included life changes before and after diagnosis, health identity change, and quality of 
care. The lack of knowledge about FMS by patients, healthcare providers and the 
public ,  Patients expected more consultation time and effective treatment than they 
received. This study on the experience of living with pain is similar to semi-structured 
interviews that gather in-depth views on the experiences of living with FMS.  
In a recent qualitative study by Cooper and Gilbert (2017) based in South Africa, 
historical data was collated from n= 15 participants, focusing on the diagnosis of 
fibromyalgia, the participants were all women aged between 23 and 59 and diagnosis 
occurred in private healthcare settings . The study conducted in-depth interviews, and 
narrative analysis was used for data analysis, which is a comparable procedure to those 
found in other social support literature in the Netherlands and the UK (Dwarswaard et 
al., 2015, Campbell et al., 2011). The social factors on employment was related to 
fibromyalgia and musculoskeletal chronic pain conditions, with little attention to the 
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inﬂuence of informal social support. The findings described fibromyalgia as a chronic 
illness that is hidden, and is based on a diagnosis of exclusion, which can result in 
challenges to credibility. Furthermore, the study observed that individuals experience 
widespread chronic pain that appears to affect their daily living activities. The study 
limitations included the context of the study, as healthcare in South Africa may be 
different to the UK, thus limiting transferability to this the UK context.  
Many studies have focused on the experience of diagnosis (Armentor, 2017, Matarın 
Jimenez. et al., 2017, Embuldeniya et al., 2013) with these studies, focusing on other 
aspects of patients’ experiences, such as social support and effectiveness of 
medications, rather than understanding pain. Alongside this explorination of what 
works best for FMS patients in relation to pain (Vincent et al., 2016, Eilertsen et al., 
2015) has been explored.  Other complex aspects of the condition include living with 
a chronic condition related to functional disability that affects social and familial 
relationships.  As such, individuals living with chronic widespread musculoskeletal 
pain experience discuss diminished social, recreational, and community activities, and 
thus a decrease in the ability to maintain social relationships. Due to the importance 
of these aspects, further research is required in this area (Sim & Madden 2008). 
In a qualitative study conducted by Escudero-Carretero,et al( 2010) the experiences of 
patients with FMS towards the health system and its professionals were explored. 
Patients with fibromyalgia were included (n=20) including one male. A content 
analysis was used in the study for delving into patient experience. The participants 
were recruited through health professionals in the Andalusian Health Service and 
patients’ associations. The finding of the study were included that, patients describe a 
difficult experience, with symptoms that may involve incapacity for daily activities. 
Until knowing their diagnosis, they feel a lack of understanding and also loneliness. 
They develop different coping strategies, as looking for information or association. 
The study presents a limitation of not being conducted in the UK, therefore limiting 
transferability to a UK health context.  
The invisibility of the illness creates difficulties for individuals who are affected in 
terms of work and social activities. A study by Armentor (2017) used a convenience 
sampling process in a qualitative investigation about women living with FMS. The 
study was based in a rheumatology clinic, and a snowball sample consisting of 20 
Chapter Three a Qualitative Study Of The Experiences Of People Living With Chronic Widespread  
(Fibromyalgia) Regarding Assessment, Management And Interventional Approaches 
63 
 
women participated in this study, all 20 women were diagnosed 12 years before the 
study. Participants were recruited from local rheumatologists’ offices and snowball 
sampling from the referrals of existing interviewees, and the various approaches used 
by people with FMS to manage their social roles with others, including family, friends 
and medical professionals, were explored. The findings suggested that disbelief and a 
lack of understanding often led participants to avoid social interactions with friends 
and family, in an attempt to hide from the stigma associated with an invisible and 
contested illness. Participants reported that the lack of awareness and knowledge about 
FMS contributed to creating a sense from others that the illness is not real. Awareness 
and knowledge of FMS did not always relieve stigma. As this study was conducted in 
the USA, the results may not suitable for trasnferability to the UK population, due to 
the different healthcare systems and availability of interventions between the two 
countries. Research is therefore required to capture rich data from a UK based sample 
of people living with fibromyalgia. 
A recent qualitative study by Vincent et al. (2016) explored the characteristics, causes, 
and management strategies of fibromyalgia flares. A total of 44 participants (30 
women and 14 men), recruited from an existing, national registry of patients with 
fibromyalgia who have been seen at Mayo Clinic in Rochester, USA.  Using seven 
open-ended questions, patients were asked to describe how a flare differs from their 
typical fibromyalgia symptoms, and how they coped with fibromyalgia flares and the 
factors associated with flares. Content analysis was used to analyse the results. The 
authors sought to understand how patients perceived fibromyalgia flares, and what 
triggers and alleviating factors patients identified for their symptoms. The study found 
that flares were associated with the avoidance of physical, social, and psychological 
stimulation. Avoiding activities may indicate a lack of knowledge of or ability to use 
healthy coping strategies, as for some participants, social interactions were 
emotionally and physically challenging.  There were some inherent limitations in the 
study, which included the fact that data was collected by text response to the survey, 
rather than using interviews or focus groups to allow for deeper understanding of the 
experience. Thus, to avoid such a limitation in this research, qualitative semi-
structured interviews can be  used in order  to gather in-depth information regarding 
patients’ experiences of their condition. Another limitation of the US-based study was 
that authors did not specifically conceptualise the flare ups and their fluctuating 
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symptoms regarding pain or fatigue level of severity, which are key symptoms of 
fibromyalgia. Similarly to a number of other studies described, this study was 
conducted in the USA, and as such, it is important to explore a UK based population 
given the differences in healthcare between the two countries. 
In a qualitative study conducted by Eilertsen et al. (2015) to investigate the fatigue 
experience of illness, and its impact on daily living across several long term illnesses 
including fibromyalgia, multiple sclerosis, ankylosing spondylosis, and stroke, 
interviews were conducted with 95 mixed Northern European participants, comprising 
66 women and 29 men. Of which 25 were FMS patients, the interviews were carried 
out at places chosen by the patients. Similar experiences of fatigue were found across 
different long-term illnesses in this study. Unpredictable fatigue and sleepiness were 
commonly expressed with pain and increased stress sensitivity. There was also a lack 
of energy, which had an impact on social relationships and on how the patients 
managed their daily activities. All patients felt lack of understanding and disbelief 
from others. The large variation in how long the participants had suffered from their 
illnesses may be a limitation of this study. Thus, some differences identified in the 
analysis might reflect differences in how the interviews were conducted, rather than 
actual differences between diagnostic groups. The study highlighted the similarity of 
the experience of pain and fatigue across a number of long-term conditions, and that 
such symptoms are not specific to fibromyalgia.  
3.2.2. Emotional Aspects of Fibromyalgia  
Emotional aspects of fibromyalgia are considered an important part of the condition 
by many authors, yet, as identified from the literature review, there are few empirical 
studies that have specifically investigated the extent and nature to which the emotional 
component contributes to the experience of fibromyalgia. The concept of alexithymia 
was introduced in previous chapters, and some studies have indicated the difficulty 
that people with fibromyalgia have in emotional recognition.  
A previous qualitative study by Calsius, et al (2015), of 30 women diagnosed with 
FM, patients were recruited from “Ziekenhuis Oost-Limburg” (ZOL) in Belgium 
(Genk) and in 10 different physical therapist practices data were collected. The study 
has supported the concept of lack of emotional recognition. Patients had been 
identified as having alexithymia and patients failed to express body awareness( BA) a 
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representation of alexithymia. The psychological factors contrasted with somatic 
dichotomy, the moral credibility of patients, and the experience of treatment used. 
Despite these limitations, this forms an interesting avenue for research. Therefore, 
identifying the emotional features of people living a chronic widespread pain 
conditions may affect their daily living activities and warrants further exploration. In 
this research, an assessment of emotional recognition using a standardised inventory 
was carried out to assess alexithymia and emotional recognition.   
Emotional recognition may affect patients’ perceptions of interventions in which they 
participate. A qualitative study by Matthias et al. (2012) of 26 female patients ages 
ranged from 24 to 62 were  recruited from primary care clinics, the study aimed to 
ascertain the perceptions of a multicomponent intervention, tested in a randomised 
controlled trial for people with chronic musculoskeletal pain. Patients in this study 
were interviewed at the Veterans Affairs AV medical centre, at which they enrolled in 
Evaluation of Stepped Care for Chronic Pain (ESCAPE). As grounded theory guided 
the qualitative analysis, the findings of this study identified that self-management 
education was particularly significant. Patients identified the nurse care manager who 
administered the intervention as being integral to their ability to  
self-manage their chronic pain. Furthermore, the study depicted self-management as 
involving more than activities and strategies, but also acknowledged the central role 
of relationships and support in pain self-management. Patients in this study were all 
veterans of the recent wars in Iraq and Afghanistan, sampled from one VA primary 
medical centre. Given the sometimes unique experiences of veterans, all results may 
not apply to patients with chronic pain cared for in other clinical settings. Participants 
were interviewed only one time, a median of two months after completion of the 
intervention. The investigators were unable to ascertain how long the effects of the 
support from the nurse lasted after patients completed the study and were left to self-
manage on their own. The study not only acknowledged the role of self-management 
education as part of a multicomponent intervention, but also identified components 
involved in facilitating self-management. Experiences of self-management were 
therefore explored in this research, and are discussed in the subsections to follow. 
A qualitative study by Sallinen et al. (2010) used a narrative interview method to 
collect the narrative life stories of 20 women with fibromyalgia. Participants were 
recruited from rehabilitation courses in the Rheumatism Foundation Hospital in 
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Heinola, Finland.  Data was analysed by using stepwise regression to elicit the impact 
of peer support, as described and reflected on in the patients’ narratives after 
rehabilitation intervention. The study identified four main domains of experiences of 
peer support, namely permission to talk, need to information, reciprocity, and self-
evaluation through comparison. The meanings ascribed to peer support were mainly 
positive, although the participants also expressed thoughts about fear of future, 
hopelessness and mental health issues. A major limitation of the study is small number 
of participates who were volunteered in the rehabilitation groups. The importance of 
the support domains was further explored in the current study, in addition to exploring 
other avenues of how people with fibromyalgia access support and information. Such 
knowledge should allow the development of better healthcare services, contribute 
towards a more holistic management of FMS, and provide support to those who had 
recently been diagnosed.   
The literature on the experiences of living with fibromyalgia is diverse, particularly in 
terms of assessing and managing FMS, where various intervention approaches and the 
healthcare processes have been mentioned by individuals living with fibromyalgia. 
Furthermore, the literature has addressed a number of aspects that appear to influence 
singly and in combination, the experience of living with a long-term condition, such 
as fibromyalgia. There has been considerable focus on the impact of receiving a 
diagnosis, and on the varying experiences of the journey leading to diagnosis. Various 
other aspects that impact the experience of fibromyalgia have also been explored, 
including the experience of the symptoms of pain and fatigue, and the consequent 
impact on functional and daily activities, and the strategies to cope with the pain, 
fatigue and cognitive dysfunction. The impact on social and familial relationships has 
also been explored. A recurring theme explored by multiple studies is the impact of 
living with  a condition, that despite considerable effects on daily living, has an 
element of ‘invisibility’, and a perceived lack of understanding by friends, family and 
healthcare professionals alike. Although psychosocial factors are often attributed to 
such conditions, the way in which emotional aspects influence cognition and other 
perceptions has not been widely explored. Furthermore, a large number of studies were 
not conducted in the UK. A qualitative study was therefore designed to explore these 
aspects, with the overall purpose of developing a framework model for the experiences 
of UK patients living with this long-term condition, in terms of symptoms description, 
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diagnostic processes, impact on daily activities, and management strategies. 
3. 3 Aims:     
 Therefore in this chapter the following objectives have been identified.  
This study addressed six key questions: - 
1. To explore the experience of service users’ in  the process of obtaining a 
diagnosis  
2. To explore the emotional experiences of sufferers 
3. To explore the experiences of the support received   
4. To explore the experiences of coping  and managing daily living activities  
5. To explore the interventions that have been accessed by sufferers and their 
experiences of these interventions 
6. To explore the experiences of living with pain   
3.4 Methods 
A qualitative study design using semi-structured interviews was adopted, and the 
framework method of analysis was used to describe the individuals’ experiences of 
living with the condition.  
3.4.1 Design and sampling 
As mentioned above, a qualitative design utilising semi-structured interviews was 
adopted. Participants were individuals living with FMS who had attended a 
Fibromyalgia Support Group in the North of England. Twelve individuals who had 
attended the support group consented to take part in the study upon invitation. A 
participant information sheet (which can be found in Appendix (7)) was sent to each 
participant in January 2016. The sample was purposeful, as it aimed to achieve a range 
of views and experiences of living with pain. The Fibromyalgia Support Group was 
appropriate to target due to the diversity of views, and the experiences of seeking 
assistance from different health service locations. To be included in the study, the 
participants had to be living with FMS, and have experience of living with FMS in the 
last three months. The interviews were recorded and transcribed, and the data was kept 
in a secure cabinet at the Northumbria University for the purposes of this study. The 
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interviews were listened to by the researcher only. The names of all individuals were 
changed to protect their anonymity, and all information collected was kept 
confidential, as only the research team had access to it. In addition, all quotes that were 
used in the final report were anonymised, and the names and details of participants did 
not and will not appear in any printed document. Case report forms (CRFs) (i.e. 
complete interview data) were stored securely in a locked cabinet at the Northumbria 
University, and will be destroyed a year after the end of the research. Data can be 
withdrawn if a request is made before a specified deadline. 
Table 3. 4: Interview timetable. 
Date Interview 1 Time Interview 2 Time 
9th March 2016 P1 10 am -11:30 am P2 12pm-01:30pm 
14th March 2016 P3 10 am -11:30 am P4 12pm-01:30pm 
15th March 2016 P5 10 am -11:30 am P6 12pm-01:30pm 
16th March 2016 P7 10 am -11:30 am P8 12pm-01:30pm 
18th March 2016 P9 10 am -11:30 am P10 12pm-01:30pm 
23rd March 2016 P11 10 am -11:30 am P12 12pm-01:30pm 
 
 
3.3.1.1. Demographic Information 
The 12 participants were all women with age of 27–60. see section 3.6.2 a rational for 
samble size .The current study included the onset of illness to FMS diagnosis was five 
years (range: 0.3–10). Nine participants had co-morbidities (chronic neck pain, 
chronic back pain, fatigue, depression, sleep disturbance, muscle and joint pain). Six 
people were retired, and four were unemployed. One participant was a paid worker 
and one participant was unemployed and disabled because of illness, the 
characteristics of the people involved are detailed in Table 3.5. 
Table 3. 5: Characteristics of Participants. 
Participa
nts 
Age Sex Employment Point of pain 
experience (years) 
Previous diagnosis 
P01 60 Female Retired Three years Polymyalgia 
P02 38 Female Employment 
states 
 Five years Juvenile arthritis 
P03 27 Female Employed       One year  Guillain-Barre syndrome 
P04 55 Female Retired Two year Psoriasis(growing pain) 
P05 54 Female Retired Five years Diabetes  
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P06 45 Female Unemployed Twenty-five years Knee arthritis 
P07 46 Female Unemployed Ten years Hypermobility syndrome  
P08 62 Female Retired One year and two 
month 
Plantar fasciitis  
P09 60 Female Retired Ten years  Repetitive strain  
P10 39 Female Unemployed Four years Arthritis/ back pain  
P11 39 Female Unemployed Five years Hypermobility syndrome 
P12 57 female Retired Ten years Hypothyroidism  
 
 
3.4.2. Data collection 
The interviews were carried out with each of the twelve participants, and lasted an 
average duration of 1 hour and 30 minutes. Interviews were conducted from the 9th 
March to the 23rd of March 2016, at a time chosen by the interviewees.  Participants 
provided written informed consent before the interviews started (the consent form 
used for this study can be found in Appendix (6)). The interview schedule guide, which 
was developed based on the literature review (Table3.6), was piloted with supervisors, 
and revised before commencing the actual study. The interview guide mentioned 
above was informed by previous qualitative studies that highlighted the limited 
literature regarding the understanding of individuals’ views on pain experience and its 
asscoiatd emotional impact. The principal researcher moderated the flow of interviews 
through a schedule guide, which were digitally recorded and transcribed. The 
participants were aware that the researcher had a background in chronic pain 
management and was a physiotherapist, which allowed natural conversations to occur. 
3.4.3. Schedule of semi-structured interview 
As stated in Chapter 3, the preferred method of data collection in this research was 
semi-structured interviews, with the use of open-ended questions designed to motivate 
individuals to talk about their experiences of living with chronic pain. Patients’ 
perspectives were taken into consideration when designing the interview schedule for 
this study. However, the interview schedule was flexible and used prompts where 
required. In all cases, the interview began with issues relating to certain symptoms 
such as pain and fatigue. Table 3.6 presents the interview guide used. 
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3.4.4. Data Analysis 
‘Framework Analysis’ is a method of analysis used to facilitate data analysis by 
indexing relevant information, and liking elements and dimensions to develop 
categories that lead to the final theme (Ritchie, 2003a). The Framework method allows 
the researcher to gain an overview of the data, and determine themes to be used in the 
study. However, the framework method is flexible enough to also allow for new 
themes to be produced (Robson, 2011). The advantages of using the framework 
method is that it is suitable to answer specific questions, as it is very systematic, 
comprehensive and enhances the credibility of the analysis process (Srivastava, 2009).  
As discussed in Chapter 3, for this phase of the study, the framework method is 
appropriate as it can answer specific questions regarding individuals pain experiences, 
daily living with chronic pain, and the process of management. In order to enhance the 
credibility of the findings, frequent peer checks of the developing themes was 
Opening questions 
Questions were firmly inclusive to explore the service users’ experience of living with chronic 
widespread pain (Fitzcharles et al.)assessment and management was started without specific 
influence. 
History/ Background /symptoms 
- What do you feel is going on in your body? Describe the feelings that you experience? 
- What does the Fibromyalgia mean to you? Tell me about the History symptoms that you 
feel? 
- What does the diagnosis mean to you, tell me how you feel when you were diagnosed with 
fibromyalgia? 
Current state 
- What impact has fibromyalgia had on their quality of life? “How has fibromyalgia affected 
your life? 
Treatment 
-  What treatments do you have used to manage your condition? 
Experience 
- How they feeling about services been received from NHS? What they expect to receive? 
Gaps in treatment 
- How you think about other service can be more help from those organizations who 
involving in manage your condition. 
Private /alternative treatment 
- Who do you seen in privet sector? 
Deal /future treatment / management 
- What kind of interventions you may chose for manage you condition? 
Probe:  
- How? Would patients involved? 
Table 3. 6: Interview Guide. 
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conducted by the principal researcher, and the emerging findings were discussed with 
the supervision team.  
The framework approach has a series of interrelated stages, as discussed in Chapter 3. 
The  researcher  began familiarisation with the data to recognise common themes, and 
to comprehend the data as an entirety, with the interview guide used in-line with the 
aims of the study, and the data gathered from the participants’ transcripts. Following 
this, coding and development of a thematic framework took place. Similar subthemes 
were identified from the data index and grouped together under an initial theme. At 
this stage, the same process was applied to all data captured from the individuals’ 
transcripts, with new themes emerging. Subsequently, this data was sorted by theme 
and summarised in matrix-based charts, while retaining the language of participants 
(Ritchie, 2003b). This helped to recognise the data as a whole, which is crucial for the 
subsequent development of themes (Ritchie and Lewis., 2003).  
3.4.5. Familiarisation 
The familiarisations process identified emerging themes within the data. SA read the 
transcripts repeatedly, and used a color-coding method to determine codes and themes 
relevant to the research questions. Familiarisation is the first step in the analytic 
process , in which the researcher gains an overview of the information coverage, and 
become thoroughly familiar with the data (Ritchie,  2003 ). This supports the 
construction of a thematic framework.  
Figure 4.2 details the initial thoughts following a period of familiarisation. Capturing 
the lack of understanding by healthcare professionals, and the lack of support by both 
healthcare providers and communities to people with widespread chronic pain were 
the key findings of this stage.  
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3.4.6. Thematic framework 
The framework approach is considered flexible enough to allow novel, unanticipated 
themes to emerge (Ritchie and Spencer, 2002). Following familiarisation, the 
transcripts were reviewed line by line to identify codes, and group these into initial 
descriptive themes. Eight initial themes were devised from the data, where the first 
four participants’ transcripts were reviewed line by line, and a thematic framework 
was developed. The emergent themes were discussed and peer checked with the 
academic supervisor.  This framework was applied to the remaining transcripts in a 
process termed ‘indexing’ (Ritchie, 2003b). The thematic framework was flexible 
enough to allow new themes to emerge, which occurred over the course of the data 
analysis. Following completion of this stage of the analysis, new themes were 
discussed with the academic supervisor. The thematic framework, provided in Figure 
3.2 , was developed and refined over the course of the analysis. The themes developed 
were relevant to the topic of the study, recurred across the data set, and were related 
to the research objectives.   
One of the key points emerging was the individuals’ views of living with pain, which 
included patients’ experiences of pain, interventions, support and emotional aspects.  
The lack of understanding and support of patients and their concerns also emerged 
from the familiarisation procedure, and developed the subthemes. Thematic 
framework. A chart per heading with sub headings was devised. Data was emerged 
from the original context, and rearranged according to the appropriate thematic 
 Participants had strong beliefs that GPs and professionals should be up to date 
regarding fibromyalgia diagnosis and management. Healthcare providers were 
deemed to not know much about the condition, to the frustration of people 
living with FMS. 
 Self-finding is the process that involves the patient being independently able to 
access information. Participants often found information from such process 
unhelpful. Procedures to do this were discussed, which included internet, 
posture, support groups, GPs and rheumatologists. 
 Participants described psychosocial issues and their associated challenges, and 
how they often made them unconfident of how to deal with such condition. 
  Patients living with FMS felt their psychosocial needs were not met. 
Figure 3. 1 : Initial thoughts following familiarisation. 
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reference. Charting consists of the information drawn from the thematic framework 
(Ritchie and Spencer, 1994) The matrix-based charts of each theme involved in the 
charting phase included the sub-themes along the top, and each participant down the 
side.  The charts included summarised data under each of these headings, to allow the 
researcher to get a ‘feel’ for the data in that theme and across participants (Ritchie and 
Spencer, 2002).  
A data summary captures what the participants are frequently saying regarding their 
living experiences, while the researcher is making the data more manageable (Ritchie, 
2003a).  During the charting phase, it became clear that the main focus was on 
misdiagnosis, and being unclear if the symptoms were related to FMS, which caused 
individuals frustration. The psychosocial impact on daily living activities, and 
individuals being tired and exhausted because of the pain, fatigue, and unrefreshing 
sleep were frequently highlighted at this phase. Within this aspect of the analysis, the 
development of elements and dimensions was carried out.  Elements were identified 
according to the underlying dimensions, to illustrate themes and to expend the 
experience of living with pain, in order to capture the relevant dimensions of the 
phenomena. Once the underlying dimensions were identified, the data had to be 
examined, and elements had to be combined into different responses to a set of 
categories that discriminate between different manifestations of the data (Ritchie,  
2003 ).  
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Patient’s experiences 
1.1 Diagnosis 
1.1.1 Previous diagnosis 
1.1.2 Testing 
1.1.3 Misdiagnosis 
1.2 Pain description 
1.2.1 Varity of causes of pain 
1.2.2 Nerve pain 
1.2.3 Constant pain 
1.2.4 Worsening pain 
1.2.5 Cope and self-managing 
1.2.6 Memory impairment 
1.3 interventions 
1.3.1 Medications efficacy 
1.3.2 Pain clinic 
1.3.3 Physiotherapy 
1.3.4 Massage 
1.3.5 Hydrotherapy 
1.3.6 CBT 
1.3.7 Chiropractor 
1.3.8 Acupuncture 
1.3.9 Psychotherapy 
1.3.10 alternative therapy/herbal/reflexology 
1.4 Support 
1.4.1 GPs 
1.4.2 H C professionals 
1.4.3 family/friends 
1.4.4 NHS 
1.4.5 Private 
1.4.6 Resources 
1.4.7 Attitude of HCP 
1.4.8 Lack of support 
Emotional aspects 
2.1 Annoyed/angry/ increase stress 
2.2 Depression 
2.3 Anxiety 
2.4 Fatigue/Tiredness 
2.5 Unrefreshing sleep 
2.6 Frustration 
2.7 Frightening 
Difficulties faced 
3.1 understanding of condition 
3.2 Challenging speciality 
(physiotherapy/Nurses/GP) 
3.3 Fighting to referral 
3.4 Disabled and loss of work 
3.5 Resources availability 
Patients concerns 
4.1 Gps update 
4.2 Need for specialist 
4.3 public awareness 
4.4 combination  
4.5 Functioning/muscle power 
Research 
5.1 Further research 
5.2 Funding 
 
 
 
 
 
 
 
 
Figure 3.2 Indexed thematic framework 
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3.3.1.6. Developing Categories and Themes 
Following the charting stage, which enhances the credibility of the data analysis 
process through providing a clear audit trail, categories were developed. The principal 
researcher explored the analytic steps of framework analysis to develop categories. 
Ritchie and Lewis. (2003) described the process of identifying categories, which 
involves exploring elements and dimensions to identify differences within the data. A 
set of categories that differentiate between the variability of the identified dimensions 
were devised. Data interpretation began the process of linking categories within the 
data, and developing a higher order themes informed by the developed categories 
(Spencer, 2014b).  
Figure 4.4 illustrates the illness experiences, and the development of the journey to 
diagnosis. The same process was applied for the four figures below .Some overlapping 
between categories remained even at the later stages in the framework analysis, due to 
the richness and complexity of the illness experiences. 
3.5. Findings  
The main themes and subthemes developed through the analytic process revealed four 
linked higher order themes. These are the journey to diagnosis, coping with the 
variability and unpredictability of symptoms, the availability of and satisfaction with 
current healthcare practices and services, and the emotional influences. 
3.5.1. Journey of Diagnosis 
Participants were asked how they felt about the history of their symptoms and how 
they managed their condition. Participants discussed being misdiagnosed, and finding 
it difficult to explain the type of pain they were experiencing. Another area that was 
regularly raised was comparing FMS symptoms with other illness experiences. All 
participants unfavourably remarked that no or very little information was given to 
them following their FM diagnosis. All participants had their diagnosis confirmed by 
a secondary care specialist (rheumatologist), as FMS is hidden in uncertainty and lack 
of knowledge, and it is not easy for others to understand living with fibromyalgia.  
 Participants reported that physicians were unaware of how to perform the examination 
of tender points, due to the lack of understanding of their condition. Misdiagnosis was 
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frequently viewed as a cause of critical anxieties for people living with FMS. 
Commonly, the individuals living with FMS developed a self-strategy of coping with 
their condition, but were unable to manage flare-ups, because of the varied nature of 
the symptoms, which made it difficult for participants to describe their living 
experiences. The participants were asked about when and where they had been 
diagnosed, and different perceptions were highlighted concerning the diagnosis 
procedure.  Generally, the participants had negative views about the support that 
people living with FMS received from the health services.  
 The participants also discussed their experiences of being misdiagnosed, and their 
concerns about the development of expertise understanding and management of FMS 
in UK. This appeared when patients debated their GPs and consultants, and found it 
difficult to be involved in the management of their condition, because of the lack of 
understanding of the cause of their pain. Furthermore, the participants described that 
they often asked to be referred to a consultant, as the primary care was unable to offer 
them something that could help to maintain daily living activates (DLA). Furthermore, 
the patients often chose not to go back to the GPs upon referral to a consultant, because 
of the pain severity and fatigue.  
Figure 3.3: illustrates the development of this theme Journey to diagnosis. The 
diagram depicts the development of the initial themes from the thematic framework 
through to higher order themes. The elements, which capture the essence of patients’ 
perceptions of living with chronic widespread pain, were then grouped into 
dimensions. Dimensions with commonalities between them were grouped into 
categories, and finally into the higher order themes. 
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Figure 3.3: Development of the Journey to diagnosis’ theme.
Initial thematic framework   
reference 
1.1 Diagnosis  
1.1.2 Testing 
1.1.3 Misdiagnosis 
3.1 Understanding of condition 
3.2 Challenging speciality   
3.3 Fighting for a referral 
1.2.1 Variety of causes of pain  
1.4.8 Lack of support 
1.4.1 GPs  
1.4.4 NHS 
1.4.2 Health care professionals   
3.5 Resources availability 
1.4.7 Attitude of HCP  
4.1 GPs updates 
4.2 Need for specialists    
 
Categories 
Lack of understanding / 
support 
- GPs  
- Professionals  
- Working places  
- Communities 
 
Patients views about 
diagnosis  
- Misdiagnosis   
- Varity of 
testing/examination  
- No specific test for 
FMS   
Service availability for 
referral  
-   GPs 
- Rheumatologist 
- Pain specialist  
-  Orthopaedic doctor 
 
 
Journey of 
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Detected elements (examples) and the dimensions within 
the data 
Lack of understanding  
- The rheumatology there had said mine was linked with fibromyalgia, but they 
couldn’t explain how it links (PT2,L1913) 
- The consultants, they weren’t agreeing with GP (PT11,L696)  
-  If there were more GPs, I think, who were more.  like, more knowledgeable   of 
the condition, it would help. (PT3, L752) 
Variety of examination and testing    
- I had to go, for these last two years, under every test that you could imagine. 
Everything came back clear and that’s when I went to the rheumatologist. (PT4, 
L336) 
- Doctor did tests, x-ray and MRI scans and GP said it was fibromyalgia and he said 
there’s not a lot that can be done for it. (PT9, L338) 
- “  There isn’t a test for fibromyalgia.” (PT5, L368) 
Misdiagnosis 
- I was constantly told “It’s just growing pains.  Oh, nothing to worry about…” all 
the time.   (PT4, L338) 
- It’s been more than 10 years. I suffered for 5 years before they even knew what 
was going on( P11,L748) 
- They said it was arthritis, they thought.  But.  They never really (PT9,L690) 
 
Appropriate referral /Availability   
- I think I’ve had a lot of help from rheumatologist, which has definitely been 
beneficial (PT1, L644 ) 
- Orthopaedic, I guess.  And he said that it’s not plantar fasciitis, it’s fibromyalgia in 
your feet (PT7, L194 ) 
- CBT I didn’t find what I needed there.  I thought I was wasting time (PT12,L1974) 
Support  
- My GP has always been supportive(P11,1617)  
- I don’t feel I get the support from the doctors, even now they know. (PT4, L752)   
- I didn’t get any support apart from people who have got fibro.  Doctors, anything 
else, no.  Medical profession, none whatsoever. (PT6, L662) 
- Well, rheumatology, he just gave me a leaflet for the joint hypermobility, nothing 
for the fibro.  and nothing really from the doctors. (PT7,L495)   
- I don’t feel I get the support from the doctors, even now they know(PT4,L752) 
- The doctors didn’t have any leaflets; there was no counselling, nobody 
(PT10,L441)    
 
Class/final 
theme 
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The overall concern identified by the participants when attending primary and 
secondary care and specialists was the misdiagnosis of FMS, because of the lack of 
understanding of the condition. The lack of understanding, misdiagnosis and support 
were elements that the participants considered to be significant issues in the context 
of the assessment and management of their chronic widespread pain. The availability 
of management and appropriate referral procedure were also highlighted by the 
participants as key aspects of the diagnosis process. 
Eight out of twelve participants were dissatisfied with how they were treated by GPs, 
professionals and therapists due to the lack of understanding of their condition. These 
participants questioned how the misdiagnosis and understanding of pain features was 
linked to FMS. They also attributed misdiagnosis to the difficulties involved in 
treating their chronic widespread pain. 
PT2: I was misdiagnosed when I was a child in ’83…  Until 2011, I 
was misdiagnosed.  And then re-diagnosed in 2011 with the 
fibromyalgia, arthritis.  But they believe I’ve had it since the age of 4.  
And so that’ll be 36 years of this.L185 
PT3: It’s a bit of a learning curve.  I think it’s a bit of a learning curve 
for her as well.  She doesn’t specialise in it.  Her speciality is, like, with 
skin.  Like is dermatology.  So it’s a bit different.( L567)  
PT 4: PT4: I was constantly told “It’s just growing pains.  Oh, nothing 
to worry about…” all the time. The consultant finally wrote a letter to 
my GP to say it was fibromyalgia to treat that…  They have nothing 
but respect for me now. They talk to me much better.(L410) 
 
PT5 : The GP didn’t have any idea, the GPs don’t know about 
everything.  I mean, I’ve had other medical conditions in the past. 
(L275) 
PT7: I kept going there and GP’s thought the plantar…  And then I 
went in one day and he said “, you look ill.  Tell me, from your feet 
up, what’s the matter.”  And it was just pains, pains, and pains. 
(L361) 
PT11:  I was referred to the hospital.  They said that it was just…  Is 
it hyperflexibility?  I don’t know the word.  They were saying that my 
muscles were too flexible. I think it was something like that.  I don’t 
know the…  Yeah, I think it was that.  So, they couldn’t do anything 
(L748)   
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Other observations concerning the person living with FMS being involved with such 
a variety of examinations, testing, and diagnosis processes were highlighted as 
experiences that the participants went through to assess their chronic widespread pain. 
They were left frustrated at not being able to access the appropriate healthcare service, 
and mentioned the variability of diagnosis processes frequently.  
PT1: Well, the doctor actually thought perhaps it’s something else and sent 
me to see a consultant, which was when some extra tests were done. Actually 
the consultant did come up with a suggestion of some tests that the GP might 
want to make.( L324) 
 
PT2: I had numerous x-rays, scans, things like that, but…  They were very 
dismissive even as a child .They’ve tested me for everything.(L214)    
PT3 After all the tests had been done, and then gone through just to rule out 
everything else.  So, like, arthritis and stuff like that.  And…  I can’t 
remember what else was looked for. And then it was just last year when I was 
starting to have, like, the MRIs.  The scans.  (L131) 
PT4: They sent me for hip x-rays, knee x-rays, shoulder x-rays, everything 
was coming back clear with tests and x-rays and things. (L169)  
PT7: I had to have an MRI and I had to lie like that in the MRI 
machine.(187) 
PT9: Doctor did x-ray…  He did tests and he said it was fibromyalgia and he 
said there’s not a lot that can be done for it, apart from trying to find a drug 
that suits.(338) 
PT10: All they did was blood tests and then, at the end, he just did the 
pressure points.  They were doing all these blood tests for rheumatoid 
arthritis, something else.B – division (L402 )    
 
Another point discussed was the fact that the appropriate referral and availability of 
rheumatologists were often not accessible to FMS patients in the UK, even though the 
participants were referred by GPs to other healthcare professionals, such as pain 
specialists and physiotherapists. Waiting time was also a concern for people living 
with such chronic pain. Furthermore, the participants mentioned being caught between 
GPs and rheumatologists, and in some cases, being refereed to orthopaedics, as the 
GPs thought their presentation linked to comorbid conditions, such as neck pain or  
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low back pain. The participants were offered medication as treatment for fibromyalgia 
and fatigue symptoms, and some of them made positive observations regarding 
rheumatological management. However, a number of participants brought up negative 
memories regarding experiences of being constantly referred to different kinds of 
healthcare sites.  
PT1: To be honest, the waiting time from the doctor referring me to 
actually getting an appointment with the NHS was four months.(L595) 
PT6: I went to the rheumatology.  Moreover, they said I had 
fibromyalgia, and they gave me a leaflet and said “You’ve got 
fibromyalgia.  There you are.  You are done.  There’s nothing more we 
can do for you.”  Then finding a doctor who believed in it, which was 
quite hard.(L342) 
PT2: It’s just the attitude – especially neurologists, because I had to see 
a neurologist last year.  And when they diagnosed the problem with my 
legs, they didn’t want the word ‘fibromyalgia’ mentioned.  They didn’t 
want that word mentioned.  And that was their attitude.  “You don’t 
mention that name.  It does not exist.”(L882) 
PT8 I had a pain management, and I am down to do a mindfulness – 
eight-week mindfulness course, through the NHS,(L966) 
PT10: the doctors at the hospital, the rheumatologist – although one of 
them was very nice to diagnose it – they didn’t have the literature. They 
didn’t.  They just said “Continue with the cocodamol.”  And that was 
it.(L1000 )   
The invisibility of chronic widespread pain was an issue facing most of the 
participants. Furthermore, they reported a lack of compatibility between the pain, 
symptoms and other comorbid conditions. GPs and healthcare professionals observed 
patients physically, which was not mirrored by how the patients felt inside (i.e. with 
respect to physical appearance not matching the individual’s feelings). The 
participants also described how the misdiagnosis of their condition was an additional 
difficulty posed by the healthcare system itself, due to the limited time available to see 
specialists. Long waiting lists in the sites of assessment and management of GPs, 
rheumatologists, psychologists and alternative therapists also emerged as a common 
theme. As such, many participants reported the need for a specific pathway that FMS 
patients can go through to obtain a correct diagnosis.  
T1: Reading a consultant report, that was when Gp then said “I 
apologise.  You have got polymyalgia.  I should have recognised it 
earlier.( L695) 
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PT11: It’s been more than 10 years.  It took them 5 years to diagnose 
that I have this.  I suffered for 5 years before they even knew what 
was going on.  I was referred to the hospital X.  They said that it was 
just…  Is it hyperflexibility?  I don’t know the word.  They were 
saying that my muscles were too flexible. (L748) 
PT2: The rheumatologist there had said mine was linked with 
fibromyalgia, but they couldn’t explain how it links. (L207)  
 
That fact that the aetiology of FMS is unknown makes it a hidden illness, which results 
in difficulties being faced by people having the condition. Furthermore, the 
participants frequently mentioned how challenging it was for physicians to diagnose 
the disorder in both primary and secondary care, the misunderstanding of the history 
of living with pain, and the varieties of  FMS symptoms and how they linked with 
comorbid conditions, such as fatigue and rheumatoid arthritis. GPs and healthcare 
professionals were described as not confident in the management of FMS, and that it 
seemed they could not expose the quality of service offered to individuals. Most (7/12) 
participants blamed GPs and healthcare professionals for not providing effective 
intervention approaches, and not taking into account the unpleasant effects of the 
pharmacological treatment prescribed for their condition.  
PT2: The GPs just don’t wish to know now. (L207 )  
PT10: Doctors said “Oh, I haven’t got a leaflet.  Go and look it up on 
the internet.”  And that was it.(L441) 
PT4: I would say, with the doctors…  I mean, they’ve not been horrible, 
the local doctors.  But I’ve had to fight with them to listen, to believe 
me, to get me referred. (L525)  
PT5: The GP, you know, didn’t have a clue about fibromyalgia, didn’t 
have a clue about what my pain was. (L740) 
PT3: Obviously I’ve not heard back from the rheumatologists, but 
that’s kind of how things go, apparently.(L525) 
PT7: Well, rheumatology, he just gave me a leaflet for the joint 
hypermobility, nothing for the fibro. (L950)   
PT8: There’s no publicity in the GP’s surgery or anything, Just like 
some kind of advice place that would tell you what’s available, even if 
it is the NHS or medication, but give. (L1248) 
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The participants had a perception of a lack of support because of the misunderstanding 
and lack of knowledge of the natural course of the condition by both professionals and 
community sites. There were not any investigations performed on these sites, and 
services were viewed as not appearing to work together or not being linked. 
PT:12 I don’t think I’ve had anyone who genuinely understands it and 
accepts that it’s quite.  It’s not a serious condition in that you lose 
independence, but it’s serious in that, you know, you’re no longer 
able to do You’re less functional than you used to be.(L2095) 
PT12: when you go to the specialist, they kind of think “Well, what 
are you doing here?”  Because you’re walking in and you’re not 
obviously…  You know.  And they see people really, really poorly.  
Do you know what I mean?  So you kind of feel a bit of a fraud.  And 
then you come out and you’ve still got the same problems that you 
went in with.  So you don’t kind of get that help.  You don’t need 
highly specialised people in rheumatoid arthritis.(L2049) 
The journey to diagnosis was highlighted as a challenge for both healthcare 
professionals and people living with chronic widespread pain, and was characterised 
with limited access to the healthcare system. The diagnosis procedure of fibromyalgia 
itself was unclear, as no standard process of diagnosing chronic widespread pain 
existed. The overall theme emerging from the discussions with the participants was 
that understanding the condition and gaining knowledge about it, are exclusive 
responsibilities for the GPs and specialists, regardless of resources availability.  
3.5.2. Coping with variability and unpredictability of symptoms 
The participants mentioned having numerous symptoms during daily living, with 
different pain severity. They also highlighted that they had difficulty managing, 
coping and functioning. This theme served to illustrate that the experiences of flare-
ups of pain and symptoms is quite variable among the participants. The sub-themes 
that emerged from the data were grouped together to produce the final theme, as 
depicted in Figure 3.4.   
The unpredictability of FMS symptoms, and the constant and worsening pain were 
highlighted by most participants. Furthermore, the variability of symptoms 
recurrences was behind the participants’ concerns that the symptoms could affect their  
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daily living activities. In addition, they reported trying to cope with their pain, with 
varying degrees of success.  
In addition, the participants were also concerned that the pain was taking over their 
bodies, and mentioned how this impacted their life, and their ability to cope with the 
severity of the pain.  
The results presented here highlight issues such as the concerns around activities and 
functions, the impact of constant pain all over the body, particularly in muscles and 
joints, and the struggle to tolerate the pain. Figure 4.5 demonstrates the development 
of this theme. 
PT2: I mean, just sort of the pain you get is a variation of pain…It is 
really hard to say.  It’s so hard to say. Basically it’s everything. 
Everything.  Joints, muscle and bone.(L445). 
PT6: It can move anywhere.  My hands are bad, can be bad.  I don’t 
know if...  That’s about it.  It can be anywhere.(L231)  
If I’ve been walking a lot, it tends to be hips and legs.  If I’ve been 
cooking or baking – hands and arms.  So, yes, it just depends what I’ve 
been doing.  I’ll put arms in as well.  Oh, the same intensity? it can be 
a little bit or it can be a lot where I can’t move and I have to just stop 
and wait until it eases. If my hands are bad, they don’t work, they lock.  
So I have to wait until they just loosen a bit and ease up.  It could take 
about 20 minutes or so just waiting until they’re loose and I can move 
them again.(L279) 
PT12: I just get muscle pain all the time, whenever I use my muscles.  
So it’s just a case of not overdoing any muscle…  And just keeping 
everything…  Trying to release all the time…. So, if I do something 
else, like, there’ll be pain in the shoulder.  So it’s kind of all over.  All…  
Depending on what I’ve done.(L304) 
 
The participants recognised the value of coping with the pain, and taking time to 
develop this ability. However, they reported that flare-ups made it difficult to cope 
with the pain. The participants also shared their points of views on how the pain could 
be managed, and what medications work best for the pain level. Medications were 
prescribed by GPs, and the participants were not certain of what helped with regards 
to the symptoms they had in that day. A few of the participants (3/12) pointed that 
medications were not beneficial for their condition. 
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PT6: I had a major flare-up after the operation, where my bowel 
packed up, my bladder packed up…  It was just horrendous, 
but…  That’s the pain we cope with.  We get pain…  Well, I 
get pain, it could be anywhere.  One day it could be my arm, 
next day it could be my leg. It’s obviously coming from my 
head, but I don’t know what sets it off.  So…  So that…  I find 
that is the hardest…  Is the panic…  And the pain.  The rest I 
can cope with. (L167)  
 
PT7: I went back to the doctor and said “I cannot cope with the 
pain.”  And I explained, because it was a different doctor, that 
I was meant to be coming off the pregablin and he went “We 
can put you on tramadol – which I don’t really want to do…”  
And I went “Oh, I don’t really want to go on that either.”  “Or 
we’ll try you on…”  And it was this other medication, which 
I’ve tried, but I remember it made me feel sick (L654 ) 
 
PT9: I went to the GP and got the medication every month.  And 
I was on them for maybe six, seven months.  And I was doing 
fine.  I was coping.  Still in pain, but coping with it.(L783) 
 
The participants reported that they were unable to function because of the pain severity 
and fatigue, as well as losing muscle strength. Performing daily activities and exercise 
was also highlighted as an issue for people with FMS. Furthermore, the participants 
discussed difficulties with movement during daily living activities, as can be clearly 
gleaned from the transcripts. The exercise approach advocated for people living of 
FMS was met with some annoyance by the participants, as they often felt quickly 
exhausted. 
PT6:  I used to get so annoyed and thinking “Exercise!  I can’t 
function, never mind exercise!”  Exercise works if you can get 
somebody who knows what they’re doing L729 
PT9: I would sit in the chair and I couldn’t do a thing after a 
swim.  So, the doctor had said maybe half it, half your time – I 
used to do an hour and then I halved it to half an hour. Fine.  I 
didn’t find it hard, swimming for half an hour, for an hour.  It 
was after I came home.  I was exhausted L981 
PT9: If I go into a shop and I’m trying to get round, I’m sort 
of…  If there’s people everywhere, I don’t like it.  Because they 
tend to knock into you and you’re sensitive to…  You might…   
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Someone might just think they’re tapping you, but you really 
feel it sometimes, you know.  So I like to try and have room to 
move around.  I don’t like crowds.L896 
 
Constant pain was highlighted by the majority of participants. They felt such pain all 
over the body, particularly over the neck, shoulder, ribs, back and feet, and generally 
across all of the musculoskeletal system. The participants were unable to differentiate 
whether the pain was in the muscles or bone, and obviously felt the pain was quite 
deep. They described that the pain had become their life, where they had to work 
through it themselves, wondering what could be done to reduce it, and often feeling 
that they could not cope with.   
PT1: To be honest, it kind of comes in ups and downs and 
sometimes one symptom is worse.  Restless legs was one thing 
that, at one point.L455 
PT2: It’s just constantly there.  You know, you wake up with 
pain; you go to bed with pain.  And it’s just excruciating pain, 
constantly. L153  
PT4: I said “I’m still tired.  I’ve got pains, still” I was constantly 
tired. L 307 
PT6: I get constant pain in my shoulders and my neck, all the 
time.  That doesn’t go away.  I get constant pain in my chest, 
all the time, and just under my arm – like as if you’re having a 
heart attack, it feels like that.  I get a lot of pains in my jaw.  
That’s it, really. L193 
PT10: it doesn’t feel the same pain.  Fibromyalgia is a 
constant ache and a different pain.  This pain is an ache in the 
joint.  L399  
PT11: I don’t know how to explain it.  But the pain is mostly in 
my back neck.  The back of my neck. Constant headache.   
Constantly, I’ve.  L286,  
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Figure 3. 4:  Development of the ‘Coping with the variability and unpredictability of symptoms’ theme. 
Categories 
Activities and functions 
- Pain aggravation  
- Cannot cope 
- Can’t function  
- Self-managing  
Severity of Pain 
- Constant pain 
- Sensation pain  
- Worsening pain   
Disability and employment 
- Lack of 
understanding   
- Frightened  
- Loss of work  
- Disbelief in legitim-
acy of pain  
Difficulties /awareness 
- NHS  
- Communities  
-  Work places 
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framework reference 
1.2 Pain description  
1.2.3 Constant pain  
1.2.2 Nerve pain 
1.2.4 Worsening pain 
2.4 Fatigue/tiredness 
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power  
3.1 Understanding of 
condition  
1.2.1 Variety of causes 
of pain 
1.2.5 Coping and self-
managing 
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3.4 Disability and loss 
of work 
4.5 Public awareness  
1.4.4 NHS 
1.4.3 Family/friends 
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Class/fina
l theme 
Detected elements (examples) and the dimensions with the data 
DL activities / constant pain  
- Honestly, they used to be.  I used to get so annoyed and thinking “Exercise!  I can’t function (PT6,L729 )  
- I was exhausted. I couldn’t do a thing after a swim (PT9,L998 )  
- I’m literally pain from head.  Literally head to toe. (PT3L723) 
- I having constant pain, it just drags you down and it really, becomes your life (PT1,L259) 
- I’m constantly aching around my ribs (PT12,L932) 
Worsening pain/ sensation of pain 
- The pains were getting worse.  The tiredness was getting worse(PT4,L311) 
- The worst symptoms I ever had was when the arms and the elbows, and I was trying to work. It was just 
trying to cope with it. (PT9,L907) 
- The burning sensation, I’ve been getting that for the last, just over a year.  And I didn’t understand it 
(PT11,L365) 
- I get a sharp pain, I’m sensitive every now and again. It’s like a shooting pain.  (PT7,L216) 
Different pain /difficulty coping 
- It varies.  I mean, mainly it’s all over, but I get a lot of sort of pain in the hip It’s sort of, actually, the 
bottoms of the feet and the ankles. (PT8,L185) 
- It differs literally from day-to-day what pain I get(PT3,L723) 
- It is different, but it’s all come back now.  So, I don’t know why. (PT10, 790) 
- The flare-up kicked in.  And I went back to the doctor and said “I cannot cope with the pain. (PT7,L654) 
Tolerance of pain / Fright of pain 
- When the pain gets heavy, I get, like, chest pains…  Like, my chest tightens.  So then I really struggle to 
breathe.  I also get a lot of pins and needles in my arms and legs (PT11,L215) 
- I get this nerve pain, from top. It shoots.  I mean, shoots right through my body to go right out my toes, 
It’s horrendous (PT10,L327) 
- Initially, when I first had fibro, I didn’t get much information and I didn’t know what a flare-up was and I 
remember I was frightened. (PT7,L902) 
- I would never, ever hold a baby now.  I just wouldn’t do it because I’m too frightened. (PT5,L903) 
Loss of work  
- I’m staying at work, struggling to stay at work, so I don’t get a sick warning…  Which is stupid…?  But 
you might lose your job, so…(PT7,L909) 
Views on legitimacy of pain  
- I got diagnosed last year and it became a problem and work management didn’t believe me. (PT4, L23) 
- If you had a GP that actually believed in it, it would be absolutely brilliant. (PT6,L910) 
- Awareness.  Making people more aware of what fibromyalgia (PT11,L 2044) 
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A common theme that emerged from the data was the worsening pain felt by the 
participants, and the loss of control over some aspects of their lives, as the medications 
were just taking the edge of the pain level off. The findings discussed below highlight 
the worsening pain, tiredness and difficulty functioning because of the pain severity. 
The participants experienced pain that affected every part of their lives. The results in 
this dimension (worsening pain sub-theme) showed that the participants’ feelings of 
pain increased over time, as pain unpredictably evolved and progressed during the 
diagnosis journey.  
PT4: The pains were getting worse.  The tiredness was getting 
worse.…  I was at work.  I was falling asleep at work. ( L311)   
PT5: Worsening pain: things like a repetitive.  Like knitting.  If 
my hands will knit, I knit sometimes because just.  It distracts 
and sometimes it can take my mind off the pain. (L581) 
PT9: The worst symptoms I ever had was when the arms and 
the elbows, and I was trying to work…  It was just trying to 
cope with it. (L907) 
PT11: when the pain gets heavy, I get, like, chest pains…  Like, 
my chest tightens.  So then I really struggle to breathe. (L234)  
PT12: The worst symptom is just back pain, probably, I think.  
Back pain and weakness.  It’s the weakness, I would say.  
(L1593) 
 
Whilst all participants expressed a sense of loss of daily living functions, the quotes 
below demonstrate that some of the participants (6/12) developed acute nerve pain, 
and expressed concern about the sharp, shooting and burning nature of the pain, and 
how such pain impacted every part of their lives. Furthermore, the participants didn’t 
understand the pain, as no information was given to them regarding nerve pain, and 
how it might affect their lives.  
A number of participants described the varying experience of pain, in terms of the 
different types of pain felt, and how such pain differed from day to day. Furthermore, 
they reported a variety of symptoms related to pain in all joints and muscles, and 
described how they were unable to cope with their pain and with daily living activities. 
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PT1: I think I would have gone mad by now.  With the pain and 
with the…  Well, with the pain…  Because it would affect 
absolutely every minute of my life.(L551) 
PT2: Because of this I’ve been left 80% paralysed of the legs.  
You know.  And you don’t want to see people like that.L767 
PT5: One day when I couldn’t walk.  I mean, I could just about 
get round my flat holding on to the furniture, but I couldn’t go 
outside, I couldn’t...  Everything hurt.(L488) 
 
The participants believed that the tolerance of chronic widespread pain was an issue 
influenced by psychological factors, and that their concern regarding the lack of 
information contributed to aggravating their pain. They felt frightened to get involved 
in any of the daily living activities, or struggled to do so because of the pain they felt 
in every part of their bodies.  
PT1: Annoyed, more than anything else, that I’m actually 
somebody who has got this.  It has such a big impact on what I 
can do, when I can do it and I think mostly I’m just…  Well, I 
was going to say angry(L238).   
PT6: I can just be driving along and all of a sudden I get an 
anxiety attack or a panic attack.  It’s just…  At night, it’s like 
fright and flight.(L577)   
 
At the time of the interviews, about half of the participants were unemployed due to 
anxiety and distractions caused by the chronic widespread pain and other FMS 
symptoms. One of the participants was employed, and felt she was able to continue 
with her paid job, while another was disabled because of the misdiagnosis of her 
condition, and was unable to work, despite having support from family to manage 
DLAs (see Table 4.3). With regards to their abilities to do work and perform daily 
living activities, the participants reported trying to engage in work, but finding the 
process challenging due to the lack of understanding of their condition in the 
workplace. In addition, due to the unpredictability of the symptoms, the participants 
reported a lack of understanding by employers at times. 
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PT3: I would really like, for more people to actually be more 
understanding of it. Because not everybody knows.  And I’m kind of 
thinking, like, the government do need to step into things.  And put into 
the workplace.(L835) 
 
PT5: it seems like being honest with them, there’s no understanding in 
the workplace for fibromyalgia. There isn’t anything out there.  Not 
that I know…  Especially in the workplace.  I think work…  Big 
workplaces need to be aware of it…  Because it’s a hidden disability 
and…  Just because it’s hidden, people judge you. (L752) 
 
PT4: I go back for the second interview, in the actual department that 
I’m applying for…  “Oh, you’ve done really well…  Now to ask you, 
have you got any disabilities?”  So you just say “Fibromyalgia.”What’s 
that?”  Then you tell them and you say “Well, I’ve got medication to 
control that…”  You get a letter in the post saying you haven’t been 
successful.( L271 ) 
 
PT6: Half of the people with fibro don’t work, because they cannot 
work, because they cannot function. (L742) 
 
PT7: So I’m staying at work, struggling to stay at work, so I don’t get 
a sick warning…  Which is stupid…  But you might lose your 
job.(L909) 
 
The participants described how they were questioned at times about whether they 
genuinely had been ill and suffering with pain by people at work, and even by GPs, as 
a result of physically looking well. The described how such an experience was 
frustrating for them, as they could not describe or explain more about the phenomenon 
of their disability. In addition, the majority of participants felt that it was a challenge 
for them to express how the lack of knowledge among healthcare professionals and 
communities was affecting their DLAs . 
PT4: I got diagnosed last year and it became a problem and work 
management didn’t believe me, they had issues with me having 
appointments and things like that.  (L23) 
PT6: Even if you had a GP that actually believed in it, it would be 
absolutely brilliant.(L910) 
PT11 Awareness.  Making people more aware of what fibromyalgia is.  
Because, I find, like even at work…  Whether at work of social, you 
know…  When I’m in a social, sort of, place…  People don’t 
understand what my condition is.(L2044)   
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The participants also highlighted issues such as coping with the variety of symptoms, 
having difficulty managing functional activities and coping with pain, the pain taking 
over the body, and the impact of symptoms on daily life. Furthermore, the participants 
pointed out that medications were not beneficial for their condition. They also found 
it challenging to convey how the lack of knowledge among healthcare professionals, 
communities and workplaces was affecting their DLAs, which at times, made them 
unable to continue with paid work. 
3.5.3. The availability and satisfaction with current healthcare 
practices and services  
The interviews with participants illustrated that the lack of understanding of the 
disorders was reflected on the therapeutic approaches prescribed, as individuals noted 
that the interventions and treatment must be individualised. A key focus of the 
discussion involved the varieties of interventions that the participants encountered, 
their availability to people with FMS, and the participants’ beliefs reading the 
interventions’ efficacy. Furthermore, the challenges the participants faced due to the 
varieties of intervention approaches, their availability for the management of their 
condition, and the inappropriate referral procedures were highlighted. Figure 3.5 
illustrates the developments of this theme. 
The participants also expressed their views on attending various health services, and 
on the limited availability of access to the NHS services. The participants had specific 
individual views regarding how this long-term condition influenced their everyday 
lives, and their experience of contact with primary and secondary care. Moreover, the 
need for a specific programme for FMS was discussed.  
The participants who had experienced several intervention approaches felt that each 
intervention did not work independently. Medications such as gabapentin, pregabalin 
and duloxetine were thought to work in combination in some days, and not in others. 
Furthermore, the participants also found the cost of some interventions a barrier, such 
as massage and chiropractic intervention, as these interventions are only available in 
private care, which in many cases was beyond their means, and made them feel 
helpless to cope with their condition. The following sub-theme (efficacy of 
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interventions) details the participants’ views on the interventions’ availability, and 
their satisfaction with them.  
PT1: The medication hasn’t much changed other than the steroids that 
I was taking for the polymyalgia, which was the thing that would take 
that pain away, but there isn’t anything that takes the fibromyalgia 
pain away. Similar painkillers for both.  Similar anti-depressants.  
(L308) 
PT2: painkiller.  They didn’t really do any good.  Painkillers don’t 
seem to…  They don’t, like, take the pain away. It just takes the edge, 
sort of thing. (L513) 
PT5: just taking something like Paracetamol didn’t help, so I had to 
learn to...  I got other painkillers, but I just had to learn to, if the pain 
was very bad. I’ve been through a lot of different tablets, painkillers, 
Duloxetine.  Yeah, it’s a mixture.  I tried Gabapentin and that didn’t 
work so I tried Pregabalin and that doesn’t work by itself, but it works 
with other things.  Duloxetine is one and some Codeine, to find the 
right ones and I think now it’s probably the combination that helps the 
most. (L516)  
PT1: The medication some days it works better than others.  I don’t 
know (L321). 
 
Complementary therapy as a combination was reported to provide the participants 
with some help. The participants thought massage, graded exercises, and hydrotherapy 
could help if those who performed these approaches had the knowledge and skills, 
because they felt the majority of the pain can come from the muscles tension. 
Moreover, this element of combination and use a load of different interventions, like 
exercise and massage with force, again, made things worse.  Other than that, nothing 
helped with symptoms and pain.  
 
PT6: The massage and doing the hydrotherapy that is going to work 
absolutely brilliant.  For me personally. We get a discounted massage 
after. If we could get that on the National Health, it would be absolutely 
brilliant.(L757) 
T8: we have to get massages through the support group privately which 
really, helped.(L 826) 
PT11: I went to see a chiropractor privately, it did help, but I couldn’t 
afford it.  Because of my condition I had to leave work, so I…  Yeah.  
Because back then I was working more hours; I was getting paid 
more I’ve seen a chiropractor Yeah. That helped, but the cost was too 
much. It’s too expensive, yeah.(L1193)    
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PT10: Acupuncture wasn’t working at all and I knew straightaway it 
wasn’t working at all .(L1092) 
PT6:  Exercise works if you can get somebody who knows what they’re 
doing. If you go to an exercise class, you’ve got to keep up with people. 
Nothing worked, then you’d be back to square one again. (L 736)   
PT8: Nothing works, but it is not fair.  What else?  Not a lot really.  I 
had a pain management, and I am down to do a mindfulness – eight-
week mindfulness course, through the NHS, I think they should try and 
go a bit more alternative.  Maybe stuff like massages. (L 966) 
PT11: They sent me to a physiotherapist.  The physiotherapist gave me 
some exercises.  That didn’t help. Because the physiotherapists said 
they couldn’t do anything with me; they said they couldn’t help me 
(L759) 
PT12: I can’t think of anything that privately is available that would be 
helpful.  And I’m really pleased that they’re offering acupuncture on 
the National Health. (L 2478) 
The pilgrimage from one intervention to another was an experience reported by most 
of the participants who were in search for a treatment to reduce their pain and make 
them feel better. The participants reported trying different approaches, none of which 
worked effectively for their FMS symptoms. Thus, healthcare professionals were 
viewed as lacking in the knowledge required to enable them to prescribe effective 
treatment, which may be due to the limited recourses and collaborative research 
undertaken in the UK. Furthermore, it was highlighted that not all GPs and specialists 
applied the same criteria to treat the chronic widespread pain of FMS. Because of the 
participants’ dissatisfaction with the aforementioned issues, their relationship between 
healthcare professionals was sometimes strained. The participants also mentioned 
their frustration regarding the number of specialists they had to consult, as they were 
frequently passed from GPs to other healthcare professionals, which made finding a 
solution within the primary and secondary care systems more difficult.  
In addition, the participants highlighted that they felt they needed a specialist for their 
condition. It was also felt that GPs and healthcare professionals needed to update their 
knowledge to develop a proper understanding of the condition. Furthermore, the 
participants thought that they would not benefit from prescribed medications and 
interventions approaches. The lack of understanding of the condition by healthcare 
professionals was cited among the participants as a key problem, especially when 
contrasted with other illnesses having specialist sites and facilities available. 
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PT3: The GP doesn’t specialise in it.  Her speciality is, like, with skin.  
Like is dermatology.  So it’s a bit different. When I went back, for the 
follow up appointment after all of my referrals – she did say, “Right, 
well, here’s one piece.  One piece of information that I know.” (L 641) 
PT6: Exercise works if you can get somebody who knows what 
they’re doing. (L736) 
PT10 Doctors were all very, very helpful.  Really helpful.  They 
didn’t know enough about it either,. They didn’t have the knowledge.  
(L612) 
The participants also reported that they been referred to Cognitive Behavioural 
Therapy (CBT), and described their experiences as being time consuming, and having 
left an impression of a lack of understanding of their condition. Specialists argued that 
multiple factors may be combined with such a condition, such as psychological 
factors, which upset the participants Due to these issues, as well as to being distressed 
by the therapeutic technique, and viewing it as unhelpful in the management of chronic 
widespread pain, the participants attempted, at times, to avoid going back to CBT. 
 
PT4: I mean, I’ve had CBT…  Cognitive behavioural therapy, they’ve 
sent me for. I said “I think I’m right and I think you’re wrong.”  And 
he argued black and blue with me to the point that he made me cry and 
he turned round and said “What are you crying for?  I’m right.  You’re 
wrong.  That’s why you’re here.”  And I walked out and never went 
back but never again will I go back for CBT because it’s upset me.” In 
fact it’s made it worse (L562) 
PT7: I think those therapies; all the therapies are good, apart from 
maybe the CBT.(L1420) 
PT12: I have been referred to cognitive behaviour through to the pain 
clinic, it was just about writing down emotional things all the time and 
I really didn’t feel that that was relevant. I thought I was wasting her 
time, you know, really She was looking into my psychological 
wellbeing( L777) 
On the other hand, some participants highlighted that CBT was beneficial, especially 
when the professional focussed on how people can manage living with this illness.  
PT1: The GP did refer me for CBT twice, because the first time. It did 
help. it helped, because it just then focussed on “How can I live with 
this?  I’ve got to live with this, so what can I do to help myself?”.  It 
was good and it’s certainly something that I would ask to return to in 
the future if I felt I needed it again. (L412)  
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Figure 3. 5: Development of: the ‘’patients views, regarding availability and satisfaction with current healthcare practices and services’’ theme
Detected elements (examples) and the dimensions with the data 
Efficacy of interventions 
- CBT helped, because it just then focussed on “How can I live with this?  I’ve got to live with this 
(PT1,L412) 
- I think now it’s probably the combination that helps the most.  (PT5,L516)  
- I went to see a chiropractor privately. It did help, was very helpful, but I couldn’t afford it. (PT11,L1193) 
- The massage and doing the hydrotherapy that is going to work absolutely brilliant.  For me personally. 
(PT6,L784) 
Nothing works  
- All sorts.  Physiotherapy, nothing worked (PT11,L1539) 
- The medication not really doing a significant (PT8,L1195) 
- noting has worked (PT6,L349) 
Tried different approaches  
- Various medication, which didn’t do much really. (PT8,L364) 
- The medication some days it works better than others and physiotherapy wasn’t work(PT1,L305) 
- The medication doesn’t work for the pain levels (PT4,L600) 
- physio-ultrasound and different routes, different technique (PT8,L1224) (PT9,L1371) 
- I had acupuncture.  That didn’t really help I would say- it just didn’t do anything at all (PT9,L794) 
- Exercise   works if you can get someone who knows what they are doing (PT6,L729) 
- When I first started swimming, I would do a lot, you know.  And then I’d go home and I’d be really bad. 
(PT11,2282) 
Inappropriate referral and support  
- But never again will I go back for CBT it’s upset me.” In fact, it’s made it worse (PT4,L566) 
- Being referred to psychologists, who just think, no, it doesn’t exist.  And I was like – you’re having a 
laugh.  Obviously (PT3,L135 ) 
- I didn’t get any support, people think “Oh, yeah.  You’re fine.  You’re just having a bad day.”  So…  And 
that’s family as well. (PT6,L662) 
Views on approaches availability  
- There isn’t enough of those facilities.  If I could go to a hydro-pool every day, I would be content. 
(PT10,L674) 
- I’ve had psychologist interventions to try and work out non-medical ways of coping (P05L573 ) 
- I think a better service needs to be created. (PT4, L729) 
Chiropractor needed  
- Chiropractor – that was very helpful.  If he was available on the NHS I would go regularly, (PT11,L1742) 
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Moreover, a small number of participants highlighted that psychologists were helpful 
in combination with other approaches, while another participant mentioned that the 
psychologist she visited did not believe FMS existed, even though people with FMS 
had psychological issues, as is highlighted in more detail in the fourth theme.  
PT5: I’ve had psychologist interventions to try and work out non-
medical ways of coping.  So things like mindfulness, relaxation 
techniques, including just relaxing in a comfortable position with or 
without music or with or without trying to do a self-hypnosis thing in 
my head – talking myself into it.(L537)  
PT3: Being referred to psychologists, who just think, no, it doesn’t 
exist.  And I was like – you’re having a laugh.  Obviously (L135)  
 
The participants believed that the lack of support was due to a lack of understanding, 
which influenced the services provided, and impacted their decisions not to go back 
to the specialist. The understating of the condition was considered the biggest 
challenge facing physicians and healthcare professionals, and contributed to the 
dissatisfaction of the intervention approaches offered to people with FMS. In addition, 
the participants mentioned being disappointed with the quality of care, and the 
procedures provided in the NHS, and felt that their condition was not cared for at the 
same level as other illnesses. Furthermore, the participants discussed how their social 
lives were compromised, as a result of the invisibility of the condition, the disbelief of 
other people of the severity of pain they felt, and being judged by people because they 
appeared physically well.   
PT4: Totally disagreed with the therapist I had.  He asked me a question 
and I told him the situation and he said that I was in the wrong and that 
his idea was right.  (L562 )         
PT3:  Psychotherapy: Being referred to psychologists, who just think, 
no, it doesn’t exist.  And I was like – you’re having a laugh.  
Obviously.(L 135)   
PT6: I didn’t get any support, people think “Oh, yeah.  You’re fine.  
You’re just having a bad day.”  So…  And that’s family as well.  (L662 
) 
Following further discussions regarding the need for a chiropractor, the participants 
felt that chiropractors helped with the management of their condition. However, the 
participants raised the issue of costs, and not being able to offered the therapeutic  
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technique. Chiropractic and osteopathy were used as separate services to improve 
musculoskeletal disorders, and were reported to have positive effects, which made the 
participants question their unavailability in the NHS. 
PT11: I’ve seen a chiropractor Yeah. That helped, but the cost was too 
much. It’s too expensive, If it was available on the NHS I would go 
regularly, you know.  If massage and chiropractor were available, I 
would probably go for those two if he was available.(L1743)  
PT3: I’ve had chiropractor, I’ve been seeing a chiropractor for about 
four years on a regular basis for four years now, which helps. So I’m 
happy to actually stick with going to see chiropractor (L747) 
PT12: I paid for chiropractor I’ve paid for those before.  And what’s 
the other type of back specialist? .I’ve had an osteopathy, yeah.  But 
there’s nothing structurally wrong with my back.  It was just to help the 
muscle pain.( L2471)  
 
Understating the condition and the associated pain was seen as essential for the 
management of the condition, and for offering interventions that could support patients 
with FMS. The participants discussed feeling anxious about the services provided, 
both in primary and secondary healthcare, as they described how the interventions and 
support they received made them feel unvalued and helpless. The participants found 
it difficult to access the required level of services.   
PT4: if I want anything about it in between, going to the doctor’s 
“No, you’re under rheumatology.  We can’t help you.”  They’re 
doctors.  They should be able to help you in between.  But, no…  
Hospital service, fantastic.  For my psoriasis, arthritis, rheumatologist 
– fantastic.  Doctors…  Unless it’s not to do with my condition, it’s 
about something else, yeah, great. (L832) 
PT10: The doctors will give me anything I.  If I say “I think this 
might help,” they would give it to me, because, as I say, I don’t think 
they’ve got all the knowledge.  They are supportive.  But they don’t 
know.  There’s no treatment … There’s no answer.  Doctors can say 
“Right, that”  When I go to the doctor’s some of them say “Well, that 
could be fibromyalgia,” but it might not be. (L 831) 
Other points of view expressed by the participants included the accessibility and 
availability of services, their experiences of the diagnosis processes, and the efficacy 
of interventions they had. Most of the participants (9/12) highlighted that some  
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facilities had to be developed and available in the NHS, so that people could get access 
to them easily, especially if such services  proved to be supportive and helpful for 
treating their condition. Some participants strongly expressed the need for their views 
to be considered.  
PT3: I think there should be more funding towards things like this.  
So that help is available for people. Not disability benefits, but…  
Like mobility if there were more GPs, I think, who were more…  
Like, more knowledgeable of the condition, it would help.  (L 572) 
PT5: but I know people don’t get that support and help, so I think 
more information would be good.  Some GPs I know don’t believe it, 
believe in it.(L843)  
PT8: There’s not much information as to what’s available.  Even 
support groups, you have got to go and find them yourself on the 
internet.  There’s no publicity in the GP’s surgery or anything, Just 
like some kind of advice place that would tell you what’s available, 
even if it is the NHS or medication, but give you alternative therapies, 
you know. 1247 It just knows what’s available really, is the hardest 
thing.(L1448) 
PT10: Only from home.  From the internet.  The doctors…  As I say, 
he didn’t have any leaflets; there was no counselling, nobody…  That 
was it…  “You’ve got fibromyalgia.  Go and look it up on the 
internet.”  And that’s all I got told.(L565) 
PT4: It’s bad enough suffering chronic fatigue without a tablet that 
adds that extra tiredness on top.  But I would like, if physio is the 
answer to help with things…  I think a better service needs to be 
created. (L 727) 
T6: Nothing.  They’ve given me no. Nothing for my fibromyalgia 
whatsoever.(L809)   
The participants expressed that the service availability for people living with 
fibromyalgia gave them a feeling of helplessness, due to the effect that the pain had 
on them, and the difficulty of obtaining a referral to an appropriate healthcare 
professional. The issue of referral to the right professionals was debated in the line 
with providing chronic pain education. The participants mentioned being distressed 
because healthcare providers were not prepared to provide a range of interventions, or 
prescribe how to effectively use the service they already had. The link between the 
misunderstanding of pain and the effect of the condition on daily functions was also 
highlighted by the participants. 
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PT1: NHS-wise, useless. Because, the staff that at the hospitals, it isn’t 
nice.  They treat you as if you are a malingerer.  And they just don’t 
want to know, through lack of understanding. Because of your 
condition, there’s nothing more we can do.”(L670) 
PT4: I don’t feel I get the support from the doctors, even now they 
know…. They’ve got the official information from the 
consultant.(L746)  
PT2: I’ve never been given any professional support or anything.  You 
know, you’re sort of told “This is what it is.  We don’t know exactly 
what causes it, why it’s doing what it’s doing” but you’re just sort of 
being told to get on with it really.(L496) 
PT5: I mean it would be great if all this just came from the GP.  
Maybe that’s not realistic, but it should... it should come without too 
much of a fight for people.(L1025) 
PT6: I would like more support from the doctors, more 
understanding, because that would help our condition a lot – with the 
stress, because that gives you anxiety.  Maybe a clinic that’s just for 
people with fibromyalgia.  Something like what other conditions have 
got, which we haven’t got…  Where you can actually go and they 
understand you.  (L628) 
PT7: Nothing really from the doctors. A new doctors said I will go 
on-line for you, and I will have a look and see what they are doing in 
America.”  Because obviously, they lead the way, in America, for 
fibromyalgia, so hopefully he will dig something out.  I do not know.  
However, I think I will be more supported at my GP now.  Definitely, 
with the new doctors.(L714) 
The findings above indicate the limited availability of intervention approaches and 
access within the NHS for individuals living with fibromyalgia. They also highlight 
the participants’ dissatisfaction with the diagnosis processes and interventions 
efficacy, and their frustration with the variety of approaches being tried. In addition, 
the participants highlighted the need for a specialist for their condition. CBT was  
referred to as useful by some participants, however, others felt a ‘hands on’ approach 
was required. Throughout this theme, a clear dissatisfaction with healthcare services 
can be detected, as well as the wish of the participants to contribute to service design 
for this condition. The resulting lack of support was due to a lack of understating of 
the condition, which influenced the quality of services provided. 
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3.5.4 Emotional Influences  
The following theme, deduced from the participants’ views and experiences, 
highlights the fact that FMS has a psychological and emotional impact on self-identity. 
Emotional features appeared to affect the participants’ daily living, and some 
participants felt they were emotional during the journey of diagnosis and pain 
management procedures. Moreover, they pointed out some of the hurdles and issues 
in both healthcare communication and social activities. A number of participants 
avoided contacting a health care professional, and even attempted to avoid or minimise 
social interaction with family and friends, as it was deemed frustrating for them not to 
be believed regarding the severity of pain they were suffering.   
Psychological issues were reported by a number of participants, who often felt 
depressed because of the misunderstanding of their illness in healthcare, community 
and work places. The participants questioned themselves at the time of pain regarding 
credibility, and often felt frustrated by the lack of understanding of their condition. In 
addition, some of the participants reported that the aforementioned experiences 
contributed to the loss of their jobs. The participants also mentioned how they 
struggled to explain to healthcare professionals how the pain and fatigue influenced 
their lives, which amplified the chance of anxiety and depression. Furthermore, some 
participants highlighted that professional care, such as CBT, was focused on their 
psychological stories, rather than how the condition affected their daily lives. The lack 
of understanding was most clearly seen in the absence of relationship between the 
patients and healthcare professionals, which led to a lack of an appropriate support for 
FMS.  
PT4: Really depressed.  Because of this, I’ve lost my job.  Well, not 
because of it, but because there is no understanding out there, in the 
workplace.  I’ve lost my job. (L 207) 
PT9: That was the bit where…  It came to the point where I knew, when 
I couldn’t manage my job, that I went into depression – I started 
suffering with depression.(L573) 
PT11: it upsets me…  Because I don’t have control of my own life. 
Yeah I feel depressed, when I struggle to do something, like, in the 
house…  I get depressed because of it .(L614 ) 
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PT12: I can understand it, because if you go there and…  If you’re in 
pain and you feel down, you can be dragged down. I think they were 
just trying say “We understand why you’re depressed, but it will add 
to your pain.”  So, you know, this is…  “Let’s look at your mind as 
well as your body.(L728)   
The participants reported the presence of emotional influences such as anxiety and 
depression. They also mentioned how tiredness affected their ability to manage their 
daily living activities, and made performing simple functions and tasks difficult, due 
to sleep disturbance. Most of the participants reported that they had a good relationship 
with healthcare providers. However, they pointed out that the lack of support and 
understanding of people with fibromyalgia by GPs and HCPs led to anxiety and 
depression. In particular, the participants felt distress and anxiety as a result of the lack 
of understanding of how the pain influenced their psychological and social wellbeing. 
Figure 3.6 details the development of this theme. 
PT8: I was so agitated at the time, I thought, the sort of anxiety 
symptoms. I got to the point where I couldn’t even do my job.  And I 
thought there was something wrong.  I was going to work – I was 
shattered because I…  I’d sort of go to sleep wide awake and woke up 
tired – like exhausted – and just couldn’t concentrate (L405).  
PT4: Anxiety attack.  Well, I don’t suffer from anxiety…  And I went 
to the doctor’s and he said it could be your fibro again.  I felt like I…  
It was just dead tight and I couldn’t breathe (L205).  
PT6: Anxiety.  I get a lot of panic attacks. Just, yeah.  It can be anything.  
It can be anything or nothing.  I can just be driving along and all of a 
sudden I get an anxiety attack or a panic attack.  It’s just…  At night, 
it’s like fright and flight. (L565) 
PT9: I suffer with anxiety and Doctor gives me   I think, it was these 
little, tiny red tablets, I think, I mis-something they were…  I can’t 
remember the name.  But he gave me a month’s worth and he said “Try 
those.”  And I took them for a couple of weeks at home, but they just…  
They were really bad.  I couldn’t get off to sleep at all. (L189) 
PT12: I was anxious at not completing and doing everything I wanted 
to do in the day.(L824)   
Furthermore, some participants reported sleep disturbance, and unrefreshing sleep, 
which affected their daily living activities. However, their often healthy physical 
appearance appeared to undermine the extent of their symptoms and suffering to the 
general public. The participants also reported experiencing loss of function  
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due to the nonrestorative sleep and fatigue, which, in many cases, impacted their 
employment. 
PT1: not being able to sleep.  You feel absolutely useless during the 
day, because it’s an effort to stand up and walk from one room to the 
other and then you go to bed on a night-time and you cannot sleep.( 
L430)  
PT3 I literally I struggle to get to sleep.(L717) 
PT4 It’s horrible…  And it’s lack of sleep, as well.  (L286) 
PT6 I couldn’t sleep.  I used to be awake all night.  I would just get 
pains all the way through my body but they kept saying “It’s all in 
your head.  There’s nothing wrong with you.”  Because then they 
didn’t know about fibromyalgia I couldn’t sleep… And not being able 
to sleep…  For years…  Because there was no medication that they 
would give you.(L327) 
PT8: I just need something at night to help with the sleep.(L772) 
PT9: I don’t seem to be able to sleep, although I’m shattered. (L459)  
 
Tiredness was commonly experienced by the participants. In addition, the participants 
also mentioned that the severity of pain during the day could be exacerbated by the 
unrefreshing sleep, which worsened the impact of the pain on their daily functions. 
Furthermore, they described how they struggled to sleep because of the chronic 
fatigue, and that despite taking medications such amitriptyline, they still felt tired and 
anxious. They also noted that the lack of physical energy prevented them from 
performing daily activities, and made them avoid socialising.  
PT1: The tiredness. You feel absolutely useless during the day, I think 
that kind of impacts as well on the depression (L261) 
PT3: The chronic fatigue.  Because I’ll have days where I literally I 
struggle to get to sleep. It almost gets to the point I can’t get out of 
bed because I am so tired.  (L348) 
PT4: The chronic fatigue is horrendous.  It’s really…  It’s so bad that, 
the fatigue, because, yeah, it’s painful – the pains – and…  I was just 
left to deal with it, if something could just say to the brain “You’re 
staying awake until I tell you you’re going to sleep.”  But there’s 
nothing for chronic fatigue.  It’s bad enough suffering chronic fatigue 
without a tablet that adds that extra tiredness on top. (L289) 
PT5: Tiredness?  Yes, and people don’t believe how tired you can 
possibly be.(509) 
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Figure 3. 6: Developing of the ‘Emotional aspects ‘theme 
Initial thematic 
framework  
2.1 Emotional aspects 
2.2 Annoyed/angry 
2.3 Depression 
2.4 Anxiety 
2.5 Fatigue/Tiredness 
2.6 Unrefreshing sleep 
1.4.8 Lack of support 
1.3.1 Medications 
efficacy 
2.8 Frightening 
1.4.7 Attitude of HCP 
2.7 Frustration 
4.7.Functioning/muscle 
power 
1.2.6 Memory 
impairment 
Detected elements (examples) and the dimensions with the data 
Patients’ identity and Impacts 
- The anxiety, I’ve always self-esteem issues. But if it.  It’s aggravated by tiredness.  So trying to actually stay awake is sometimes 
a bit of a struggle.(PT3,L 409) 
- Annoyed, more than anything else, that I’m actually somebody who has got this.  It has such a big impact on what I can do 
(PT1,L246) 
Impact of sleep on daily  activities  
- The tiredness. You feel absolutely useless during the day; I think that kind of impacts as well on the depression (PT1,L261). 
- Tiredness: Tired?  Yes, and people don’t believe how tired you can possibly be. (PT5,L509) 
- Just very tired.  If I do anything at all, I was feeling dreadful.  Worse than, actually (P10,L374) 
Sleep Disturbance 
- I couldn’t sleep.  I used to be awake all night.  I would just get pains all the way through my body but they kept saying “It’s all in 
your head. (PT6L,327) 
- I don’t seem to be able to sleep, although I'm shattered (PT9,L459) 
Cannot do work 
- I was anxious at not completing and doing everything I wanted to do in the day.  And that was getting me down(P12,L824) 
- I don’t have control of my own life, I feel depressed. Struggle to do house work(PT11,L595) 
- The fatigue, it’s painful – the pains and I was just left to deal with it, so I just dealt with it. But the fatigue, because I was falling 
asleep at work and I thought “This cannot go on.”  (PT4, L366) 
Hard to describe and Feeling Frustrated 
- it’s hard to explain, quite frequently, headaches. It feels like it’s going to explode, kind of headache(PT8,L274) 
- I don’t know how to explain it. The pain is mostly in my back neck.  The back of my neck. Constant headaches.  Constantly, I’ve 
(PT11,L286) 
- understanding the condition, that is the most frustrating part (PT6,L954) 
- Anything I try and do It just gets frustrating (PT8,L618) 
Memory impairment 
- I’ve got a really bad short-term memory, so trying to remember, Can’t remember how to do my work.  But I’ve got my little 
routines.(PT7, L1115) 
- I would want something to help me sleep.  And maybe the concentration because, even though I’m sleeping, the concentration’s 
still gone (PT8,L130) 
Feeling Depressed/Helplessness 
- Really depressed.  Because, like…  Because of this, I’ve lost my job.  Well, not because of it, but because there is no 
understanding out there, in the workplace.  I’ve lost my job. (PT4,L261)   
- The fact that you really can’t do something because you’re even more depressed, is not really helpful, I didn’t 
find.(PT12,L846)   
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PT8: I don’t know.  I was so agitated at the time, yeah.  Yeah, it 
helped me sleep, but it didn’t do a lot for, I thought, the sort of anxiety 
symptoms. I got to the point where I couldn’t even do my job. (L405)  
PT10: Just very tired.  If I do anything at all, even, you know…  
We’ve bought a hoover that’s a hand-held hoover…  I could hoover 
the living room. I was feeling dreadful.  Worse than, actually, before 
(L374)  
PT11: I feel like I drain from energy, physically…  I can’t do long 
drives now.  It just feels like I’m exhausted by the end of it. (L730) 
PT12 I was, you know, tired and exhausted.  Prior to that, my thyroid 
had packed up, so I had hypothyroidism…  So that was completely 
reduced, so that’s aching muscles, fatigue, all that stuff.(L904 )   
 
The participants reported tiredness, anxiety and depression as factors that prevented 
them from managing DLAs, and being able to work. They also described the difficulty 
they had in functioning and controlling their lives, and mentioned struggling to even 
do simple housework. 
PT4: The fatigue…  Because I was falling asleep at work and I 
thought “This cannot go on.” ( L547) 
PT11: it upsets me…  Because I don’t have control of my own life. 
Yeah I feel depressed when I struggle to do something, like, in the 
house…  I get depressed.(L595)  
 PT12: I was anxious at not completing and doing everything I wanted 
to do in the day.  And that was getting me down.  So they did say 
“Accept it.  Organise yourself.  And do these two things…”  And that 
helped.  Pacing yourself.(L824) 
 
Another viewpoint that the participants shared was that they felt they needed to 
understand their condition after the journey of diagnosis.  In addition, the participants 
mentioned feeling unable to describe their condition, which often made them feel 
frustrated. Unhelpful beliefs regarding their experience of pain among healthcare 
providers as well as communities was also highlighted as a common issue they 
struggled with. The participants expressed that, in addition to the lack of knowledge 
about the condition, such beliefs were also a result of people only focusing on their  
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physical appearances. The participants mentioned attempting, and failing, to change 
such viewpoints about their condition, which often left them feeling frustrated and 
helpless.  
PT8: It’s…  Oh, it’s hard to explain…  It feels like it’s broken.  It’s 
kind of like that kind of pain. (L287) 
PT6: There’s just obstacles in our way all the time.  And just not 
understanding the condition.  That is the most frustrating part.  I think 
if we had that it would be half the battle.(L954) 
PT3: Being referred to psychologists, who just think, no, it doesn’t 
exist.  And I was like – you’re having a laugh.  Obviously,( L135)     
PT6P: I got medical help as soon as I went to the rheumatology.  
Moreover, they said I had fibromyalgia, and they gave me a leaflet 
and said “You’ve got fibromyalgia.  There you are.  You are done.  
There’s nothing more we can do for you.”  Then finding a doctor who 
believed in it, which was quite hard – a GP.(L342) 
 
Another experience that the participants described was memory impairment, where 
they highlighted the difficulty they had to concentrate, remember things, and perform 
daily living activities and tasks in their work.  
PT7: I’ve got like a really…  I’ve got a really bad short-term memory, 
so trying to remember…  Went to a class at work.  I loved it.  Decided 
to become an instructor.  It is just that…  It’s trying to remember, like, 
11 routines. I cannot fit anything else in.  Can’t remember how to do 
my work.  But I’ve got my little routines.  And I forget them.  You 
know.  And things like that.  But I think it’s good for your memory, 
because everything else I just forget.  But that, I’ve got to try and 
remember, even if it’s just for that one hour. (L1115) 
PT8: It probably sounds weird, but my concentration.  My memory.  
Because, the pain – yeah, it’s there and you accept it.  But the 
concentration really drives my mad. It’s frustrating.  The 
concentration is, to me, the worst…  The one that has the worst effect 
on me.(L627) 
Because of the pain severity and the frequent flare-ups, the participants reported that 
they could not function or preform daily living activities. They also noted how they 
felt frustrated because their fibromyalgia symptoms were perceived as cognitive 
dysfunction.  
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Overall, the emotional impact of FMS could greatly affect the individual living with 
the condition. Sleep disturbance, memory impairment, depression and anxiety were 
each discussed by the participants. With respect to clinical practice, the understating 
of the physiology and pathophysiology of FMS pain and the influence of symptoms 
by GPs and professionals is required.  Healthcare professionals must value the 
pathophysiological process occurring during a pain experience. The participants 
believed that HCPs should take part in education programmes to value the pain process 
and the experience of living with FMS, and to inform the interventions prescribed for 
the condition. In general, the study revealed enormous variations in the pain 
experiences, journeys to diagnosis, and views among people with fibromyalgia 
regarding their condition.  
3.6 Fibromyalgia Impact Questionnaire 
Regarding the impact of fibromyalgia assessed by use of the FIQ, the total score of the 
domains can be found in appendix 16. The mean score shows a high impact of 
fibromyalgia in the participants’ sample, as can be seen from Table 3.7.  
Table.3 7: Total FIQ score 
Participant Number Total FIQ Score 
1 84.25 
2 70.82 
3 58.38 
4 88.68 
5 80.53 
6 86.1 
7 80.67 
8 56.67 
9 75.67 
10 69.1 
11 85.53 
12 67.1 
Average 75.29167 
As can be seen from table 3.7 show, the total FIQ scores for all participants are 
presented, and also the mean score.  The average FM patients score about 50, while 
the severely afflicted score 70 plus. 88.68 represent the highest score recorded in this 
study, followed by 86.1, 85.53, 80.53, and 80.67, while the lowest score recorded was  
lowest score 58.38. An average score of 75.29 was recorded, indicating the high scores 
of those participants, and that their daily living activities are affected by FMS. 
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3.7 Toronto Alexithymia scale (TAS) 
The subjects were asked to indicate the extent to which they agreed or disagreed with 
each statement on a five-point Likert scale. The statements related to difficulty 
identifying feelings (DIF), difficulty describing feelings (DDF),  and externally-
oriented thinking (Baeza-Velasco et al.). The mean score result of TAS shows high 
alexithymia in this sample of participants, as Table 3.10 shows below. 
 The participants were asked to rate (i.e. score) 20 TAS items using a Likert scale, 
ranging from 1= very slight or not at all, 2= a little, 3= moderate, 4=quite a bit, and 5= 
extremely. The total combined score of all participants was 717. A score equal to or 
less than 51 indicates non-alexithymia, equal to or greater than 61 indicates 
alexithymia, and between 52 and 60 indicates possible alexithymia. 
Table 3.8:  The participants’ scores on the “difficulty describing feelings” category 
DDF 
  PT1 PT2 PT3 PT4 PT5 PT6 PT7 PT8 PT9 PT10 PT11 PT12 
1 1 3 2 2 3 4 1 4 3 1 2 2 
3 1 3 3 5 3 5 5 2 5 5 5 4 
6 2 3 4 5 4 5 1 3 5 2 4 2 
7 1 2 4 4 3 5 2 3 3 5 2 3 
9 1 2 4 4 3 5 4 3 5 3 5 4 
13 1 5 2 4 3 4 1 1 3 2 1 2 
14 1 5 2 5 3 4 1 2 5 2 2 1 
 
Table 3 9: The participants’ scores on the “difficulty identifying feeling” category 
DIF 
 PT1 PT2 PT3 PT4 PT5 PT6 PT7 PT8 PT9 PT10 PT11 PT12 
2 3 5 4 4 4 5 5 4 4 2 3 4 
4 4 4 4 5 3 5 3 3 3 2 3 3 
11 2 2 3 3 4 4 1 3 1 2 2 1 
12 1 2 1 5 3 1 1 1 1 1 2 2 
17 1 2 1 4 4 5 1 5 5 1 2 3 
 
Table 3. 10: The participants’ scores on the “externally oriented thinking” category 
EOT 
  PT1 PT2 PT3 PT4 PT5 PT6 PT7 PT8 PT9 PT10 PT11 PT12 
5 3 2 4 1 2 4 3 4 5 4 2 2 
8 4 3 3 4 3 4 3 3 5 1 4 4 
10 3 1 4 1 2 2 1 4 5 4 2 3 
15 4 4 5 1 3 5 3 2 5 1 3 3 
16 5 4 2 5 3 3 1 5 3 3 1 4 
18 2 2 4 1 2 2 1 3 5 3 5 2 
19 5 3 3 5 2 5 5 3 2 3 2 3 
20 4 4 1 3 3 4 1 2 1 1 1 5 
Total  49 61 60 71 60 81 44 60 74 48 53 56 
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Total scores of each participants showed that the highest score is 81 score and another 
participant present the score of 74 participant, participant scored 71, one participant 
scored 61 followed by three participant has reported the score of 60. As it can be seen 
in the table (3.10), three participants reported less by 44, 48 and 49. The total score for 
12 participants 717 with average of 59.75 see table (3.11) 
Table 3. 11: The total scores and the average score of the sample 
PTs 1 2 3 4 5 6 7 8 9 10 11 12 Average  
Total 
scores 
49 61 60 71  60    81 44 60 74 48 53 56 59.75 
 
3.8 summary of key findings  
 The primary qualitative study highlighted some difficulties that the 
participants faced regarding a perceived lack of understanding by healthcare 
professionals and the general public concerning the management of their 
condition, and the emotional and physical impact of FM. 
 This lack of understanding often led the participants to avoid going back for 
further medical interventions. These findings suggest that the participants 
were not managing their daily living activities, due to symptoms such as 
disabling fatigue and worsening pain. The study also highlighted the variety 
of intervention approaches used, with varying and often limited success.  
 Emotional impact features (fatigue, depression and anxiety) were found to 
accelerate the participants’ pain, and affect their daily living activities.  
 Participants had high FIQ scores indicating they were severely affected by the 
impact of fibromyalgia and also had high alexithymia scores. 
 3.9 Discussion  
This study has expanded the knowledge base regarding people views, experience of 
living with chronic widespread pain (FMS) and understanding of issues with coping 
and self-management of FMS. A number of studies (Macfarlane et al., 2016, Wolfe et 
al., 2011, Fitzcharles et al., 2013d), suggested that initial management should involve 
patient education and focus on non- pharmacological therapies and a specific need for 
individuals by shared decision-making with patients and may involve psychological 
therapies with pharmacotherapy for pain or a multimodal rehabilitation programme for 
more severe disability. The current study developed these findings by additionally 
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using  FIQ self-report and TAS instrument to explore FM impact, patients’ ability of 
self-managing and the impact of psychological and emotional features that impact 
upon  fibromyalgia patients’ daily living. The results are broadly consistent with a 
Belgian study by Calsius ( 2015) . This  qualitative study collected data in a focus 
group of 30 women diagnosed with FM ,used two self-report questionnaires (Toronto 
Alexithymia Scale TAS -20 and Hospital Anxiety and Depression Scale HADS),. 
recruited from physical therapist practices.  Alexithymic FM patients, were found to 
be primarily failing in expressing their bodily experiences  a representation of 
alexithymia. The current study has developed an in depth understanding of the 
experience of living with FMS and views and experiences of healthcare and 
interventions within a UK setting.  
The aim of this study was to capture service users’ views and experiences of 
fibromyalgia.  This study addressed six key questions: - 
 To explore the experience of the process of obtaining a diagnosis . 
 To explore the emotional experiences of sufferers. 
 To explore the experiences of support.   
 To explore the experiences of coping  and managing daily living activities  
 To explore the interventions that have been accessed by sufferers and their 
experiences of these interventions. 
 To explore the description of living with pain. 
This qualitative study highlighted four main themes, journey of diagnosis, coping with 
variability and unpredictability of symptoms, availability and satisfaction with current 
health care practices and services and the emotional influences. Participants reported 
facing difficulties regarding a perceived lack of understanding by health and medical 
professionals and community regarding management of the condition and the 
emotional and physical impact of FMS. This lack of understanding often led 
participants to avoid going back for further health and medical intervention. These 
findings suggested people were not managing daily living activities due to symptoms 
such as disabling fatigue and worsening pain. This part of the study has illustrated a 
variety of intervention approaches are used with variable and often limited success. 
The participants’ perspectives have illuminated the need for support required for 
people living with FMS and need for education and standardisation of approaches in 
clinical practice.  These findings have  similarities with  a qualitative study by Briones-
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Vozmediano et al. (2013) who conducted a study in Spain of fibromyalgia patients (n 
=12), 10 were women and 3 were men aged range 29 to 61 years. Patients recruited 
were from associations in a region in the east of Spain, utilising semi -structured 
interviews to understand the experiences of challenging FMS cases. Patients reported 
that the need for greater moral support from professional was required.  Participants 
also reported symptoms characteristic of flares included pain, fatigue, body 
aches/exhaustion, and variety of other symptoms. This study shares some similarities 
with the current study, however the therapeutic relationship with healthcare 
professionals was commented upon positively. The finding of the need for support was 
illuminated in the current study. Briones-Vozmediano et al (2013) was undertaken in 
Spain, thus the study undertaken as part of this thesis has provided understanding of 
support required within a UK setting. It is thus clear, that individuals living with FMS 
feel the need for further support from healthcare professionals.  
A recent USA-based qualitative study by Vincent et al. (2016) of 44 participants 
demonstrated that periods of symptom exacerbation (flares) are commonly 
experienced by patients with fibromyalgia, and that symptoms of flares can be 
differentiated from every day or typical symptoms of fibromyalgia. These observations 
concur with our findings, where the participants reported symptoms characteristic of 
flares, including body aches/exhaustion, pain, fatigue, and a variety of other 
symptoms. In addition, our study showed that the participants sought more support 
from GPs and health professionals for cases of flare-ups, as they could not cope with 
the pain. The current  study described the views of living with pain, and how emotional 
factors impact patients’ symptoms and daily living. It used framework analysis to 
analyse the text, allowing for an in-depth exploration of the findings. In contrast, the 
USA study used content analysis, which may have resulted in a lack of in-depth 
analysis and discussions.                    
The findings from our study also share some similarities with the qualitative study of 
(Eilertsen et al., 2015), which explored the similarities and differences in the 
experiences of fatigue in FMS compared with multiple sclerosis and ankylosing 
spondylosis. The study reported that FMS patients described a feeling of invisibility 
and a difficulty describing the experiences of fatigue. In our study, this aspect was 
clearly observed, as the participants described the influence of fatigue in a lot of detail, 
including the impact of unrefreshing sleep and fatigue on emotions and daily life. As 
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such, the study was able to elucidate the links between pain severity and sleep 
difficulty and fatigue.  
A qualitative study by Dennis et al. (2013) of women with FMS (n=20) ,were contacted 
through an online support group and a ‘real world’ support group. Participants 
demonstrated that symptoms of fibromyalgia acted as parallel effects of a comorbid 
illness.  The study pointed out that patients should be informed that medications’ 
effects will take time, and that a rapid reduction of pain is not predicted in most cases. 
Furthermore, GPs and healthcare professionals in both primary and secondary care 
sites need to consider a holistic approach to diagnose and treat chronic widespread 
pain and comorbid conditions that addresses both the physical, psychosocial and 
emotional impact and processing. Moreover, the psychological issues aggravated the 
patients’ symptoms and pain intensity were reported. 
In our research study, the participants reported a lack of energy and being unable to 
function, as the fatigue interfered with their daily activities, and made them feel tired 
for most of the day.  In addition, the participants discussed how the fatigue and chronic 
widespread pain associated with their condition often influenced all aspects of physical 
activity.  
A narrative interview by Sallinen et al. (2010), focusing on the experience of work 
ability and functioning of patients livening with FMS (n=20) of women aged 34–65 
years was conducted, patients participated in FM rehabilitation courses at the 
Rheumatism Foundation Hospital. The study identified four concerns regarding lived 
experience, coping with fluctuation symptoms, exhaustion confusion, and severe pain 
and fatigue combined with substantial decrease in work ability and functioning a 
dynamic movement. However, people with chronic widespread pain are often 
concerned about unemployment and having high medical utilizations rates regard to 
fatigue symptoms and was not been relieved by rest. Furthermore, our study has 
reported the effect of fatigue and pain among fibromyalgia patients in the UK, and 
discussed the emotional impact of the symptoms on patients’ lives. 
Another qualitative observational study by Lukkahatai et al. (2016) used a sample of 
120 women diagnosed with FM recruited from community physicians and 
practitioners, and utilised a self-report questionnaire to measure fatigue and pain, and 
a cluster analysis to analysis the data using SPSS. The non-UK study found that fatigue 
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was associated with widespread pain, symptoms flare-ups, cognitive dysfunction and 
psychological aspects such as anxiety and depression. The limitation of the study that 
attempted to identify relationships among self-reported symptoms. It is commonly 
known that the intensities of FMS symptoms change frequently.  In contrast, our 
qualitative study developed an in-depth understanding of the issues associated with 
fatigue in FMS, and the links between pain and the wider impact on the daily lives of 
patients, which could not have been achieved through a self-report questionnaire.  
A study by Eilertsen et al. (2015) found similar findings to those of our study regarding 
the unpredictable and uncontrollable aspects of fatigue. In particular, the impact of 
tiredness and fatigue, resulting from nonrestorative sleep, on daily functioning was 
discussed. The invisibility of fatigue was highlighted as a challenge, which was also 
discussed in-depth our study. Similar to our findings, the lack of understanding and 
belief were reported in this study, where the participants pointed out that clinical 
awareness may allow healthcare professionals to offer adequate information on FMS, 
and establish effective intervention approaches for managing the condition. 
The difficulties facing FMS patients regarding sleep disruption, physical functioning 
and disability, tiredness, and psychological hardships such as depression and anxiety, 
have been highlighted by a number of research studies.  A qualitative cross-sectional 
study conducted in Spain by Miro et al. (2011) used semi-structured interviews of 
women with FMS (n=104) recruited from community. The study highlighted an 
eloquent point that sleep disorders mediate pain and emotional distress, and that sleep 
quality plays a significant role in the relationship between pain and functioning. Our 
study also provided an insight and a deeper understanding of FMS patients’ 
experiences of sleep disorders during the day, where the participants reported feeling 
useless, finding it difficult to perform any daily activity, and waking up unrefreshed 
and exhausted, even after having had sleeping tablets’ 
Non-pharmacological approaches of coping with pain should be debated, including the 
importance of approaches that target anxiety and sleep disorders. Access to 
physiotherapy and psychotherapy needs to be recommended, or at least given more 
consideration for FMS patients. These procedures and practices do not appear to be 
currently in place based on the findings of our study. 
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A narrative review by McMahon et al. (2012),focused on the theories and narrative of 
chronic illness  experience, and examined the impact of chronic widespread pain 
conditions on the identities of patients. The review aimed to empower people to tell 
their own personal experiences of the diagnosis process and impact of fibromyalgia, 
and used narrative analysis to review the illness experiences from narrative studies on 
chronic pain. In contrast, our study used a framework analysis to provide an in-depth 
account of the experiences of misdiagnosis, and the lack of understanding of the pain 
that FMS patients suffered, and how they coped with such pain. Furthermore, the use 
of framework analysis enabled the provision of in-depth information on the complexity 
of the living experience with such pain, and emotional influences of the condition. Our 
study reported that there was poor knowledge and a lack of understanding of the 
etiology and pathogenesis of FMS by physicians and HCPs, which made the 
participants feel disappointed and frustrated about the social and community 
consequences.  
A qualitative study by Jelin et al. (2012) focused on the provision of intervention 
approaches using web based technology (web-based home interventions) in Norway. 
Seven women who were interviewed about their experiences of such interventions 
programmes, telephone interviews were chosen which utilised information 
technology, such internet and smart phones, to facilitate communications between 
healthcare providers and patients. The data was analysed by systematic text 
consecrations, and the results highlighted the formation of relationships of trust 
between HCPs and the patients. In addition, HCPs were found to play an important 
role regarding the assessment and management of chronic pain, updating knowledge, 
and working together with the patients to deliver batter services. The study also 
highlighted the difficulties HCPs faced due to the limited availability of resources, 
research and financial support. The participants valued HCPs’ support and were able 
to build a rapport with them, extending beyond dealing with their condition. In 
addition, the participants believed that the availability of nurse care might assist the 
consultation to and support of people with chronic pain. Furthermore, they also 
mentioned that the use of technology could help to provide patients with an easy 
communication connection to healthcare professionals and nurses, and facilitate the 
access to high quality care when they need it.  
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A review study of 75 articles conducted in New Zealand by Annemarie (2010) 
emphasised that the crucial distinction between disorder and illness in debating the 
condition’s labels enable access to the health services. The study also stated that the 
limited currency that fibromyalgia holds in the health dialogue, and the lack of 
convincing elements of the condition (like clear biomedical indicators that make the 
condition objectively visible) lead to reduced credibility. However, most of the studies 
on this context were non-UK based..  Our study depicts the challenges that the 
participants faced in obtaining a diagnosis, often resorting to seeing multiple 
healthcare professionals, and feeling a general lack of understanding of their condition. 
This has important implications for UK based healthcare, in that it highlights that 
individuals living with FMS are having difficulties with diagnosis and access to 
relevant services.  
A an interpretive study in Sweden discussed the challenges FMS patients faced 
regarding daily living activities (Audulv et al., 2012). Individuals with the chronic 
illness (n=21), Eight women diagnosed with FM were interviewed, the participants 
chosen the location for their individual interviews (e.g., their home, work place, or the 
university). And although the study’s findings had similarities with our study, the focus 
was to provide a standard to help healthcare professionals support the self-
management of patients with chronic pain. However, self-management is often a 
variable process in chronic disorders in general, and in fibromyalgia specifically a 
(musculoskeletal pain disorder), as the illness and life circumstances are ever-
changing, which might demand continuous changes and adaptations to the individual’s 
life. Due to these reasons, the empirical qualitative study reported in this thesis aimed 
to capture the day to day lives of individuals, the impact of fibromyalgia, and the 
challenges associated with pain and fatigue.  
The findings of our study corroborate those of the study by Cooper and Gilbert (2016) 
in which 15 participants living with fibromyalgia were interviewed in South Africa 
about their social support experiences (Cooper and Gilbert, 2016). The study 
highlighted the importance of social support for coping with the illness experience of 
fibromyalgia, due to the complex nature of the condition, and the uncertainty and 
multiplicity of its features. The limited access to the healthcare system was also 
discussed, as the participants reported the lack of support they received regarding the 
management of their condition. Our study also showed that the availability of services 
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was a concern, and demonstrated several shortcomings in the referral process. In 
addition, the participants believed that the lack of support had an enormous influence 
on their daily lives.  
Self-management of pain was also frequently discussed by participants. Self-
management is complex and involves managing the physical and psychological 
aspects of chronic pain conditions (Stewart et al., 2014). The  previous study analysed 
n=45 studiesof the experiences of FMS symptoms  using thematic analysis,  and 
identified  numerous physical, psychological, and social health consequences due to 
chronic pain or long-term pain. Likewise chronic widespread pain classified as 
musculoskeletal chronic pain represents the majority of pain disorders affecting older 
adults.  During the interviews, the psychological impact of the condition was also 
frequently discussed, where the participants mentioned a lack of understanding from 
healthcare professionals of their psychological needs. As such, support with the 
physical and psychological aspects of the condition must be provided, current 
challenges and shortcomings in this regard must be addressed. Furthermore, the in-
depth discussions on the emotional impact of fibromyalgia in the interviews 
demonstrates the need to focus on this aspect within interventions, and to educate 
healthcare professionals on its importance, in order to effectively support the self-
management of the condition. This contrasted with another study by Toussaint et al 
(2014) of   30 women living with FMS aged 40 - 54 years, who were assessed during  
forgiveness education sessions and analysis of themes. The study were conducted on 
Mayo Clinic, Rochester, USA using a qualitative assessment of a forgiveness 
education for these patients. The study findings  suggested that forgiveness education 
is acceptable and feasible in patients with fibromyalgia. 
A qualitative study by Matthias et al. (2012) .discussed the challenges associated with 
service availability issues with participants living with chronic pain (n=26), female 
patients recruited from a veterans primary care clinic in Indiana, USA. Self-
management, education and the important role played by nurse care were all discussed 
by the participants. The study highlighted varying perceptions of nurse care, with most 
participants viewing nurses as good listeners and a strong source of support. In 
addition, the participants mentioned how nurse care helped them overcome frustrations 
and lack of motivation, and provided them with emotional support. The study used 
grounded theory analysis, which focuses on understanding participants’ perspectives. 
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Although the study’s findings had some similarities with our study, the availability of 
nurse care was not frequently discussed in our study, unlike rheumatologists and GPs, 
who were frequently mentioned. This may be explained by the different contexts and 
samples of the two studies, where in our study, the participants were concerned about 
a direct line of support from nurses (help in between), as they felt frustrated with the 
limited access to the healthcare system when they needed it.  
Several previous studies have focused on the development of clinical guidelines for 
the diagnosis and management of fibromyalgia. However, there is limited literature 
exploring the actual illness experience (Raff et al., 2014, Namane et al., 2013, 
Govender et al., 2011). The qualitative study reported in this thesis aimed to capture 
the service users’ views and experiences of fibromyalgia and fatigue symptoms to 
provide an in-depth understanding of the condition, and discuss the services 
specifically offered for chronic widespread pain. The qualitative findings gained from 
the participants’ experiences showed a lack of knowledge among healthcare 
professionals and communities about the condition. 
The psychosocial impact of FMS on patients, which includes emotional distress and 
emotional awareness, expression and processing (alexithymia), seems to play a key 
role in the management of the condition. However, there is an unclear association 
between alexithymia and pain intensity, as has been highlighted in some studies, where 
alexithymia appeared to be mediated by negative effects such as depression. (Lumley 
et al., 2011, Di Tella and Castelli, 2013, Calsius et al., 2015, Di Tella and Castelli, 
2016). Our study showed that depression was reported by patients living with FMS, 
who felt that the unpredictability of symptoms and their flare-ups made, it a struggle 
for them to function and control their lives. Participants who reported being depressed 
tended to report pain severity and feeling frustrated. 
A previous study by Tuzer  et al. (2011) of 70 fibromyalgia (FM) patients using the 
Toronto Alexithymia Scale, reported difficulty in recognising physical sensations by 
patients, as the bodily expressions of emotions could lead alexithymic individuals to 
misunderstand their emotional arousals as signs of syndrome, further worsening the 
symptoms. Our qualitative study focused on the experiences of living with pain, where 
the participants reported difficulty in describing and understanding the symptoms. A 
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difficulty in identifying feelings can predict affective pain, as well as psychological 
aspects, particularly anxiety.  
The findings of our study have parallel values with   a previous qualitative study by 
Arnold et al (2008) in which 48 women diagnosed with FMS. focus groups were 
conducted at each of three sites including, Seattle Rheumatology Associates 
(community-based rheumatology private practice), Seattle, Washington, University of 
Cincinnati Medical Center (university-based primary care private practice), 
Cincinnati, Ohio and University of Michigan Medical Center (university-based 
rheumatology practice), Ann Arbor, Michigan. Patients reported that had the greatest 
impact on their quality of life including pain, sleep disturbance, fatigue, depression, 
anxiety, and cognitive impairment. They had a substantial negative impact on social 
and occupational function. Likewise, participants in our study determined that pain 
and fatigue were the most of clinical features of FMS.  
 
Contrary to our study participants were mostly resembled the difficulty to copy with 
pain. A qualitative study by De Vries et al (2011) semi-structured interview was 
conducted among 21 subjects (9 male, 12 female )diagnosed with chronic 
musculoskeletal pain (CMP) . Data was analysed by means of thematic analysis. 
Participants reported a variety of styles in coping with pain including some promoting 
and the effect of pain medication varied, finding access to healthcare services, and 
asking for support were considered.  
The finding of our study showed similarity to study by Rodham et al (2010) conducted 
structured interviews with four women with FMS, participants recruited through the 
local FMS support group in the south-west of England, Data were analysed using 
interpretative phenomenological analysis. Participants reported feeling isolated from 
healthcare professionals, whom they felt they had to convince that they had something 
‘real’ and from friends and family because the unpredictability of their symptoms. 
3.10 Conclusion  
The study presented in this chapter discussed the difficulties that the participants faced 
regarding a perceived lack of understanding by healthcare professionals and the 
general public of the management of FMS, and the emotional and physical impact of 
the condition. This lack of understanding often led participants to avoid going back for 
further health and medical interventions. These findings show that the participants 
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were not able to manage their daily living activities due to symptoms such as disabling 
fatigue and worsening pain. The study also highlighted that a variety of intervention 
approaches were used with varying and often limited success. The participants’ 
perspectives have illuminated the need for support required for people living with FM 
and need for education and standardisation of approaches in clinical practice.  To date 
there are cross sectional studies focusing on Alexithymia, In addition, our qualitative 
study has provided depth to the existing cross sectional studies focusing on 
alexithymia, through the frequent reporting of cognitive dysfunction and distress 
Seeking support from a health and medical professionals featured strongly throughout 
the interviews. Thus, their role in supporting management of FMS is prominently 
highlighted, the subsequent phase of the current  research is a quantitative study based 
on a national survey of healthcare professionals. The study aims to describe current 
FMS practice in the UK, analyse the differences in approaches for the management of 
FMS between healthcare professionals, and explore attitudes and opinions regarding 
the outcome of interventions. The study aspires to contribute towards decreasing the 
integrated nature of pain and the impact of the condition on daily life, as well as to 
support people living with FMS to understand their condition, and to ultimately self-
manage. 
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4.1 Introduction  
4.1.1 Section A: United Kingdom Fibromyalgia Survey  
In a previous study upon which our study was based, a self- completion questionnaire 
was used to survey two professional interest groups in rheumatology recruited from 
the National Association of Rheumatology Occupational Therapists (n=140), and the 
Rheumatic Care Association of Chartered Physiotherapists (n=61). The foremost 
therapeutic objective targeted by occupational therapists (OTs) was increased 
functional ability, while increased exercise tolerance and general fitness was the main 
aim of physiotherapists (PTs). Pain reduction and management was rated as the second 
objective for both groups (Sim and Adams, 2003b). Larger scale studies have since 
been conducted and are presented below. 
In  a descriptive survey of Latin American and European patients (n=900,  aged: 45–
59 years), and physicians (n= 1824) who had  been in practice for 11–30 years across 
regions, it was found that patient- and physician-rated disease perception and impact 
were often higher in Latin America than in Europe. Patient and physician perspectives 
concerning FMS impact and disruption were often misaligned within the same region, 
when incorporating cultural differences. As with all surveys, some limitations were 
present, including that respondents may have not perfectly recalled their experiences 
and feelings at the time of the survey, as respondents' feelings, attitudes, and 
perceptions are subject to change with time. In addition, the survey only provided a 
snapshot of the respondents' experiences, and did not seek to address how these might 
have changed longitudinally (Clark et al., 2013). 
 A cross-sectional survey of FMS patients (n=1651) was used to validate the 
fibromyalgia survey questionnaire (FSQ), instruments also, including the wide pain 
index (WPI) and the Symptoms Severity Score (SSS). The participants, who all had a 
diagnosis of FMS, were recruited by FMS self-help organisations and nine clinical 
institutions of different levels of care. The participants were assessed using the 
American College of Rheumatology’s 1990 classification criteria, and the data 
analysis was descriptive.  The study demonstrated the feasibility, reliability and 
validity of the FSQ in a survey of German FMS-patients. While the reliability, and 
convergent and discriminant validities of the FSQ were good, further validation studies 
of the FSQ in clinical and large population settings are needed. The study confirmed 
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the high levels of distress reported by FMS patients, which can be located at the 
extreme end of the continuum of distress, and the conceptuality of FMS as a varying 
illness (Hauser et al., 2012a). 
A large scale survey in six European countries was conducted by Perrot  et al. (2012) 
on 1622 participants, of which n=809 were primary care physicians (PCPs), and the 
remainder being recruited from secondary care, which included rheumatologists, 
neurologists, psychiatrists and pain specialists. Data was analysed using descriptive 
and inferential analysis, and it was found that almost 90% of PCPs  reported  difficulty 
in discriminating FMS symptoms from other comorbid conditions, a percentage that 
was significantly higher than in the other specialties. The study highlighted the need 
for improved training of physicians, particularly PCPs and psychiatrists, in the 
diagnosis of FMS. The questions in this survey were framed in “yes/no” or 5-point 
Likert scale formats, which did not capture detailed accounts of physicians’ 
experiences, or additional unanticipated responses (Perrot  et al., 2012). 
In a Japanese market research, an internet survey of  20407 participants was conducted 
(Nakamura. et al., 2014). The Japanese Fibromyalgia Impact Questionnaire was used 
to determine the epidemiologic features and symptoms of FMS, and compare them to 
other chronic pain disorders. Statistical analyses were performed using the SAS 
software and an analysis of covariance. The study found that individuals with FMS 
had greater restrictions on their functionality than individuals with chronic pain . There 
were several limitations to the study, including the fact that people with no or limited 
internet access, and people who were not included in the database, could not participate 
in the survey.  Moreover, no physicians assessed whether the participants met the 
diagnostic criteria for FMS in this survey.    
Although there is literature regarding fibromyalgia in Europe, USA and Latin 
America, there has been relatively little attention to the condition in the Middle East, 
particularly in such countries as Libya, where pain management is not a high priority 
of healthcare system. Furthermore, the availability of opioid medication is limited, and 
pain-related governmental policies are absent (Elzahaf et al., 2016). Patients are often 
diagnosed with chronic pain rather than receiving a specific diagnosis of fibromyalgia. 
In addition, there are few studies that have been conducted on FMS. A cross-sectional 
telephone survey was conducted using an Arabic version of the Structured Telephone 
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Interviews Questionnaire on Chronic Pain. Twelve individuals were interviewed, and 
it was found that the prevalence of chronic pain lasting for longer than 3 months in the 
general adult population of Libya was approximately 20%, which is a comparable level 
with those of Europe and North America.  
The most commonly reported causes of chronic pain were disc problems, headaches 
and migraines. Furthermore, the most common sites of pain reported by the 
respondents were the upper, lower back (24.6%) and knees (13.1%). In a study by 
(Tashani et al., 2017) conducted on 71 patients, 34% were diagnosed with having low 
back pain, 19% with osteoarthritis and rheumatoid arthritis, and the rest of patients had 
multiple sources of pain, including neck and shoulder pain, and lower leg and foot 
pain. The study used a cross-culturally adapted PASS20 questionnaire to measure pain 
related anxiety. The finding of this study suggest that Libyan patients with chronic 
pain exhibited high levels of fear of pain and impaired concentration. However, several 
limitations were reported which might restrict the validity of the findings, including 
the small sample size, and the fact that the treatment received by the patients was not 
documented. Furthermore, it was not possible to evaluate the construct validity of the 
Arabic pass20 because the study did not administrate other instruments that assess pain 
related anxiety symptoms.  
The aforementioned studies suggest that health policies, and education and training 
programmes in Libya need to be improved to ensure that patients with chronic pain 
receive effective management (Elzahaf et al., 2016). Due to the paucity of literature in 
the Middle East on FMS, our study aimed to conduct a preliminary survey of current 
practice regarding the identification, diagnosis and management of chronic widespread 
pain, and establish whether clinicians would consider that there were patient cases 
corresponding with the definition of ‘fibromyalgia’ provided by the ACR. 
Thus, this exploratory survey study aimed to describe and compare the current practice 
in the UK and Libya regarding the assessment and management of fibromyalgia, and 
the attitudes and opinions regarding the condition.    
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4.2 Aims 
 To explore the current practice for FMS in the UK and Libya 
 To consider similarities and   differences in views and approaches to the 
management of FMS between the UK and Libya   
 To explore the attitudes and opinions regarding the outcome of interventions 
4.3 Pilot study  
The nature of this study was explorative, and the questions of the quantitative survey 
were based on the previous study by Sim and Adams (2003). The survey was checked 
for validity and consistency by an academic physiotherapist, and then piloted on the 
six members of physiotherapy association of the UK. The responses obtained from the 
pilot study anticipated that the response rate of the questionnaire was likely to be 50%. 
However, due to the lower rank devoted to participating, a response rate of 
approximately 20% was expected. Amendments were made to the questionnaire based 
on the feedback from the pilot study, which included terms and questions relating to 
interventions approaches. It is generally recommended to conduct a pilot study on a 
smaller sample (usually about 10% of the final sample) to help adapt the final study 
based on the anticipated response rate (Mathers, 2009 ). 
4.4 Methods  
4.4.1 Design of the questionnaire  
This exploratory study was conducted in order to collect data on a wide range of topics 
relating to the practice of fibromyalgia assessment and interventions. A survey was 
used in order to obtain a large sample size and address a broad range of relevant topics. 
The questionnaire was designed specifically for the study, and developed based on an 
earlier work by (Sim and Adams, 2003). The questions were mostly ‘closed’, and were 
either categorical or used ordinal Likert scales.  The questionnaire consisted of 23 
questions, and contained some open questions and spaces for comments. 
The demographic data included region, profession, speciality, current professional 
status, patients’ descriptions, and the proportion of patients diagnosed and referred 
who fulfilled a case definition of fibromyalgia. The questionnaire enquired about the 
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practice of healthcare professionals regarding the diagnosis, assessment and 
management of FMS.   
In this study, in order to establish a case definition for the purpose of the survey, we 
included a definition of FMS in the questionnaire. This definition was based on that of 
(Wolfe et al., 1990), and the American College of Rheumatology’s  2010 classification 
criteria (Giordano et al., 1999). We anticipated that healthcare professionals would 
have treated patients with FMS who had been referred under a variety of diagnostic 
labels.  
4.4.2 Ethical approval 
The study’s protocol was submitted on the 9th of September 2014 to the Departmental 
University Research Ethics Committee, who requested major amendments before an 
approval could be granted. The resubmission of the ethics application was made on 
the 3rd of March 2015. The project then received an ethical approval through the 
Department of Sport, Exercise and Rehabilitation’s ethics committee on the 12th of 
May 2015, with reference number HLSSA300415 (see the Appendix (3). 
4.4.3 Participants 
The participants included listed members of the British Pain Society (BPS), which 
represents healthcare professionals in all regions of UK. The participants were 
identified from the BPS’ database as professionals who were interested in the area 
covered by the survey, in order obtain a representative sample of UK HCPs. Initial  
contact was made with the pain society to provide a database of healthcare 
professionals.   
The sample of participants also included a representation of healthcare professionals 
from Libya. The setting for survey B was Tripoli (the capital city) and its neighbouring 
city, Zawia. These participants were selected to identify and explore the existing 
Libyan HCPs’ practices and attitudes on FMS. The participants were  recruited by 
principal researcher, who had personal connections with HCPs in Libya, via email or 
face to face meetings. The sample of Libyan healthcare professionals included 
physicians, physiotherapist and rheumatologists. A questionnaire with an invitation, 
consent form and information sheet was provided to the participants. All personal 
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information was anonymised for the purpose of the research, and it was indicated that 
feedback would be sent to the participants upon their request. The sampling strategies 
and criteria used for recruiting participants to this study depended on the population of 
interest, the features and patterns of the condition under study, and the context in which 
interventions and services were provided.  
Effective sampling, which determines how well a sample represents the population, 
before drawing the information required (Curtis, 2013 ). The researcher should be 
aware of the limitations of the sampling frame, and attempt to address them in order 
to enhance the external validity of the questionnaire, and contrast it with the internal 
validity, when considering the generalizability of the study’s results. 
The survey was distributed to the healthcare professionals (n=600) identified and 
recruited from the British Pain Society’s database. The questionnaire queried the 
participants regarding their beliefs and current practices, as well as their views and 
attitudes concerning the assessment and management of musculoskeletal widespread 
pain. The respondents consisted of 53 UK-based healthcare professionals, two of 
whom were not UK residents, who completed the questionnaire and returned it to the 
address provided in a paid envelope. The same questionnaire was sent to Libyan 
healthcare professionals, where the respondents (n=15) included physicians (n=8), 
physiotherapists (n=6), and a rheumatologist (n=1). This sample was recruited through 
direct personal communication by principal researcher, who had personal links with 
healthcare professionals in Libya. In addition, the sample recruitment did not require 
ethical approval, according to the Libyan health guidelines.  
4.4.4 Sample recruitment 
The potential participants were identified by the British Pain Society, who agreed to 
make their database of members available to us. Potential respondents were thus 
identified, representing a range of UK health professionals who were interested in pain 
management. 
An invitation letter (Appendix (12)), a written explanation of the survey (information 
sheet) (Appendix (14)), and a consent form (Appendix (13)) were combined with the 
questionnaire (Appendix (15)). An attached reply slip (a stamped addressed envelope) 
was also included. 
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4.4.5 Design of the survey 
The survey was designed based on a previously published questionnaire-based survey 
study in the UK (Sim and Adams, 2003). The current questionnaire aimed to describe 
current UK healthcare practice regarding the assessment and management of 
fibromyalgia. The diagnostic criteria were provided and illustrated in the adopted 
version of survey used a diagram according to the ACR criteria (2010).   
The principal components of the survey were similar to those of a previously published 
survey of OTs and PTs (Sim and Adams, 2003b), Sim and Adams, 2003), where our 
version was modified to enhance the aforementioned previous work, and include 
multidisciplinary teams within the UK. Closed and open questions were used, with 
some open questions being used to gain an understanding of issues in more detail and 
depth (Plowright, 2011 ). 
The content of the questionnaire was based on a review of the literature on FMS, 
including the small amount of literature available on the physical management of the 
condition.  
The principal components of the survey were: 
 Demographic information 
 Occupation and area of work 
 Diagnosis, frequency and source of referrals 
 Usual management objectives 
 Specific interventions adopted 
 Perceived responsiveness of patients to physical management 
 Attitudes and beliefs regarding the nature of FMS and its management 
Most of the quantitative data was gathered in the form of frequency counts and median 
values. 
4.4.6 Data collection procedure  
The participants identified through the membership database of the BPS received an 
invitation letter asking if they would participate in this research. They also received an 
information sheet explaining the research, and an informed consent form. A reply slip 
and a pre-paid envelop were also sent to the participants, so they could indicate their 
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agreement to participate in the study. The questionnaires were returned by post to the 
researcher. A second mailing was carried out three weeks after the initial mailing.  
4.4.7 Validity and reliability 
Content and face the validity was  assessed and evaluated by  n=4 Health Care 
Professionals HCPs. Amendments were made in light of pilot study and their 
comments. All participants received the same questionnaire 
4.5 Data Analysis  
Appropriate descriptive and non-parametric statistics using SPSS version 24 were 
carried out. Most data was presented in the form of frequency counts and median 
values. Comparisons were made between the UK and Libya on the attitudes and 
opinions regarding fibromyalgia. Statistical significance was set at p=0.05, and all tests 
were two-tailed. 
4.6 Results  
This section presents the results of the questions on the general details of the 
respondents and their practices. Descriptive analyses were performed on all data to  
describe clinicians’ practices and views. The participants were also able to make some 
comments if they wished to do so.  
4.6.1 Number of respondents 
The respondents consisted of 53 members of the British pain society (BPS), initial 
sample 
size, were 600 members of the (BPS), making the total sample size n=53. The data on 
the initial questionnaires sample size (i.e. the number of potential participants 
identified and invited), and number of UK respondents is presented in Table 4.1 
Table 4 1: Response rate 
Initial sample 
size  
Number of UK 
respondents 
600 53 
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4.6.2 Demographic data 
Table 4.2 shows that the greatest number of UK responses came from the South East, 
followed by the Midlands and the South West. This data is also illustrated in Figure 
4.1. 
Table 4. 2: Analysis of respondents by region 
Region 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid North East 3 5.7 5.7 5.7 
North West 2 3.8 3.8 9.4 
South East 14 26.4 26.4 35.8 
South West 8 15.1 15.1 50.9 
Midlands 9 17.0 17.0 67.9 
London 6 11.3 11.3 79.2 
Wales 2 3.8 3.8 83.0 
Scotland 6 11.3 11.3 94.3 
Northern Ireland 1 1.9 1.9 96.2 
Non UK 2 3.8 3.8 100.0 
Total 53 100.0 100.0  
 
 
 
Figure 4. 1: Analysis of respondents by region 
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Table 4.3 and Figure 4.2 show the division of respondents by profession. It can be seen 
from the table that most respondents were pain management specialists, followed by 
physiotherapists. Of the total number of respondents (n= 53), 41 were pain 
management specialists, four were psychologists, and four were physiotherapists. 
Other respondents included an anaesthesiologist (n=1), a nurse (n=1), a pain nurse 
(n=1), and an expert patient (n=1), 
 
Table 4.3: Professional specialties of respondents  
 
Profession 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Pain management 
specialist 
41 77.4 77.4 77.4 
Physiotherapist 4 7.5 7.5 84.9 
Psychologist 4 7.5 7.5 92.5 
Others 4 7.5 7.5 100.0 
Total 53 100.0 100.0  
 
 
 
Figure 4. 2: Division of respondents according to their professional specialty 
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The respondents were asked about the setting in which they worked. There responses 
showed that that the majority worked in an outpatient setting, as can be seen from 
Table 4.4. This clinical setting data is also illustrated in Figure 4.3. 
Table 4. 4: Clinical settings in which the respondents worked 
Clinical Setting 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid In- patients 8 15.1 15.1 15.1 
Out patients 42 79.2 79.2 94.3 
Community 3 5.7 5.7 100.0 
Total 53 100.0 100.0  
 
 
 
Figure 4. 3: Clinical settings in which the respondents worked 
 
4.6.3 Diagnosis 
The respondents were asked if they saw patients that would fit the description of 
fibromyalgia provided (irrespective of the actual diagnosis), during the last 12 months. 
The responses show that the majority of respondents saw patients who either closely, 
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or more or less fitted the description of fibromyalgia (~94%), as can be seen from 
Table 4.5 and Figure 4.4. 
Table 4.5: Proportion of patients fitting the description of fibromyalgia 
 Patients fit the description in the last 12 months 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Yes, I have seen patients who 
closely fit this description 
48 90.6 90.6 90.6 
Yes, I have seen 
patients/clients who more or 
less 
2 3.8 3.8 94.3 
NO, I have not seen patient 3 5.7 5.7 100.0 
Total 53 100.0 100.0  
 
 
Figure 4. 4: Proportion of patients fitting the description of fibromyalgia. 
  
The respondents were also asked about the number of new patients/clients fitting the 
description of fibromyalgia seen in the last 12 months. The answers to this questions 
are presented in Table 4.6, and illustrated in Figure 4.5. 
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Table 4.6: Number of new patients fitting the description of fibromyalgia in last 12 months 
New patients/clients fitting this description in the last 12 months 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 1-4 patients, per month. 17 32.1 34.0 34.0 
5-9 patients, per month. 18 34.0 36.0 70.0 
10-15 patients, per 
month. 
15 28.3 30.0 100.0 
Total 50 94.3 100.0  
Missing  3 5.7   
Total 53 100.0   
 
 
 
 
Figure 4. 5: Number of new patients fitting the description of fibromyalgia in last 12 months 
 
Table 4.7 and Figure 4.6 show the proportion of the patients having a diagnosis of 
fibromyalgia, according to the respondents’ answers. 
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Table 4. 7: Proportion of patients having a diagnosis of fibromyalgia 
 Proportion of  patients having a diagnosis of FMS 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid All of them 2 3.8 4.1 4.1 
More than half of 
them 
24 45.3 49.0 53.1 
About half of them 15 28.3 30.6 83.7 
Less than half of 
them 
6 11.3 12.2 95.9 
Almost none of 
them 
2 3.8 4.1 100.0 
Total 49 92.5 100.0  
Missing  4 7.5   
Total 53 100.0   
 
 
Figure 4. 6: Proportion of patients having a diagnosis of fibromyalgia 
The questionnaire also asked the respondents regarding the frequency with which 
patients fitting the definition of fibromyalgia were referred from specific healthcare 
sources. The respondents answered using a Likert scale, where 1= often, 2=sometimes, 
3= seldom and 4 =never. Table 4.8 demonstrates that the highest median response (of 
1) was for general practitioners and rheumatologists, followed by rehabilitation 
therapists (2). Patients were seldom referred from either anaesthetists or psychologists. 
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Table 4. 8: The median response for patients referred by each healthcare source 
Referral source Median response 
GP 1 
Orthopaedic 3 
Neurologist 3 
Psychologist 4 
Anaesthetist 4 
Rehabilitation Therapist 2 
Self-Referral 4 
Rheumatologist 1 
 
The respondents were asked about the descriptions that best fit the referral of 
patients/clients with fibromyalgia. Their responses indicated that 58.0% of patients 
came to their clinics after trying other forms of treatment. Furthermore, the 
respondents reported that 32.0% of the patients came to their clinics after all, or nearly 
all other forms of treatment have been attempted. Table 4.9 and Figure 4.7 present and 
illustrate the full set data, respectively. 
Table 4. 9: How the referral of patients with fibromyalgia is best described 
  Best describes the patients /clients with Fibromyalgia 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Patients come to me without 
any previous management 
2 3.8 4.0 4.0 
Patients to me at an early 
stage of their assessment 
2 3.8 4.0 8.0 
Patients come to me after 
other  forms of treatment 
29 54.7 58.0 66.0 
Patients come to me after all 
or nearly all, other forms   of   
treatment have been 
attempted 
16 30.2 32.0 98.0 
combination 1 1.9 2.0 100.0 
Total 50 94.3 100.0  
Missing . 3 5.7   
Total 53 100.0   
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Figure 4. 7: How the referral of patients with fibromyalgia is best described 
The respondents were also asked to respond by either ‘Yes’ or ‘No’ to whether they 
considered that the patients/clients they had seen to have fibromyalgia only. It can be 
seen from Table 4.10 and Figure 4.8 that the responses were fairly equally divided, 
though a substantial number of respondents considered the patients they had seen to 
have other diagnoses in addition to fibromyalgia. 
Table 4.10: Responses regarding whether patients were considered to have fibromyalgia only. 
 Patients/clients consider to have fibromyalgia only 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No 15 28.3 30.0 30.0 
Yes 35 66.0 70.0 100.0 
Total 50 94.3 100.0  
Missing  3 5.7   
Total 53 100.0   
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Figure 4.8: Responses regarding whether patients were considered to have fibromyalgia only 
  
The respondents were then asked about patients considered to have co-morbid 
conditions. Table 4.11 and Figure 4.9 show that most respondents reported depression 
(37%) and irritable bowel syndrome (IBS) (37%) followed by musculoskeletal pain 
(neck and back pain, and joint pain).  
 
Table 4.11: Patients considered to have co-morbid conditions 
 Patients considered to have Co-morbid condition 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid IBS 6 11.3 37.5 37.5 
Depression 6 11.3 37.5 75.0 
Nick and Back 
pain 
3 5.7 18.8 93.8 
Joints pain 1 1.9 6.3 100.0 
Total 16 30.2 100.0  
Missing  37 69.8   
Total 53 100.0   
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Figure 4.9: Patients considered having co-morbid conditions 
 
Table 4.12 and Figure 4.10 below show that 77.6% of patients were considered to have 
fibromyalgia under other diagnostic labels. When questioned about these other 
diagnostic labels, the greatest number of labels pertained to other musculoskeletal 
conditions, such as chronic neck and back pain (53.6%), followed by chronic fatigue 
(21.2%), as can be seen from Table 4.13 and Figure 4.11.  
Table 4.12: Patients considered having fibromyalgia under other diagnostic labels 
 Patients consider to have fibromyalgia  under other diagnostic labels 
 Frequency Percent Valid Percent Cumulative Percent 
Valid No 11 20.8 22.4 22.4 
Yes 38 71.7 77.6 100.0 
Total 49 92.5 100.0  
Missing  4 7.5   
Total 53 100.0   
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Figure 4.10: Patients considered having fibromyalgia under other diagnostic labels 
 
 
Table 4.13 shows that 15 patients were seen under chronic neck and low back pain, six 
under chronic fatigue,   and seven under polymyalgia.   
Table 4.13: Patients seen under other diagnostic labels 
Patients seen under other diagnostic labels 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Chronic Neck & 
LBP 
15 28.3 53.6 53.6 
Chronic Fatigue 6 11.3 21.4 75.0 
Polymyalgia 7 13.2 25.0 100.0 
Total 28 52.8 100.0  
Missing  25 47.2   
Total 53 100.0   
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Figure 4. 11: Patients seen under other diagnostic labels  
Few respondents reported that the other diagnostic labels included chronic fatigue, , 
polymyalgia and chronic low back pain (CLBP), cognitive dysfunction, joint 
hypermobility, degenerative disc disease of the spine (DDD), migraine, and pelvic 
pain. 
4.6.4 Symptoms and functional activity 
The subsequent section of the questionnaire related to symptoms and their impact on 
physical and functional activity. The respondents were asked about the extent to which 
their patients/clients generally showed an increase in pain as a result of an increase in  
the level of physical activity. Table 4.14 shows that 26 respondents indicated that 
physical activity resulted in a severe or very severe increase in pain, while 18 
respondents reported a moderate increase in pain. Only one respondents reported a 
mild increase in pain following physical activity. Figure 4.12 illustrates the full set of 
data. 
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Table 4.14: Patients showing an increase in pain as a result of an increase in the level of 
physical activity. 
 Patients /clients generally show an increase in pain with an increase 
in  level of physical activity 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Mild 1 1.9 2.0 2.0 
Moderate 18 34.0 36.0 38.0 
Severe 26 49.1 52.0 90.0 
Most severe 5 9.4 10.0 100.0 
Total 50 94.3 100.0  
Missing  3 5.7   
Total 53 100.0   
 
 
 
Figure 4.12: Patients showing an increase in pain resulting from an increase in the level of 
physical activity. 
The respondents were then asked about whether their patients/clients used assisted 
equipment, such as walking aids. Table 4.15 shows that 55.1% of the respondents 
reported the use of assisted equipment by their patients, while 42.9% reported that such 
equipment was only sometimes used by their patients.  
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Table 4.15: Patients using assisted equipment (e.g. walking aids) 
Patients /clients use assisted equipment Patients 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Yes 27 50.9 55.1 55.1 
No 1 1.9 2.0 57.1 
Sometimes 21 39.6 42.9 100.0 
Total 49 92.5 100.0  
Missing  4 7.5   
Total 53 100.0   
 
 
Figure 4. 13 Patients using assisted equipment (e.g. walking aids) 
 
 
Table 4.16 shows that most of the daily living activities were affected due to 
fibromyalgia, with 74.0% of respondents reporting that all daily living aspects of their 
patients’ lives were affected. Walking was particularly affected (16%), as illustrated 
in Figure 4.14.  
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Table 4.16: Daily living aspects/activities most affected by fibromyalgia 
 Patients daily living are most affected due to chronic widespread pain 
(fibromyalgia) 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Walking 8 15.1 16.0 16.0 
Running 1 1.9 2.0 18.0 
Shopping 1 1.9 2.0 20.0 
None of these 3 5.7 6.0 26.0 
All Of These 37 69.8 74.0 100.0 
Total 50 94.3 100.0  
Missing  3 5.7   
Total 53 100.0   
 
 
Figure 4.14: Daily living aspects/activities most affected by fibromyalgia 
4.6.5 Clinical features 
The frequency of presentation of the various clinical features of fibromyalgia were 
reported using a Likert scale, where 1= always, 2= often, 3=sometimes, 4= seldom, 
and 5= never. The median value for each of clinical feature is shown in the Table 4.17. 
It can be seen that the occurrences of most clinical features were rated as “always” or 
“often”. Furthermore, the table shows that the lowest median response was for 
peripheral circulatory, followed by loss of joint range. On the other hand, the most 
frequent clinical features reported were pain, excessive fatigue, psychological features 
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and tenderness on palpation, followed by loss of function, localised pain, loss of 
muscle power and stiffness,.  
Table 4. 17:  Median responses for frequency of clinical features presented by patients 
Clinical Feature Median response 
Generalised pain 1 
Localised pain 2 
Tenderness on palpation 1 
Excessive fatigue 1 
Loss of muscle power/endurance 2 
Loss of joint range 3 
Stiffness 2 
Loss of function 1.5 
Psychological aspects 1 
Peripheral circulatory 4 
Others 2 
 
The respondents were also asked to identify the clinical feature they found to be most 
important to the patient. Table 4.18 and Figure 4.15 demonstrate that pain was 
considered to be the most important symptom to patients, followed by fatigue. Pain 
was reported by 65.% of the respondents, fatigue by 28.6%, and loss of function as a 
result of pain and fatigue by 6%.  
Table 4. 18: Most important clinical features to patients 
Most important clinical features to FMS patients 
 
Frequen
cy Percent Valid Percent 
Cumulative 
Percent 
Valid Pain 32 60.4 65.3 65.3 
Fatigue,Tirednes
s 
14 26.4 28.6 93.9 
Loss of Function 3 5.7 6.1 100.0 
Total 49 92.5 100.0  
Missing . 4 7.5   
Total 53 100.0   
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Figure 4. 15: Most important clinical features to patients 
 
4.6.6 Primary symptoms: pain assessment and measurement 
The questionnaire also asked the respondents if they routinely assessed or measured 
pain, and how they assessed or measured it. Table 4.19 shows that 19 respondents  used 
a numerical rating scale (39.6%), 16 respondents reported using multiple measurement 
scales (33.3%), six did not routinely use a measure for pain intensity (12.5%),  three 
respondents used verbal rating scales (6.3%), and two used a visual analogue scale 
(4.2%). Only one respondent used the McGill Pain Questionnaire. Figure 4.16 
illustrates the full set of this data. 
Table 4.19  Measurement of pain intensity 
 Measurement of  pain intensity of fibromyalgia patients 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Numerical rating scale (e.g. 1-10) 19 35.8 39.6 39.6 
Verbal rating scales (e.g. severe, 
moderate 
3 5.7 6.3 45.8 
Visual analogue scale 2 3.8 4.2 50.0 
McGill Pain Questionnaire (long or 
short form 
1 1.9 2.1 52.1 
Other 1 1.9 2.1 54.2 
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Do not routinely measure pain 
intensity 
6 11.3 12.5 66.7 
Multiple 16 30.2 33.3 100.0 
Total 48 90.6 100.0  
Missing  5 9.4   
Total 53 100.0   
 
 
Figure 4.16: Measurement of pain intensity. 
  
The participants were also asked if they routinely assessed or measured other 
dimensions of pain besides intensity pain, and how they assessed or measured them.  
Responses in Table 4.20 show that five respondents used the Brief Pain Inventory 
(BPI), while 47 respondents did not routinely measure other dimensions of pain for 
people with fibromyalgia. 
Table 4. 20: Measurement of pain dimensions other than its intensity. 
 Measurement of pain dimensions other than its intensity. 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid BPI 5 9.4 100.0 100.0 
Missing  47 88.7   
System 1 1.9   
Total 48 90.6   
Total 53 100.0   
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The respondents were subsequently asked if they used standardised assessment scales 
for fibromyalgia patients. Table 4.21 indicates that the majority of respondents (50.%) 
reported that they did not use a standardised assessment for fibromyalgia, while 50% 
reported that they used standardised assessment scales.  
Table 4.21: Use of standardised assessment scales or measures for fibromyalgia patients 
  Standardised assessment scales or measures for fibromyalgia 
patients 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No 23 43.4 50.0 50.0 
Yes 23 43.4 50.0 100.0 
Total 46 86.8 100.0  
Missing  7 13.2   
Total 53 100.0   
 
Table 4.22 and Figure 4.17 show that 45.5% of the respondents reported that they used 
the Brief Pain Inventory (BPI) as a standardised assessment scale, while 31.8% used 
the Hospital Anxiety and Depression Score (HADS). On the other hand, only 22.7% 
of the respondents reported the use of Pain Self-Efficacy Questionnaire (PSEQ) as a 
standardised assessment scale.  
Table 4. 22: Use of standardised assessment measures 
Use of standardised assessment measures 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid HADS 7 13.2 31.8 31.8 
BPI 10 18.9 45.5 77.3 
PSEQ 5 9.4 22.7 100.0 
Total 22 41.5 100.0  
Missing  31 58.5   
Total 53 100.0   
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Figure 4.17: Use of standardised assessment measures 
4.6.7 Pharmacological approaches: medication prescribed to 
patients with FMS 
The respondents were asked about the medications they prescribed to FMS patients in 
their practice. Table 4.23 and Figure 4.18 show that 85.7% of the respondents used a 
combination of medications. Furthermore, the data shows that 12.2% of the 
respondents did not prescribe medications, while amitriptyline was rarely prescribed 
by the respondents to fibromyalgia patients. 
Table 4.23: Medications prescribed to patients with fibromyalgia 
 Medications prescribed to patients with fibromyalgia 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Amitriptyline 1 1.9 2.0 2.0 
Combination 42 79.2 85.7 87.8 
Do not 
Prescribe 
6 11.3 12.2 100.0 
Total 49 92.5 100.0  
Missing  4 7.5   
Total 53 100.0   
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Figure 4. 18 : Medications prescribed to patients with fibromyalgia. 
 
Table 4.24 shows that 59.2% of the respondents reported that patients sometimes 
attended their clinics with medications specifically for their symptoms, while 16.3% 
reported that patients attended with no medications. Additionally, 24.5% of the 
respondents reported that patients attended their clinics with medications specifically 
for their symptoms. The full set of data relating to this questions is illustrated in 
Figure 4.19 
Table 4.24: Patients presenting with medications specifically for their symptoms. 
 Patients consider to have fibromyalgia, come without medications 
specifically for their symptoms 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Yes 12 22.6 24.5 24.5 
No 8 15.1 16.3 40.8 
Sometimes 29 54.7 59.2 100.0 
Total 49 92.5 100.0  
Missing  4 7.5   
Total 53 100.0   
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Figure 4. 19: Patients presenting with medications specifically for their symptoms 
 
4.6.8 Non-pharmacological interventional approaches 
A number of non-pharmacological interventional approaches were ranked by the 
respondents on a Likert scale in terms of frequency of use, where 1=always/almost 
always, 2=often, 3=sometimes, 4=seldom, and 5=never/almost never. The median 
responses for these interventional approaches are shown in Table 4.25. 
Table 4.25: Median responses for use of non-pharmacological interventional approaches 
Intervention Median Response 
Stretching exercise 2 
Aerobic exercise 3 
Graded exercise programme 2 
Group exercise 3 
Hydrotherapy 3 
Postural re-education 3 
Functional activity re-education 2 
Cognitive behavioural therapy 2 
Relaxation 2 
Acupuncture 3 
Ergonomic evaluation 5 
TENS 3 
Ultrasound 5 
Manual therapy 5 
Massage 5 
Energy conservation 3.5 
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Table 4.25 indicates that the most frequently used interventions were  stretching 
exercises, graded exercise programmes, functional activity re-education, cognitive 
behavioural therapy, and relaxation. These five interventions were frequently reported,  
followed by aerobic exercise, hydrotherapy, postural re-education and TENS. In 
contrast, ergonomic evaluation, ultrasound, manual Therapy and massage were seldom 
used. 
4.6.9. The use of a specific management programme by HCPs for 
FMS  
The respondents were asked about the use of a specific management programme for 
fibromyalgia.  Table 4.26 shows that 62.0 % of the respondents had a management 
programme for chronic pain in general, but only 12.0% of respondents had a 
management programme specifically tailored for fibromyalgia.  The remainder of 
respondents had no specific management programmes. The responses are illustrated 
in Figure 4.20. 
Table 4.26: Use of a specific management programme for fibromyalgia 
 Use of a specific management programme for fibromyalgia 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No 13 24.5 26.0 26.0 
Yes, for chronic pain 
patients in general 
31 58.5 62.0 88.0 
Yes, specifically for 
fibromyalgia patients 
6 11.3 12.0 100.0 
Total 50 94.3 100.0  
Missing  3 5.7   
Total 53 100.0   
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Figure 4.20: Use of a specific management programme for fibromyalgia  
 
The respondents were then asked regarding the components of the specific 
management programmes they used for fibromyalgia. Table 4.27 shows that, of the  
respondents, physiotherapy registered the most common use (41.7%), followed by the 
use of lidocaine infusion (33.3%), with 16.7% of respondents reporting the use of 
CBT. 
Table 4.27: Frequency of prescribing specific management programmes for fibromyalgia  
Frequency of prescribing specific management programmes for fibromyalgia 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Psychological Group 
Sessions 
1 1.9 8.3 8.3 
Physiotherapy 5 9.4 41.7 50.0 
CBT 2 3.8 16.7 66.7 
Lidocaine infusion 4 7.5 33.3 100.0 
Total 12 22.6 100.0  
Missing  41 77.4   
Total 53 100.0   
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Figure 4. 21: Frequency of prescribing specific management programmes for fibromyalgia. 
The respondents were subsequently queried about the responsiveness of fibromyalgia 
patients to the interventional approaches. The respondents provided their answers 
using a Likert scale, where 1= extremely responsive, 2= very responsive, 3= 
moderately responsive , 4= quite unresponsive, and 5= extremely unresponsive. As 
can be seen from Table 4.28, 62% of the respondents reported moderate response to 
interventional approaches, while 28. % reported their patients to be quite 
unresponsive to the interventional approaches. The full set of results for this question 
is illustrated in Figure 4.22. 
Table 4. 28: Responsivity of fibromyalgia patients to interventional approaches 
Responsivity of fibromyalgia patients to interventional approaches 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Extremely  
responsive 
1 1.9 2.0 2.0 
Very  responsive 2 3.8 4.0 6.0 
Moderately  
responsive 
31 58.5 62.0 68.0 
Quite 
unresponsive 
14 26.4 28.0 96.0 
Extremely 
unresponsive 
2 3.8 4.0 100.0 
Total 50 94.3 100.0  
Missing  3 5.7   
Total 53 100.0   
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Figure 4. 22: Responsivity of fibromyalgia patients to interventional approaches  
 
4.6.10 Aims of fibromyalgia rehabilitation programmes 
The respondents were asked about what they hoped to achieve from a fibromyalgia 
rehabilitation programme. 
Table 4. 29: Breakdown of the reported aims of rehabilitation programmes 
 Aims of fibromyalgia rehabilitation programmes 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Improve Physical Function 27 50.9 65.9 65.9 
Cope with pain 10 18.9 24.4 90.2 
Understanding the Condition 4 7.5 9.8 100.0 
Total 41 77.4 100.0  
Missing  12 22.6   
Total 53 100.0   
 
Table 4.29 shows a breakdown of the reported aims of a rehabilitation programme.   
27 respondents (65.9%)  reported that improving physical function for fibromyalgia 
patients was the main aim, while coping with pain was reported as the main aim by 10 
respondents (24.4%).  A small number of respondents indicated that improving the 
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patients’ understanding of the condition was their main target. Figure 4.23 depicts the 
responses to this question in visual form.   
  
Figure 4. 23: The reported aims of fibromyalgia rehabilitation programmes  
 
4.6.11 Clinicians’ attitudes and opinions 
The attitudes and opinions of the respondents on FMS patients were rated on a Likert 
scales, where 1= strongly agree, 2= agree, 3= neither, 4= disagree, and 5= strongly 
disagree. The statements and the median responses provided for them by the 
respondents are shown in Table 4.30. It can be seen that there was agreement with the 
psychological involvement in the condition, the importance of improving the 
functional ability of patients, and that the diagnosis is made once all other diagnoses 
have been tried and rejected. Neutral responses were obtained regarding patients being 
well informed on their condition, their ability to self-manage, and on if treatment must 
not aggravate pain. 
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Table 4.30: Median responses to attitudinal questions 
Statement about FMS patients Median Response  
Patients have considerable psychological overlay 2 
Treatment must not aggravate patients’ pain 4 
Restoring function is more important than treating 
pain 
2 
The diagnosis is made once all others diagnoses 
have been tried and rejected 
2 
Patients are generally well informed on their 
condition 
4 
Patients are able to self-manage their condition  3 
 
 
4.7 Section B: Fibromyalgia survey (Libyan) 
This section reports upon the parallel survey carried out in Libya, using the same 
survey. 
4.7.1 Data collection 
The questionnaires, along with invitations, consent forms and information sheets, were 
handed to a convenience sample of participants, recruited through clinical contacts. In 
total 25 participants agreed to participate in the study, however, only 15 respondents 
returned the questionnaire with the consent form to researcher. The respondents 
included eight physicians, six physiotherapists, and 1 rheumatologist. The setting for 
this survey was in two Libyan cities (Tripoli (the capital city), and Zawia). This survey 
did not require ethical approval from the Libyan health authority because the 
researcher followed the European guide for research.  
4.7.2 Data analysis 
4.7.2.1 Demographic data 
Table 4.7.1 and Figure 4.7.1 show the breakdown of respondents by city. 
Table 4.7. 1: Breakdown of respondents by city 
City 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Tripoli  10 62.5 66.7 66.7 
Zawia  5 31.3 33.3 100.0 
Total 15 93.8 100.0  
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Figure 4.7.1: Breakdown of respondents by city  
 
Table 4.7.2 presents the professional specialties of the respondents. The table shows 
that eight respondents were medicine physicians (53.3%), six were physiotherapists 
(40.0%), and one was a rheumatologist. 
Table 4.7.2: Professional specialties of the respondents  
Profession 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Rheumatologist 1 6.3 6.7 6.7 
Physiotherapist 6 37.5 40.0 46.7 
Medicine 
Physician 
8 50.0 53.3 100.0 
Total 15 93.8 100.0  
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Figure 4.7.2: Respondents per professional specialty 
 
Table 4.7.3 shows that the clinical setting for the majority of the respondents was 
inpatient (46.7%), followed by private (33.3%). Two respondents were based in 
outpatient, and one in community. 
Table 4.7.3: Clinical settings of the respondents 
Clinical Setting 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Inpatient 7 43.8 46.7 46.7 
Outpatient 2 12.5 13.3 60.0 
Community 1 6.3 6.7 66.7 
Private 5 31.3 33.3 100.0 
Total 15 93.8 100.0  
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Figure 4.7 3: Clinical settings of the respondents  
 
4.7.2.2. Diagnosis 
Table 4.7.4 shows that when the respondents were asked if they had seen patients that 
fit the description of fibromyalgia in last 12 months, 80% responded that they had seen 
patients who more or less fitted the description, while  20% reported that they had seen 
patients who closely fit the description.  
 
Table 4.7.4: Proportion of respondents who saw patients fitting description of fibromyalgia 
Proportion of respondents who saw patients fitting description of fibromyalgia in the last 12 
months 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Yes, I have seen patients 
who closely fit this 
description 
3 18.8 20.0 20.0 
Yes, I have seen 
patients/clients who more or 
less 
12 75.0 80.0 100.0 
Total 15 93.8 100.0  
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Figure 4.7. 4: Proportion of respondents who saw patients fitting description of fibromyalgia  
 
The respondents were then asked about the number of new patients fitting the 
description of fibromyalgia who attended their clinic in the last 12 months. Table 4.7.5 
shows that 73.3% of the respondents reported that 1-4 new patients per month attended 
their practice; while 20% reported 5-9 new patients per months. Figure 4.6.5 illustrates 
the respondents’ answers to this question. 
 
Table 4.7.5: Number of new fibromyalgia patients attending the respondents’ clinics in the 
last 12 months 
New patients/clients fitting the description of fibromyalgia in the last 12 months 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 1-4 patients per month 11 68.8 73.3 73.3 
5-9 patients per month 3 18.8 20.0 93.3 
10-15 patients per 
month 
1 6.3 6.7 100.0 
Total 15 93.8 100.0 
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Figure 4.7.5: Number of new fibromyalgia patients attending the respondents’ clinics in the 
last 12 months  
The respondents were asked regarding the proportion of patients who had  a diagnosis 
of fibromyalgia. 40% of  the respondents stated that there were no patients attending 
their practice with a diagnosis of fibromyalgia. Furthermore, the respondents reported 
that patients who fulfilled the definition provided on the questionnaire were diagnosed 
with chronic pain, such as low back pain. The full results of this question are shown in 
Table 4.7.6 are illustrated in Figure 4.7.6. 
 
Table 4.7.6: Proportion of patients who had a diagnosis of fibromyalgia 
Proportion of  patients diagnosis of FM 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid More than half of them 1 6.3 6.7 6.7 
About half of them 4 25.0 26.7 33.3 
Less than half of them 1 6.3 6.7 40.0 
Almost none of them 3 18.8 20.0 60.0 
None of them 6 37.5 40.0 100.0 
Total 15 93.8 100.0  
 
 160 
 
 
Figure 4.7.6: Proportion of patients who had a diagnosis of fibromyalgia 
Referral sources of FMS patients were ranked by the respondents on a Likert scale, 
where 1= often, 2=sometimes, 3= seldom, and 4 =never. As can be seen from  
Table 4.7.7, the most frequent referral source indicated by the respondents was  
rheumatologists, followed by general practitioners, orthopaedics, and self-referrals, 
which all had a median rank of 2. The least frequent referral sources were anaesthetists 
and psychologists. 
Table 4.7.7: The median response for patients’ referral sources 
Referral source Median response 
GP 2 
Orthopaedic 2 
Neurologist 2.5 
Psychologist 4 
Anaesthetist 4 
Rehabilitation Therapist 3 
Self-Referral 2 
Rheumatologist 1.5 
 
The respondents were also asked regarding what best describes the patients regarding 
their previous management of the condition. 33.3% of the respondents reported that 
patients attended their practices without any previous management, while an identical 
percentage of respondents reported that patients had some other forms of treatment 
before attending their clinics. Table 4.7.8 and Figure 4.7.7 present the full set of 
respondents’ answers.  
 161 
 
 Table 4.7. 8:How referral of patients with fibromyalgia is best described  
What best describes the patients/clients in terms of previous management 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Patients come to me without any previous 
management 
5 31.3 33.3 33.3 
Patients come to me at an early stage of 
their assessment 
1 6.3 6.7 40.0 
Patients come to me after other  forms of 
treatment 
5 31.3 33.3 73.3 
Patients come to me after all, or nearly all 
other forms of treatment have been 
attempted 
3 18.8 20.0 93.3 
Compound 1 6.3 6.7 100.0 
Total 15 93.8 100.0  
 
 
Figure 4.7. 7: How referral of patients with fibromyalgia is best described 
 
The respondents were subsequently asked if patients were considered to have 
fibromyalgia only. Table 4.7.9 shows that 80% of the respondents reported that 
patients were considered to have other diagnoses in addition to fibromyalgia. 
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Table 4.7. 9: Proportion of patients considered by respondents to as have fibromyalgia only 
Patients/clients considered to have fibromyalgia only 
 Frequency Percent Valid Percent Cumulative Percent 
Valid No 12 75.0 80.0 80.0 
Yes 3 18.8 20.0 100.0 
Total 15 93.8 100.0  
 
 
Figure 4.7. 8: Proportion of patients considered as having fibromyalgia only  
Table 4.7.10 and Figure 4.7.9 show that the most frequent co-morbid condition 
reported by respondents for patients who attended their clinics was neck and back pain, 
followed by joint pain.  
Table 4.7. 10: Patients considered as having co-morbid conditions 
Co-morbid condition 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Neck and back 
pain 
7 43.8 77.8 77.8 
Joint pain 2 12.5 22.2 100.0 
Total 9 56.3 100.0  
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Figure 4.7. 9: Patients considered as having co-morbid conditions. 
The respondents were also asked if patients were considered to have fibromyalgia 
under other diagnostic labels. Table 4.7.11 and Figure 4.7.10 show that 60% of 
responses were “No” and 40% were “Yes”. 
Table 4.7.11: Patients considered by respondents to have fibromyalgia under other diagnostic 
labels 
Patients/clients have fibromyalgia under other diagnostic labels 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No 9 56.3 60.0 60.0 
Yes 6 37.5 40.0 100.0 
Total 15 93.8 100.0  
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Figure 4.7.10: Patients considered by respondents to have fibromyalgia under other 
diagnostic labels 
 
Table 4.7.12 shows that three respondents reported other diagnostic labels of chronic 
neck and low back pain, with the remainder of the respondents reporting osteoarthritis, 
rheumatoid arthritis, and muscle and joint pain. This data is also illustrated in  
Figure 4.7.11. 
Table 4.7. 12: Patients seen under other diagnostic labels 
Yes, other diagnostic labels 
 Frequency 
Percen
t 
Valid 
Percent 
Cumulative 
Percent 
Valid Chronic neck & 
LBP  
3 18.8 50.0 50.0 
Osteoarthritis 1 6.3 16.7 66.7 
Rheumatoid 
arthritis 
1 6.3 16.7 83.3 
Muscle and joints 
pain 
1 6.3 16.7 100.0 
Total 6 37.5 100.0  
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Figure 4.7. 11: Patients seen under other diagnostic labels 
 
4.7.2.3 Symptoms and functional activity 
The participants were asked about the extent to which patients generally show an 
increase in pain as a result of an increase in the level of physical activity. Table 4.7.13 
shows that most of the respondents reported that their patients showed a moderate to 
severe increase in pain as a result of an increase in the level of physical activity. 
Table 4.7.13: Extent to which patients showed an increase in pain as a result of an increase in 
the level of physical activity 
Extent to which patients showed an increase in pain with an increase in the 
level of physical activity 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Mild 1 6.3 6.7 6.7 
Moderate 8 50.0 53.3 60.0 
Severe 6 37.5 40.0 100.0 
Total 15 93.8 100.0  
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Figure 4.7. 12: Extent to which patients showed an increase in pain as a result of an increase 
in the level of physical activity 
 
The respondents were also asked if patients used assisted equipment. Table 4.7.14 
shows that the majority of respondents (66.7%) reported that their patients did not use 
assisted equipment.  
Table 4.7.14: Patients using assisted equipment (e.g. walking aid) 
Patients /clients use assisted equipment  (e.g. walking aid) 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Yes 2 12.5 13.3 13.3 
No 10 62.5 66.7 80.0 
Sometimes 3 18.8 20.0 100.0 
Total 15 93.8 100.0  
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Figure 4.7.13: Patients using assisted equipment (e.g. walking aid) 
 
The respondents were then asked regarding the aspects of the daily living that most 
affected their patients due to chronic pain. The respondents indicated that walking  was 
the most affected aspect of daily living. The full set of results can be seen in  
Table 4.7.15 and Figure 4.7.14. 
Table 4.7.15: Daily living aspects/activities most affected by fibromyalgia 
Aspect/activity of patients/clients’ daily living most affected by chronic 
widespread pain/fibromyalgia. 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Walking 9 56.3 60.0 60.0 
Running 3 18.8 20.0 80.0 
All of  these 3 18.8 20.0 100.0 
Total 15 93.8 100.0  
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Figure 4.7. 14: Daily living aspects/activities most affected by fibromyalgia 
 
4.7.2.4. Clinical features 
The respondents were asked about the frequency of presentation of the various clinical 
features of fibromyalgia. Furthermore, they were asked to provide their responses 
using a Likert scale, where 1= always, 2= often, 3=sometimes, 4= seldom, and 5= 
never. The median value for each clinical feature is shown 4.7.16.  It can be seen that 
most of the clinical features were rated as ‘often’, with the exception of loss of muscle 
power/endurance, and loss of joint range. 
Table 4.7.16: Median responses for frequency of clinical features presented by patients  
Clinical Feature Median Response 
Generalised pain 2 
Localised pain 2 
Tenderness on palpation 2 
Excessive fatigue 2 
Loss of muscle power/endurance 5 
Loss of joint range 5 
Stiffness 3 
Loss of function 3 
Psychological aspects 2 
Peripheral circulatory 3.5 
Others 4 
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The respondents were subsequently asked  about which clinical symptom was most 
important to the patient. Table 4.7.17 and Figure 4.7.15 show that pain was the most 
important symptom, followed by fatigue and tiredness.  
Table 4.7.17: Most important clinical features to fibromyalgia patients 
Most important clinical  symptoms/features to fibromyalgia 
patients  
 
Freque
ncy Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Pain 7 43.8 63.6 63.6 
Fatigue, 
tiredness 
4 25.0 36.4 100.0 
Total 11 68.8 100.0  
Total 15 100.0   
 
 
Figure 4.7. 15: Most important clinical features to fibromyalgia patients  
 
4.7.2.5 Primary symptoms: pain assessment and measurement 
Table 4.7.18 shows that the most frequent pain intensity measure used by the 
respondents was the verbal rating scale, followed by the numerical rating scale and the 
visual analogue scale. Three respondents did not routinely measure pain. 
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Table 4.7.18: Measurement methods of pain intensity 
Methods used to measure the intensity of fibromyalgia patients’ pain 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
  
Numerical rating scale 
(e.g. 1-10) 
4 25.0 26.7 26.7 
Verbal rating scales 
(e.g. severe, moderate) 
5 31.3 33.3 60.0 
Visual analogue scale 3 18.8 20.0 80.0 
Do not routinely 
measure pain intensity 
         3  18.8 20.0   100.0 
Total 15 93.8 100.0  
 
 
Figure 4.7.16: Measurement methods of pain intensity  
 
4.7.2.6 Pharmacological approaches: medication prescribed to patients 
with fibromyalgia  
The respondents were asked to state the frequency with which they prescribed 
medications in their practice. Six of the respondents (40%) reported that they used 
muscle relaxants, while another six respondents indicated that they did not prescribe 
any medications. Tramadol, amitryptiline, and combinations of medications were all 
seldom prescribed. The full set of data relating to this question is shown in  
Table 4.7.19 and illustrated in Figure 4.7.17. 
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Table 4.7. 19: Medications prescribed to patients with fibromyalgia 
Medication prescribed to patients with fibromyalgia 
 
Frequen
cy Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Tramadol 1 6.3 6.7 6.7 
Muscle relaxants 6 37.5 40.0 46.7 
Amitriptyline 1 6.3 6.7 53.3 
Combination 1 6.3 6.7 60.0 
Don’t prescribe 6 37.5 40.0 100.0 
Total 15 93.8 100.0  
 
 
Figure 4.7. 17: Medication prescribed to patients with fibromyalgia 
 
The respondents were then asked whether patients attended their practices without 
previous medications prescribed specifically for their symptoms. A total of 10 
respondents stated that patients attended without medications, while five respondents 
stated that patients sometimes attended their clinics with a medication. Table 4.7.20 
and Figure 4.7.18 present and illustrate the responses of the respondents, respectively.  
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Table 4.7.20: Patients presenting with medications specifically for their symptoms 
Patients/clients have fibromyalgia, come without medications 
specifically for their symptoms 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No 10 62.5 66.7 66.7 
Sometimes 5 31.3 33.3 100.0 
Total 15 93.8 100.0  
 
 
Figure 4.7.18: Patients presenting with medications specifically for their symptoms 
 
4.7.2.7 Non-pharmacological interventional approaches 
The frequencies of prescribing the use of various non-pharmacological interventional 
approaches were indicated on a Likert scale, where 1= always/almost always, 2= often,  
3= sometimes, 4= seldom, 5=  never/almost, and 6= not applicable. The median 
responses for these non-pharmacological interventional approaches are shown in Table 
4.7.21 below. 
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Table 4.7.21: Median responses for the use of non-pharmacological interventional 
approaches 
Intervention Median response 
Stretching exercise 2.5 
Aerobic exercise 2 
Graded exercise programme 3.5 
Group  exercise programme 4.5 
Hydrotherapy 4.5 
Postural re-education 2 
Functional activity re-education 2 
Cognitive behavioural therapy 5 
Relaxation 3 
Acupuncture 6 
Ergonomic evaluation 6 
TENS 6 
Ultrasound 5.5 
Manual therapy 3.5 
Massage 3.5 
Energy conservation 6 
 
As can be seen from Table 4.7.21, the frequency of using non-pharmacological 
interventional approaches such as graded exercise programmes, manual therapy, and 
massage was ranked by a median response of 3.5. Group exercise and hydrotherapy 
were seldom used, while CBT was never used. Furthermore, some interventions were 
considered to not be applicable. 
4.7 2.7 The use of a specific management programme for fibromyalgia  
The respondents were asked if they had a specific management programme for 
fibromyalgia patients. The majority of the respondents had no specific management 
programme for fibromyalgia, while only  two respondents  (13.3%) had a  management 
programme for chronic pain. The full data relating to this question is shown in  
Table 4.7.22 and illustrated in Figure 4.7.19. 
Table 4.7. 22: Use of a specific management programme for fibromyalgia 
Specific treatment/management programme for fibromyalgia 
patients 
 
Frequenc
y Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid No 13 81.3 86.7 86.7 
Yes, for 
chronic pain 
patients in 
general 
2 12.5 13.3 100.0 
Total 15 93.8 100.0  
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Figure 4.7.19 Use of a specific management programme for fibromyalgia 
 
The respondent were then asked about the responsiveness of fibromyalgia patients to 
the interventional approaches. Table 4.7.23 shows that  the majority of the respondents 
(n=14) reported that patients were ‘moderately responsive’. The full set of results to 
this question is illustrated in Figure 4.7.20. 
 
Table 4.7.23: Views of the respondents on the responsivity of fibromyalgia patients to 
interventional approaches 
Responsiveness of fibromyalgia patients to interventional approaches 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Very  
responsive 
1 6.3 6.7 6.7 
Moderately  
responsive 
14 87.5 93.3 100.0 
Total 15 93.8 100.0  
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Figure 4.7.20: Views of the respondents on the responsivity of fibromyalgia patients to 
interventional approaches  
The respondents were also asked regarding their aims and what they hoped to achieve 
from a rehabilitation programme for fibromyalgia patients. Table 4.7.24 shows that he 
majority of the respondents reported that their aim was to improve physical functions.  
Table 4.7. 24: Aims of a fibromyalgia rehabilitation programme 
Achieve from a fibromyalgia Rehabilitation Programme 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Improve physical 
function 
12 75.0 100.0 100.0 
Missing .00 3 18.8   
              Total 15 100.0   
 
4.7.2.9 Clinicians’ attitudes and opinions 
The respondents were asked to state their opinions regarding a number of statement 
relating to FMS patients (shown in Table 4.7.25), using Likert scales, where  
1= strongly agree, 2= agree, 3= neither, 4= disagree, and 5= strongly disagree =5. The 
median responses for the statements are shown in Table 4.7.25. The respondents 
agreed that FMS patients had considerable psychological overlay, and that the FMS 
diagnosis was made once all other diagnoses had been tried and rejected. They also 
agreed that patients were well informed on their condition, and that treatment must not 
aggravate pain. On the other hand, the respondents were undecided regarding whether 
patients were able to self-manage their condition. 
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Table 4.7. 25: Median responses to attitudinal questions 
Statement about FMS patients  Median response 
Patients have considerable psychological overlay 2 
Treatment must not aggravate patients’ pain 2 
Restoring function is more important than treating 
pain 
3 
The diagnosis is made once all other diagnoses 
have been tried and rejected 
2 
Patients are generally well informed on their 
condition 
2 
Patients are able to self-manage their condition 3 
 
The subsequent section present some  descriptive comparisons between the responses 
of the UK and Libyan healthcare professionals in each of the key areas of the survey 
regarding diagnosis, referral, management and attitudes and opinions.   
4.7.2.10. Descriptive comparison between the two groups (UK and 
Libyan HCPs) regarding the number of participants in this study. 
The total of UK potential sample were 600 participants and the number of UK 
respondents were 53, however, the total of Libyan sample were 25 participants and 
respondents’ number were 15. Table 4.7.26 
Table 4.7.26 the number of participants/respondents  
Samples Total UK sample Total Libyan sample 
Participations 
Number 
600 25 
Respondents 53 15 
4.7.2.11 Descriptive comparison between the two groups (UK and Libyan HCPs) 
regarding the number of patients HCPs see each month. 
Forty three percent of UK-based respondents indicated that they saw a new patient 
each month, compared with 73.3% for the Libyan sample. Table 4.7.1 shows a 
breakdown of the numbers of new patients seen each month by the two groups. 
 
Table 4.7.27: Number of new patients seen each month (UK and Libyan samples) 
New patients seen each month  UK sample Libyan sample 
1-4 patients per month 34% 73.3% 
5-9 patients per month 36% 20% 
10-15 patients per month 30% 6.7% 
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4.7.2.12 Descriptive comparison between the two groups on referral sources 
The majority of UK respondents reported that patients were often referred by GPs 
(81.3%) and rheumatologists (84.2%), compared with the Libyan respondents who 
reported a smaller proportion of patients referred by GPs (45.5%), and a higher 
proportion by Orthopaedics (66.7%). See table 4.7.28 
Table 4.7.28: Comparison between UK and Libyan HCPs’ responses on patients’ 
referral sources 
Patients referred under  UK sample Libyan sample 
GPs  81.3% often  45.5% often 
Rheumatologist  88.2% often 50% often 
Orthopaedics  23.3% sometimes 66.7% sometimes 
 
4.7.2.13 Comparison between the two groups on specific management 
programmes (SMP) for FM see table 4.7.29 
Table 4.7.29: Comparison between UK and Libyan respondents’ answers on specific 
management programmes 
Treatment received UK sample Libyan sample 
 Specific management programme 
(SMP) for FM 
No Yes No Yes 
26% 12% 86.7% 0.0% 
 SMP for chronic pain in general  62% 13.3% 
 
 
4.7.2.14 Comparison between UK and Libyan respondents’ answers on 
pharmacological management programmes. 
 
Table 4.7.30 Comparison between UK and Libyan respondents’ answers on pharmacological 
management programmes. 
 
Medications prescribed to patients with fibromyalgia 
 UK sample Libyan sample 
Amitriptyline 2.0% 6.7% 
Combination 85.7% 40% 
Tramadol - 6.7% 
Muscle relaxants - 40% 
Do not Prescribe 12.2% 6.7% 
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4.7.2.15:  Descriptive comparison of the attitudes and opinions of UK 
and Libyan respondents. 
Table 4.7.31: Descriptive comparison of the attitudes and opinions of UK and Libyan 
respondents’ 
 UK sample 
Median 
Response 
Percentages Libyan 
sample 
Median 
Response 
Percentages 
Statement about FMS patients     
Patients have considerable 
psychological overlay 
2 49.0% 2 80% 
Treatment must not aggravate 
patients’ pain 
4 52% 4 64.3% 
Restoring function is more 
important than treating pain 
2 46% 2 35.7% 
The diagnosis is made once 
all others diagnoses have been 
tried and rejected 
2 38% 2 7.7% 
Patients are generally well 
informed on their condition 
4 26% 4 38% 
Patients are able to self-
manage their condition  
3 33.3% 3 38.% 
 
 
4.8 Discussion  
The study described in this chapter aimed to explore current practice for fibromyalgia 
in the UK and Libya. This included exploring  approaches to the assessment and 
managements of FMS regionally, and between the UK and Libya, as well as 
investigating the attitudes and opinions of HCPs regarding the condition and 
responsiveness to interventions used in clinical practice, and the availability of such 
interventions. The responses showed regional variability of current practice in both 
diagnostic and management approaches. This study has developed and expanded a 
previous UK based survey study of physiotherapists and occupational therapists (Sim 
and Adams 2003), which investigated approaches to fibromyalgia. This was achieved 
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by extending the scope of research to include other professional groups involved in the 
management of fibromyalgia, exploring the use of pharmacological management,  as 
well as exploring the assessment and management of fibromyalgia in Libya. 
It was valuable to conduct the parallel survey on chronic widespread pain in Libya in 
order to consider  different healthcare professionals practice, gain a broad view of the 
differences in approaches to the management of chronic widespread pain, and 
highlight the issues surrounding incorporation of intervention approaches and 
availability. Responses from both the UK and Libya were consistent with the 
diagnostic criteria for fibromyalgia set by the American College of Rheumatology 
(Giordano et al., 1999).  
 
To follow, the findings of this study are discussed in terms of the diagnosis processes 
used in practice, the interventions used by healthcare professionals, and their views of 
standardised approaches, and how the results may develop the future of assessment 
and management of fibromyalgia and influence directions for future research.  
4.8.1 Diagnosis and referral 
The definition of fibromyalgia used in the study was based on the 1990 diagnostic 
criteria produced by the American College of Rheumatology,   which requires the 
presence of chronic widespread pain for three months or longer, as well as 11 of 18 
specific tender points (TP) sites. The results from the survey showed that the 
respondents reported a high percentage of patients closely fitting the description 
(90%), with a further 3.8% of patients who more or less fitted the description.  
Although the ACR criteria has been approved by the ACR board, it is often not  
formally adopted as a screening tool for FMS-like disorders (Smythe, 2011, 
Thompson, 2010), as diagnostic practice is often variable with inconsistent application 
of the criteria (Wolfe et al., 2013). It was therefore helpful to have included the criteria 
in the questionnaire. 
Differential diagnosis is common, with patients being referred under different 
diagnoses. Consistent with the findings of other studies, the results of our study 
showed that a high proportion of patients who fitted the diagnostic criteria of FMS 
were diagnosed differentially with other conditions. As a result of differential 
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diagnosis and different routes of referral, it was found that patients were both 
diagnosed and referred by different specialties.  
The finding that the most common referral source were GPs and  rheumatologists is 
similar to the findings of Choy et al. (2010) and Able. et al. (2016), suggesting that 
rheumatologists were more likely to use a diagnostic label of fibromyalgia, and that 
patients with these symptoms were more likely to be referred to rheumatologists rather 
than any other specialty. In addition, the study by Choy et al. (2010) identified a high 
level of referral from GPs, which is comparable to the findings of our study. The results 
of our study also concur with current literature regarding the self-reported ability of 
physicians to diagnose fibromyalgia. These findings contrast with those of  
 
 (Hayes et al., 2010) who found that 25% reported doubt in diagnosing fibromyalgia. 
However, this may have reflected the variability of patients with symptoms of pain 
and fatigue. This figure was reduced for specialists, who presumably have greater 
training and awareness in recognising symptoms and applying diagnostic criteria. 
Given that the sample in the current study was recruited from the British Pain Society, 
it was largely, by definition, a sample of specialists, who had a specific interest in pain 
management. 
Choy et al. (2010) found that general practitioners reported deficiencies in diagnosing 
and treating FMS more frequently than specialists did. As patients first attend primary 
care, where they may either receive a diagnosis or be referred onwards to a specialist 
for diagnosis and treatment, a future direction of research would be to investigate the 
assessment, diagnosis and management within the primary care setting.  It is important 
to note that fibromyalgia is often a co-morbid condition, which may also obscure its 
diagnosis  (Wolfe et al., 2011). This fact was clearly observed from the findings of our 
study, where clinicians agreed that fibromyalgia often manifested as a co-morbid 
condition. Furthermore, similar to other studies, it was found that FMS coexisted with 
a diagnosis of another somatic disease, such as inflammatory arthritis, osteoarthritis, 
or a mental disorder such as depression (Ablin et al., 2013, Fitzcharles et al., 2013c, 
Eich et al., 2012 ). The results also showed that rheumatoid arthritis was the most 
frequent co-morbid condition, consistent with the results of (Martin et al., 2014) who 
found that participants who completed clinician data were reported that to have another 
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diagnosis causing pain, such as rheumatoid arthritis, osteoarthritis, degenerative disc 
disease (DDD), neuropathy, and chronic pain. The presence of comorbid disorders 
might be an essential factor that can be used to help the diagnosis of FMS. 
Furthermore, the co-morbidity may influence treatment approaches and options, 
though this was not formally investigated in our study.  
 
A population-based study using the 31-point self-report questionnaire found that 17% 
of 845 patients with osteoarthritis, 21% of 5210 with rheumatoid arthritis, and 37% of 
439 with systemic lupus erythematosus, fulfilled the 2010 ACR criteria for 
fibromyalgia (Wolfe et al., 2011), illustrating that difficulties in diagnosis may be 
related to such comorbidity. However, it could also be argued that fibromyalgia is not 
a distinct clinical entity, but rather a response shown by many patients who exhibit a 
chronic condition. The results of our study also show that the UK respondents reported 
that (53.6%),  of patients attended their clinics under labels of chronic neck and back 
pain, and 21.4% of patients under labels of chronic fatigue. The finding from Libya 
was differed a bit and the diagnosis is not formally used in Libya though this study 
provides the first evidence that clinicians do recognise the condition . 
(Kim et al., 2012) highlighted that physicians who referred patients to a rheumatologist 
for suspected FMS missed a diagnosis of inflammatory or degenerative arthritis, or 
soft tissue rheumatism in 45% of patient conditions. However, FMS may also be over 
diagnosed, which carries the risk of failing to identify and treat conditions that are 
highly amenable to therapy (Fitzcharles and Boulos, 2003). The results of our study 
show that the respondents reported GPs and rheumatologists as the most frequent 
source of patients referral, where more than half of the patients attending their clinics 
were diagnosed with FMS. 
4.8.2 Symptoms and clinical features 
Our results agreed with the clinical features identified in the ACR diagnostic criteria, 
and reported by previous studies, in that symptoms often include a diverse series of 
other conditions, such as physical and mental fatigue, disrupted or non-restorative 
sleep, headache, irritable bowel, psychiatric disorders, cognitive impairment, and other 
functional complaints (Schmidt et al., 2011, Abeles et al., 2007). Furthermore, our 
results are congruent with a previous Delphi study building consensus via 
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questionnaires and systematic opinion feedback, which involved 23 clinicians with 
expertise in FMS, and 100 patients with FMS as defined by ACR criteria. Both panels 
consistently ranked pain highest. Fatigue, impact on sleep, health-related quality of 
life, comorbid depression, and cognitive difficulty were also ranked highly (Mease et 
al., 2008). Our results regarding the frequency of occurrence of clinical features show 
that pain was generally ranked highest by healthcare professionals, followed by  
fatigue. Loss of function was less often reported, in contrast to a Delphi study by Mease 
et al. (2008), who found that patients, but not clinicians, ranked stiffness highly. 
However, this is consistent with the results of the qualitative study in Chapter 3 of 
patients’ perspectives, where joint stiffness was highly ranked among people with 
fibromyalgia, and was reported to affect the ability to perform functional activities. 
 
The symptoms of fibromyalgia are often found to impact all functional and daily living 
activities. This was also supported by the results of the Fibromyalgia Impact 
Questionnaire (FIQ) presented in the previous chapter. 
The results of our study also showed that patients often had clinical features such as 
localised pain, loss of muscle power, loss of function, stiffness, and psychological 
issues. All of these features received high rankings from the respondents. Moreover, 
the study found that pain, functional disability, and fatigue severity were ranked as the 
top three categories by the highest proportion of physicians when evaluating FMS 
severity, which concurs with the findings of the study by Silverman et al. (2010). 
However, comorbidities increase the complexity of patients’ symptoms, and are likely 
to impact on the rapidity of diagnosis. This means that patients may require more 
consultation time, and that collaboration with HCPs and specialists may be essential 
to produce an optimal diagnosis and management approach  (Arnold et al., 2011, Davis 
et al., 2011, Ahmad and Tagoe, 2014). 
4.8.3 Pain assessment and measurement 
In our study, the majority of HCPs (50%) reported that they did not use a standardised 
assessment instrument in UK practice and showed that Libya HCPs used assessment 
tools more than UK.  The most frequently used assessment instrument was the 
numerical rating scale (1-10), which was used by 39.6% used of HCPs, followed by 
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the verbal rating scale (6.3%), and the visual analogue scale (4.2%). Our results also 
show that the Hospital Anxiety and Desperation Score (HADS) was used by 31.8% of 
HCPs, and the Brief Pain Inventory (BPI) was used by 45.5% of HCPs, as assessment 
tools in the UK. However, despite the German guidelines which recommend the use 
of the fibromyalgia survey questionnaire to assess FMS-like symptoms and severity 
(Hauser et al., 2012a), and the fact that the FIQ is most often used as an outcome 
measure in many studies of FMS, they appear to be used relatively rarely in clinical 
practice.  
4.8.4. Pharmacological approaches: Medication prescribed to patients 
with fibromyalgia 
A recent study on pharmacological approaches found that amitriptyline had effects on 
FMS symptoms of pain, sleep disturbance, fatigue, affective symptoms, functional 
deficit and cognitive impairment, whereas non-pharmacological therapies routinely 
had multidimensional targets (Perrot and Russell., 2014). These findings differ from 
our study’s, in that combinations of medications were found to be prescribed for 
patients by the majority of the respondents (85.7%), whereas amitriptyline was less 
often prescribed, presumably due to its side effects. However, our results concur with 
the recommendations regarding pharmacological management of symptoms of 
fibromyalgia (Knight. et al., 2013 , Häusera et al., 2010 ).  
Our results also demonstrated the variety of medications used for  FMS patients in UK, 
2.0% prescribed amitriptyline where, for instance 12.2% of HCPs reported that they 
do not prescribe any medications for FMS patients. However, in Libya, 40 % of HCPs 
prescribed muscle relaxants, 6.7% prescribed amitriptyline, and 6.7% prescribed 
tramadol, where 40 % of HCPs do not prescribe any medications. Interesting 
comparisons can be between our findings and those of the study by Roskell. et al. 
(2011 ), who found that tramadol combined with paracetamol was more likely to have 
30% improvement in pain, compared with either medication alone. The variability of 
practice, and the differences found between the results of our study and the literature 
may be explained by the study being conducted in the UK, and most of the published 
literature being based in the USA, where healthcare practices differ significantly. In 
fact, the German guideline favoured non-pharmacological treatment, and advocated 
timely limited medications only in moderate and sever forms of FMS pain  (Eich et 
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al., 2012 , Sommer et al., 2012), which appear to be the approaches used by the 
clinicians in our study. The EULAR 2016 guidelines highlighted the change in 
attitudes regarding intervention approaches to FMS, but offered varying 
recommendations with regards to the use of pharmacological interventions such as 
amitriptyline, pregabalin and duloxetine, which are commonly used for FMS 
(Macfarlane et al., 2017). Given the fact that there is no single treatment currently 
targeting all symptoms of FMS,   multidisciplinary management is required, using a 
comprehensive multifaceted medications plan that integrates pharmacotherapy, 
cognitive behavioural therapy, patient education, lifestyle changes (e.g. stress 
reduction, sleep hygiene), physical therapy, and exercise. 
4.8.5 Non-pharmacological interventional approaches 
(Carville et al., 2008b) reported that exercise therapy had the greatest evidence base, 
and featured as their highest recommendation for FMS management. Our results also 
showed that the respondents most often used active interventions, such as exercise. In 
particular, graded exercise programmes and stretching exercises were most frequently 
used, followed by aerobic exercises. These results show similarities to previous 
studies, where aerobic exercises were found to reduce fibromyalgia symptoms, and 
improve physical capacity, although such exercises need to be slow and build up 
gradually, in the form of a graded exercise programme (Fitzcharles et al., 2013b, Busch 
et al., 2007). Our study also showed that the respondents sometimes used hydrotherapy 
for FMS patients. A recent study reported that pool/water therapy showed broad 
efficacy across all domains of FMS (Perrot and Russell., 2014). Furthermore, the study 
highlighted that when a facility is available, pool exercises can be quite economical. 
These findings are consistent with the reports from patients in Chapter 3, where the 
lack of service availability for this intervention was highlighted by fibromyalgia 
patients in north east of UK, and which they would have liked to have available. In 
line with previous studies by (Miro et al., 2011, Schmidt et al., 2011, Ang et al., 2010, 
Hsu et al., 2010), who demonstrated that CBT was effective for pain, sleep disturbance, 
cognitive and functional impairment, CBT was frequently used by the respondents in 
our study, with  40% of the respondents using CBT in their practice. This may have 
been due to the particular sample of respondents in this survey, who were recruited 
from the British Pain Society. It was interesting to note that although Libyan clinicians 
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acknowledged the role of psychological factors in FMS, as CBT is not routinely used 
in Libya, it was not part of their practice.  
The respondents less often used specific techniques, though acupuncture was 
identified as an intervention that was sometimes used. This is unsurprising as the 
literature on acupuncture for FMS is equivocal, with some studies and patients 
suggesting no benefit, and others, such as Deare et al. (2013), demonstrating that   
acupuncture, added to standard therapy, resulted in a 30% improvement in pain.  Forty 
percent of the respondents of this study reported that they did not prescribe specific 
treatment management programme for FMS, while 50.8% reported that they 
prescribed treatment for chronic pain in general. Only six respondents reported the 
prescription of treatment specifically for FMS.  
4.8.6 Clinicians’ attitudes and opinions 
 
Both UK and Libyan respondents considered patients with FMS to have considerable 
psychological overlay. The UK respondents agreed that restoring function is more 
important than treating pain, though the Libyan respondents were undecided.   
Furthermore, the respondents agreed that a fibromyalgia diagnosis was made once all 
others diagnoses have been tried and rejected, which is consistent with the findings of 
previous research studies (Able. et al., 2016, Choy et al., 2010), and is consistent with 
the findings of our study regarding comorbid symptoms, differential diagnosis, and the 
variety of diagnostic labels used. 
4.9.Summary of key findings of the survey 
 
 Diagnosis and differential diagnosis:  About half of patients already had a 
diagnosis of fibromyalgia, though many fitted the description of FMS 
provided, but were referred under different diagnostic labels. This was the case 
for both the UK and Libya. The most common differential diagnostic label was 
chronic neck and back pain.  
 Clinical features: Pain was the primary presenting symptom, followed by 
fatigue. 
 Referral sources: Patients were most often referred by GPs and  
rheumatologists 
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 Physical and functional activity: Physical activity often resulted in a 
moderate to severe increase in pain. All daily activities were affected, 
particularly walking. 
 Assessment: Many UK respondents  did not routinely assess pain and it was 
assessed more often in Libya. ?  For those who assessed pain, the most common 
instruments used were numerical, verbal, and visual analogue scales. The BPI 
was sometimes used, but no respondent reported using the FIQ. 
 Pharmacological management: There were differences in pharmacological 
management between the UK and Libya, with combinations of drugs being 
commonly used in the UK, and muscle relaxants more frequently prescribed in 
Libya. Many of the respondents were not medical practitioners, and therefore 
did not prescribe any medications. 
 Non-pharmacological management: The most frequently used  
non-pharmacological approaches were active approaches, such as graded 
exercise programmes and other forms of exercise. CBT was used in the UK, 
but was not used in Libya, where manual therapy was more often used. Manual 
and massage therapy was not used by the UK respondents. 
 Aims of rehabilitation: The respondents in both countries viewed the primary 
aims of rehabilitation to be to improve function and to cope with pain. 
 Attitudes and opinions: The respondents in both countries had similar 
attitudes and opinions. For example, both considered that there was a 
considerable psychological overlay in the condition, but were undecided about 
whether patients could self-manage their condition. 
 
4.10. Conclusions 
The study presented in this chapter showed that there were no standardized assessment 
or management programmes during the journey of FMS diagnosis, and that specialities 
are needed for better symptom management and intervention approaches. 
Furthermore, the study highlighted that FMS shared symptoms with other co-morbid 
conditions, that patients were labelled under a variety of diagnostic labels, such as 
chronic neck and back pain, chronic fatigue and IBS, and that a diagnosis was made 
once other diagnoses have been tried and rejected. In addition, it was found that 
physical and daily living activities were affected as a result of pain severity, and that 
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patients with fibromyalgia had a considerable psychological overly. Pharmacological 
approaches that were routinely prescribed to fibromyalgia patients were reported to 
include muscle relaxants and painkillers, which are medications that are prescribed for 
chronic pain in general. Furthermore, physiotherapy and CBT were prescribed to 
reduce pain and increase physical function, while no medications were prescribed 
specifically for FM symptoms. 
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5.1 Introduction 
This section provides an overview of the main study findings and the original 
contribution of the thesis is also discussed.  
5.2 Aims of the Study 
The thesis sought to answer the following research questions 
4. What are views and experiences of service users regarding their 
condition the impact upon their lives and how these influence their 
health care seeking behaviours and experiences of interventions?  
5. What are the range of fibromyalgia interventions and the diagnostic/ 
assessment process they have experienced/sought? 
6. What is current practice regarding fibromyalgia in the UK and what is 
current practice in Libya. 
The specific aims of the study were as follows: 
 To explore participants’ views and experiences regarding issues that 
impact upon their condition. 
 To explore service users’ and service providers’ views regarding the 
experience and management of fibromyalgia. 
 To explore the extent to which emotional issues impact upon the 
experience of fibromyalgia. 
 To describe current practice for FMS in the UK and Libya 
 To consider similarities and  differences in approaches to the management of 
FMS between the UK and Libya 
 To explore service users’ and service providers’ attitudes and opinions 
regarding the nature of fibromyalgia and the interventional approaches used. 
5.3 Original Contribution to Knowledge 
 This study is the first to explore health professionals’ views of the diagnosis 
and management of fibromyalgia in a Middle Eastern country. Such data is 
currently lacking. 
 This study is also the first to explore and synthesis of the views of service 
users and service providers in the UK. 
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 The study provides an in depth exploration of the various dimensions of the 
experience of fibromyalgia from a service user’s perspective. 
 The study provides a description of practice of health care professionals from 
different backgrounds in the UK regarding fibromyalgia pharmacologically 
and non- pharmacologically. 
5.4 Synthesis of Main Findings. 
The synthesis of findings is presented in the following sections relating to diagnosis 
and the journey to diagnosis, the clinical features, variability and unpredictability of 
symptoms, the experience of available interventions and management of symptoms 
and emotional experience and expression. 
5.4.1 Diagnosis and the Journey to Diagnosis. 
Participants referred to the variety of examinations and tests they had undergone in 
order to reach a diagnosis. There is yet no definitive test for fibromyalgia and the 
diagnosis is made upon the presenting symptoms in the absence of any other organic 
finding from objective tests. This has of course raised controversy as to whether 
fibromyalgia exists as a distinct clinical entity and as such is referred to as a syndrome.  
Many sufferers reached their diagnosis by either a GP or a consultant and the time 
taken to reach a diagnosis was variable and could take a number of years. This was 
also confounded by many co-morbidities and medications taken by participants.  
Patients questioned why the referral process should take such a long time to see a 
consultant, though perhaps this may have been due to a lack of clarity about which 
specialist to whom the patient should be referred and indeed, if there are specialist 
facilities available within the various regions. The reasons for referral or non-referral 
was not specifically explored in this study  and is an area that could be developed in 
future research. The difficulty of diagnosis and the effect of the label of ‘fibromyalgia’ 
was not always perceived to be helpful. Comparable to the reports of participants in 
the exploratory interviews, a range of diagnostic tests were noted by practitioners who 
also considered a range of differential diagnoses. It was particularly interesting to note 
that whilst fibromyalgia is not a diagnosis that is used in Libya, the health care 
professionals, who were both medical doctors and physiotherapists….., recognised the 
syndrome from the definition provided on the questionnaire and also provided the 
same differential diagnoses to the UK clinicians. Although the syndrome is well 
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documented in Western society, it appears that although the syndrome is recognised 
in the Libya, it is not diagnosed specifically as fibromyalgia. Clinical features were 
reported consistently between clinicians and patients. It appeared that it was the 
variability and unpredictability of symptoms that proved difficult to manage.  
5.4.2 Variability and Unpredictability of Symptoms 
Clinical features as recognised by the ACR diagnostic criteria were consistent across 
the participants and also the UK and Libyan clinicians. The primary presenting 
symptom of pain was closely followed by fatigue, however participants reported that 
the fatigue and unrefreshing sleep affected every aspect of their lives, mood and 
functioning. This appeared to be the most difficult symptom to manage both by 
participants and clinicians. The most distressing characteristics was the 
unpredictability of the symptoms and their fluctuation on a daily basis.  Many 
participants struggled with the lack of control over their symptoms and felt that they 
could manage their pain if they felt more in control of exacerbations and flare ups and 
could find an approach that appeared to work consistently.  
It appears that there is not only variability of the experience of the symptoms and 
ability to function between patients but also variability within patients. 
5.4.3 Experience of Available Interventions and Management of 
Symptoms 
Many participants had tried a range of interventions with varying degrees of success 
which included a range of medications and sometimes in conjunction with non-
pharmacological interventions. It was interesting to note that whilst practitioners 
reported using active interventions in their practiced, such as exercise and CBT, 
patients had accessed other interventions privately such as chiropractic and 
acupuncture. This concords with findings from previous studies of seeking CAM 
therapies for fibromyalgia (Hardy-Pickering and Adams 2007).  There was variability 
amongst participants which is consistent with varying presentations of fibromyalgia, 
varying chronicity and co-morbidity and differing experiences of referral with some 
participating in pain management programmes. Findings were consistent with the 
heterogeneity of the condition.  Practitioners offered a range of interventions and some 
had specific fibromyalgia programmes, though more often they had chronic pain 
management programmes. This was also the case in Libya, where fibromyalgia is 
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recognised as a chronic pain syndrome but not given a specific label or diagnosis. 
Although there is evidence of effectiveness for cognitive- behavioural therapy, many 
respondents did not find this helpful. This was perhaps surprising as the basic tenet is 
to help people to cope with their symptoms and daily activities more effectively and 
focus upon managing their symptoms, rather than finding a ‘cure’. It is also surprising 
as this is the basic tenet of pain management programmes and it is suggested that 
perhaps participants were unaware of the interventions that fall under the aegis of CBT 
and considered this aspect consisted of a psychological input for something that was ‘ 
all in the head’ and thus  felt they were not believed.  The interventions used and the 
treatment priorities were largely similar to the earlier study conducted by (Sim and 
Adams, 2003b).  
Current guidelines recommend exercise as a primary component in any management 
programme. It is however, interesting to note that respondents found that physical 
activity and walking increased their pain and thus they were reluctant to engage in 
exercise. This emphasises the need for patient education and support which was also 
identified in the qualitative study.  
5.4.4 Emotional Experience and Expression 
Participants often reported emotional feelings associated with their condition.  Most 
of these were reactive to the pain and fatigue and lack of ability to function. They 
described feelings of fear, related to anxiety, and of sadness, related to depression. 
These are well documented in the literature. However, they often described feelings of 
frustration and annoyance. These are more characteristic of anger. Some used the word 
‘angry’ though it is an emotion that is not well documented or discussed in the 
literature. 
Participants exhibited high levels of alexithymia and so they had difficulty in 
recognising, explaining and differentiating their emotions.  This would affect their 
cognitions and response to interventions and also their feelings of being understood by 
clinicians, which was an important theme within the interviews.  Clinicians in the UK 
and Libya both agreed that there was a high level of psychological involvement in 
fibromyalgia. Participants on the other hand often did not acknowledge the extent of 
psychological involvement and resented being referred to a psychologist or perceived 
the implication that their condition was not ‘real.’ However, some participants 
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understood the purpose of psychological intervention, either as cognitive-behaviour 
therapy or as part of a pain management programme was to help them live better with 
their condition and find ways of coping on a daily basis with the symptoms and the 
fluctuation of symptoms. These findings support the theory of a stress-induced 
disruption of the HPA axis ( McBeth et al 2005:McVeigh et al 2007), due to exposure 
to prolonged stressful symptoms, with consequent amplified pain perception.  High 
levels of fibromyalgia impact and alexithymia corroborate the qualitative findings. 
This high level of alexithymia  indicates an inability to identify accurately their own 
feelings and thus limits their ability to regulate their emotions and also verbal 
communications of psychological distress, which impacts upon depression and 
anxiety, perceived disability and relationships with others, including health 
professionals. 
5.4.5 Lack of Understanding 
Lack of understanding was a recurring theme from the interviews with participants 
who felt that they were not understood by either health professionals, their families or 
the general public. Some patients reported having lost their jobs because of the 
disability and lack of understanding in the workplace if they were honest about the 
condition and told the employer that they have Fibromyalgia and felt there was a 
stigma attached to the condition.  They also felt they could not get a job because of the 
FMS and this affected their daily life, resulting in feelings of felt frustration in living 
with a long-term condition, often returning to doctors seeking further assessment for 
their pain. However, with no definitive results from investigational tests, they felt there 
were few options available for management. The feeling of a lack of understanding 
related to the ‘invisibility’ of their condition and also its variability and 
unpredictability and also the lack of research that has been conducted on the condition 
in the UK and an absence of definitive clinical guidelines upon which to base 
interventional approaches.  It was an interesting paradox that health professionals, in 
contrast, did not think patients were well informed about their condition.  This is 
possibly due to the way that patients accessed information, which tended to be from a 
support group or from the internet. As such, much information is unsolicited and 
patients are often not able to critically evaluate claims made on the internet or in the 
popular press.  Patients reported not being consulted regarding their options and 
preferences for management and control of symptoms by health professionals.  There 
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is a need for advice and support from a trained health professional as a point of contact, 
perhaps at regular follow-ups after assessment and/or intervention with an approach 
that involves shared decision making with the patient. 
5.4.6 Role of Self-Management 
Self –management is a complex phenomenon that can be difficult to define and thus, 
there is no single understanding of individuals self –management (Kendall et al., 
2011).  A multi-dimensional process of self-manage of pain individuals determined 
pain being an active in their treatment, engaged in the personal development of skills 
and being aware of their own responses to symptoms (Stewart et al., 2014) because 
of lack of understanding of the illness people with FMS were struggled to manage 
their condition symptoms. Further research on what is meant by self-management by 
clinicians and also how patients can be supported to self-manage is warranted.  
5.4.7 Conclusion 
Fibromyalgia is a difficult and distressing condition and its prevalence appears to be 
increasing in the Western world.  It is also reported in the Middle East, though there is 
not a specific diagnostic label of fibromyalgia for this chronic pain condition. Sufferers 
report a range of symptoms and experience and, as the diagnosis is based upon 
symptoms, may experience a long journey to obtaining a diagnosis. Variability within 
and between patients results in a range of approaches with little standardisation and 
considerable variability between regions. There are no specific guidelines for 
management, though recommendations and current evidence suggests a 
multicomponent approach. Emotional and psychological factors appear to play an 
important mediating role and this should be explored in management practices.  There 
is a need for standardisation of services and service availability in the UK and more 
support and guidance for people with fibromyalgia in order to manage their condition 
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1.1 Introduction  
This section provides the implications of the study and discusses the limitations and 
direction for future research, and finally reflections upon the process of conducting 
the study. 
6.2 Future Research   
This is the first study that has documented fibromyalgia in the Middle East, specifically 
in Libya, where the diagnosis is not used.  However, the clinicians recognised the signs 
and symptoms and the syndrome and treated it accordingly, and in a similar manner to 
that described to their UK counterparts with the exception of psychological 
involvement.  There is much scope for research into how fibromyalgia is recognised, 
diagnosed and managed in the Middle East. This data is hitherto lacking.  It would be 
difficult to conduct a national survey in Libya in the current political situation; 
however, future research might involve conducting in depth interviews with clinicians 
in various regions that would be accessible. The study provides some information 
regarding what could be considered as standard care or usual care. This could be used 
to assist with the design of a UK based randomised controlled trial of a multimodal 
intervention for fibromyalgia and investigating such aspects as dose and duration of 
exercise interventions.  The few RCTs that have been undertaken have shown 
equivocal results and have lacked standardisation.  
6.2 Recommendations for Policy and Practice 
From both the survey and the interviews, it is clear that there is a variability of services 
in the UK available to people with fibromyalgia and it is difficult to ascertain what 
standard care or usual care entails.  At present, there are EULAR recommendations for 
fibromyalgia (Macfarlane et al., 2017, Carville et al., 2008a) however; there are few 
specific guidelines particularly regarding dose and duration of available interventions. 
There is also varying availability of services and patients have often experienced 
symptoms for some time before they have been diagnosed and are thus more difficult 
to treat. It is recommended that patients are referred at an early stage to a specialist 
clinician and receive information, advice and support perhaps from a multidisciplinary 
team. There was general agreement amongst both patients and the health professionals 
that maintenance of physical and daily functioning is essential otherwise getting tired 
will keep them in bed for up to  three days’ after and be detrimental to physical and 
psychosocial functioning.  
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Service users need to have reliable and informed knowledge and education about 
chronic widespread pain /fibromyalgia and providers need to also understand the 
variable presentation and effects upon different patients, who may have multiple co-
morbidities and varying clinical presentations and response to interventions. It is also 
suggested that there is a need for education and awareness particularly in the primary 
care setting, and also a more standardised approach to management and onward 
referral if appropriate.   
Ideally, face-to-face interviews with HCPs in Libya may be preferable to 
operationalize the in-depth interviews in the future, although this is likely to be 
resource intensive and to produce a better understanding of the condition occurrence 
and health care professionals’ attitudes regarding recognition of widespread chronic 
pain (CWP) in Libya. Only by conducting more epidemiological studies in the 
developing world will we be able to understand the determinants and distribution of 
CWP worldwide fully.  
6.3 Limitations 
A limitation of the study is its small sample size and, for the qualitative study,  its 
geographical restriction to one site , albeit a large region that was covered by the local 
fibromyalgia group and which fell under various NHS Trusts with differing practices 
and services for fibromyalgia.  
There was a disappointing response to the postal survey from the British Pain Society.  
In addition, there was a very considerable delay in response from the BPS  regarding 
the  agreement which was made between BPS and Northumbria University and BPS 
to purchase  a list of email members (address labels) in order to distribute the 
questionnaires. Originally, it was intended to start with the survey and use the findings 
to inform the development of the interview schedule for patients, however, due to this 
delay of almost one year, it was necessary to commence with the interviewing patients 
as the first phase of the study. The design of the survey was adapted to allow for more 
open questions and exploration of responses to questions. Perhaps a link to an online 
survey may have produced a better response rate. 
 The limitations of section B (Libyan sample) included using a convenience sampling 
method as there is no infrastructure or comparable organisation to the BPS in Libya.  
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A further methodological limitation is the number of participants in the study, 
concerning the restriction of gathering Libyan participants, causing a lack of 
theoretical saturation. The limitations of section B (Libyan sample), after contacting 
the participants by email and handing the questionnaire to the HCPs in Libya by the 
principal researcher and due to the politic situation in Libya there were limitations of 
collecting the sample and the responder rate was restricted. Clearly, there is a need for 
epidemiological studies that estimate the prevalence of chronic widespread pain in 
Libya to determine the scale of the problem. It was valuable to conduct the parallel 
survey on chronic widespread pain in Libya in order to compare results from different 
healthcare professionals practice, gain a broad view of the differences in approaches 
to the management of chronic widespread pain.   
 
6.9 Reflections of Undertaking the Study.  
My experience was based on managingof chronic pain conditions, where I provided 
physical and psycho-social support for people who have experienced difficulties 
associated with chronic illness . Individuals that I have worked with have been 
diagnosed with a variation of chronic pain, for instance, chronic neck and back pain, 
stroke, multiple sclerosis and joint pain.Referrals to the specialist could come from GP 
surgeries and other Health social services. My  reflection  demonstrate that the 
purposeful design of this mixed methods  study  captured service users and service 
providers views and experiences in UK and Libya.  
Undertaking this qualitative and quantitative research study has been a valuable 
learning experience of exploring the phenomena of both experience of living with 
chronic pain and the interventions approaches currently used for such chronic pain. I 
have expanded understanding of the nature of research process and using the multiple 
phase study to gain deep consideration of what is been going in the domain for the 
topic undertake and understand the sometimes messy nature of the research process. 
Although involved in The research development sessions I have attended  provided me 
with more learning skills, as well as adopting the skills provided. Learning new skills 
in the journey of the research study is a rational approach and  helped to open a new 
way of understanding, not just the new skills, but also   familiarisation with the data 
collected and the relationship between knowledge, learning and approaches efficiency. 
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This research study has also provided some key concepts which have helped me 
examine my own academic and professional values, and strategies for possible 
fluctuations to my own future practice. 
My reflections over the design and process of waof conducting research and the utility 
of the research projectunderpins both philosophy and practice and synthesised the 
perspectives in both lived with chronic widespread experience and practice explored 
in this research.   
The purpose of using semi--structured interviews is that to enhance the  understanding 
the individuals features of experience of living with chronic pain.  I was able to develop 
my skill and confidence in designing and developing the research instruments to 
address the research topic and  develop my confidence  and reflect upon  the process 
of gathering the data. . I found that participants did not struggle with my English 
language understanding, their responses and positive feelings that made me confident 
to complete the twelve interviews, also encouragement, and support from my 
supervisors had a huge impact upon my experience and confidence  of conducting 
qualitative interviews.   
From the beginning  of the interview, welcoming the participants, I was very active 
in conducting the interview with a smiley face and eye contact. I also watched  every 
step of  their response, understanding the questions and keep maintained the schedule 
flow so that the interview could be completed with comfort and satisfaction of 
theme. In addition, I tried to follow the interview strategy with them. People with 
chronic pain can tell what they feel is going in their body, living with pain all over 
the body that majorly affects their life and I found the description of their pain to be  
horrendous.   For example, from the first interview, the participant described her pain 
annoyed more than anything else describe and acutely had a significant impact on her 
life. It just everything in the whole body because of not a hundred percent well and 
having consent pain, struggling to do any stuff and get depression because of that and 
more generally tiredness. The work issue was her first concern to face with her 
manager because of long term sick in winter, and she had been advised to apply for 
retirement on health ground. However, people with long-term condition they do not 
expect early retirement because of their pain, as the participant thought she, not that 
ill bout a long time realised she was that ill. Because of the severity and verities of 
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symptoms of such illness and the influence of pain levels upon daily living activities. 
If I would not listen to patients’ stories, I could not presume how much they were 
suffering. It is very challenging to deliberate patients understanding, as they could 
not express themselves, patients were frustrated because of the lack of support, I 
would offer some help to them to improve physical functions if it is possible. Form 
patients’ perspectives I would be convinced that this is a real condition as a result of 
interviewing these patients and gathering depth views of experiences. I think either 
patients or healthcare professions poorly understand the condition, despite the 
unknown causes of this illness people involved in the long journey of diagnosis, 
varieties of testing and non-standardised intervention approaches, because of these, 
patients developed psychological issues such as anxiety and depression. Thus the 
journey of understanding the condition started with immersing myself in their stories 
and their narrative and helped my familiarisation with the data. 
 
 Individuals  whom I interviewed currently had a multitude of presenting chronic 
widespread pain, fibromyalgia and physical and psychological concerns, including  
involvement or lack of availability of  specific interventions.  I was conscious from the 
literature that unclear aetiology of the condition with unstandardized interventions. 
Individuals portrayed different expression of living with pain, and found the support 
group to be very helpful.  
The compounding of the illness background and patients’ experience of the condition   
requires medical and other health care professional s to be cognisant of the range of 
emotional, psychological and physical  factors associated with fibromyalgia   in order 
to be able to apply effective interventions and support to patients with a diverse range 
of symptoms and co-morbid factors. This may involve appropriate assessment on a 
number of domains and a more targeted and individualised  approach to interventions. 
The use of a specialised programme may also be recommended. 
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Faculty of health and life Sciences, City campus. Northumbria University, Newcastle 
upon Tyne. (Poster), 23th May 2015. 
 
Abstract 
 
Chronic widespread pain conditions such as fibromyalgia (FM) are prevalent and 
costly to the economy. Diagnosis is based upon symptoms and although its existence 
as a distinct clinical entity is debated, it causes great suffering and distress for those 
affected.  
Due to the unclear pathophysiology, controversy regarding its existence as a clinical 
entity and variability in diagnosis, clinical management if often difficult, and 
frequently employs heterogeneous interventions The purpose of this research study is 
to describe current practice for fibromyalgia in the UK. It also aims to capture service 
users’ and service providers’ views and experiences of fibromyalgia and its 
management. 
A mixed methods approach will be used. In Phase 1 an online, specifically designed 
survey will be distributed to rheumatologists, pain management and physiotherapy 
clinics in all regions of UK using extant databases.  In the second phase semi-
structured interviews will involve a sample of people suffering from FM recruited from 
the fibromyalgia self-help group in the North East. 
From this study, current practice for fibromyalgia in the UK will be elucidated.  
Implications in terms of current practice, and participants’ experiences will be 
explored including their emotional and lived experience, information seeking and 
experiences of seeking and receiving health care.
  
 
Presentation 
Title: Service Users and Service Providers Views and Experiences of Chronic Widespread Pain 
Conditions Practice and Participation.  
Mr Sedik Abokdeer, Professor Nicola Adams, Dr, Jenni Monghan  
Faculty of health and life Sciences, City campus. Northumbria University, Newcastle upon 
Tyne. (Presentation), 26th June 2017. 
 
Abstract  
Background: Chronic widespread pain and fatigue conditions such as fibromyalgia (FM) are 
prevalent and costly to the economy.  Due to the unclear pathophysiology, controversy regarding 
its existence as a clinical entity and variability in diagnosis, clinical management if often 
difficult, and frequently employs heterogeneous interventions. People with fibromyalgia face 
challenges regarding obtaining a diagnosis and subsequent treatment.  
Aim: The aim of this study (Phase 1).  Was to explore the experiences of people with 
fibromyalgia.   
Method:   The study was carried out in two phases. Phase 1 consisted of twelve semi-structured 
interviews conducted with people diagnosed with FM. Participants also completed the 
Fibromyalgia Impact Questionnaire ( FIQ) and Toronto Alexithymia Scale (TAS) Phase 2 
consisted of a national survey of health and medical professionals from the British Pain Society 
regarding their views and management practices of fibromyalgia.  This study focuses on the 
findings of the qualitative interviews in Phase 1.  The sample for Phase 1 were recruited from 
the fibromyalgia self-help group in the North East.  Framework analysis was used for the 
analysis.   
Findings: The analysis focus on participants experience of living with fibromyalgia and their 
experiences of obtaining a diagnosis,  pain management by health professionals, ways of coping 
with the condition and its impact on their daily lives. .  The main themes identified were:   The 
following themes were identified:  Implications in terms of participants’ experiences were 
explored including their views of journey of diagnosis, current practice availability, emotional 
and lived experience, information seeking and experiences of seeking and receiving health care 
in the UK. The primary qualitative study highlighted some difficulties participants faced 
regarding a perceived lack of understanding by health and medical professionals and also the 
general public regarding management of the condition and the emotional and physical impact of 
FM. This lack of understanding often led participants to avoid going back for further health and 
medical intervention. These findings suggested people were not managing the daily living 
activates regarding to symptoms such as disabling fatigue and worsening pain. This part of the 
study has illustrated a variety of intervention approaches are used with varying and often limited 
success.  The participants’ perspectives have illuminated the need for support required for people 
living with FM and need for education and standardisation of approaches in clinical practice.
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A project Approval letter 
 12/05/15 
 
HLSSA300415 
Patients’ And Practitioners’ Views And Experiences Of Chronic Widespread Pain 
(Fibromyalgia) And Its Management In The UK And Libya 
 
Dear Sedik, 
 
I can confirm that the above-named project has received ethical approval through the 
Department of Sport, Exercise and Rehabilitation ethics process. 
 
Please retain this letter for your records. 
Yours Faithfully, 
 
Dr Mick Wilkinson (Ethics Chair) 
 
Mick Wilkinson, PhD, MSc, BA (Hons), FRSS 
Senior Lecturer,  
Department of Sport, Exercise and Rehabilitation 
 
T:  +44 (0)191 243 7097 
 
E:  mic.wilkinson@northumbria.ac.uk 
 
NB225, Northumberland Building, Northumbria University, Newcastle upon Tyne, NE1 8ST, United Kingdom 
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 Project Amendment Form       
 
Project Title: Patients’ And Practitioners’ Views 
And Experiences Of Chronic Widespread Pain 
(Fibromyalgia) And Its Management In The UK 
And Libya 
Date original ethical approval received: 
12/05/15 
Principal Investigator: Sedik Abokdeer  Project  ref: HLSSA300415 
Date: 22/02/2016 
Description of Amendment/Change: 
The administration of the Fibromyalgia Impact Questionnaire in addition to the interview. FIQ were 
derived from information gathered from patient reports, functional status instruments and clinical 
observations. Impact Measurement Scale (AIMS) was used to assess the content validity of 10 items 
which consisted of work difficulty, feeling good, pain fatigue, rest and stiffness. Burckhardt, C.S., et al. 
(1991). Bennett, R M et al (2009). The degree of correlation between change in FIQ scores and change 
in patients will be compared. 
Reference  
Burckhardt, C.S., Clark, S.R, & Bennett, RM. (1991). The Fibromyalgia Impact Questionnaire: 
Development and validation. Journal of Rheumatology, 18, 728-734. 
Bennett, R  M, Friend R, Jones D K, Ward R, Han K B & Ross L R (2009) the Revised Fibromyalgia 
Impact Questionnaire (FIQR): validation and psychometric properties Arthritis Research & Therapy 
2009, 11: 4 , R120 
Reasons for Amendment/Change: 
To assess their function and impact of fibromyalgia to augment the qualitative data. The 
validity of Fibromyalgia Impact Questionnaire measuring patient's' subjective responses will 
continue to be important and anticipate to use the FIQ in a large clinical trial. This phase 
wasn't included before is because is still under discussion. 
Anticipated Implications: 
The anticipated implications are that it will extend the timescale of the interview by another 5 
minutes; an overall time of the data collection of interview and Fibromyalgia Impact 
Questionnaire will be 45 minutes to 50 minutes roughly.   
Acceptance 
Signature:  
Date: 22/02/16 
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Follow-up action passed to: 
Reason for Rejection: 
  
 
 
 
 
 
 
 
 
APPENDIX 3 
 
 
 
 
 
Fibromyalgia Support Group agreement letter 
 
 
 
 
 
 
 
 
 
 
 
 
 248 
 
 
 
 
 
 
 
 
 
Agreement Letter 
 
 249 
 
  
 
 
 
 
APPENDIX 4 
 
 
 
 
 
  Invitation Latter for Interview Phase 1 of the Study   
 
 
 
 
 
 
 
 
 
 
 
 
 
 250 
 
                 
Invitation Letter 
 
   Faculty of Health and Life Sciences 
PGR Room 431 
Northumberland building 
City campus 
Northumbria University 
Date       March 2015                                                                                                            
Newcastle upon Tyne 
NE1 8ST, UK 
Dear <<TTILE>> <<SUNAME>> 
 
My name is Sedik Abokdeer I am qualified BSc physiotherapy Worked with a background in 
Low back pain management, and MSc in health and social care (physical therapy specialist).  At 
present, I am a full-time doctoral student in affiliation with Northumbria University.  For my 
doctorate, I am undertaking research that looks at issues of ‘fibromyalgia’ interventions to people 
exhibiting interventions performances that have historical and/or present involvement with Local 
Authority health Services. 
On the basis of your present position I have identified you as being involved in the provision of 
collaborative health services to this intervention and/or as a helper of investigation that inform 
and/or impact upon the life course of these fibromyalgia syndrome patients. 
I am writing to ask you take part in a semi-structured INTERVIEW conducted by me.  The 
purpose of this interview is to better understand your present experience or organisational 
involvement with these interventions, as well as your perceptions of how your involvement(s) 
impact of interventions upon the life course of this population with fibromyalgia syndrome. 
 
I have attached an information sheet and informed consent to this email.  If you are interested 
in participating I would ask that you take the time to review the accompanying Information 
Sheet and return the attached INFORMED CONSENT care of my attention as 
confirmation of your willingness to participate.  In-kind I will be in contact so as to agree a 
date, time, and location that suits you for purposes of facilitating this interview.  If you have any 
questions please do not hesitate to contact me directly. 
This study has received ethical approval from the Faculty of Health and Life Sciences Ethics 
Committee at Northumbria University. 
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Sincerely, 
 
Sedik Abokdeer  
PhD student Researcher 
M: 07448378709 
sedik.abokdeer@northumbria.ac.uk
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                       Consent form                       
Project Title: - Service Users and Service Providers Views and              
Experiences of Chronic Widespread Pain Conditions (Fitzcharles et al.): Practice 
and Participation. 
 
Named Researcher:    MR: Sedik Abokdeer  
                  PhD Researcher 
            M: 07448378709 
            Sedik.abokdder@northumbria.ac.uk  
 
This form is designed to confirm that you have been fully informed about the research being 
undertaken, that you understand what you are being asked to do and that you consent to 
participate in the research. 
Please INITIAL the boxes that correspond to your choices 
YES 
 
NO 
 
1. I wish to participate in the INTERVIEW associated with this research. 
 
 
 
2. I have read & understood the attached information sheet giving details of the 
project. 
 
 
 
3. I have had the opportunity to ask any questions about the research, my 
involvement in it, and am satisfied with the answers I have been given. 
  
4. I am aware decision to consent is entirely voluntary and I understand that I am 
free to withdraw at any time without giving a reason. 
  
5. I understand that if I elect to withdraw from participating  in this research my 
decision will not impact upon my standing with the organisation for which you 
work 
  
6. I understand the data gathered in this project will form the basis of a doctoral 
thesis and may inform reports and/or publications and/or presentations. 
  
7. I understand that my name will not be used in the named researcher’s thesis 
and in any other report, publication, and/or presentation resulting from the data 
collected, and that every effort will be made to protect my confidentiality. 
  
8. I consent to being audio recorded for purposes of data collection. 
 
 
 
9. I know that if I am in any way unhappy with the conduct of the research, I may 
approach Professor Jennifer Watling; Associate Dean for Research and 
Innovation; Northumbria University; Coach Lane Campus, Benton; Newcastle 
upon Tyne; NE7 7XA;  
Tel:- 0191 215 7771     email : - Janice.armstrong@northumbria.ac.uk      
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Please SIGN the following, PRINT your name, and DATE 
 
Participant’s Signature:   --------------------------------------------------Date: -----/------/------- 
 
Participants Name (in CAPITALS): ----------------------------------------------------------------------
- 
The named researcher signs/dates in the space provided to confirm that the participant 
understands the purpose of the research, their role, and that they have the right to withdraw at 
any time. 
 
Researcher’s Signature:  ------------------------------------------ Date: -------/------------/-----
---- 
 
CONTACT DETAILS FOR SUMMARY OF RESULTS 
 
I would prefer to receive the results by (please tick one): 
 
Post       
 
 
Email     
 
Postal address: 
……………………………………………………………………………………………………
…………………… 
……………………………………………………………………………………………………
……………………………………………………… 
……………………………………………………………………………………………………
……………………………………………………………………………………………………
……………………………………………………………………………………………………
……………………………………………………………………………………………………
………………………………………………………………… 
 
Email: 
……………………………………………………………………………………………………
………………………………………… 
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interviews, phase 1 
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Semi-Structured Interview Schedule                           
 
Semi-Structured to be undertaken with 
Fibromyalgia Self-help Group. 
 
Title of the Project:  Service Users’ and Service Providers’ Views and Experiences of 
Chronic Widespread Pain Conditions (Fitzcharles et al.): Practice and Participation  
 
Named Researcher: MR: Sedik Abokdeer 
 
The interviews aim to derive the following information, thought a sim-structured interviews is 
used to capture the subjects’ views and experiences and discussed freely from the schedule in 
order to further understanding the condition.  
Time Available: 50 Minutes 
This study is NOT part of any treatment programme and that they will NOT be offered any 
treatment as a result of issues that arise in the study. 
INTERVIEW GUIDE 
In this phase I will begin with asking you 
What do you feel is going on in your body? Could you tell me the process of going of pain of 
FM (you can use images or drawings or whatever helps you to describe it to me) body map is 
provided. 
Prompts 
 Describe the feelings that you experience. 
 How does this make you feel? 
 How does these feeling and symptoms affect you/your life? 
History/ Background /symptoms  
What does the Fibromyalgia mean to them? Tell me about the History symptoms that you feel? 
Prompts   
 How long do you remember having symptoms? 
 What made you seek medical help? 
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 What was the response of your doctor? 
Diagnosis  
What does the diagnosis mean to them, tell me how you feel when you were diagnosed with 
fibromyalgia? 
Prompts 
 How long before you were diagnosed 
 When were you diagnosed? 
 What information did you get on your condition and from whom? 
 
Current state 
What impact has fibromyalgia had on their quality of life? “How has fibromyalgia?  
affected your life" 
Prompts 
 What are your worst symptoms? 
 If you had to choose a symptom to treat, what would be your priority? 
 Can you tell me what treatment/interventions you have had for your condition? 
 When do you get support and help with your condition? 
 
Treatment  
What treatments do patients with fibromyalgia use to manage their condition? 
Prompts 
 How helpful do you find your interventions? 
 What do you think works best for you? Is it referring to medication, treatment, and 
exercise or pain management? 
 Why do you think of interventions works best for you? 
 
NHS experienced  
How they feeling about services been received from NHS? What they expect to receive? 
 Prompts 
 Can you tell me about your experience of treatment within the NHS? 
 Is there anything you would like to have included in your treatment that you did not have? 
 Are you still receiving treatment from the NHS? 
 
Gaps in treatment 
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How they think about other service can be more help from those organization who involving in 
manage their condition.  
Prompt 
 Is there anything else that could be done e.g. in the community/leisure/Governmental 
level that you feel would help you? 
 
Private /alternative treatment 
Who they seen in privet sector? 
Prompt 
 Do you see anyone privately (e.g. a CAM therapist) 
 
Deal /future treatment / management  
What kind of interventions they may chose for manage their condition? 
Prompt 
 
 If you could choose your own package of care, what aspects would you choose? 
 
Anything else  
 
What is more information they are think is important to be mentioned about their experience of 
living with fibromyalgia? 
Prompt 
 Is there anything else you would like to tell me about your experience of fibromyalgia? 
 Is there anything else you would like to add that has not been discussed? 
Closure of interview 
 
Thankfulness   
 
Thank you very much for your participation 
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INTERVIEW INFORMATION SHEET 
 
Project Title:   
Service Users and Service Providers Views and Experiences of Chronic Widespread Pain    
Conditions   (Fitzcharles et al.):  Practice and Participation. 
  
INTERVIEW INFORMATION SHEET 
 
We would like to invite you to take part in our research study which involves taking part in an 
interview about your experience of interventions for fibromyalgia. We have provided this 
information sheet to help you understand why the research is being done and what it will involve 
for you before you decide whether to take part or not. This would take about 10 minutes to read. 
We would like you to read the information carefully and discuss it with other people if you wish. 
You are very welcome to speak to Sedik Abokdeer, the researcher if you need more explanation 
or more information 
 
What is the research about? 
The purpose of this research is to help us explore the influences that make some people take part 
in interventions for fibromyalgia and the factors that make others not to take part. The research 
also aims to explore the types of interventions that you have found to be useful and why and the 
types of interventions and services you would like to receive. So, we are interested in your views 
and experiences your ‘voice’ on this matter. 
 
Why have I been asked? 
You have been asked because you have been diagnosed as suffering from fibromyalgia and are 
attending a self-help group in the region. 
 
What am I being asked to do? 
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You are being invited to participate in a semi-structured INTERVIEW facilitated by the named 
researcher.  This interview is estimated to be 45-60 minutes in duration.  You will be asked to 
share from the perspective of your experiences in been live with condition and working with 
fibromyalgia self-help group exhibiting interventions conducts who have a history of and/or 
current involvement with local authority health services.  The interview will take place at a 
location of your choice. It could be in a local private meeting room arranged with the researcher 
or at your home. If the interview is not held at home, any travelling expense incurred to get to 
the interview venue will be fully reimbursed. 
At the interview, the researcher will first review this information sheet with you and answer any 
questions you may have.  The researcher will then ask you to sign the consent form if you are 
happy to continue to take part in the research. The researcher will then ask you some questions 
regarding your thoughts and views about the fibromyalgia interventions programme (the physical 
activates) and your participation in the research. 
The interview will be audio recorded with your permission, and the researcher and interviewee 
will be present in the interview room.  
 
What happens if I do not want to participate? 
Participation is completely voluntary. It is entirely up to you to decide if you would like to take 
part.   
 
What would happen if I agree to participate and then change my mind? 
You are under no obligation to take part and if you do decide to take part, you are free to withdraw 
at any time if you change your mind without giving a reason.  However, the data collected from 
the interview will still be used in the research with all personally identifiable information 
removed. It will not be possible to withdraw the data at this stage. If you have already 
communicated interest and agreed to participate, kindly contact the named researcher to decline 
your interest.  
   
Will my participation in the research be kept confidential? 
 
Yes, you taking a part in the research will be kept confidential, only the research team will know 
about your participation in the research; all personal data will be kept confidential and will not 
appear in any printed documents associated with this research. 
 
What will happen to the information that is gathered from the interviews? 
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All the information collected will be kept confidential. After the interview, the researcher will 
keep up the information with your code and any other identifiable information secured behind 
lock and key at Northumbria University accessible to only the named researcher and/or encrypted 
electronically. Only the research team will have access to this information. Any quotes that are 
used in the final report will be anonymised. Names and details of participants will not appear in 
any printed document. Case report forms (CRFs) - i.e completed interview data will be stored 
securely in a locked cabinet at the Northumbria University and destroyed a year after the end of 
the research, data can be withdrawn of the request is made before a specified deadline. 
 
What will happen to all the information collected for the research and how will the research 
report be disseminated? 
All the information collected will be looked at to identify participants common thoughts and 
views and about the interview transcription sheet. These will then be used to produce a final 
report. The final report will be presented to the Northumbria University. This final report will 
form part of the researchers Ph.D. degree. A summary of the research finding will be sent to all 
the participants and the full report can be requested by the participants after the final report has 
been produced. The research findings will also be disseminated to the UK Strategic Health 
Authority, who may wish to publish the results on their website and newsletter. 
It is anticipated that peer-reviewed publication and national/international conference presentation 
may also arise from this study. 
 
Who will read and/or have access to the published results? 
This research will be used in the named researcher’s doctoral thesis.  Following the completion 
of this thesis faculty, staff, and students affiliated with Northumbria University will have access 
to the thesis and its contents.  Additionally it is the named researcher’s intention to make the 
conclusions of this research available to the local authorities and other organisations participating 
in an effort to both inform health work practice, as well as to improve the services currently 
afforded the fibromyalgia patients of concern.   
 
Who can I contact if I want to know anything else about this study? 
You are most welcome to contact the named researcher and/or the named researcher’s project 
supervisor if you require further information relative to this study.  Contact information for both 
parties is as follows: 
PROJECT SUPERVISOR     NAMED RESEARCHER 
Prof Nicola Adams     MR Sedik Abokdeer 
Faculty of Health and Life Sciences   Faculty of Health and Life Sciences 
B131                    PGR Room 431 
Coach Lane Campus West                 Northumberland building  
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Northumbria University     Northumbria University 
Coach Lane       City campus 
Benton       Newcastle upon Tyne 
Newcastle upon Tyne     NE1 8ST, UK     
NE7 7XA 
0191 215 6620      07448378709 
nicola.adams@northumbria.ac.uk   sedik.abokdeer@northumbria.ac.uk  
1. Who can I contact if I am unhappy with the conduct of the research? 
If you are in any way unhappy with the conduct of the research, you may approach:  
 
ASSOCIATE DEAN OF FACULTY  
Professor Jennifer Watling 
Northumbria University 
Coach Lane Campus, Benton 
Newcastle upon Tyne 
NE7 7XA 
Tel. 0191 215 7771 
Janice.armstrong@northumbria.ac.uk     
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APPENDIX 8  
 
 
 
 
 
 
Fibromyalgie Impact Questionnaire (FIQ) 
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FIBROMYALGIA IMPACT QUESTIONNAIRE (FIQ) 
 
Dear <<TTILE>> <<SUNAME>>                              Date:      March 2015 
 
Instructions: For questions 1 through 11, please circle the number that best describes how you 
did overall for the past week if you do not normally do something that is asked, cross the 
question out. 
 Always Most Occasionally Never 
Do shopping? 0 1 2 3 
Do laundry with a washer and dryer? 0 1 2 3 
Prepare meals? 0 1 2 3 
Wash dishes/cooking utensils by hands?  0 1 2 3 
Vacuum a rug? 0 1 2 3 
Make beds 0 1 2 3 
Walk several streets? 0 1 2 3 
Visit friends or relatives? 0 1 2 3 
Do garden work? 0 1 2 3 
Drive a car? 0 1 2 3 
Climb stairs? 0 1 2 3 
12. Of the 7 days in the past week, how many days did you feel good? 
 0 1 2 3 4 5 6 7 
13. How many days last week did you miss work. Including housework, because of 
fibromyalgia? 
 0 1 2 3 4 5 6 7 
 
 
        
Continued……….. 
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FIBROMYALGIA IMPACT QUESTIONNAIRE (FIB)- page 2 
Directions: For the remaining items, mark the point on the line best indicates how you felt 
overall for the past week. 
14. When you worked, how much did pain or other symptoms of your fibromyalgia interfere 
with your ability to do your work, including housework?    
    *__I__I__I__I__I__I__I__I__I__* 
No problem with work                                                                     Great difficult with work 
 
15. How bad has your pain been?    
      *__I__I__I__I__I__I__I__I__I__* 
          No pain                                                                                              Very severe pain  
16. How tired have you been? 
    *__I__I__I__I__I__I__I__I__I__* 
No tiredness                                                                                                   Very tired 
17. How have do you felt when you get up in the morning? 
                                           *__I__I__I__I__I__I__I__I__I__* 
     A work well rested                                                                        A work very tired  
18. How bad has your stiffness been? 
    *__I__I__I__I__I__I__I__I__I__* 
       No stiff                                                                                                      Very stiff  
19. How nervous or anxious have you felt? 
     *__I__I__I__I__I__I__I__I__I__* 
 Not anxious                                                                                             Very anxious 
 
20. How depressed or blue have you felt? 
 
    *__I__I__I__I__I__I__I__I__I__* 
        Not depressed                                                                              Very depressed 
 
Thank you very much for your participation 
 
Appendix  
267 
 
 
 
 
 
 
 
APPENDIX 9  
 
 
 
Self-report measurements Sheet Toronto Alexithymia Scale (TAS) 
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Self-report measurements Sheet. Toronto 
Alexithymia Scale ( ( TAS )   
 
F1 F2 F3 F4 F5 
Difficulty Identifying Feelings Very 
slightly or 
not at all 
A 
little 
moderatel
y 
Quite a 
bit 
extremely 
1 I am often confused about what 
emotion I am feeling. 
     
3 I have physical sensations that even 
doctors don’t understand. 
     
6 When I am upset. I don’t know if I 
am sad, frightened, or angry. 
     
7 I am often puzzled by sensations in 
my body. 
     
9 I have feelings that I can’t quite 
identify. 
     
13 I don’t know what’s going on 
inside me. 
     
14 I often don’t know why I am angry  
 
    
Difficulty Describing Feelings  
2 It is difficult for me to find the right 
words for my feelings. 
     
4  I am able to describe my feelings 
easily. 
     
11 I find it hard to describe how I feel 
about people. 
     
12 People tell me to describe my 
feelings more. 
     
17 It is difficult for me to reveal my 
innermost feelings even to close 
friends. 
     
Externally-Oriented Thinking  
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5 I prefer to analyse problems rather 
than just describe them. 
     
8 I prefer to just let things happen 
rather than to understand why they 
turned out that way. 
     
10 Being in touch with emotions is 
essential. 
     
15 I prefer talking to people about 
their daily activities rather than 
their feelings. 
     
16 
 
 
I prefer to 
watch“light“entertainment shows 
rather than psychological dramas   
     
18  I can feel close to someone, even 
in moments of silence. 
     
19 I find examination of my feelings 
useful in solving personal problems 
     
20 Looking for hidden meanings in 
movies or plays distracts from their 
enjoyment. 
     
 
Thanks for your participation 
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Sample of transcript Fibromyalgia patient’s transcript 
from study 1 
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Sample interview 9/3/2016  
  
To start the interview with,   
Q   Can you to describe your feeling, how you feel with pain.  If you could draw your feeling 
though this map...If you could just shadow the place that you have pain through all the body, 
you know? Use the Body map just to help you to describe your feeling...  
  
A Okay, yes.  I mean, it can be anywhere.  And so...It’s a lot round the neck and shoulders, but 
it also goes across the chest as well, sort of like that.  And then back.  It could be anyway in the 
back.  And hips and legs.  That was where it started with me, was the legs here.  And then it 
just...  It can move anywhere.  My hands are bad, can be bad.  I don’t know if...  That’s about it.  
It can be anywhere. Yup, anywhere. Yeah.  It can be feet.  Yes, it can be anywhere.  
It moves, yeah.  And it also depends what I’ve been doing. So if I’ve been walking a lot, it 
tends to be hips and legs.  If I’ve been cooking or baking – hands and arms.  So, yes, it just 
depends what I’ve been doing.  I’ll put arms in as well.it can be a little bit or it can be a lot 
where I can’t move and I have to just stop and wait until it eases. If my hands are bad, they 
don’t work, they lock.  So I have to wait until they just loosen a bit and ease up.  It could take 
about 20 minutes or so just waiting until they’re loose and I can move them again.  
  
Q  So with these symptoms and the pain that you have had, how does this make you feel when 
you get that pain?  
A   Depressed, frustrated.  Because I can’t finish what I’m doing or if I’m out somewhere and 
it’s my legs that hurt, it takes me a longer time to get where I’m going.  It’s frustrating mostly.  
Q  So with this pain and you get frustrated and a lot of struggling with the pain, so how does 
this affect your life?  
A It slows it down.  I can’t do anything quickly, I can’t do anything on the spur of the moment.  
I have to plan things more, plan leading up to what I want to do, say, go somewhere perhaps 
and then plan after it to recover to give myself a recovery period – a day or two days if it’s 
something quite major.  So there’s a lot more planning.  It takes me a long time to get ready in 
the morning to come out.So I get up very early, take pain tablets, soak my hands in hot water 
which helps them loosen up and move.  Things like that. It all takes time, yeah.  It takes more 
time.to warm them up, yeah  
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Q  So with all of these symptoms and pain, I would like to ask you about the history and 
symptoms that you have.  How long do you remember you have these symptoms?  
A   I went to the doctor about them in 2000 and... I think it was the end of 2009 and I got an 
appointment with the doctor at the hospital in 2010.  It started with my legs.  I thought it was 
something like...  Because we’d had a very bad winter with lots of ice and walking on ice you 
tense up your muscles so that you don’t fall, but my legs relaxed again.  They never were 
without pain after that and I thought it was something to do with that, but the doctor asked me 
about pain elsewhere, which I did have, I just didn’t connect it and he said it sounds like 
fibromyalgia because those are all the places that people get pain when they have fibromyalgia.  
I hadn’t heard of it before so when he said that, and I paid attention to my pain, it was right. 
The GP referred me to the hospital and I got the appointment in 2010, so that was the doctor at 
the hospital.  The GP didn’t have any idea. He just didn’t know. The GP just didn’t know.  He 
said, “I’ve got no idea so I’ll refer you on.”  But the doctor at the hospital knew all about it so 
he had a lot of patients with it and he said, “There isn’t a test for fibromyalgia.”  But he said, 
“Well, I’ll X-ray you,” which he did, X-rayed.  And he said, “We have to rule out things, look 
for other things like arthritis or...”  And he said, “It’s not that so it’s...”  He says, “I think it’s 
fibromyalgia.”  
Q what made you seek medical help?  
A  Because the pain was quite bad still and it never eased off.  It was just always there and just 
taking something like Paracetamol didn’t help, so I had to learn to...  I got other painkillers, but 
I just had to learn to, if the pain was very bad, it meant rest or stay still anyway for a little while 
and don’t do too much.  You have to just do a little bit at a time.  
  
Q  How long before you have been diagnosed?  How long you experienced of pain? And do 
remember when you were diagnosed exactly?  
A  I would say about six months. It was summertime.  It was...  I think it was June or July, it 
was June or July. I didn’t bring any of my notes with me, I should have. For dates and things. It 
took about six months to get the referral appointment, I think, so yeah.That’s what made me 
think as well.  When the winter was just about finished, the pain wasn’t going away so I 
wondered what it was.  
Q   So when you been referred to the hospital,    to see the specialist, was it a rheumatologist or 
other specialist?  
A Yes, a rheumatologist.  
Q   And with the rheumatologist in the hospital.  What information you get about your 
condition? Fibromyalgia.  How did you get the information through?  
  
A   The doctor at the hospital gave me a couple of leaflets. And that explained what it was and 
where it was likely to occur in the body and...  It didn’t offer treatments, but it just explained 
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what it was. So that’s how I learned what it was I looked...  Once I got home after that, I did 
look it up on the computer, but I stopped doing that because everything I read about, every 
person that I read about, they all ended up in a wheelchair. So I stopped looking it up on the 
computer.  
Q  So what are your worst symptoms that you had?  
A   The worst ones ever?  The worst ones, I suppose, were when... one day when I couldn’t 
walk.  I mean, I could just about get round my flat holding on to the furniture, but I couldn’t go 
outside, I couldn’t...  Everything hurt, everything. One makes the other worse.  If I’m 
depressed, I tend to be in more pain.  If I have a lot of pain, then it’s depressing and frustrating 
and...  Yes, those things.Tired?  Yes, yes.  And people don’t believe how tired you can possibly 
be.  
Q   So with all of these symptoms.  Can you tell me about the treatments and interventions that 
you had to manage these symptoms?  
A    I’ve been through a lot of different tablets, painkillers, to find the right ones and I think 
now it’s probably the combination that helps the most.  I mean, Paracetamol I do take.  Wait a 
minute and I’ll tell you. Duloxetine.  Yeah, it’s a mixture.  I tried Gabapentin and that didn’t 
work so I tried Pregabalin and that doesn’t work by itself, but it works with other things.  
Duloxetine is one.With, with...  Not the Gabapentin, they stopped that one.I’ve got Pregabalin, 
Duloxetine, some Codeine. I mean, it’s not just one thing that works with the fibromyalgia.  It’s 
different.  
Q   So do you have other morbidity conditions with fibromyalgia?    
A   The diabetes was diagnosed the year before in 2009, in January 2009.  
  
Q  So you have been through lots of medications. Have you been on other interventions?  
A   I’ve had psychologist interventions to try and work out non-medical ways of coping.  So 
things like mindfulness, relaxation techniques, including just relaxing in a comfortable position 
with or without music or with or without trying to do a self-hypnosis thing in my head – talking 
myself into it.Or things like a repetitive...  Like knitting.  If my hands will knit, I knit 
sometimes because just...  It distracts and sometimes it can take my mind off the pain.   
Or colouring.  Colouring’s a big thing.  So sometimes I could do those just to take my mind off 
it and think about something else.  
  
Q   So when you are being engaged with other works, the pain is going off a bit and you feel 
settled down a bit?  And did you find this helpful?  
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A    Yes, yes.  If I can break it, then sometimes it stays away.  It’s breaking it. Yes, it was good.  
And the psychology also talked a lot about pacing. Just doing enough and not doing too much.  
And if you feel good one day, don’t suddenly think, “I can do everything, go back to normal” 
because the next day you’ll be crippled and it takes longer to recover, which...  That was very 
useful because you do think, “Oh, I’m feeling really good today.  I can do everything – go 
everywhere, do everything,” but then the next day or two days or three days, you can’t move.  
It takes longer. Just a little bit, just a little bit.  If you feel good, do a little bit more, but not kill 
yourself in a day.  
Q  So when did you get support for your condition?  
A  When I went to the pain clinic.  I asked to be referred to the pain clinic when we were doing 
different tablets, trying different tablets, and they suggested the Duloxetine as well as the 
psychologist.  And there was a physiotherapist there as well with the psychologist and she gave 
me some exercises to do, which sometimes help and sometimes don’t. Got information on 
mindfulness – what it is and how to do it.  And relaxation and I got tape... not tapes, but CDs.  
With mindfulness, I don’t know what you call it.  Someone talks and you listen and it helps you 
get into that state.  One for mindfulness and one for just general relaxation.  
Q  So how did you find that intervention you had?  
A   It was more or less the same time.  I think I got the psychology...  I had a few psychology 
appointments first and then she referred me to the physio that was in the same place.  It’s in the 
same practice.  So then I had a psychologist appointment and a physio appointment sort of one 
after the other.  I had quite a few.  I think I had six or eight psychology appointments and 
about... over a year and about three or four physio appointments. And, always the same 
psychologist and always the same physio. Yeah, it was very helpful, yes.  
Q  So what do you think worked best for your conditions?  
A  Finding the right combination of tablets, but with the relaxation things I got from the 
psychologist and the idea about pacing my energy and not using it up in one day.  I think that’s 
the most useful. And the fact that if you have to go to sleep, you have to sleep.  Don’t try and 
not sleep because, well, you probably can’t do it anyway, you probably can’t stay awake if you 
need to sleep.  In the daytime I’m talking about, as well as night.  It’s really letting your body 
tell you what it wants.  You know, if I have to rest, I have to rest or sleep. Yeah, usually I do 
sleep.  I can sleep 24 hours! Fantastic, but I make myself get up in the morning because I really 
don’t want to.  I want to stay in bed and sleep and sleep, but I don’t want to do that and miss 
out on the world.I can fall asleep on a 15-minute bus ride from my house to my mother’s house.  
Q  So you have been through GP, specialists, physiotherapists, psychologists – can I ask you 
about your experience with the NHS?  
A   NHS in general, it’s been very good for me.  Very good for me, yes.  I mean, I know NHS 
has its problems, but... and I’ve had to wait for some appointments if I’ve been referred, but 
generally it’s been very good, very good.  The GP, you know, didn’t have a clue about 
fibromyalgia, didn’t have a clue about what my pain was.  Well, alright, but he did at least say, 
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“I’ll refer you” so...  And I had to wait a few months for that but, I mean, at least I got the 
appointment. I did asked for referral?  Well, no, I just went to see the GP if he could tell me 
what it was and he said he didn’t know so he would refer me. I went back to the GP and asked 
GP, yeah. I asked for the pain management referral once I knew it was fibromyalgia and we 
were trying different drugs, because the rheumatologist sent him a letter advising him.  
Yeah, so the rheumatologist has been advising the GPs to send you to the pain management.   
That’s what I need to get, yeah.  So that’s it, that’s it, yeah.  So between all of these clinics that 
you have been visiting before, what’s the variety from this to this?  So is there any differences 
between them or...?  You have...  You mentioned the GP doesn’t know about the fibromyalgia. 
Oh, yeah.  The GP doesn’t have any idea.Yes, the GPs don’t know about everything.  I mean, 
I’ve had other medical conditions in the past.  The GP didn’t know about anything about 
gynaecology either when I had problems with that.  Nothing to do with fibromyalgia but, 
fortunately, he referred me for that as well because that required surgery.   
So I guess the GPs don’t have an idea about every single thing, that’s all I can think of.  I mean, 
maybe they...  I don’t know if it’s reasonable to think that they should have an idea about 
everything.  
  
Q So you tell me about this experience of visiting clinics so... and going for the treatment.  Is 
there anything you would like to include?  
R I don’t think so.  The pain-management people, all of those people were very good.  I mean, 
the consultant that I saw first and then the psychologist was really good and physio.  They 
were very helpful, very good .And when I asked to be referred, I mean, the GP said that was 
fine so there was no argument, so that was good. Make sure that GPs have more information 
because...  I mean, I was lucky and, you know, he referred me more or less straightaway, but 
I know people don’t get that support and help, so I think more information would be good.  
Some GPs I know don’t believe it, believe in it. Yeah, so I’ve got a different GP because 
that one retired and this other one, she’s okay as well.  So...This new one’s a bit better. The 
old one was older. No, she’s good about it.  I mean, she recommended that I be put on sick 
pay because I was...  I couldn’t manage work, I just couldn’t manage it.  If my hands are no 
good, I can’t look after somebody else because I’m not safe, especially if it’s vulnerable 
people.  And it...  You know, I can’t...  Part of it is helping somebody clean their house, 
well, I couldn’t do that either.  I can’t sometimes do that because I’m too tired or I can’t, you 
know, get down on my hands and knees and clean a floor or...  So she’s put me on sick pay 
so that... so I’m getting sick pay at the minute. And unemployed now since a second... 
January 2014,I was unemployed for a year, like, on sick pay for a year and then the Atos 
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thing, you know, with going on long-term sick pay.  I had to have interviews with those 
people and they put me on sick pay for another two years, which is up next March.  I’ve got 
another year left of sick pay.  
Q   So When you’ve been working and do you feel pain all the time or just from time to time?  
A  The more I worked, the more I, you know, the worse I felt and I was just too scared to look 
after somebody because, you know, sometimes you have to hold on to them or even if it’s a 
child, if I babysit for somebody, I would never...  I would never, ever hold a baby now.  I just 
wouldn’t do it because I’m too frightened. Yes.  It makes me feel as if I’ve got no, like... no 
purpose, I suppose.  I couldn’t go back to caring at the minute.  I couldn’t...  I can’t even do a 
computer for very long because my eyesight blurs and after 20 minutes or half an hour I have to 
come off the computer, so I’m not sure what job I could do at the minute. I mean, I’m glad I’m 
on the sick at the minute because it means I can pace myself and go to sleep if I need to and...I 
wouldn’t be able to do that if I had to show up for a job every day.  
  
Q   So did you have a support from family and friends?   
A   It was...  Yes.  I’ve only got my mother here at the minute.  My father died last year. That’s 
alright.  I have two brothers who live in America and I speak to them or email them.  I think 
I’ve got one friend who absolutely supports me, no question, and I’ve got another friend who 
almost does, but she doesn’t quite...  I think she doesn’t quite believe in the severity of the pain 
or the severity of the tiredness.  I mean, she does support me, but I think there’s a  
tiny bit of her that just doesn’t quite believe it. Official people like Atos when they do the 
interviews don’t believe it, don’t believe it.  I got refused and I had to go to a tribunal.   
Q Did you get any support from others?  
No. I don’t think there’s been any support anywhere else. No information coming through other 
places? No.  I mean, through here, this fibromyalgia group from here, which I’m very glad to 
have found. Any lecturers come in as a visitor? Yes, people come and talk through this, yes. it’s 
Very helpful.  It’s nice to be able to walk into a room and know that everybody’s the same as 
you.You don’t have to explain anything.  Yeah, so this has been really good.  
Q So you have been in NHS and have you see anybody privately?  
A No.  No. just NHS, not privately, yeah?  
  
Q  So for the future, if you’d like to have a package for your condition as a treatment, what 
would you like to choose?  
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A  Ooh, a package...  Yeah, it is.  Yes, I think it should be automatic that people get the 
information like I got from the psychologist, as well as drugs and it needs to be that people get 
the right drug or the right drug mixture combination for them, that all the doctors believe them 
– GP.  I mean it would be great if all this just came from the GP.  Maybe that’s not realistic, but 
it should... it should come without too much of a fight for people.  Drugs, relaxation, the 
psychology advice, relaxation exercises, mindfulness.  Pacing, make sure everybody knows 
about pacing – not to do too much.  For me, that was a very important thing because it comes 
with accepting that maybe you’ve always got the pain, the pain might never go away.  I’m just 
going to stand. Which at first, for me, was like defeat, you know?  Just...  I felt I should fight 
the pain more, but I think that takes too much energy and you can’t...  The pain’s going to be 
there.  It won’t get rid of the pain so pacing is important.  
Q  Before we get to the end, I have a self-Report questionnaire .  Can you fill this for me 
please?  
A  Right, yeah.  
Q   Is there anything else you would like to tell me or discuss that we haven’t got through in the 
interview or any questions you would like to ask?  
A No, I don’t think so.  Just to say it is... how important it is having groups like this, the 
fibromyalgia group. Yes, yes, very good.  
Q  Is there anything you would like to ask me before we end the interview?  
A I don’t think so,  
Q  Thanks very much, very much for coming. And it was my pleasure to meet you today.   
Thanks a lot.  
A   It was a pleasure to meet you as well.  I hope it’s helpful.  
A Yeah, it’s very really...  really very helpful that point you mentioned about your experience 
and how you get... manage through the specialist area, you know?  Thanks for coming and  
I’m really happy to listen to your experience.  That’s given me lots of key words and 
information, you know?  
  
Thank You  
 ------------------------------------------------------------------------------------------------------------- 
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19th April 2016  
  
  
THE BRITISH PAIN SOCIETY (Ortega E1)  
  
and  
  
NORTHUMBRIA UNIVERSITY (2)  
  
_____________________________________________________  
  
AGREEMENT TO USE MAILING LABELS   
FOR MARKETING PURPOSES  
______________________________________________________  
  1  
  
THIS AGREEMENT is made on the 3rd March 2016  
  
BETWEEN:  
  
(Ortega E1) THE BRITISH PAIN SOCIETY a company limited by guarantee and 
incorporated in  
England (Co. No. 5021381 ) whose registered office is at   3rd Floor, Churchill House, 35  
Red Lion Square London WC1R 4SG    (BPS) and                                                                                  
  
(2) NORTHUMBRIA UNIVERISTY, Department of Sport, Exercises and Rehabilitation 
Faculty of Health and Life Sciences, Northumberland building Room 431, Newcastle Upon Tyne 
NE1 8ST  
  
WHEREAS:  
  
(A) BPS is a national society with a  large membership, certain of which are happy to receive 
marketing material relating to the Purpose, names and addresses of which are contained on the 
Mailing Labels.  
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(B) The Labels Buyer wishes BPS to provide it with one set of the Mailing Labels to be used 
once only for the Purpose, subject to the terms of this Agreement.  
  
(C) The Charity (BPS) has granted to the company (BPS Pain Business Ltd) the right to 
market the Mailing Labels for the purposes provided for in this Agreement. The company is a 
wholly owned subsidiary of the Charity, and has covenanted to pay a proportion/all of its profits 
to the Charity.  
The mailing labels  will be invoiced through our trading company BPS Pain Business  
Ltd  
  
NOW THE PARTIES HAVE AGREED AS FOLLOWS:   
1 INTERPRETATION  
1.1  In this Agreement the following words shall have the following meanings:  
the Act means the Data Protection Act 1998 and any related data protection laws, statutes, 
regulations, directions and any non statutory guidance issued by the Information Commissioner’s 
Office, as amended, revised, updated or replaced, from time to time;  
Commencement Date means the date of this Agreement;  
Intellectual Property Rights means all patents, topography rights, design rights, trademarks, 
copyright, rights in databases, sui generis rights, trade secrets and other confidential information, 
know-how and all other intellectual property rights of a similar nature in any part of the world, 
whether registered or unregistered, and all applications and the rights to apply for the protection 
of any of the foregoing;  
Mailing Labels means the set of mailing labels with the names and addresses of all BPS members 
who have consented to receive third party marketing in connection with the Purpose, to be 
supplied by the BPS subject to the terms of this Agreement;  
Marketing Law means all laws, statutes, regulations, directions and any non statutory guidance 
issued by the Information Commissioner’s Office, the Office of Fair Trading or Ofcom in relation 
to direct marketing whether by post, fax, telephone, email, text message/sms, or any other 
electronic means, including the Privacy and Electronic Communications (EC Directive) 
Regulations 2003 as amended, revised, updated or replaced, from time to time;  
Personal Data shall have the meaning given to such expression in the Act;  
Purpose means for the purpose of marketing the specific goods or services approved in advance 
by the BPS and described in Schedule 1 which for the avoidance of doubt are courses, seminars, 
meetings or pain related products offered by the Labels Buyer (but for the avoidance of doubt, 
not on behalf of any person other than the Labels Buyer);  
Term means the period that this Agreement is in force, until it is properly terminated;  
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1.2 In this Agreement references to any statute or statutory provision shall, unless the context 
otherwise requires, be construed as a reference to that statute or provision as from time to time 
amended, consolidated, modified, extended, re-enacted or replaced.  
1.3 In this Agreement references to the masculine include the feminine and the neuter and to the 
singular include the plural and vice versa as the context admits or requires.  
1.4 In this Agreement references to Clauses and the Schedules are references to clauses of and 
the schedules to this Agreement, and the Schedules shall be deemed to form part of this 
Agreement, and in the event of any inconsistency between this Agreement and the Schedules, 
the order of precedence set out Clause 4 shall be applied;    
1.5  In this Agreement the headings will not affect the construction of this Agreement.  
1.6 In this Agreement the expression “including” shall be non exhaustive and shall mean 
“including but not limited to”.  
2 BPS’ OBLIGATIONS   
2.1 Subject to receipt of the Fee, payable in advance in cleared funds, BPS agrees to supply the 
Mailing Labels to the Labels Buyer by the Delivery Date[s] set out in Schedule 1.  
2.2 BPS agrees to promptly notify the Labels Buyer of the details of any BPS member who 
contacts the BPS indicating that they do not wish to receive any marketing material from the 
Labels Buyer, which the Labels Buyer agrees to promptly add to its direct marketing mailing 
suppression list and to immediately cease sending material to such notified persons.  
2.3 For the avoidance of doubt, the Mailing List has not been checked against the Mail Preference 
Scheme by the BPS, which the Labels Buyer shall do before sending out any marketing material 
using the Mailing Labels.  
2.4 BPS warrants that it has obtained appropriate consent under the Act from all BPS members 
on the Mailing Labels for the Label Buyer to use them for the Purpose.  
3 LABEL BUYER’S OBLIGATIONS  
3.1 The Label Buyer agrees that it shall only use the Mailing Labels for the Purpose, and on its 
own behalf.  
3.2  The Label Buyer agrees that it shall not:   
 3.2.1  make copies of the Mailing Labels; or  
 3.2.2  extract or abstract any data contained in the Mailing Labels there from; or  
 3.2.3  create a database from the Mailing Labels; or  
3.2.4 use the Mailing Labels or any information contained in them, or derived from them, for any 
reason other than the Purpose as permitted by this Agreement,  
3.2.5 use the Mailing Labels on more than the number of permitted occasions specified in 
Schedule 1;  
3.2.6 use the Mailing Labels within [3 months] pof the Delivery Dates, and if not so used, shall 
destroy them and provide evidence to BPS of such destruction upon request.  
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3.3  The Label Buyer agrees that it shall at all times:  
3.3.1 look after any Personal Data in the Mailing Labels as confidential information and keep in 
place appropriate internal organisational measures within BPS against accidental or unlawful 
destruction or accidental loss, alteration, disclosure to any third party organisation, other 
unauthorised disclosure or access to any Personal Data contained in the Mailing Labels as well 
as reasonable security programmes and procedures for the purpose of ensuring that only 
authorised BPS employees have access to such Personal Data, and that any persons whom it 
authorises to have access to such Personal Data will respect and maintain such confidentiality.  
 3.3.2  comply with the Act; and  
 3.3.3  comply with all Marketing Law.  
3.4 The Label Buyer shall immediately pass on to BPS any query, issue or correction from a BPS 
member, whether during the Term, or thereafter.  
3.5 The Labels Buyer acknowledges that any breach of its obligations under Clauses 3.1, 3.2, 3.3 
and 3.4 would have a very serious impact on the usefulness and marketability of the Mailing 
Labels, and/or on BPS’s relationships with its members, and hence on BPS’ business, and also 
that any such breach may in addition have severe regulatory consequences under the Act or 
Marketing Law, or other legislation for BPS for which damages are unlikely to be a sufficient 
remedy, and that accordingly BPS shall be entitled to immediately seek injunctive or other 
appropriate relief.  
3.6 The Labels Buyer hereby indemnifies BPS in full and shall hold BPS indemnified in full 
against all actions, claims, demands, liabilities, damages, costs, losses or expenses incurred or 
suffered by BPS as result of any breach by the Labels Buyer of its obligations under Clauses 3.1, 
3.2, 3.3 and 3.4.  
4 LIMITATION OF LIABILITY  
4.1 The following provisions set out BPS’ entire liability (including any liability for the acts and 
omissions of its employees, agents or sub-contractors) to the Labels Buyer in respect of:  
4.1.1 any breach of its contractual obligations arising under this Agreement in respect of the 
Mailing Labels; and  
4.1.2  any representation, statement, or tortious act or omission including negligence, arising 
under or in connection with this Agreement in respect of the Mailing Labels  
AND THE CUSTOMER’S ATTENTION IS IN PARTICULAR DRAWN TO THE 
PROVISIONS OF THIS CLAUSE 4:  
4.2 Any act or omission on the part of BPS or its employees agents or sub-contractors falling 
within Clause 4.1 above shall for the purposes of this Clause 4 be known as an ‘Event of Default’.  
4.3  BPS’ liability to the Labels Buyer for:  
4.3.1  death or personal injury resulting from its negligence; and 4.3.2  fraud or fraudulent 
misrepresentation shall not be limited.  
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4.4 Subject to the provisions of Clause 4.3 above BPS’ entire liability in respect of any Event of 
Default shall not exceed the greater of   
4.4.1 such sum as BPS is reasonably able to recover from its insurer under the terms of any 
insurance policy for the time being in force specifically in respect of the specific loss or damage 
suffered by the Labels Buyer in respect of such Event of Default (the Labels Buyer 
acknowledging that several of BPS’ customers are likely to be affected by any Event of Default, 
and for the avoidance of doubt also acknowledging that this condition shall not confer any rights 
on the Labels Buyer in respect of such policies or their enforcement); or  
 4.4.2  the total Fees paid for the Mailing Labels.  
4.5  Subject to Clause 4.3, above BPS shall not be liable to the Labels Buyer in respect of any 
Event of Default for any:  
 4.5.1  loss of profits (whether direct or indirect);  
 4.5.2  loss of business;   
 4.5.3  loss of goodwill;  
 4.5.4  loss of anticipated savings;  
 4.5.5  loss or corruption of data;  
4.5.6         Any type of special, indirect or consequential loss (including loss or damage suffered 
by the Labels Buyer as a result of an action brought by a third party)   
even if such loss was reasonably foreseeable or BPS had been advised in advance of the 
possibility of the Labels Buyer incurring the same.   
4.6 If a number of Events of Default give rise to substantially the same loss then they shall be 
regarded as giving rise to only one claim under this Agreement.  
4.7 The Labels Buyer hereby agrees to give BPS not less than 28 days in which to remedy any 
Event of Default hereunder, and where remedied within such period, such event shall be deemed 
not to have been an Event of Default.  
5 PRECEDENCE OF PROVISIONS  
5.1 In the event of a conflict between the provisions of the main body of this Agreement, and the 
provisions of any other Schedule, the terms of the main body of this Agreement shall prevail, 
followed by the provisions of the other Schedules.  For the avoidance of doubt, where the 
Schedules expand upon or supplement the provisions of the main body of this Agreement, they 
shall not be deemed to be in conflict.  
6 PROPRIETARY RIGHTS  
6.1 The Labels Buyer expressly acknowledges and agrees that BPS own all Intellectual Property 
Rights in or relating to or arising from the Mailing Labels and any related database of which they 
form a part, or which they form, and that it shall gain no rights in them, all of which shall at all 
times remain in the full ownership of BPS;   
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6.2 Except as expressly stated herein, this Agreement does not grant the Labels Buyer any other 
rights to, or in, patents, copyrights, database rights, trade secrets, trade names, trade marks 
(whether registered or unregistered), or any other rights or licences in respect of the Mailing 
Labels or any related documentation, including but not limited to the design, format and layout 
of the Mailing Labels.   
6.3 Nothing in this Agreement shall prevent or restrict BPS from providing the Mailing Labels 
to any third party.  
7 TERM AND TERMINATION  
7.1 This Agreement shall commence on the Commencement Date shall continue automatically 
until after the last of the Mailing Labels has been used or destroyed in accordance with this 
Aggreement or otherwise terminated in accordance with the terms of this Agreement.  
7.2  This Agreement may be terminated immediately by notice in writing:  
7.2.1 by either party if the other party is in material or continuing breach of any of its obligations 
under this Agreement and fails to remedy the same (if capable of remedy) for a period of 30 days 
after written notice of the breach by the other party;  
7.2.2  by either party, if any of the following events occurs in respect of the other party:   
7.2.2.1 if an order is made or a resolution is passed for the winding up of the other party or 
circumstances arise which entitle a Court of competent jurisdiction to make a winding-up order 
of the other party; or an order is made for the appointment of an administrator to manage the 
affairs, business and property of the other party or documents are filed with a  court of competent 
jurisdiction for the appointment of an administrator of the other party or notice of intention to 
appoint an administrator is given by the other party or its directors or by a qualifying floating 
charge holder (as defined in paragraph 14 of Schedule B1 to the Insolvency Act 1986); or   
7.2.2.2 if a receiver is appointed of any of the other party’s assets or undertaking or if 
circumstances arise which entitle a court of competent jurisdiction or a creditor to appoint a 
receiver or manager of the other party or if any other person takes possession of or sells the other 
party’s assets; or  
 7.2.2.3  if the other party makes any arrangement or composition with  
its creditors or makes an application to a court of competent jurisdiction for the protection of its 
creditors in any way; or  
7.2.2.4 if the other party is, or is reasonably considered to be unable to pay its debts when they 
fall due as defined in Section 123 of the Insolvency Act 1986; or  
7.2.2.5 if any distraint is levied against the other party or its property by any third party; or  
7.2.2.6 if such party ceases, or threatens to cease, to carry on business; or  
 7.2.2.7  if such party suffers analogous action in any jurisdiction.  
7.3 Termination of this Agreement howsoever caused shall be without prejudice to any 
obligations or rights of either of the parties hereto accrued prior to such termination and shall not 
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affect any provision of this Agreement which is expressly or by implication intended to come 
into effect on, or to continue in effect after such termination.  
7.4 Upon termination for whatever reason the Labels Buyer shall not make any further use of the 
Mailing Labels without the prior written consent of BPS and shall upon request from BPS 
promptly return to BPS all unused Mailing Labels.  
7.5  Clauses 3.3, 3.5, 3.6 and 4 shall survive termination of this Agreement.  
8 COUNTERPARTS  
8.1  This Agreement may be entered into any number of counterparts and by the parties to it 
on separate counterparts, each of which when so executed and delivered shall be an original but 
all these counterparts shall together constitute one and the same instrument.  
9 WAIVER  
9.1 The waiver by either party of a breach or default of any of the provisions of this Agreement 
by the other party shall not be construed as a waiver of any succeeding breach of the same or 
other provisions nor shall any delay or omission on the part of either party to exercise or avail 
itself of any right power or privilege that it has or may have hereunder operate as a waiver of any 
breach or default by the other party.  
10 NOTICES  
10.1 Any notice request instruction or other document to be given hereunder shall be delivered 
or sent by first class recorded post to the address of the other party set out in this Agreement (or 
such other address as may have been notified) and any such notice or other document shall be 
deemed to have been served (if delivered) on the second business day after posting.  Email and 
fax notices shall not be valid.  
11 SEVERABILITY  
11.1 If any wording in any provision of this Agreement shall be found by any court or 
administrative body of competent jurisdiction to be invalid or unenforceable the invalidity or 
unenforceability of such wording shall not affect the remainder of this Agreement and the 
remainder of such provision and all other provisions not affected by such invalidity or 
unenforceability shall remain in full force and effect.   
  
12 ENTIRE AGREEMENT  
12.1 This Agreement (as defined in condition 1 above) sets out the entire agreement between the 
parties with respect to the subject matter covered by it and supersedes and replaces all prior 
communications, drafts, agreements, representations, warranties, stipulations, undertakings and 
agreements of whatsoever nature, whether oral or written, between the parties relating to the 
subject matter of this Agreement.  
12.2 Each party acknowledges that in entering into this Agreement it is not relying upon any 
representation, warranty, promise or assurance made or given by the other party or any other 
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person, whether or not in writing, at any time prior to the execution of this Agreement which is 
not expressly set out in this Agreement.  
12.3 Nothing in this Clause 12 or elsewhere in this Agreement shall exclude or restrict any 
liability which either party would otherwise have to the other in respect of any statements made 
fraudulently by that party prior to the date of this Agreement.  
13 ASSIGNMENT AND SUBCONTRACTING  
13.1 The Labels Buyer shall not be entitled to assign or hold on trust this Agreement nor all or 
any of its rights and obligations hereunder without the prior written consent of BPS .  
13.2 The Labels Buyer agrees BPS shall be entitled to transfer the benefit and burden of this 
Agreement to any competent third party of good financial standing upon at least 30 days’ prior 
written notice, and agrees to act promptly and in good faith to take all such steps and execute all 
such documents as may reasonably be required by BPS to give effect to such novation or other 
transfer of rights or obligations under this Agreement.    
14 GOVERNING LAW AND JURISDICTION  
This Agreement shall be governed by and construed in accordance with English Law and each 
party hereby submits to the exclusive jurisdiction of the English Courts.    
SCHEDULE 1 – COMMERCIAL TERMS  
  
Fee:      £630.00  
  
Purpose:  To promote a survey on Chronic widespread  
Pain/Fibromyalgia  
  
Delivery Date (s):       Within 24 hours of receipt of signed contract  
  
Number of permitted uses:    One   
  
AS WITNESS the hands of the parties the day and year first above written:  
  
  
SIGNED by                )  
  
for and on behalf of THE BRITISH PAIN       )  
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SOCIETY in the presence of:          )  
  
  
  
  
SIGNED by                )  
  
for and on behalf of [LABELS BUYER]        )  
  
in the presence of:         ) 
   
  
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sedik  
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Recruitment Letter send to the UK Medicine and Health 
professionals sample for the Fibromyalgia questionnaire in 
phase 2  
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Inviation Leter 
 
   Faculty of Health and Life Sciences 
PGR Room 431 
Northumberland building 
City campus 
Northumbria University 
Newcastle upon Tyne NE1 8ST, UK 
Dear:  Sir or Madam  
 
Date:       Juan 2016                                                                                                          
 
My name is Sedik Abokdeer I am qualified BSc physiotherapy Worked with a background in 
Low back pain management, and MSc in health and social care (physical therapy specialist).  At 
present, I am a full-time doctoral student in affiliation with Northumbria University.  For my 
doctorate, I am undertaking research that looks at issues of ‘fibromyalgia’ interventions to people 
exhibiting interventions performances that have historical and/or present involvement with Local 
Authority health Services. 
On the basis of your present position I have identified you as being involved in the provision of 
collaborative health services to this intervention and/or as a helper of investigation that inform 
and/or impact upon the life course of these fibromyalgia syndrome patients. 
I am writing to ask you take part in a survey (Questionnaire) conducted by me.  The purpose of 
this Questionnaire is to better understand your present experience or organisational involvement 
with these interventions, as well as your perceptions of how your involvement(s) impact of 
interventions upon the life course of this population with fibromyalgia syndrome. 
 
I have attached an information sheet and informed consent to this email.  If you are interested 
in participating I would ask that you take the time to review the accompanying Information 
Sheet and return the attached INFORMED CONSENT care of my attention as 
confirmation of your willingness to participate.  If you have any questions please do not 
hesitate to contact me directly. 
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This study has received ethical approval from the Faculty of Health and Life Sciences Ethics 
Committee at Northumbria University. 
 
Sincerely, 
 
Sedik Abokdeer  
PhD student Researcher 
M: 07448378709 
sedik.abokdeer@northumbria.ac.uk  
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APPENDIX 13 
 
 
Medicine and Health professionals consent form to participate in 
the phase 2 study  
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Consent form                          
 
Project Title: Service Users and Service Providers Views and              
Experiences of Chronic Widespread Pain Conditions (Fitzcharles et al.): Practice 
and Participation. 
  
Named Researcher:    MR: Sedik Abokdeer  
                  PhD Researcher 
            M: 07448378709 
            Sedik.abokdder@northumbria.ac.uk  
 
This form is designed to confirm that you have been fully informed about the research being 
undertaken, that you understand what you are being asked to do and that you consent to 
participate in the research. 
Please INITIAL the boxes that correspond to your choices 
YES 
 
NO 
 
10. I wish to participate in the Survey associated with this research. 
 
 
 
11. I have read & understood the attached information sheet giving details of the 
project. 
 
 
 
12. I have had the opportunity to ask any questions about the research, my 
involvement in it, and am satisfied with the answers I have been given. 
  
13. I am aware decision to consent is entirely voluntary and I understand that I am 
free to withdraw at any time without giving a reason. 
  
14. I understand that if I elect to withdraw from participating  in this research my 
decision will not impact upon my standing with the organisation for which you 
work 
  
15. I understand the data gathered in this project will form the basis of a doctoral 
thesis and may inform reports and/or publications and/or presentations. 
  
16. I understand that my name will not be used in the named researcher’s thesis 
and in any other report, publication, and/or presentation resulting from the data 
collected, and that every effort will be made to protect my confidentiality. 
  
17. I know that if I am in any way unhappy with the conduct of the research, I may 
approach Professor Jennifer Watling; Associate Dean for Research and 
Innovation; Northumbria University; Coach Lane Campus, Benton; Newcastle 
upon Tyne; NE7 7XA;  
Tel:- 0191 215 7771     email : - Janice.armstrong@northumbria.ac.uk      
  
 
Please SIGN the following, PRINT your name, and DATE 
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Participant’s Signature:   --------------------------------------------------Date: -----/------/------- 
 
Participants Name (in CAPITAL: ----------------------------------------------------------------------- 
The named researcher signs/dates in the space provided to confirm that the participant 
understands the purpose of the research, their role, and that they have the right to withdraw at 
any time. 
 
Researcher’s Signature:  ------------------------------------------ Date: -------/------------/-----
---- 
Attachment (Survey) 
 
CONTACT DETAILS FOR SUMMARY OF RESULTS 
I would prefer to receive the results by (please tick one): 
 
Post       
 
Email     
 
Postal address: 
……………………………………………………………………………………………………
…………………… 
……………………………………………………………………………………………………
……………………………………………………… 
……………………………………………………………………………………………………
……………………………………………………………………………………………………
……………………………………………………………………………………………………
……………………………………………………………………………………………………
………………………………………………………………… 
 
Email: 
……………………………………………………………………………………………………
…………………………………………     
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Participations information sheet, Survey, Fibromyalgia 
Questionnaire for phase 2 
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SURVEY INFORMATION SHEET                        
Project Title: Service Users and Service Providers Views and    Experiences of Chronic 
Widespread Pain Conditions   (Fitzcharles et al.): Practice and Participation. 
  
 
What is this research about? 
To describe the current practice surrounding chronic widespread pain/fibromyalgia in the UK 
and to compare interventions and services in different regions in the UK; this follows from 
previously published work by the research team.  
Why have I been asked? 
You are being asked to take part because you are working NHS specialist in rheumatology or 
pain management and physical therapy clinics. Or you are a professional with direct contact 
and/or decision-making responsibility for fibromyalgia patients who have a history of and/or 
current involvement with Local Authority NHS services. 
What am I being asked to do? 
You are being invited to participate in a survey (questionnaire) which will take no more than 10-
15 minutes to complete.  You will be asked to share your professional experiences of working 
with fibromyalgia patients and interventions that you provide.  
What happens if I do not want to participate? 
Your participation though valued is entirely voluntary; you are in no way required to take part in 
this research.  
What would happen if I agree to participate and then change my mind? 
You are under no obligation to take part. If you do decide to take part, you are free to withdraw 
at any time without giving a reason. The data collected from the survey will still be used in the 
research with all personally identifiable information removed. It will not be possible to withdraw 
the data at this stage. If you have already agreed to participate, but then change your mind, please 
contact the named researcher to decline your interest. 
 
Will my participation in the research be kept confidential? 
Yes. Your involvement with this research will be kept confidential. Only the research team will 
know about your participation in the research. Your name and the specific details of your role 
within the organisation you represent will be kept confidential and will not appear in any 
documents associated with this research. 
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What will happen to the information that is gathered in the survey? 
All the information collected will be kept confidential. After the survey, the researcher will keep 
up the information with your name and any other identifiable information securely locked at 
Northumbria University and/or electronically encrypted. Only the research team will have access 
to this information. Information from the professionals that took part in the survey will then be 
used to complete the final report; information are used in the final report will be anonymised. 
Names and details of participants will not appear in any document. 
Case report forms (CRFs) - i.e completed questionnaire data will be stored securely at the 
Northumbria University and destroyed one year after the end of the research. The data can be 
withdrawn if the request is made before a specified deadline. 
 
What will happen to the information collected for the research and how will the research 
report be disseminated? 
All the information collected will be analysed at to identify participants’ common thoughts and 
views on the subject. These will then be used to produce a final report. The final report will be 
presented to Northumbria University and will form part of the named researcher’s Ph.D. 
degree. A summary of the research findings will be sent to all the participants and the full 
report can be requested by participants after has been produced. 
 
Who will read and/or have access to the published results? 
This research will be used in the named researcher’s doctoral thesis.  Additionally, it is the named 
researcher’s intention to make the conclusions of this research available to the Local Authority 
and other organisations to inform health care practice. 
Who can I contact if I want to know anything else about this study? 
You are welcome to contact the named researcher and/or the named researcher’s Project 
Supervisor if you require further information related to this study.  Contact information for both 
parties is as follows: 
PROJECT SUPERVISOR   NAMED RESEARCHER 
Professor Nicola Adams    MR Sedik Abokdeer 
Faculty of Health and Life Sciences  Faculty of Health and Life Sciences 
B131      PGR Room 431 
Coach Lane Campus West                                Northumberland building       
Northumbria University                                               Northumbria University  
Coach Lane     City Campus  
Benton      Newcastle upon Tyne  
Newcastle upon Tyne                                                          NE1 8ST, UK 
NE7 7XA                      07448378709  
0191 215 6620      
nicola.adams@northumbria.ac.uk   sedik.abokdeer@northumbria.ac.uk  
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2. Who can I contact if I am unhappy with the conduct of the research? 
If you are in any way unhappy with the conduct of the research, you may approach:  
 
ASSOCIATE DEAN FOR RESEARCH AND INNOVATION 
Professor Jennifer Watling  
Northumbria University 
Coach Lane Campus, Benton 
Newcastle upon Tyne 
NE7 7XA 
Tel: 0191 215 7771 
Janice.armstong@northumbria.ac.uk 
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Fibromyalgia Questionnaire, for phase 2   
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CHRONIC WIDESPREAD PAIN / FIBROMYALGIA  
QUESTIONNAIRE 
 
 
 
 
 
 
 
 
 
ALL RESPONSES ARE STRICTLY CONFIDENTIAL, AND YOU WILL 
NOT   BE IDENTIFIED 
 
 
 
THANK YOU FOR YOUR PARTICIPATION 
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MANAGEMENT OF CHRONIC WIDESPREAD PAIN /FIBROMYALGIA 
QUESTIONNAIRE 
 
 
The questionnaire is concerned with patients/clients who fit the following description:- 
 
Chronic Widespread Pain/Fibromyalgia is a debilitating 
chronic disorder 
Characterised by: 
 The presence of continual and widespread 
musculoskeletal Pain for three months or longer. 
 Symptoms which include fatigue sleep disturbance, 
tender points, anxiety and depression, cognitive deficits 
in attention, concentration and memory, and other 
symptoms such as irritable bowel syndrome, morning 
stiffness, headaches, or cramps. 
 
 
 
Please now answer each of the following questions 
 
Region 
 North East  1  
 North West  2  
 South East  3  
 South West  4  
 Midlands  5  
 London  6  
 Wales   7  
 Scotland   8  
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 Northern 
Ireland  
 9  
 Non UK  10  
 
Personal Details:-  
   1.    What is your profession 
    profession Rheumatologist  1  
 Pain management  specialist      2  
 Physiotherapist  3  
 Occupational therapist  4  
 Psychologist  5  
 Others   6  
 Please specify ……………………………………………………………………… 
                                                                                                                                                         
 
2.    What speciality do you mainly work in?  
 
 In- patients                                                             1  
 Out patients                                                                 2  
 Community                                                                 3  
 Private practice                                                          4  
 other please state   5  
 ……………………………………………………..                                          
Patients/ clients with Fibromyalgia 
 
3.  In the last 12 months have you seen patients that fit the description 
provided at the beginning of this questionnaire? 
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      Yes, I have seen patients/clients who closely fit this   
description 
 1 
      Yes, I have seen patients/clients who more or less fit this 
description 
 2 
      NO, I have not seen patients/clients who fit this description  3 
 
If no please return the questionnaire in the reply –paid envelope. Thank you 
very much for your help. 
 
4.  How many new patients/clients fit this description did you see in the last 12    
months (tick one)? 
1-4    patients, per month.                                                    1
5-9   patients, per month.                                                    2
10-15   patients, per month.                                                3
 
5.   What proportion of these patients come to you with a diagnosis of 
fibromyalgia? 
 All of them  1  
 More than half of them  2  
 About half of them  3  
 Less than half of them  4  
 Almost none of them  5  
 None of them  6  
 
Comments……………………………………………………………………………………
……….…………………………………………………………………………………………
………… 
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6.  What is the frequency with which patients fitting the definition of 
fibromyalgia (given the criteria provided above) are referred from each of the 
following sources? (tick one) 
 
 Often Sometimes Seldom Never  
General practitioner                      A 
Orthopaedic surgeon         B 
Neurologist               C 
Psychologist              D 
Anaesthetist                               E 
Rehabilitation therapist                                F 
Self-referral by patient             G 
Other (please state) 
………………………………………………………………………………. 
 
7.  Which of the following best describes the Patients /clients.  
 
Patients come to me without any previous management  1 
Patients to me at an early stage of their assessment  2 
Patients come to me after other  forms of treatment  3 
Patients come to me after all or nearly all, other forms   of   
treatment have been attempted 
 4 
None of these        5 
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Diagnosis  
   
  8.   Are there patients/clients whom you consider to have fibromyalgia only? 
 
 No  1 
 Yes  2 
If no, what other Co-morbid conditions do, they have? 
………………………………………………………………………………………………… 
 
9.  Are there patients /clients whom you consider to have fibromyalgia who 
come to you under other diagnostic labels? 
 
 No  1 
 Yes  2 
If yes give details 
………………………………………………………………………………………………… 
 
 
10.  To what extent do patients /clients generally show an increase in pain with 
an increase in  level of physical activity? 
 
 No Pain                          1 
 Mild        2 
 Moderate             3 
 Severe                       4 
 Most severe        5 
 Extreme pain  6 
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11.  Do any patients /clients use assisted equipment? (e.g. walking aid)? 
 
 Yes   1 
 No                           2 
 Sometimes   3 
 
12.  What aspect /activity of patients /clients’ daily living are most affected due 
to chronic widespread pain/fibromyalgia?  (Tick as many as apply) 
 
 Walking         A 
 Running            B 
 Shopping                C 
 Swimming                         D 
 None of these      E 
13. Please indicate how often the fibromyalgia patients you see present with 
each of the following clinical features 
 
 Always/Nearly  
Always 
Often Sometimes Seldom 
Never/Almost 
Never  
Pain –generalized             A 
Pain- localized                  B 
Tenderness on palpation                   C 
Excessive fatigue                       D 
Loss of muscle power           
and/or endurance      
     E 
Loss of joint range                     F 
Feeling of stiffness                        G 
Loss of function                             H 
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Psychological problem             
(e.g. depression, anxiety)      
     I 
Peripheral circulatory   
disorder                          
     J 
Other       K 
 
 
14.  Of the clinical symptoms identified above, which feature do you usually 
find is the most important to the patient? Please explain why: - 
 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
 
15.  Please list below the three treatments /management objectives that you 
most commonly identify following assessment of fibromyalgia patients. Please 
list in descending order of priority (e.g. highest priority objective as 
number1.). 
 
1 
………………………………………………………………………………………………… 
2 
………………………………………………………………………………………………… 
3 
………………………………………………………………………………………………… 
 
16.  By what means do you measure the intensity of fibromyalgia patients pain 
(please tick all that apply)? 
 
 Numerical rating scale(e.g. 1-
10)             
 1 
 Verbal rating scales (e.g. 
severe, moderate )           
 2 
Appendix  
307 
 
Visual analogue scale                                     3
Dolorimeter                  4 
McGill Pain Questionnaire 
(long or short form 
 5 
Other (please state below  6 
………………………………………………………………………………………………… 
 
Do not routinely measure pain intensity 
If you routinely measure dimensions of pain other than its 
intensity, please provide details:  
 7 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
 
17. Do you use any other standardised assessment scales or measures with 
chronic widespread pain/fibromyalgia patients? 
 
 No  1 
 Yes (please state 
which below) 
 2 
……………………………………………………………………………………………… 
 
 
 
Any other comments on the assessment of fibromyalgia patients:- 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
  
Medications 
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18. Which of the following medication have you prescribed to patients with 
fibromyalgia? 
 
Tramadol  
 A  
 Muscle relaxants  B  
 
Antidepressants:-  
   
 
Amitriptyline  
 C  
 
Fluoxetine  
 D  
 
Duloxetine  
 E  
 
Milnacipran 
 F  
 
Pregabalin or pramipexole  
 G  
 
 
   
 
Other 
 H  
Please state  
……………………………………………………………………………………. 
                      
……………………………………………………………………………………. 
 
19. Have these patients/clients, whom you consider to have fibromyalgia, come 
to you without medications specifically for their symptoms? 
 
 Yes   1  
 No                           2  
 Sometimes   3  
 
20. Please indicate how often you make use of each of the following interventions 
for these patients. If you do not have access to interventions (e.g. necessary 
equipment not available, not trained in its use), please tick ‘Not applicable.' 
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 Alway
s/Near
ly  
Alway
s 
Often Sometimes Seldom 
Never/Almost 
Never 
Not 
applicable 
Stretching exercise             
  
      A 
Aerobic exercise       
 
      B 
Graded exercise programme 
 
      C 
Group exercise programme 
 
      D 
Hydrotherapy        
      E 
 
Postural education             F 
Functional activity   
re- education  
      
 
G 
Cognitive behavioural Therapy   
(CBT) 
 
      
 
 
H 
Relaxation 
      I 
 
Acupuncture  
 
      J 
Ergonomic evaluation    
     
      K 
Tens   
 
      L 
Ultrasound       
 
      M 
Manual therapy        N 
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Massage 
 
      O 
Energy conservation/ fatigue 
management 
 
      p 
Other (please state) 
 
……………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………… 
 
21. Do you have specific treatment /management programme for fibromyalgia 
patients?  (tick one) 
 No  1 
 Yes, for chronic pain patients in general  2 
 Yes, specifically for fibromyalgia 
patients 
 3 
 If you have answered yes, please give 
brief details of the programme. 
  
……………………………………………………………………………………………………… 
……………………………………………………………………………………………………… 
……………………………………………………………………………………………………… 
 
22. Generally speaking, how responsive do you find fibromyalgia patients are to 
interventional approaches ? 
 
Extremely   
responsive 
Very  
responsive 
Moderately  
responsive 
Quite 
unresponsive 
Extremely     
unresponsive 
     
1 2 3 4 5 
Appendix  
311 
 
Please comment on any factors relating to the patients’ condition that tends, in 
your experience, to be associated with a good therapeutic outcome: 
 
……………………………………………………………………………………………………… 
……………………………………………………………………………………………………… 
 
23.  What do you hope to achieve from a fibromyalgia Rehabilitation 
Programme? 
 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
 
24. Please indicate your agreement or disagreement with each of the following 
statements, about fibromyalgia patients: 
 
Strongly                                                                  
Agree 
Agree Neither Disagree 
Strongly                                                                  
Disagree 
 
Patients have considerable 
psychological overlay  
     
Treatment must not 
aggravate  the patient’s pain 
     
Restoring function is more  
important than treating pain  
     
The diagnosis is made once 
all  other diagnoses have 
been  tried and rejected  
     
These patients are generally  
well informed on their 
condition 
     
Patients  are able to self-
manage their condition   
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25. Please add any final comments, on any aspect of the treatment/management of 
patients with fibromyalgia: 
 
………………………………………………………………………………………………… 
 
………………………………………………………………………………………………… 
 
Thank you very much for sparing your time to complete this questionnaire 
Please return it in the reply-paid envelope to:- 
SEDIK ABOKDEER 
Doctoral student  
Department of Sport, Exercise and Rehabilitation 
Faculty of Health and Life Sciences 
Northumberland Building Room 431, 
Northumbria University, Newcastle Upon Tyne NE1 8ST, UK 
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FIQ Results  
 
 
 
 
 
 
 
 
 
 
 
 
Appendix  
314 
 
Fibromyalgie impact questionnaire results 
Pt1 Scale Item Recode Score Range Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 7x1.43=10.01 
Work missed 3 No 0 - 7 5x1.43=7.15 
Do work 4 No 0 - 10  8 
Pain 5 No 0 - 10  7 
Fatigue 6 No 0 - 10  9 
Rested 7 No 0 - 10  9 
Stiffness 8 No 0 - 10  9 
Anxiety 9 No 0 - 10  2 
Depression 10 No 0 - 10  3 
Total score 70.82 
 
Pt2 Scale Item Recode Score 
Range 
Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 6x1.43=8.58 
Work missed 3 No 0 - 7 7x1.43=10.01 
Do work 4 No 0 - 10  10 
Pain 5 No 0 - 10  10 
Fatigue 6 No 0 - 10  7 
Rested 7 No 0 - 10  8 
Stiffness 8 No 0 - 10  7 
Anxiety 9 No 0 - 10  7 
Depression 10 No 0 - 10  10 
Total score 84.25 
 
Pt3 Scale Item Recode Score 
Range 
Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 3x1.43=4.29 
Work missed 3 No 0 - 7 1x1.43=1.43 
Do work 4 No 0 - 10  7 
Pain 5 No 0 - 10  6 
Fatigue 6 No 0 - 10  10 
Rested 7 No 0 - 10  8 
Stiffness 8 No 0 - 10  6 
Anxiety 9 No 0 - 10  3 
Depression 10 No 0 - 10  6 
Total score 58.38 
 
 
 
Appendix  
315 
 
 
 
Pt4 Scale Item Recode Score Range Normalization 
 Physical 
impairment 
1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 7x1.43=10.01 
Work missed 3 No 0 - 7 7x1.43=10.01 
Do work 4 No 0 - 10  9 
Pain 5 No 0 - 10  9 
Fatigue 6 No 0 - 10  10 
Rested 7 No 0 - 10  10 
Stiffness 8 No 0 - 10  10 
Anxiety 9 No 0 - 10  6 
Depression 10 No 0 - 10  8 
Total score 88.68 
 
 
Pt5 Scale Item Recode Score 
Range 
Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 5x1.43= 7.15 
Work missed 3 No 0 - 7 4x1.43=5.72 
Do work 4 No 0 - 10  7 
Pain 5 No 0 - 10  8.5 
Fatigue 6 No 0 - 10  10 
Rested 7 No 0 - 10  9.5 
Stiffness 8 No 0 - 10  8 
Anxiety 9 No 0 - 10  8 
Depression 10 No 0 - 10  10 
Total score 80.53 
 
 
Pt6 Scale Item Recode Score Range Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 2x1.43=2.86 
Work missed 3 No 0 - 7 6x1.43= 8.58 
Do work 4 No 0 - 10  10 
Pain 5 No 0 - 10  10 
Fatigue 6 No 0 - 10  9.5 
Rested 7 No 0 - 10  10 
Stiffness 8 No 0 - 10  10 
Anxiety 9 No 0 - 10  10 
Depression 10 No 0 - 10  8.5 
Total score 86.1 
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Pt7 Scale Item Recode Score Range Normalization 
 Physical 
impairment 
1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 7x1.43=10.01 
Work missed 3 No 0 - 7 0x1.43=0 
Do work 4 No 0 - 10  10 
Pain 5 No 0 - 10  10 
Fatigue 6 No 0 - 10  10 
Rested 7 No 0 - 10  10 
Stiffness 8 No 0 - 10  6 
Anxiety 9 No 0 - 10  8 
Depression 10 No 0 - 10  10  
Total score 80.67 
 
Pt8 Scale Item Recode Score Range Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 2x1.43=2.86 
Work missed 3 No 0 - 7 5x1.43=7.15 
Do work 4 No 0 - 10  8 
Pain 5 No 0 - 10  7 
Fatigue 6 No 0 - 10  6 
Rested 7 No 0 - 10  2 
Stiffness 8 No 0 - 10  8 
Anxiety 9 No 0 - 10  5 
Depression 10 No 0 - 10  4 
Total score 56.67 
 
 
Pt9 Scale Item Recode Score 
Range 
Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 7x1.43=10.01 
Work missed 3 No 0 - 7 0x1.43=0 
Do work 4 No 0 - 10  10 
Pain 5 No 0 - 10  10 
Fatigue 6 No 0 - 10  10 
Rested 7 No 0 - 10  10 
Stiffness 8 No 0 - 10  10 
Anxiety 9 No 0 - 10  5 
Depression 10 No 0 - 10  4 
Total score 75.67 
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Pt10 Scale Item Recode Score 
Range 
Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 5x1.43=7.15 
Work missed 3 No 0 - 7 3x1.43=4.29 
Do work 4 No 0 - 10  9 
Pain 5 No 0 - 10  8 
Fatigue 6 No 0 - 10  8 
Rested 7 No 0 - 10  10 
Stiffness 8 No 0 - 10  8 
Anxiety 9 No 0 - 10  4 
Depression 10 No 0 - 10  4  
Total score 69.1 
 
Pt11 Scale Item Recode Score 
Range 
Normalization 
 Physical impairment 1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 5x1.43=7.15 
Work missed 3 No 0 - 7 4x1.43=5.72 
Do work 4 No 0 - 10  10 
Pain 5 No 0 - 10  10 
Fatigue 6 No 0 - 10  10 
Rested 7 No 0 - 10  10 
Stiffness 8 No 0 - 10  10 
Anxiety 9 No 0 - 10  10 
Depression 10 No 0 - 10  6  
Total score 85.53 
 
Pt12 Scale Item Recode Score Range Normalization 
 Physical 
impairment 
1 No 0 - 3 2x3.33=6.66 
Feel good 2 Yes 0 - 7 5x1.43=7.15 
Work missed 3 No 0 - 7 3x1.43=4.29 
Do work 4 No 0 - 10  6 
Pain 5 No 0 - 10  6 
Fatigue 6 No 0 - 10  7.5 
Rested 7 No 0 - 10  6.5 
Stiffness 8 No 0 - 10  6 
Anxiety 9 No 0 - 10  8.5 
Depression 10 No 0 - 10  8.5 
Total score 67.1 
 
